(()=>{var{useState:b,useEffect:x,useRef:sa}=React,{Calculator:qr,Clock:Yr,Brain:Jr,AlertTriangle:Xr,FileText:Qr,CheckCircle:Zr,Moon:en,Sun:tn,Download:an,Copy:sn,Search:on,Check:rn,Info:nn}=lucide,ln=window.strokeAppStorage&&window.strokeAppStorage.appVersion||"unknown",$e=window.strokeAppStorage&&window.strokeAppStorage.prefix||"strokeApp:",Qa=window.strokeAppStorage&&window.strokeAppStorage.appDataKey||"stroke.appData.v2",ra=window.strokeAppStorage&&window.strokeAppStorage.legacyKeys||["app_version","darkMode","activeTab","patientData","nihssScore","aspectsScore","gcsItems","mrsScore","ichScoreItems","abcd2Items","chads2vascItems","ropeItems","huntHessGrade","wfnsGrade","hasbledItems","rcvs2Items","strokeCodeForm","lkwTime","currentStep","completedSteps","aspectsRegionState","pcAspectsRegions","telestrokeNote","telestrokeTemplate","thrombolysisAlertsMuted","timerSidebarCollapsed","shiftPatients","currentPatientId","consultationType","ttlHoursOverride","lastUpdated","legacyMigrated"],ko=window.strokeAppStorage&&window.strokeAppStorage.legacySessionKeys||["error_reload_attempted"],wt=12,Za="lastUpdated",Yi="legacyMigrated",qa=1,Qi=[{id:"stroke-phone",label:"Stroke Phone",phone:"206-744-6789",note:""},{id:"stat-pharmacy",label:"STAT Pharmacy",phone:"206-744-2241",note:""},{id:"rad-hotline",label:"Stroke RAD Hotline",phone:"206-744-8484",note:"Weekdays 8-5"},{id:"angio-suite",label:"Angio Suite",phone:"206-744-3381",note:""},{id:"stat-ct",label:"STAT CT",phone:"206-744-7290",note:""}],Ya=p=>{if(p==null)return null;try{return JSON.parse(p)}catch(u){return p}},Ja=(p,u)=>p==null||p==="undefined"||p==="null"?u:typeof p=="object"&&p!==null&&"data"in p&&"expiresAt"in p?typeof p.expiresAt=="number"&&Date.now()>p.expiresAt?u:p.data:p,ue=(p,u)=>{let y=localStorage.getItem($e+p);if(y!==null)return Ja(Ya(y),u);let E=localStorage.getItem(p);return E!==null?Ja(Ya(E),u):u},Zi=()=>{try{localStorage.setItem($e+Za,JSON.stringify(Date.now()))}catch(p){console.warn("Failed to update lastUpdated:",p)}},Be=(p,u,y={})=>{try{localStorage.setItem($e+p,JSON.stringify(u)),!y.skipLastUpdated&&p!==Za&&Zi()}catch(E){console.warn("Failed to save key:",p,E)}},oa=p=>{localStorage.removeItem($e+p),localStorage.removeItem(p)},es=()=>{if(window.strokeAppStorage&&typeof window.strokeAppStorage.clearAppStorage=="function"){window.strokeAppStorage.clearAppStorage({includeLegacy:!0});return}try{Object.keys(localStorage).forEach(p=>{p.startsWith($e)&&localStorage.removeItem(p)}),localStorage.removeItem(Qa),ra.forEach(p=>localStorage.removeItem(p)),Object.keys(sessionStorage).forEach(p=>{p.startsWith($e)&&sessionStorage.removeItem(p)}),ko.forEach(p=>sessionStorage.removeItem(p))}catch(p){console.warn("Storage clear failed:",p)}},Co=()=>{try{if(localStorage.getItem($e+Yi))return;ra.forEach(u=>{let y=localStorage.getItem(u);if(y===null)return;let E=Ya(y),ie=Ja(E,void 0);ie!==void 0&&localStorage.setItem($e+u,JSON.stringify(ie))}),localStorage.setItem($e+Yi,JSON.stringify(!0))}catch(p){console.warn("Legacy storage migration failed:",p)}},Ji=(p,u=[])=>Array.isArray(p)?p:u,Ze=(p=new Date)=>{try{return new Date(p).toISOString()}catch(u){return new Date().toISOString()}};var St=(p="id")=>{let u=Date.now().toString(36),y=Math.random().toString(36).slice(2,8);return`${p}_${u}_${y}`},So=async p=>{try{return await navigator.clipboard.writeText(p),!0}catch(u){return console.warn("Clipboard copy failed:",u),!1}},wo=async p=>{let u=p.filter(y=>y&&y.body&&y.body.trim()).map(y=>`=== ${y.title} ===
${y.body}`).join(`

`);return u.trim()?So(u.trim()):!1};var Ao=p=>new Promise((u,y)=>{if(!p){y(new Error("No file provided"));return}let E=new FileReader;E.onload=()=>{try{let ie=JSON.parse(E.result);if(!ie||typeof ie!="object"){y(new Error("Invalid JSON structure"));return}u(ie)}catch(ie){y(ie)}},E.onerror=()=>y(E.error||new Error("File read failed")),E.readAsText(p)}),To=[{id:"mrn",label:"Possible MRN (long numeric ID)",regex:/\b\d{7,}\b/},{id:"dob",label:"Possible DOB/date",regex:/\b\d{1,2}[\/\-]\d{1,2}[\/\-]\d{2,4}\b/},{id:"phone",label:"Possible phone number",regex:/\b(?:\+?1[-.\s]?)?\(?\d{3}\)?[-.\s]?\d{3}[-.\s]?\d{4}\b/},{id:"email",label:"Possible email address",regex:/\b[A-Z0-9._%+-]+@[A-Z0-9.-]+\.[A-Z]{2,}\b/i}],Io=p=>!p||typeof p!="string"?[]:To.filter(u=>u.regex.test(p)).map(u=>u.label),ei=()=>[{id:"telestroke-consult",title:"Telestroke Consult Pack",description:"Summary for consult documentation.",sections:[{id:"summary",title:"Summary",enabled:!0,template:`Alias: {PATIENT_ALIAS}
Age/Sex: {AGE}{SEX}
NIHSS: {NIHSS}
Dx: {DIAGNOSIS}
LVO: {LVO}
Weight: {WEIGHT_KG} kg`},{id:"times",title:"Key Times",enabled:!0,template:`LKW: {LKW}
Arrival: {ARRIVAL}
CT: {CT_TIME}
CTA: {CTA_TIME}`},{id:"imaging",title:"Imaging",enabled:!0,template:`CT: {CT_RESULTS}
CTA: {CTA_RESULTS}
ASPECTS: {ASPECTS}`},{id:"plan",title:"Plan",enabled:!0,template:`TNK: {TNK_STATUS}
EVT: {EVT_STATUS}
Disposition: {DISPOSITION}`}]},{id:"transfer-pack",title:"Transfer Pack",description:"Transfer-ready summary for receiving centers.",sections:[{id:"summary",title:"Summary",enabled:!0,template:`Alias: {PATIENT_ALIAS}
Age/Sex: {AGE}{SEX}
NIHSS: {NIHSS}
Dx: {DIAGNOSIS}
LVO: {LVO}`},{id:"imaging",title:"Imaging",enabled:!0,template:`CT: {CT_RESULTS}
CTA: {CTA_RESULTS}
ASPECTS: {ASPECTS}
Perfusion: {CTP_RESULTS}`},{id:"treatment",title:"Treatment",enabled:!0,template:`TNK: {TNK_STATUS}
EVT: {EVT_STATUS}
Transfer status: {TRANSFER_STATUS}`}]},{id:"signout-pack",title:"Signout Pack",description:"End-of-shift signout snapshot.",sections:[{id:"summary",title:"Summary",enabled:!0,template:`Alias: {PATIENT_ALIAS}
Age/Sex: {AGE}{SEX}
NIHSS: {NIHSS}
Dx: {DIAGNOSIS}
Disposition: {DISPOSITION}`},{id:"pending",title:"Pending / Follow-up",enabled:!0,template:"{PENDING_ITEMS}"}]},{id:"ich-pack",title:"ICH Pack",description:"ICH-specific bundle.",sections:[{id:"summary",title:"Summary",enabled:!0,template:`Alias: {PATIENT_ALIAS}
Age/Sex: {AGE}{SEX}
ICH Score: {ICH_SCORE}
GCS: {GCS}
BP: {BP}`},{id:"imaging",title:"Imaging",enabled:!0,template:`CT: {CT_RESULTS}
Hematoma: {HEMATOMA}
IVH: {IVH}`},{id:"plan",title:"Plan",enabled:!0,template:`Reversal: {REVERSAL}
Disposition: {DISPOSITION}`}]}],Xa=()=>({deidMode:!0,allowFreeTextStorage:!1,ttlHoursOverride:null,defaultConsultationType:"videoTelestroke",contacts:Qi}),Ft=()=>({schemaVersion:qa,settings:Xa(),shiftBoards:[],uiState:{lastActiveTab:"encounter",lastShiftBoardId:null,lastManagementSubTab:"ich",legacyMigratedAt:null,searchHighlightId:null},encounter:{clipboardPacks:ei(),clipboardPackVisibility:{}}}),na=(p,u)=>{let y={...p,...u,settings:{...p.settings,...u&&u.settings?u.settings:{}},uiState:{...p.uiState,...u&&u.uiState?u.uiState:{}},encounter:{...p.encounter,...u&&u.encounter?u.encounter:{}}};return delete y.pinnedReferences,y.shiftBoards=Ji(y.shiftBoards,[]),y.encounter.clipboardPacks=Ji(y.encounter.clipboardPacks,ei()),y},ts=p=>{let u={...p};return(Number.isFinite(u.schemaVersion)?u.schemaVersion:0)<qa&&(u.schemaVersion=qa),u},Ga=p=>{if(p.uiState&&p.uiState.legacyMigratedAt)return p;let u=na(Ft(),p),y=ue("activeTab",null);y&&(u.uiState.lastActiveTab=y);let E=ue("ttlHoursOverride",null);return Number.isFinite(Number(E))&&Number(E)>0&&(u.settings.ttlHoursOverride=Number(E)),u.uiState.legacyMigratedAt=Ze(),u},Ro=()=>{let p=Ft(),u=localStorage.getItem(Qa);if(!u)return Ga(p);try{let y=JSON.parse(u),E=na(p,y);return Ga(ts(E))}catch(y){return console.warn("Failed to parse app data:",y),Ga(p)}},Po=p=>{try{localStorage.setItem(Qa,JSON.stringify(p)),Zi()}catch(u){console.warn("Failed to save app data:",u)}};var Eo=p=>{if(typeof p=="number"&&Number.isFinite(p))return p;if(typeof p=="string"){let u=Number(p);if(Number.isFinite(u))return u;let y=Date.parse(p);if(!Number.isNaN(y))return y}return null},as=p=>{let u=ue(Za,null),y=Eo(u);if(!y||!Number.isFinite(p)||p<=0)return!1;let E=p*60*60*1e3;return Date.now()-y>E?(es(),!0):!1};Co();var is=Ro(),Xi,ja=(Xi=is.settings.ttlHoursOverride)!=null?Xi:ue("ttlHoursOverride",null),Do=Number.isFinite(ja)&&ja>0?ja:wt,Oo=as(Do),Lo=["ich","ischemic","calculators","references"],et={ich:"ich",protocols:"ischemic",calculators:"calculators",evidence:"references"},mt=p=>{if(!p)return null;let u=String(p).toLowerCase();return Lo.includes(u)?u:et[u]?et[u]:null},za=["encounter","management","trials"],Mo=p=>{if(!p)return{tab:"encounter"};let u=p.replace(/^#\/?/,"").trim();if(!u)return{tab:"encounter"};let y=u.split("/").filter(Boolean),E=y[0],ie=y[1];switch(E){case"home":return{tab:"encounter"};case"encounter":return{tab:"encounter"};case"management":return{tab:"management",sub:mt(ie)};case"ich":case"protocols":case"calculators":case"evidence":return{tab:"management",sub:et[E]};case"trials":return{tab:"trials"};default:return null}},Ho=(p,u)=>{switch(p){case"encounter":return"#/encounter";case"management":{let y=mt(u);return y?`#/management/${y}`:"#/management"}case"ich":return"#/management/ich";case"protocols":return"#/management/ischemic";case"calculators":return"#/management/calculators";case"trials":return"#/trials";case"evidence":return"#/management/references";default:return"#/encounter"}},Vo=()=>{var _i,Wi;let p=`Chief complaint: {chiefComplaint}
Last known well (date/time): {lkwDate} {lkwTime}
HPI: {age} year old {sex} p/w {symptoms} at {lkwTime}
Relevant PMH: {pmh}
Medications: {medications}

Objective:
Vitals:
Presenting BP {presentingBP}
Blood pressure: BP prior to TNK administration: {bpPreTNK} at {bpPreTNKTime}
Labs: Glucose {glucose}
Exam: Scores: NIHSS {nihss} - {nihssDetails}

Imaging: I personally reviewed imaging
Date/time Non-contrast Head CT reviewed: {ctTime}; Non-contrast Head CT Results: {ctResults}
Date/time CTA reviewed: {ctaDate} {ctaTime}; CTA Results: {ctaResults}
Telemetry/EKG: {ekgResults}

Assessment and Plan:
Suspected Diagnosis: {diagnosis}
After ensuring that there were no evident contraindications, TNK administration was recommended at {tnkAdminTime}. Potential benefits, potential risks (including a potential risk of sx ICH of up to 4%), and alternatives to treatment were discussed with the patient, patient's wife, and OSH provider. Both the patient and his wife expressed agreement with the recommendation.
TNK was administered at {tnkAdminTime} after a brief time-out.

Recommendations:
{recommendationsText}

Clinician Name`,u=()=>({age:"",sex:"",hx:"",sx:"",lkw:"",lkw_date:new Date().toISOString().split("T")[0],nihss:"",aspects:"",def:"",hct:"",cta:"",ctp:"",tnk:[],tnk_rec:"",evt_rec:"",rec_reason:""}),y=()=>[{id:"M1",name:"M1 - Anterior MCA cortex",checked:!0},{id:"M2",name:"M2 - MCA cortex lateral to insular ribbon",checked:!0},{id:"M3",name:"M3 - Posterior MCA cortex",checked:!0},{id:"M4",name:"M4 - Anterior MCA territory immediately superior to M1",checked:!0},{id:"M5",name:"M5 - Lateral MCA territory immediately superior to M2",checked:!0},{id:"M6",name:"M6 - Posterior MCA territory immediately superior to M3",checked:!0},{id:"IC",name:"IC - Internal capsule",checked:!0},{id:"L",name:"L - Lentiform nucleus",checked:!0},{id:"C",name:"C - Caudate",checked:!0},{id:"I",name:"I - Insular ribbon",checked:!0}],E=()=>[{id:"THAL",name:"Thalami (bilateral)",checked:!0,points:1},{id:"MIDBRAIN",name:"Midbrain",checked:!0,points:2},{id:"PONS",name:"Pons",checked:!0,points:2},{id:"MEDULLA",name:"Medulla",checked:!0,points:1},{id:"CEREBELLUM-L",name:"Left Cerebellar Hemisphere",checked:!0,points:1},{id:"CEREBELLUM-R",name:"Right Cerebellar Hemisphere",checked:!0,points:1},{id:"PCA-L",name:"Left Occipital Lobe (PCA Territory)",checked:!0,points:1},{id:"PCA-R",name:"Right Occipital Lobe (PCA Territory)",checked:!0,points:1}],ie=()=>({callingSite:"",callingSiteOther:"",alias:"",workingDiagnosis:"",briefHistory:"",deficits:"",imaging:"",chiefComplaint:"",lkwDate:new Date().toISOString().split("T")[0],lkwTime:new Date().toTimeString().slice(0,5),lkwUnknown:!1,discoveryDate:"",discoveryTime:"",age:"",sex:"M",affectedSide:"",weight:"",height:"",lastDOACDose:new Date().toISOString().slice(0,16),lastDOACType:"",arrivalTime:"",strokeAlertTime:"",dtnEdArrival:"",dtnStrokeAlert:"",dtnCtStarted:"",dtnCtRead:"",dtnTnkOrdered:"",dtnTnkAdministered:"",symptoms:"",pmh:"",medications:"",noAnticoagulants:!1,premorbidMRS:"",vesselOcclusion:[],presentingBP:"",bpPreTNK:"",bpPreTNKTime:"",glucose:"",plateletsCoags:"",creatinine:"",inr:"",ptt:"",plateletCount:"",platelets:"",allergies:"",contrastAllergy:!1,nihss:"",nihssDetails:"",imagingReviewed:!0,ctDate:new Date().toISOString().split("T")[0],ctTime:"",ctResults:"",ctaDate:new Date().toISOString().split("T")[0],ctaTime:"",ctaResults:"",ctpResults:"",ekgResults:"",wakeUpStrokeWorkflow:{mriAvailable:null,dwi:{positiveForLesion:!1,lesionVolume:""},flair:{noMarkedHyperintensity:!1},ageEligible:!1,nihssEligible:!1,extendCriteria:{nihss4to26:!1,premorbidMRSLt2:!1,ischemicCoreLte70:!1,mismatchRatioGte1_2:!1,timeWindow4_5to9h:!1},imagingRecommendation:"",wakeUpEligible:null,extendEligible:null},diagnosis:"",diagnosisCategory:"",tnkRecommended:!1,evtRecommended:!1,rationale:"",tnkConsentDiscussed:!1,patientFamilyConsent:!1,presumedConsent:!1,preTNKSafetyPause:!1,tnkAdminTime:"",admitLocation:"",recommendationsText:"",transferAccepted:!1,transferRationale:"",transferChecklist:{imagingShared:!1,transferCenterCalled:!1,acceptingPhysicianNotified:!1,transportArranged:!1,etaConfirmed:!1,bpGoalsCommunicated:!1},transferImagingShareMethod:"",transferImagingShareLink:"",transportMode:"",transportEta:"",transportNotes:"",disposition:"",doorTime:"",needleTime:"",punctureTime:"",tnkContraindicationChecklist:{activeInternalBleeding:!1,recentIntracranialSurgery:!1,intracranialNeoplasm:!1,knownBleedingDiathesis:!1,severeUncontrolledHTN:!1,currentICH:!1,recentMajorSurgery:!1,recentGIGUBleeding:!1,recentArterialPuncture:!1,recentLumbarPuncture:!1,pregnancy:!1,seizureAtOnset:!1,lowPlatelets:!1,elevatedINR:!1,elevatedPTT:!1,abnormalGlucose:!1,recentDOAC:!1},tnkContraindicationReviewed:!1,tnkContraindicationReviewTime:"",decisionLog:[],recommendations:{neuroChecks:!1,noAntithrombotics:!1,bpControl:!1,followUpCT:!1,mri:!1,ekg:!1,echo:!1,lipids:!1,therapies:!1,dvtPpx:!1,neuroConsult:!1},ichBPManaged:!1,ichReversalOrdered:!1,ichNeurosurgeryConsulted:!1,sahGrade:"",sahGradeScale:"",sahBPManaged:!1,sahNimodipine:!1,sahEVDPlaced:!1,sahAneurysmSecured:!1,sahNeurosurgeryConsulted:!1,sahSeizureProphylaxis:!1,cvtAnticoagStarted:!1,cvtAnticoagType:"",cvtIcpManaged:!1,cvtSeizureManaged:!1,cvtHematologyConsulted:!1,tiaWorkup:{mriDwi:!1,ctaHeadNeck:!1,ecg12Lead:!1,telemetry:!1,echo:!1,labsCbc:!1,labsBmp:!1,labsA1c:!1,labsLipids:!1,labsTsh:!1},tiaWorkupReviewed:!1,toastClassification:"",cardiacWorkup:{ecgComplete:!1,telemetryOrdered:!1,echoOrdered:!1,extendedMonitoring:"",extendedMonitoringType:"",pfoEvaluation:"",pascalClassification:""},dissectionPathway:{antithromboticStarted:!1,antithromboticType:"",imagingFollowUp:"",vascularImagingDate:""},screeningTools:{phq2Score:"",phq2Positive:!1,mocaScore:"",mocaReferral:!1,stopBangScore:"",stopBangPositive:!1,seizureRisk:""},secondaryPrevention:{bpTarget:"",bpMeds:"",bpIntensiveCandidate:!1,ldlCurrent:"",ldlTarget:"<70",statinDose:"",ezetimibeAdded:!1,pcsk9Added:!1,inclisiranConsidered:!1,glp1ra:"",glp1raIndication:"",sglt2i:"",sglt2iIndication:"",colchicineConsidered:!1,colchicineIndication:"",cyp2c19Tested:!1,cyp2c19Result:"",diabetesManagement:"",smokingStatus:"",smokingCessationRx:"",exercisePlan:"",exerciseMinPerWeek:"",dietPlan:"",dietAdherence:"",antiplateletRegimen:"",daptDuration:"",followUpTimeline:""},ichAnticoagResumption:{ichLocation:"",caaFeatures:!1,chadsVascScore:"",hasbledScore:"",timeSinceICH:"",decision:"",rationale:"",laaoConsidered:!1},carotidManagement:{stenosisSide:"",stenosisDegree:"",symptomatic:!1,intervention:"",medicalManagement:""},esusWorkup:{cardiacMonitoringType:"",cardiacMonitoringDuration:"",afDetected:!1,teePerformed:!1,teeFindings:"",hypercoagWorkup:!1,esusAntiplatelet:""},doacTiming:{strokeSeverity:"",hemorrhagicTransformation:!1,htClassification:"",doacInitiationDay:"",doacAgent:""},hemorrhagicTransformation:{detected:!1,classification:"",symptomatic:!1,managementActions:"",antithromboticHeld:!1,reimagingPlanned:!1},angioedema:{detected:!1,severity:"",aceInhibitorUse:!1,stepsTaken:{},intubated:!1,resolved:!1,onsetTime:""},dysphagiaScreening:{bedsideScreenPerformed:!1,bedsideScreenResult:"",instrumentalAssessment:"",npoStatus:!1,slpConsultOrdered:!1},earlyMobilization:{timingDecision:"",mobilizationStarted:!1,sessionFrequency:"",contraindications:""},postTnkBpMonitoring:{monitoringActive:!1,bpReadings:[],lastBpTime:""},vteProphylaxis:{ipcApplied:!1,pharmacoProphylaxis:"",enoxaparinDose:"",postTpaTimerStarted:!1,hematoStabilityConfirmed:!1,antiXaMonitoring:!1},feverManagement:{feverDetected:!1,maxTemp:"",feverProtocolInitiated:!1,bsasScore:"",infectionWorkupSent:!1,escalationLevel:""},osmoticTherapy:{agentUsed:"",indication:"",serumSodium:"",serumOsmolality:"",sodiumTarget:"",correctionRate:""},nutritionalSupport:{feedingRoute:"",ngPlacementDay:"",pegConsiderationDay:"",nutritionConsultOrdered:!1,caloricTarget:""},drugInteractions:{aedDoacInteraction:!1,aedType:"",statinInteraction:!1,statinInteractionDrug:"",doacDoseAppropriate:"",doacDoseReductionCriteria:""},anticoagBridging:{bridgingNeeded:!1,doacType:"",crCl:"",procedureRisk:"",holdDays:"",resumeDay:"",warfarinBridgeIndication:""},youngAdultWorkup:{tier1Complete:!1,tier1Items:{ctaMra:!1,tteBubble:!1,ecg:!1,telemetry:!1,drugScreen:!1,basicLabs:!1},tier2Complete:!1,tier2Items:{tee:!1,extendedMonitoring:!1,aplPanel:!1},tier3Items:{rcvsWorkup:!1,thrombophilia:!1,fabry:!1,cadasil:!1,vasculitis:!1}},mrsAssessment:{discharge:"",day30:"",day90:"",month6:"",month12:""},drivingRestrictions:{counselingProvided:!1,restrictionDuration:"",drivingEvalReferral:!1,commercialDriver:!1,residualDeficits:""},returnToWork:{workingAge:!1,priorOccupation:"",rtBarriers:[],vocationalRehabReferral:!1,expectedTimeline:"",phasedReturnPlan:!1},sexualHealthCounseling:{discussed:!1,clearanceGiven:!1,medicationReview:!1,concerns:""},airTravelRestrictions:{counselingProvided:!1,restrictionDuration:"",supplementalO2Needed:!1},spasticity:{screenPerformed:!1,ashworthScore:"",location:"",treatment:"",botoxReferral:!1},centralPain:{screenPerformed:!1,painPresent:!1,painType:"",treatment:""},fatigue:{screenPerformed:!1,fatiguePresent:!1,severity:"",management:""},substanceScreening:{alcoholAuditC:"",alcoholCounseling:!1,substanceUseScreen:!1,substancesIdentified:""},hormonalRisk:{combinedOCPUse:!1,hrtUse:!1,migraineWithAura:!1,counselingProvided:!1},cvtAnticoag:{acutePhase:"",transitionAgent:"",duration:"",apsStatus:"",etiologyProvoked:!1},palliativeCare:{screeningTriggered:!1,consultOrdered:!1,goalsOfCareDiscussed:!1,goalsOfCareOutcome:"",dnrPostponementAlert:!1},fallsRisk:{screenPerformed:!1,highRisk:!1,preventionPlanInitiated:!1,balanceProgramReferral:!1},pregnancyStroke:!1,decompressiveCraniectomy:{considered:!1,age:"",nihssThreshold:!1,territorySize:"",timing:""},rehabReferral:{pt:!1,ot:!1,slp:!1,neuropsych:!1,socialWork:!1,vocationalRehab:!1},dischargeChecklist:{antiplateletOrAnticoag:!1,statinPrescribed:!1,bpMedOptimized:!1,diabetesManaged:!1,smokingCessation:!1,dietCounseling:!1,exerciseCounseling:!1,followUpNeurology:!1,followUpPCP:!1,rehabilitationOrdered:!1,patientEducation:!1,drivingRestrictions:!1},dischargeChecklistReviewed:!1}),L=(e,a)=>{try{let i=ue(e,void 0);return i==null?a:Array.isArray(a)&&!Array.isArray(i)?(console.warn(`Invalid data type for ${e}, expected array. Resetting to default.`),a):i}catch(i){return console.warn(`Error loading ${e} from localStorage:`,i),a}},$o=(e,a)=>{try{return ue(e,a)}catch(i){return console.warn(`Error loading ${e}:`,i),a}},_o=(e,a)=>{try{Be(e,{data:a,expiresAt:Date.now()+864e5})}catch(i){console.warn(`Error saving ${e}:`,i)}},[ne,la]=b(()=>is),oe=ne.settings||Xa(),_e=e=>{la(a=>{let i=typeof e=="function"?e(a):e;return na(Ft(),i)})},ss=(()=>{let e=ne.uiState.lastActiveTab||"encounter";return et[e]?"management":e})(),os=(()=>{let e=mt(ne.uiState.lastManagementSubTab);return e||et[ne.uiState.lastActiveTab]||"ich"})(),[Q,We]=b(ss),[ti,rs]=b(!1),[Te,ca]=b(null),[Bt,da]=b(null),[$t,ns]=b(Oo),[ma,At]=b(!1),[ls,_t]=b(!1),[pt,ai]=b(()=>{let e=ue("caseSummaryCollapsed",null);return e!=null?e===!0:window.innerWidth<640}),[Wo,cs]=b(!0),[ds,ii]=b(!1),[Ce,si]=b(()=>ue("showAdvanced",!1)===!0),[oi,ms]=b({institutionLinks:[],ttlHoursOverride:null}),[ri,pa]=b(!1),[ga,ua]=b(oe.ttlHoursOverride||wt),[be,Tt]=b(L("patientData",{})),[h,Ie]=b(L("nihssScore",0)),[A,tt]=b(L("aspectsScore",10)),[Ue,ni]=b(ue("darkMode",!1)===!0),[ba,ha]=b(""),[Uo,ps]=b(!1),[Ko,gs]=b(!1),[le,z]=b(""),[li,us]=b(!1),[fa,bs]=b(L("telestrokeTemplate",p)),[Se,ci]=b(new Date),[g,Re]=b(()=>{let e=L("lkwTime",null);return e?new Date(e):new Date}),[Ke,di]=b(ue("thrombolysisAlertsMuted",!1)===!0),[It,va]=b(null),[hs,Wt]=b(!1),[ya,mi]=b(0),[pi,gt]=b("saved"),[gi,xa]=b(null),[ui,bi]=b([]),[hi,Ut]=b([]),[fi,Ge]=b(!1),[fs,ut]=b("header"),[bt,Na]=b(""),[vs,Rt]=b(!1),[ka,Ca]=b({}),[Go,jo]=b(""),[Sa,wa]=b(L("currentStep",0)),[Kt,Aa]=b(L("completedSteps",[])),[Gt,Ta]=b(L("shiftPatients",[])),[je,ht]=b(L("currentPatientId",null)),[zo,Ia]=b(!1),[Pe,vi]=b(()=>{let e=ue("timerSidebarCollapsed",null);return e!=null?e===!0:window.innerWidth<1024}),[we,ft]=b(L("consultationType",oe.defaultConsultationType||"videoTelestroke")),[he,vt]=b(os),[jt,zt]=b(!1),[Ra,ys]=b(((Wi=(_i=ne.encounter.clipboardPacks)==null?void 0:_i[0])==null?void 0:Wi.id)||"telestroke-consult"),[qo,Yo]=b(!1),[Jo,Xo]=b(!1),[Qo,Zo]=b(!1),[er,tr]=b({}),yt=ne.shiftBoards||[],Pt=ne.encounter.clipboardPacks||ei(),xs=ne.uiState.lastShiftBoardId||(yt[0]?yt[0].id:null),Z=yt.find(e=>e.id===xs)||null,Ns=sa(null),ar=sa(null),qt=sa({tnkRecommended:!1,evtRecommended:!1,transferAccepted:!1,tnkContraindicationReviewed:!1,tnkConsentDiscussed:!1,tnkAdminTime:""}),[T,Y]=b(L("gcsItems",{eye:"",verbal:"",motor:""})),[M,fe]=b(L("mrsScore","")),[R,ve]=b(L("ichScoreItems",{gcs:"",age80:!1,volume30:!1,ivh:!1,infratentorial:!1})),[$,Yt]=b({a:"",b:"",thicknessMm:"",numSlices:""});x(()=>{let{a:e,b:a,thicknessMm:i,numSlices:s}=$;if(e&&a&&i&&s){let o=parseFloat(i)/10*parseFloat(s),n=parseFloat(e)*parseFloat(a)*o/2;isNaN(n)||ve(c=>{let d=n>=30;return c.volume30!==d?{...c,volume30:d}:c})}},[$]);let[_,ye]=b(L("abcd2Items",{age60:!1,bp:!1,unilateralWeakness:!1,speechDisturbance:!1,duration:"",diabetes:!1})),[W,xe]=b(L("chads2vascItems",{chf:!1,hypertension:!1,age75:!1,diabetes:!1,strokeTia:!1,vascular:!1,age65:!1,female:!1})),[P,Ee]=b(L("ropeItems",{noHypertension:!1,noDiabetes:!1,noStrokeTia:!1,nonsmoker:!1,cortical:!1,age:""})),[De,ze]=b(L("huntHessGrade","")),[Oe,qe]=b(L("wfnsGrade","")),[D,de]=b(L("hasbledItems",{hypertension:!1,renalDisease:!1,liverDisease:!1,stroke:!1,bleeding:!1,labileINR:!1,elderly:!1,drugs:!1,alcohol:!1})),[q,Ye]=b(L("rcvs2Items",{recurrentTCH:!1,carotidInvolvement:!1,vasoconstrictiveTrigger:!1,female:!1,sah:!1})),[Et,Dt]=b("ischemic"),[ir,ks]=b({clinic:!1,map:!1}),[J,at]=b(L("strokeCodeForm",u())),[it,Ot]=b(L("aspectsRegionState",y())),[st,Jt]=b(L("pcAspectsRegions",E())),[t,r]=b(L("telestrokeNote",ie())),Xt={ischemic:{title:"Ischemic Stroke Studies",hasSubsections:!0,subsections:{acute:{title:"Acute Trials",trials:[{name:"SISTER Trial",nct:"NCT05948566",phase:"Phase 2",status:"",description:"TS23 (monoclonal antibody to \u03B12-antiplasmin) for late thrombolysis in acute ischemic stroke patients presenting 4.5-24 hours from last known well",inclusion:["Age \u226518 years","Suspected anterior circulation acute ischemic stroke","NIH Stroke Scale score \u22654 prior to randomization (participant must have a clearly disabling deficit if NIHSS is 4-5)","Time from last known well: 4.5-24 hours","Favorable baseline neuroimaging consisting of ALL of the following:","\u2022 ASPECTS \u22656 on CT (or ASPECTS \u22657 on MRI)","\u2022 Favorable perfusion imaging on CTP/MR-PWI consisting of ALL:","  - Mismatch ratio of penumbra:core >1.2","  - Mismatch volume >10 cc","  - Ischemic core volume <70 cc","Able to receive assigned study drug within 4.5 to 24 hours of stroke onset or last known well","Informed consent obtained from participant or legally authorized representative","Study drug administration encouraged within 90 minutes after qualifying perfusion image (allowed up to 120 minutes)"],exclusion:["Received endovascular treatment with clot engagement (patients with groin puncture but no clot engagement due to spontaneous distal migration are permitted)","Received or planned to receive intravenous thrombolysis","Pre-stroke modified Rankin score >2","Previous treatment with TS23 or known previous allergy to antibody therapy","Known pregnancy, breastfeeding, or plan to breastfeed within 3 months of receiving TS23","Positive urine or serum pregnancy test for women of childbearing potential","Known previous stroke in the past 90 days","Known previous intracranial hemorrhage, intracranial neoplasm, subarachnoid hemorrhage, or arteriovenous malformation","Known active diagnosis of intracranial neoplasm","Clinical presentation suggestive of subarachnoid hemorrhage (even if initial CT scan was normal)","Surgery or biopsy of parenchymal organ in the past 30 days","Known trauma with internal injuries or persistent ulcerative wounds in the past 30 days","Severe head trauma in the past 90 days","Persistent systolic blood pressure >180mmHg or diastolic blood pressure >105mmHg despite best medical management","Serious systemic hemorrhage in the past 30 days","Hereditary or acquired hemorrhagic diathesis or coagulation factor deficiency","Use of dual antiplatelet agents within 48 hours prior to stroke symptom onset","International normalized ratio (INR) >1.7 or partial thromboplastin time (PTT) > 2x upper limit of normal","Use of direct thrombin inhibitors or direct factor Xa inhibitors within past 48 hours unless aPTT, INR, platelet count, ecarin clotting time (ECT), thrombin time (TT), or appropriate factor Xa activity assays are normal","Glucose <50 mg/dL or >400 mg/dL","Platelets <100,000/\xB5L","Known severe renal failure with creatinine >3 mg/dL or glomerular filtration rate <30 mL/min","Severe contrast allergy that cannot be managed medically","Suspected cerebral vasculitis based on medical history and CTA/MRA","Suspected intracranial dissection based on medical history and CTA/MRA","Intracranial stenosis related to atherosclerosis proximal to intracranial thrombus","Intracranial stent in place proximal to the intracranial occlusion","Acute myocardial infarction in past 7 days","Major surgery (requiring intubation or transfusion) in past 30 days","Suspicion of aortic dissection on history, examination, or imaging","Presumed septic embolus; suspicion of bacterial endocarditis","Life expectancy <90 days","Currently participating in another investigational drug or device study"]},{name:"STEP-EVT Trial",nct:"NCT06289985",phase:"Adaptive Platform",status:"",description:"NIH StrokeNet adaptive platform trial optimizing endovascular therapy for mild stroke and medium/distal vessel occlusions",inclusion:["Age \u226518 years","Acute ischemic stroke due to large vessel occlusion (LVO) or medium vessel occlusion (MVO)","Within 24 hours of last known well","For Low NIHSS Domain:","\u2022 NIHSS 0-5 with ICA or M1 occlusion","\u2022 Disabling symptoms despite low NIHSS","For Medium/Distal Vessel Occlusion Domain:","\u2022 M2, M3, or M4 occlusion","\u2022 A1, A2, or A3 occlusion","\u2022 P1, P2, or P3 occlusion","\u2022 Appropriate perfusion imaging criteria demonstrating salvageable tissue","Ability to start EVT within appropriate time window","Pre-stroke mRS \u22642 (able to live independently)","Informed consent from patient or legally authorized representative"],exclusion:["Known pre-existing medical, neurological or psychiatric disease that would confound outcome evaluations","Known serious, advanced, or terminal illness with life expectancy <6 months","Unfavorable vascular anatomy limiting endovascular access to occluded artery","Acute occlusions in multiple vascular territories","Suspected septic embolus","Suspected bacterial endocarditis","Seizure at stroke onset with postictal residual impairments","Contrast allergy precluding EVT that cannot be adequately pre-medicated","Chronic total occlusion of target vessel","Known intracranial dissection","Known vasculitis","Known moyamoya disease or syndrome","Pregnancy or positive pregnancy test","Currently breastfeeding","Large core infarct (ASPECTS <3 or core volume >100cc depending on time window)","Evidence of intracranial hemorrhage on baseline imaging","Clinical suspicion of subarachnoid hemorrhage despite negative imaging","Known bleeding diathesis or coagulopathy","Platelet count <50,000/\u03BCL","INR >3.0","Blood glucose <50mg/dL","Refractory hypertension (SBP >185 or DBP >110 despite treatment)","Currently participating in another interventional clinical trial"]},{name:"PICASSO Trial",nct:"NCT05611242",phase:"Phase 3 RCT",status:"",description:"Mechanical thrombectomy with vs without acute carotid stenting for tandem lesions",inclusion:["Age 18-79 years","Acute ischemic stroke in the anterior circulation","Tandem lesion consisting of:","\u2022 Proximal carotid artery stenosis 70-100% by NASCET criteria or complete occlusion","\u2022 Intracranial large vessel occlusion (ICA terminus, M1, or proximal M2)","Within 16 hours from stroke onset or last known well","Pre-stroke mRS 0-2","NIHSS \u22654","For presentation \u22646 hours: ASPECTS \u22657 on non-contrast CT","For presentation >6-16 hours:","\u2022 ASPECTS \u22657 AND","\u2022 Ischemic core volume <50cc on perfusion imaging","\u2022 Mismatch ratio >1.8","\u2022 Mismatch volume >15cc","Ability to undergo groin puncture within treatment window","Informed consent obtained"],exclusion:["Proximal carotid stenosis secondary to dissection","Proximal carotid stenosis secondary to vasculitis","Pre-stroke mRS >2","Known hemorrhagic diathesis","Known coagulation factor deficiency","Absolute contraindications to antiplatelet therapy","Need for acute therapeutic anticoagulation that cannot be stopped","Platelet count <100,000/\u03BCL","INR >1.7","aPTT >1.5x normal","Blood glucose <50mg/dL or >400mg/dL","Serum creatinine >3.0mg/dL unless on dialysis","Evidence of intracranial hemorrhage on baseline CT/MRI","Clinical suspicion of subarachnoid hemorrhage","Large territory infarction (>1/3 MCA territory)","Known severe contrast allergy that cannot be adequately pre-medicated","Known pregnancy or positive pregnancy test","Life expectancy <90 days due to comorbid conditions","Enrollment in another interventional clinical trial","Previous carotid endarterectomy or carotid stenting on affected side","Contralateral carotid occlusion","Intracranial stenosis in addition to the tandem lesion","Known cardiac source of embolism requiring anticoagulation","Recent MI within 30 days with ongoing cardiac issues","Severe or unstable congestive heart failure","Uncontrolled hypertension (SBP >185 or DBP >110 despite treatment)"]},{name:"TESTED",nct:"NCT05911568",phase:"Comparative Effectiveness",status:"",description:"EVT vs medical therapy in LVO with pre-existing disability (mRS 3-4)",inclusion:["Age \u226518 years","Pre-stroke mRS 3-4 for at least 3 months prior to index stroke","Large vessel occlusion:","\u2022 ICA terminus","\u2022 M1 segment of MCA","\u2022 Dominant/co-dominant M2 segment","Within 24 hours of last known well","NIHSS \u22656","ASPECTS \u22653 on non-contrast CT or \u22654 on MRI","For 6-24 hour window: evidence of salvageable tissue on perfusion imaging","Able to undergo groin puncture within time window","Informed consent from patient or legally authorized representative"],exclusion:["Pre-stroke mRS 0-2 or mRS 5-6","Life expectancy <6 months from non-stroke condition","Pre-stroke disability deemed temporary or reversible","Known pregnancy","Evidence of intracranial hemorrhage","Large established infarct (>1/3 MCA territory)","Bilateral strokes","Known vasculitis or moyamoya","Intracranial tumor","Currently participating in another stroke intervention trial","Inability to follow up at 90 days"]}]},inpatient:{title:"Subacute Enrollment",trials:[{name:"VERIFY Study",nct:"NCT05338697",phase:"Observational",status:"",description:"Early TMS/MRI/clinical measures to predict upper extremity motor recovery",inclusion:["Age \u226518 years","Acute ischemic stroke within 7 days of onset","Upper extremity weakness (shoulder abduction and/or finger extension \u22644 on MRC scale)","Able to provide informed consent or has LAR","Able to participate in study assessments","Expected to survive at least 90 days"],exclusion:["Contraindications to TMS:","\u2022 Implanted electronic devices (pacemaker, cochlear implant, etc.)","\u2022 Intracranial metal","\u2022 History of seizures","\u2022 Active psychiatric medication affecting cortical excitability","Contraindications to MRI","Unable to complete follow-up visits at 30 and 90 days","Pre-stroke mRS >2","Bilateral upper extremity weakness","Previous stroke affecting motor function","Other neurological conditions affecting motor function","Pregnancy"]},{name:"DISCOVERY Study",nct:"NCT04916210",phase:"Observational",status:"",description:"Cognitive trajectories and biomarkers after stroke (includes AIS/ICH/SAH)",inclusion:["Age \u226518 years","Admitted with one of the following:","\u2022 Acute ischemic stroke","\u2022 Intracerebral hemorrhage","\u2022 Aneurysmal subarachnoid hemorrhage","Radiographic confirmation of stroke diagnosis","Baseline visit can be completed within 6 weeks of stroke","Fluent in English or Spanish","Has study partner who knows patient well (contact \u22651x/week)","Able to provide informed consent or has LAR","Expected to survive at least 1 year"],exclusion:["Pre-stroke dementia diagnosis","Pre-stroke cognitive impairment interfering with daily activities","Concurrent enrollment in interventional trial affecting cognition","Unable to complete study protocol due to:","\u2022 Severe aphasia preventing cognitive testing","\u2022 Severe motor impairment preventing testing","\u2022 Blindness or severe visual impairment","\u2022 Deafness or severe hearing impairment","Active substance abuse","Severe psychiatric illness affecting participation","Terminal illness with life expectancy <1 year","Previous enrollment in DISCOVERY","Planned move out of area within study period"]}]},imaging:{title:"Imaging Studies",trials:[{name:"ESUS Imaging Study",nct:"NCT03820375",phase:"Observational",status:"",description:"Cardiac and intracranial vessel wall MRI to reclassify ESUS",inclusion:["ESUS diagnosis","Age \u226518 years","Within 30 days of index stroke"],exclusion:["MRI contraindications","Known stroke etiology"]},{name:"MOCHA Imaging",nct:"PMC8821414",phase:"Observational",status:"",description:"Automated intracranial vessel-wall analysis for non-stenotic ICAD detection",inclusion:["Atherosclerotic lesions within the cerebrovascular tree clinically detected based on stenosis presence on clinical luminal imaging","Presence of two or more atherosclerotic risk factors:","\u2022 Age >50 years for men or >60 years for women","\u2022 Hypertension","\u2022 Diabetes mellitus","\u2022 Hyperlipidemia","\u2022 Obesity","\u2022 Smoking history","No clinical evidence for other intracranial vasculopathies","High-resolution MRI vessel wall imaging available"],exclusion:["Poor MRI image quality limiting vessel wall analysis","Known intracranial vasculopathy (vasculitis, moyamoya, dissection)","Unable to undergo MRI scanning","Contraindications to MRI contrast if required for imaging protocol"]}]}}},ich:{title:"Intracerebral Hemorrhage Studies",hasSubsections:!0,subsections:{trials:{title:"Trials",trials:[{name:"SATURN Trial",nct:"NCT03936361",phase:"Phase 3",status:"",description:"Statins for intracerebral hemorrhage: Continue vs discontinue after lobar ICH",inclusion:["Age \u226550 years","Spontaneous lobar intracerebral hemorrhage confirmed by CT or MRI","Taking statin therapy at time of ICH onset for \u22651 month","Modified Rankin Scale \u22644 at time of randomization","Randomization within 7 days of ICH","Clinical indication for statin therapy (dyslipidemia, atherosclerotic disease, diabetes)","Able to provide informed consent or has LAR","Expected to survive at least 6 months"],exclusion:["Deep (non-lobar) ICH location","Secondary causes of ICH:","\u2022 Trauma","\u2022 Known brain tumor","\u2022 Known vascular malformation or aneurysm","\u2022 Hemorrhagic transformation of ischemic stroke","\u2022 Known or suspected CNS vasculitis","\u2022 Coagulopathy (INR >1.5, platelet count <100,000)","\u2022 Drug-related (cocaine, amphetamines)","Recent MI (<3 months) or unstable angina","Coronary revascularization within past year","Diabetes mellitus with prior MI or coronary revascularization","Clear contraindication to statin discontinuation per treating physician","Statin-related myopathy or rhabdomyolysis","Severe hepatic impairment (ALT/AST >3x ULN)","Life expectancy <6 months from non-ICH condition","Unable to follow study protocol","Pregnancy or breastfeeding","Participation in another interventional trial"]},{name:"ASPIRE Trial",nct:"NCT03907046",phase:"Phase 3",status:"",description:"Apixaban vs aspirin for stroke prevention after ICH in atrial fibrillation",inclusion:["Age \u226518 years","Spontaneous ICH confirmed by CT or MRI","Non-valvular atrial fibrillation (paroxysmal, persistent, or permanent)","CHA2DS2-VASc score \u22652","Randomization 14-180 days after ICH","Modified Rankin Scale \u22644 at randomization","Able to take oral medications","Informed consent obtained"],exclusion:["Clear indication for anticoagulation other than AF:","\u2022 Mechanical heart valve","\u2022 Recent DVT/PE requiring anticoagulation","\u2022 Left ventricular thrombus","Left atrial appendage closure device","Valvular AF (moderate-severe mitral stenosis, mechanical valve)","Secondary causes of ICH requiring specific treatment","Creatinine \u22652.5mg/dL or CrCl <25mL/min","Hepatic insufficiency (Child-Pugh B or C)","Active bleeding or high bleeding risk condition","Uncontrolled hypertension (BP \u2265180/100 on multiple readings)","Platelet count <100,000/\u03BCL","Hemoglobin <8g/dL","Need for dual antiplatelet therapy","Contraindication to aspirin or apixaban","Pregnancy or breastfeeding","Life expectancy <1 year","Unable to adhere to study protocol","Participation in another antithrombotic trial"]},{name:"cAPPricorn-1 Trial",nct:"NCT06393712",phase:"Phase 2",status:"",description:"Intrathecal ALN-APP (mivelsiran) for cerebral amyloid angiopathy",inclusion:["For sporadic CAA:","\u2022 Age \u226550 years","\u2022 Meets Boston Criteria v2.0 for probable CAA","\u2022 Prior symptomatic lobar ICH \u226590 days ago","For Dutch-type hereditary CAA:","\u2022 Age \u226530 years","\u2022 Confirmed E693Q APP variant","\u2022 Prior ICH \u226590 days ago (if applicable)","MRI evidence of CAA (microbleeds, superficial siderosis)","Modified Rankin Scale \u22644","Able to undergo lumbar punctures","Adequate contraception if childbearing potential","Informed consent obtained"],exclusion:["ICH within 90 days of screening","Other cause of ICH identified","ALT or AST >3\xD7 upper limit of normal","eGFR <30 mL/min/1.73m\xB2","Platelet count <100,000/\u03BCL","INR >1.5 or aPTT >1.5\xD7 ULN","Contraindication to lumbar puncture","Active CNS infection or inflammation","Intrathecal pump or shunt","Spinal cord compression or injury","History of chemical or radiation meningitis","Pregnancy or breastfeeding","Life expectancy <2 years","Chronic use of anticoagulation that cannot be stopped for LP","Prior treatment with gene therapy or oligonucleotide therapy","Participation in another interventional trial within 30 days"]},{name:"FASTEST Trial",nct:"NCT03496883",phase:"Phase 3",status:"Actively recruiting",description:"Recombinant Factor VIIa (rFVIIa) for acute ICH within 2 hours of symptom onset to prevent hematoma expansion",inclusion:["Age 18-80 years","Spontaneous supratentorial ICH confirmed by CT","ICH symptom onset \u22642 hours before treatment","Hematoma volume 2-60 mL","Intraventricular hemorrhage (IVH) score \u22647","Glasgow Coma Scale \u22658","Able to receive study drug within 2 hours of symptom onset","Informed consent from patient or legally authorized representative"],exclusion:["On anticoagulation therapy (warfarin, DOAC, heparin)","Known coagulopathy","Secondary ICH:","\u2022 Trauma","\u2022 Known vascular malformation (AVM, aneurysm)","\u2022 Brain tumor","\u2022 Hemorrhagic conversion of ischemic stroke","\u2022 Dural venous sinus thrombosis","Brainstem hemorrhage excluded; cerebellar hemorrhage permitted","Planned surgical evacuation within 24 hours","Pre-existing severe disability (mRS >2)","Known allergy to rFVIIa","History of thromboembolic disease within 30 days","Pregnancy","Life expectancy <3 months from pre-existing condition"]}]},observational:{title:"Observational",trials:[{name:"MIRROR Registry",nct:"NCT04494295",phase:"Observational Registry",status:"",description:"Minimally invasive endoscopic ICH evacuation using Aurora Surgiscope System",inclusion:["Age \u226518 years","Spontaneous supratentorial ICH confirmed by CT","ICH volume \u226520mL","Surgery planned within 24 hours of last known well","NIHSS >5","Baseline mRS \u22642","GCS \u22655","Ability to undergo general anesthesia","Informed consent from patient or LAR"],exclusion:["Secondary ICH due to:","\u2022 Vascular lesion (AVM, aneurysm, dural fistula)","\u2022 Brain tumor","\u2022 Trauma","\u2022 Hemorrhagic transformation of ischemic stroke","\u2022 Moyamoya disease","Fixed and dilated pupils","Bilateral extensor posturing","Infratentorial or brainstem ICH","Intraventricular hemorrhage as primary pathology","Life expectancy <6 months from other condition","Uncorrectable coagulopathy (INR >1.4, platelets <100,000)","Known pregnancy","Prisoner or ward of state","Participation in another interventional trial"]},{name:"DISCOVERY Study (ICH Cohort)",nct:"NCT04916210",phase:"Observational",status:"",description:"Cognitive trajectories and biomarkers after ICH",inclusion:["Age \u226518 years","Admitted with intracerebral hemorrhage","Radiographic confirmation of ICH","Baseline visit within 6 weeks of ICH","Fluent in English or Spanish","Has study partner with regular contact","Expected survival \u22651 year"],exclusion:["Pre-existing dementia","Unable to complete cognitive testing","Concurrent enrollment in cognitive intervention trial","Active substance abuse","Severe psychiatric illness","Terminal illness with life expectancy <1 year"]}]}}},rehab:{title:"Rehabilitation",trials:[{name:"MR-PICS Study",nct:"NCT06506279",phase:"Phase 2",status:"",description:"Motor Recovery through Plasticity-Inducing Cortical Stimulation using CorTec Brain Interchange System for chronic stroke recovery",inclusion:["Post-ischemic stroke patients with upper extremity deficit","Chronic stroke (minimum 6 months post-stroke)","Age 22-80 years","Able to participate meaningfully in rehabilitation (Upper Extremity Fugl-Meyer score 25-45)","Disability measured between 3-4 on modified Rankin Scale","Minimum 30% preservation of corticospinal tract integrity","Ability to provide informed consent","Medically stable and cleared for neurosurgical procedure","Willingness to comply with study protocol and follow-up visits","Access to caregiver support during recovery period"],exclusion:["Seizure disorder or history of seizures","Contraindications to neurosurgical procedures","Contraindications to MRI scanning","Active psychiatric condition that would interfere with participation","Pregnancy or nursing","Life expectancy less than 2 years","Current participation in other interventional clinical trials","Inability to stop anti-platelet medications 7 days before and 3 days after surgery","Therapeutic anticoagulation that cannot be safely interrupted","Active substance abuse or dependence","Severe cognitive impairment preventing informed consent","Glenohumeral subluxation, adhesive capsulitis, or upper extremity contractures with associated pain that would limit participation","Implanted electronic devices incompatible with study procedures","Prior brain surgery or cranial implants","Hemorrhagic stroke (intracerebral hemorrhage excluded)","Bilateral stroke or multiple stroke locations"]}]},cadasil:{title:"CADASIL",trials:[{name:"CADASIL Registry",nct:"NCT05567744",phase:"Observational Registry",status:"",description:"Longitudinal registry for genetically confirmed or suspected CADASIL",inclusion:["Confirmed NOTCH3 mutation or suspected CADASIL","Age \u226518 years"],exclusion:["Unable to provide consent"]}]}},G={apixaban:{name:"Apixaban (Eliquis)",class:"Direct Factor Xa Inhibitor",halfLife:"8-12 hours",halfLifeNote:"Prolonged in renal impairment",thrombolysisThreshold:"48 hours since last dose",thrombolysisNote:"Consider anti-Xa level if <48h - thrombolysis may be given if anti-Xa <30 ng/mL",ichReversal:{primary:"4-Factor PCC (Kcentra) 50 IU/kg (max 5000 IU)",alternative:"Activated PCC (FEIBA) 50 IU/kg if 4F-PCC unavailable",note:"Andexxa (andexanet alfa) is NOT recommended due to cost, availability, and thrombosis risk"},monitoring:"Anti-Xa level (calibrated for apixaban)"},rivaroxaban:{name:"Rivaroxaban (Xarelto)",class:"Direct Factor Xa Inhibitor",halfLife:"5-9 hours (young), 11-13 hours (elderly)",halfLifeNote:"Prolonged in renal impairment",thrombolysisThreshold:"48 hours since last dose",thrombolysisNote:"Consider anti-Xa level if <48h - thrombolysis may be given if anti-Xa <30 ng/mL",ichReversal:{primary:"4-Factor PCC (Kcentra) 50 IU/kg (max 5000 IU)",alternative:"Activated PCC (FEIBA) 50 IU/kg if 4F-PCC unavailable",note:"Andexxa (andexanet alfa) is NOT recommended due to cost, availability, and thrombosis risk"},monitoring:"Anti-Xa level (calibrated for rivaroxaban)"},dabigatran:{name:"Dabigatran (Pradaxa)",class:"Direct Thrombin Inhibitor",halfLife:"12-17 hours",halfLifeNote:"Significantly prolonged in renal impairment (up to 28h if CrCl <30)",thrombolysisThreshold:"48 hours since last dose",thrombolysisNote:"Consider dTT or ECT if <48h - thrombolysis may be given if dTT/ECT normal or aPTT <40s",ichReversal:{primary:"Idarucizumab (Praxbind) 5g IV (2 x 2.5g vials)",alternative:"4-Factor PCC (Kcentra) 50 IU/kg if idarucizumab unavailable",note:"Idarucizumab is the ONLY FDA-approved specific reversal agent for dabigatran"},monitoring:"dTT (dilute thrombin time), ECT, or aPTT (less reliable)"},warfarin:{name:"Warfarin (Coumadin)",class:"Vitamin K Antagonist",halfLife:"20-60 hours",halfLifeNote:"Variable, depends on individual metabolism",thrombolysisThreshold:"INR \u22641.7",thrombolysisNote:"Contraindicated if INR >1.7, PT >15s, or aPTT >40s",ichReversal:{primary:"Vitamin K 10mg IV + 4-Factor PCC (Kcentra) based on INR and weight",pccDosing:"INR 2-4: 25 IU/kg; INR 4-6: 35 IU/kg; INR >6: 50 IU/kg (max 5000 IU)",alternative:"FFP 10-15 mL/kg if PCC unavailable (less effective, volume overload risk)",note:"Vitamin K should always be given for sustained reversal"},monitoring:"INR, PT"},heparin:{name:"Unfractionated Heparin (UFH)",class:"Indirect Thrombin Inhibitor",halfLife:"1-2 hours",halfLifeNote:"Dose-dependent, cleared faster at higher doses",thrombolysisThreshold:"24 hours if therapeutic dosing",thrombolysisNote:"Contraindicated if aPTT >40s - wait for normalization",ichReversal:{primary:"Protamine sulfate 1mg per 100 units UFH (last 2-3 hours)",maxDose:"Max 50mg protamine per dose",note:"Protamine has rapid onset; re-dose if continued bleeding"},monitoring:"aPTT, anti-Xa level"},lmwh:{name:"Low Molecular Weight Heparin (Enoxaparin, etc.)",class:"Indirect Factor Xa/IIa Inhibitor",halfLife:"4-6 hours",halfLifeNote:"Prolonged in renal impairment",thrombolysisThreshold:"24 hours since last therapeutic dose",thrombolysisNote:"Contraindicated within 24h of therapeutic dose; prophylactic dosing may be acceptable",ichReversal:{primary:"Protamine sulfate 1mg per 1mg enoxaparin (if <8h since dose)",note:"Protamine only partially reverses LMWH (~60% anti-Xa activity neutralized)"},monitoring:"Anti-Xa level (preferred), aPTT (unreliable)"}},Le={SISTER:{id:"SISTER",name:"SISTER Trial",nct:"NCT05948566",category:"ischemic",quickDescription:"Late thrombolysis (4.5-24h) for anterior circulation stroke, no TNK/EVT",lookingFor:["Anterior circulation stroke","Late presenter (4.5-24h from LKW)","NOT getting TNK or EVT","Has salvageable tissue on CTP (mismatch profile)"],keyCriteria:[{id:"age",label:"Age \u226518",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=18},required:!0},{id:"nihss",label:"NIHSS \u22656 (or 4-5 disabling)",field:"nihss",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.nihss)||((i=e.strokeCodeForm)==null?void 0:i.nihss))>=4},required:!0},{id:"timeWindow",label:"4.5-24h from LKW",field:"lkw",evaluate:e=>{let a=e.hoursFromLKW;return a!==null&&a>=4.5&&a<=24},required:!0},{id:"noTNK",label:"No IV thrombolysis",field:"tnkRecommended",evaluate:e=>{var a;return((a=e.telestrokeNote)==null?void 0:a.tnkRecommended)===!1},required:!0},{id:"noEVT",label:"No EVT planned",field:"evtRecommended",evaluate:e=>{var a;return((a=e.telestrokeNote)==null?void 0:a.evtRecommended)===!1},required:!0},{id:"aspects",label:"ASPECTS \u22656",field:"aspects",evaluate:e=>parseInt(e.aspectsScore)>=6,required:!0},{id:"premorbidMRS",label:"Pre-stroke mRS \u22642",field:"premorbidMRS",evaluate:e=>{var a;return parseInt((a=e.telestrokeNote)==null?void 0:a.premorbidMRS)<=2},required:!0},{id:"ctpMismatch",label:"CTP mismatch profile",field:"ctpResults",evaluate:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.ctpResults)||"").toLowerCase();return a.includes("mismatch")||a.includes("penumbra")||a.includes("salvageable")},required:!0}],exclusionFlags:[{id:"priorStroke90d",label:"Prior stroke <90 days",field:"priorStroke90d"},{id:"priorICH",label:"Prior intracranial hemorrhage",field:"priorICH"},{id:"onAnticoag",label:"On anticoagulation",field:"noAnticoagulants",evaluate:e=>{var a;return((a=e.telestrokeNote)==null?void 0:a.noAnticoagulants)===!1}}]},STEP:{id:"STEP",name:"STEP-EVT Trial",nct:"NCT06289985",category:"ischemic",quickDescription:"Adaptive platform for mild LVO or medium/distal vessel occlusions",lookingFor:["Two domains: Low NIHSS with LVO, OR Medium/Distal Vessel Occlusion","Low NIHSS (0-5) + ICA/M1 occlusion, or","M2/M3/M4, A1-A3, P1-P3 occlusion regardless of NIHSS"],keyCriteria:[{id:"age",label:"Age \u226518",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=18},required:!0},{id:"timeWindow",label:"Within 24h from LKW",field:"lkw",evaluate:e=>{let a=e.hoursFromLKW;return a!==null&&a<=24},required:!0},{id:"premorbidMRS",label:"Pre-stroke mRS \u22642",field:"premorbidMRS",evaluate:e=>{var a;return parseInt((a=e.telestrokeNote)==null?void 0:a.premorbidMRS)<=2},required:!0},{id:"vesselOcclusion",label:"LVO or MeVO present",field:"vesselOcclusion",evaluate:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.vesselOcclusion)||[]).length>0},required:!0},{id:"domainMatch",label:"Matches Low-NIHSS or MeVO domain",field:"nihss",evaluate:e=>{var n,c,d;let a=parseInt(((n=e.telestrokeNote)==null?void 0:n.nihss)||((c=e.strokeCodeForm)==null?void 0:c.nihss)),i=((d=e.telestrokeNote)==null?void 0:d.vesselOcclusion)||[],s=a<=5&&(i.includes("ICA")||i.includes("M1")),o=i.some(m=>["M2","M3","M4","A1","A2","A3","P1","P2","P3"].includes(m));return s||o},required:!0}],exclusionFlags:[{id:"pregnancy",label:"Pregnancy",field:"pregnancy"},{id:"hemorrhage",label:"Evidence of hemorrhage",field:"hemorrhage"}]},PICASSO:{id:"PICASSO",name:"PICASSO Trial",nct:"NCT05611242",category:"ischemic",quickDescription:"Tandem lesion: carotid stenosis + intracranial LVO",lookingFor:["Tandem lesion (carotid + intracranial)","Extracranial ICA stenosis 70-100%","Plus intracranial LVO (ICA-T, M1, proximal M2)"],keyCriteria:[{id:"age",label:"Age 18-79",field:"age",evaluate:e=>{var i,s;let a=parseInt(((i=e.telestrokeNote)==null?void 0:i.age)||((s=e.strokeCodeForm)==null?void 0:s.age));return a>=18&&a<=79},required:!0},{id:"timeWindow",label:"Within 16h from LKW",field:"lkw",evaluate:e=>{let a=e.hoursFromLKW;return a!==null&&a<=16},required:!0},{id:"nihss",label:"NIHSS \u22654",field:"nihss",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.nihss)||((i=e.strokeCodeForm)==null?void 0:i.nihss))>=4},required:!0},{id:"premorbidMRS",label:"Pre-stroke mRS 0-2",field:"premorbidMRS",evaluate:e=>{var a;return parseInt((a=e.telestrokeNote)==null?void 0:a.premorbidMRS)<=2},required:!0},{id:"aspects",label:"ASPECTS \u22657",field:"aspects",evaluate:e=>parseInt(e.aspectsScore)>=7,required:!0},{id:"tandemLesion",label:"Tandem lesion present",field:"ctaResults",evaluate:e=>{var i,s;let a=(((i=e.telestrokeNote)==null?void 0:i.ctaResults)||((s=e.strokeCodeForm)==null?void 0:s.cta)||"").toLowerCase();return a.includes("tandem")||a.includes("carotid")&&(a.includes("m1")||a.includes("ica"))},required:!0}],exclusionFlags:[]},TESTED:{id:"TESTED",name:"TESTED",nct:"NCT05911568",category:"ischemic",quickDescription:"EVT in patients with pre-existing disability (mRS 3-4)",lookingFor:["Patient with EXISTING disability (mRS 3-4)","LVO stroke within 24h","ASPECTS \u22653"],keyCriteria:[{id:"age",label:"Age \u226518",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=18},required:!0},{id:"premorbidMRS",label:"Pre-stroke mRS 3-4",field:"premorbidMRS",evaluate:e=>{var i;let a=parseInt((i=e.telestrokeNote)==null?void 0:i.premorbidMRS);return a>=3&&a<=4},required:!0},{id:"nihss",label:"NIHSS \u22656",field:"nihss",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.nihss)||((i=e.strokeCodeForm)==null?void 0:i.nihss))>=6},required:!0},{id:"timeWindow",label:"Within 24h from LKW",field:"lkw",evaluate:e=>{let a=e.hoursFromLKW;return a!==null&&a<=24},required:!0},{id:"aspects",label:"ASPECTS \u22653",field:"aspects",evaluate:e=>parseInt(e.aspectsScore)>=3,required:!0},{id:"lvo",label:"LVO present",field:"vesselOcclusion",evaluate:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.vesselOcclusion)||[]).some(s=>["ICA","M1","M2"].includes(s))},required:!0}],exclusionFlags:[]},SATURN:{id:"SATURN",name:"SATURN Trial",nct:"NCT03936361",category:"ich",quickDescription:"Statin continuation vs discontinuation after lobar ICH",lookingFor:["Lobar ICH (NOT deep/basal ganglia)","Already on statin therapy","Age \u226550"],keyCriteria:[{id:"age",label:"Age \u226550",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=50},required:!0},{id:"lobarICH",label:"Lobar ICH location",field:"ichLocation",evaluate:e=>{let a=(e.ichLocation||"").toLowerCase();return a.includes("lobar")||a.includes("cortical")},required:!0},{id:"onStatin",label:"On statin at ICH onset",field:"onStatin",evaluate:e=>e.onStatin===!0,required:!0},{id:"mrs",label:"mRS \u22644 at randomization",field:"mrsScore",evaluate:e=>parseInt(e.mrsScore)<=4,required:!0}],exclusionFlags:[{id:"deepICH",label:"Deep/non-lobar ICH",field:"ichLocation"},{id:"recentMI",label:"Recent MI <3 months",field:"recentMI"}]},ASPIRE:{id:"ASPIRE",name:"ASPIRE Trial",nct:"NCT03907046",category:"ich",quickDescription:"Apixaban vs aspirin post-ICH in atrial fibrillation",lookingFor:["ICH patient with atrial fibrillation","Randomize 14-180 days post-ICH","CHA2DS2-VASc \u22652"],keyCriteria:[{id:"age",label:"Age \u226518",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=18},required:!0},{id:"ichConfirmed",label:"ICH confirmed",field:"diagnosis",evaluate:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ich")||a.includes("hemorrhage")||a.includes("hemorrhagic")},required:!0},{id:"afib",label:"Atrial fibrillation",field:"pmh",evaluate:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.pmh)||"").toLowerCase();return a.includes("afib")||a.includes("atrial fib")||a.includes("af ")||a.includes("a-fib")},required:!0},{id:"mrs",label:"mRS \u22644",field:"mrsScore",evaluate:e=>parseInt(e.mrsScore)<=4,required:!0}],exclusionFlags:[{id:"mechValve",label:"Mechanical heart valve",field:"mechValve"}]},FASTEST:{id:"FASTEST",name:"FASTEST Trial",nct:"NCT03496883",category:"ich",quickDescription:"rFVIIa within 2 hours of ICH onset for hematoma expansion prevention",lookingFor:["Acute ICH within 2 HOURS of symptom onset","Hematoma volume 2-60 mL","Not on anticoagulants","Age 18-80"],keyCriteria:[{id:"age",label:"Age 18-80",field:"age",evaluate:e=>{var i,s;let a=parseInt(((i=e.telestrokeNote)==null?void 0:i.age)||((s=e.strokeCodeForm)==null?void 0:s.age));return a>=18&&a<=80},required:!0},{id:"ichConfirmed",label:"ICH confirmed on imaging",field:"diagnosis",evaluate:e=>{var s,o,n,c;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||((o=e.strokeCodeForm)==null?void 0:o.diagnosis)||"").toLowerCase(),i=(((n=e.telestrokeNote)==null?void 0:n.ctResults)||((c=e.strokeCodeForm)==null?void 0:c.ctResults)||"").toLowerCase();return a.includes("ich")||a.includes("hemorrhage")||i.includes("hemorrhage")||i.includes("bleed")},required:!0},{id:"timeWindow",label:"Within 2h of onset",field:"lkw",evaluate:e=>{let a=e.hoursFromLKW;return a!==null&&a<=2},required:!0},{id:"volume",label:"Hematoma 2-60 mL",field:"ichVolume",evaluate:e=>{let a=parseFloat(e.ichVolume);return!isNaN(a)&&a>=2&&a<=60},required:!0},{id:"noAnticoag",label:"Not on anticoagulants",field:"noAnticoagulants",evaluate:e=>{var a;return((a=e.telestrokeNote)==null?void 0:a.noAnticoagulants)===!0},required:!0},{id:"gcs",label:"GCS \u22658 (not deeply comatose)",field:"gcs",evaluate:e=>{let a=parseInt(e.gcsScore);return!isNaN(a)&&a>=8},required:!0},{id:"premorbidMRS",label:"Pre-stroke mRS \u22642",field:"premorbidMRS",evaluate:e=>{var i;let a=parseInt((i=e.telestrokeNote)==null?void 0:i.premorbidMRS);return!isNaN(a)&&a<=2},required:!0}],exclusionFlags:[{id:"onAnticoag",label:"On anticoagulation",field:"onAnticoag"},{id:"largeIVH",label:"IVH score >7",field:"largeIVH"},{id:"brainstem",label:"Brainstem hemorrhage",field:"brainstemICH"},{id:"secondary",label:"Secondary ICH (trauma, AVM, tumor)",field:"secondaryICH"}]},VERIFY:{id:"VERIFY",name:"VERIFY Study",nct:"NCT05338697",category:"ischemic",quickDescription:"Observational: TMS/MRI to predict motor recovery",lookingFor:["Acute ischemic stroke within 7 days","Upper extremity weakness","Inpatient enrollment opportunity"],keyCriteria:[{id:"age",label:"Age \u226518",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=18},required:!0},{id:"ueWeakness",label:"Upper extremity weakness",field:"symptoms",evaluate:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.symptoms)||"").toLowerCase();return a.includes("arm")||a.includes("upper")||a.includes("hand")||a.includes("weakness")},required:!1},{id:"premorbidMRS",label:"Pre-stroke mRS \u22642",field:"premorbidMRS",evaluate:e=>{var a;return parseInt((a=e.telestrokeNote)==null?void 0:a.premorbidMRS)<=2},required:!0}],exclusionFlags:[{id:"seizures",label:"History of seizures",field:"seizures"},{id:"implants",label:"Implanted devices (pacemaker, etc.)",field:"implants"}]},DISCOVERY:{id:"DISCOVERY",name:"DISCOVERY Study",nct:"NCT04916210",category:"ischemic",quickDescription:"Observational: Cognitive trajectories post-stroke",lookingFor:["Any stroke type (AIS, ICH, SAH)","Baseline visit within 6 weeks","Able to complete cognitive testing"],keyCriteria:[{id:"age",label:"Age \u226518",field:"age",evaluate:e=>{var a,i;return parseInt(((a=e.telestrokeNote)==null?void 0:a.age)||((i=e.strokeCodeForm)==null?void 0:i.age))>=18},required:!0},{id:"strokeConfirmed",label:"Stroke confirmed",field:"diagnosis",evaluate:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("sah")},required:!0}],exclusionFlags:[{id:"preDementia",label:"Pre-existing dementia",field:"preDementia"}]}},Cs={bp_pre_tnk:{id:"bp_pre_tnk",category:"Blood Pressure",title:"Pre-thrombolysis BP target",recommendation:"Maintain BP <185/110 mmHg before and during IV thrombolysis administration.",detail:"Use IV labetalol 10-20 mg or nicardipine 5 mg/hr (titrate by 2.5 mg/hr q5-15 min, max 15 mg/hr). If BP cannot be maintained <185/110, thrombolysis is contraindicated.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",medications:["Labetalol 10-20 mg IV","Nicardipine 5 mg/hr IV"],conditions:e=>{var n,c;let a=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase(),i=a.includes("ischemic")||a.includes("stroke")||a.includes("lvo"),s=e.timeFromLKW,o=s&&s.total<=4.5;return i&&(o||((c=e.telestrokeNote)==null?void 0:c.tnkRecommended))}},bp_post_tnk:{id:"bp_post_tnk",category:"Blood Pressure",title:"Post-thrombolysis BP target",recommendation:"Maintain BP <180/105 mmHg for 24 hours after IV thrombolysis.",detail:"Monitor BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",medications:["Labetalol IV PRN","Nicardipine infusion"],conditions:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.tnkAdminTime)}},bp_post_evt:{id:"bp_post_evt",category:"Blood Pressure",title:"Post-EVT BP management (Class III: Harm)",recommendation:"Do NOT target SBP <140 mmHg after successful EVT reperfusion. Maintain SBP <180/105.",detail:"ENCHANTED2/MT and OPTIMAL-BP trials demonstrated that intensive BP lowering (SBP <140) post-EVT was associated with worse functional outcomes (Class III: Harm). Standard target SBP <180/105 is recommended.",classOfRec:"III",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",caveats:"Based on ENCHANTED2/MT (2023) and OPTIMAL-BP (2024). Applies to successful reperfusion (mTICI 2b-3).",conditions:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.evtRecommended)}},bp_ich_acute:{id:"bp_ich_acute",category:"Blood Pressure",title:"ICH acute BP target",recommendation:"Target SBP 130-150 mmHg within 2 hours of ICH onset. Initiate rapid treatment for SBP >150.",detail:"Nicardipine infusion preferred for reliable titration. Avoid SBP <130 (risk of renal AKI). Maintain target for at least 24 hours.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Spontaneous ICH 2022",reference:"Greenberg SM et al. Stroke. 2022;53:e282-e361. DOI: 10.1161/STR.0000000000000407",medications:["Nicardipine 5 mg/hr IV (titrate to 15 mg/hr)","Labetalol 10-20 mg IV bolus PRN"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral")}},bp_ischemic_no_lysis:{id:"bp_ischemic_no_lysis",category:"Blood Pressure",title:"Ischemic stroke BP (no thrombolysis)",recommendation:"Permissive hypertension: treat only if BP >220/120 mmHg in first 24-48 hours. Lower by 15% in first 24 hours if treating.",detail:"For patients not receiving thrombolysis or EVT, aggressive BP lowering may worsen ischemic penumbra. After 24-48h, initiate oral antihypertensives to target <130/80 for secondary prevention.",classOfRec:"I",levelOfEvidence:"C-EO",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var s,o,n;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase();return(a.includes("ischemic")||a.includes("stroke")||a.includes("lvo"))&&!((o=e.telestrokeNote)!=null&&o.tnkRecommended)&&!((n=e.telestrokeNote)!=null&&n.evtRecommended)}},tnk_standard:{id:"tnk_standard",category:"Thrombolysis",title:"IV TNK for acute ischemic stroke",recommendation:"Administer TNK 0.25 mg/kg (max 25 mg) single IV bolus within 4.5 hours of symptom onset.",detail:"TNK is the preferred thrombolytic due to single-bolus dosing (Class I, LOE A). Administer at spoke and transfer immediately for EVT evaluation if LVO suspected. Do not delay for imaging beyond NCCT.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",medications:["TNK 0.25 mg/kg IV bolus (max 25 mg)"],conditions:e=>{var o;let a=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase(),i=a.includes("ischemic")||a.includes("stroke")||a.includes("lvo"),s=e.timeFromLKW;return i&&s&&s.total<=4.5}},tnk_extended_imaging:{id:"tnk_extended_imaging",category:"Thrombolysis",title:"Extended window TNK (4.5-24h)",recommendation:"TNK 0.25 mg/kg (max 25 mg) IV bolus may be considered in the 4.5-24 hour window when perfusion imaging shows salvageable tissue (core <70 mL, mismatch ratio >1.2).",detail:"Based on TIMELESS trial (2025): TNK in the 4.5-24h window with perfusion mismatch showed improved functional outcomes. Also supported by EXTEND/WAKE-UP criteria (DWI-FLAIR mismatch for wake-up strokes). Requires CTP or MRI DWI/perfusion before treatment.",classOfRec:"IIa",levelOfEvidence:"B-R",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026; TIMELESS Investigators. NEJM 2025.",medications:["TNK 0.25 mg/kg IV bolus (max 25 mg)"],conditions:e=>{var o;let a=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase(),i=a.includes("ischemic")||a.includes("stroke")||a.includes("lvo"),s=e.timeFromLKW;return i&&s&&s.total>4.5&&s.total<=24}},evt_standard:{id:"evt_standard",category:"EVT",title:"EVT for LVO within 6 hours",recommendation:"EVT recommended for anterior LVO (ICA, M1) within 6 hours of onset with NIHSS >= 6 and ASPECTS >= 6.",detail:"Do not delay transfer for TNK response. Administer TNK at spoke and transfer immediately for EVT evaluation.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var o,n;let a=parseInt((o=e.telestrokeNote)==null?void 0:o.nihss)||e.nihssScore||0,i=e.timeFromLKW,s=(((n=e.telestrokeNote)==null?void 0:n.vesselOcclusion)||[]).some(c=>/ica|m1|mca/i.test(c));return a>=6&&i&&i.total<=6&&s}},evt_late_window:{id:"evt_late_window",category:"EVT",title:"EVT late window (6-24h)",recommendation:"EVT recommended 6-24 hours from onset for anterior LVO with favorable perfusion imaging or good collaterals (NIHSS >= 6).",detail:"Based on DAWN/DEFUSE-3 criteria. Requires CT perfusion or MRI DWI/perfusion showing target mismatch. Age >= 80 requires NIHSS >= 10. Good collateral status on CTA may independently predict benefit in late window.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",caveats:"Collateral grading on multiphase CTA or single-phase CTA may support EVT candidacy when CTP unavailable.",conditions:e=>{var o,n;let a=parseInt((o=e.telestrokeNote)==null?void 0:o.nihss)||e.nihssScore||0,i=e.timeFromLKW,s=(((n=e.telestrokeNote)==null?void 0:n.vesselOcclusion)||[]).some(c=>/ica|m1|mca/i.test(c));return a>=6&&i&&i.total>6&&i.total<=24&&s}},evt_large_core:{id:"evt_large_core",category:"EVT",title:"EVT for large ischemic core (ASPECTS 3-5)",recommendation:"EVT can be beneficial for anterior LVO with ASPECTS 3-5 within 24 hours when NIHSS >= 6.",detail:"Based on SELECT2, RESCUE-Japan LIMIT, and ANGEL-ASPECT (2023). Despite larger infarcts, EVT still provides benefit. Goals-of-care discussion recommended. Higher sICH rates (~10%) and mortality. Consider patient/family preferences.",classOfRec:"IIa",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026; SELECT2 (NEJM 2023); ANGEL-ASPECT (NEJM 2023); RESCUE-Japan LIMIT (NEJM 2023).",caveats:"Trial eligibility: SELECT2 (ASPECTS 3-5, NIHSS >=6, LVO, <24h); ANGEL-ASPECT (ASPECTS 3-5, core 70-100mL, <24h); RESCUE-Japan LIMIT (ASPECTS 3-5, <24h).",conditions:e=>{var o,n;let a=parseInt((o=e.telestrokeNote)==null?void 0:o.nihss)||e.nihssScore||0,i=e.aspectsScore,s=(((n=e.telestrokeNote)==null?void 0:n.vesselOcclusion)||[]).some(c=>/ica|m1|mca/i.test(c));return a>=6&&i>=3&&i<=5&&s}},evt_basilar:{id:"evt_basilar",category:"EVT",title:"EVT for basilar artery occlusion",recommendation:"EVT is recommended for basilar artery occlusion within 24 hours of symptom onset.",detail:"Based on ATTENTION and BAOCHE trials (2023). Benefit demonstrated up to 24 hours. Consider in posterior circulation strokes with significant deficit.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var s;let a=e.timeFromLKW;return(((s=e.telestrokeNote)==null?void 0:s.vesselOcclusion)||[]).some(o=>/basilar/i.test(o))&&a&&a.total<=24}},dapt_minor_stroke:{id:"dapt_minor_stroke",category:"Antithrombotic",title:"DAPT for minor stroke/TIA",recommendation:"Dual antiplatelet therapy (aspirin + clopidogrel) for 21 days in minor ischemic stroke (NIHSS <= 3) or high-risk TIA, then transition to single antiplatelet.",detail:"Start within 24 hours of onset. Loading dose: ASA 325 mg + clopidogrel 300 mg, then ASA 81 mg + clopidogrel 75 mg daily for 21 days. Based on CHANCE/POINT trials.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",medications:["ASA 325 mg load then 81 mg daily","Clopidogrel 300 mg load then 75 mg daily x 21 days"],conditions:e=>{var o,n,c;let a=parseInt((o=e.telestrokeNote)==null?void 0:o.nihss)||e.nihssScore||0,i=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase();return(i.includes("ischemic")||i.includes("stroke")||i.includes("tia"))&&a<=3&&!((c=e.telestrokeNote)!=null&&c.tnkRecommended)}},anticoag_af_timing:{id:"anticoag_af_timing",category:"Antithrombotic",title:"Early DOAC initiation in AF-related stroke",recommendation:"Initiate DOAC early after AF-related ischemic stroke based on infarct severity: minor stroke within 48 hours, moderate stroke day 3-5, severe/large stroke day 6-14.",detail:"Based on CATALYST meta-analysis (ELAN, OPTIMAS, TIMING, START pooled data). No increased risk of symptomatic ICH with early DOAC initiation vs delayed. Individual timing should consider hemorrhagic transformation on imaging. DOAC preferred over warfarin (Class I, LOE A).",classOfRec:"IIa",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021 + CATALYST Meta-Analysis 2025",reference:"Fischer U et al. Lancet Neurol. 2025. CATALYST: Collaboration for Antithrombotic Timing After Acute Ischaemic Stroke.",medications:["Apixaban 5 mg BID (preferred)","Rivaroxaban 20 mg daily","Dabigatran 150 mg BID"],caveats:"Timing categories per CATALYST: minor (NIHSS <8, small infarct) 48h; moderate (NIHSS 8-15) day 3-5; severe (NIHSS >15 or large infarct) day 6-14. Reassess imaging before starting if any concern for hemorrhagic transformation.",conditions:e=>{var c,d,m;let a=(((c=e.telestrokeNote)==null?void 0:c.medications)||"").toLowerCase(),i=(((d=e.telestrokeNote)==null?void 0:d.pmh)||"").toLowerCase(),s=i.includes("afib")||i.includes("atrial fib")||i.includes("a-fib")||i.includes("af ")||a.includes("apixaban")||a.includes("rivaroxaban")||a.includes("eliquis")||a.includes("xarelto")||a.includes("warfarin")||a.includes("coumadin")||a.includes("dabigatran")||a.includes("pradaxa"),o=(((m=e.telestrokeNote)==null?void 0:m.diagnosis)||"").toLowerCase();return(o.includes("ischemic")||o.includes("stroke"))&&s}},sicas_dapt:{id:"sicas_dapt",category:"Antithrombotic",title:"Symptomatic intracranial atherosclerosis (sICAS) DAPT",recommendation:"DAPT (aspirin + clopidogrel) for 90 days for severe symptomatic intracranial stenosis (70-99%), then aspirin 325 mg monotherapy.",detail:"Do NOT offer intracranial stenting as initial treatment (Class III). Add high-intensity statin with LDL target <70 mg/dL. Based on SAMMPRIS trial evidence.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"AAN Intracranial Atherosclerosis Practice Advisory 2022 (reaffirmed 2025)",reference:"AAN Practice Advisory 2022. Reaffirmed 2025.",medications:["ASA 325 mg daily (after 90-day DAPT)","Clopidogrel 75 mg daily x 90 days","High-intensity statin"],conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("intracranial")||a.includes("icas")||i.includes("intracranial stenosis")||i.includes("icas")}},statin_ischemic:{id:"statin_ischemic",category:"Statin",title:"High-intensity statin for ischemic stroke",recommendation:"Initiate high-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) with LDL target <70 mg/dL.",detail:"Add ezetimibe if LDL not at goal on max statin. Consider PCSK9 inhibitor if still not at goal. Start during hospitalization.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",medications:["Atorvastatin 80 mg daily","Rosuvastatin 20-40 mg daily","Ezetimibe 10 mg if LDL not at goal"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ischemic")||a.includes("stroke")||a.includes("tia")||a.includes("lvo")}},reversal_warfarin:{id:"reversal_warfarin",category:"Reversal",title:"Warfarin reversal in ICH",recommendation:"Administer IV Vitamin K 10 mg + 4-factor PCC (KCentra) for ICH on warfarin. Target INR <1.5 within 4 hours.",detail:"PCC preferred over FFP (faster, lower volume, more predictable reversal). Recheck INR at 30-60 minutes. Repeat PCC if INR remains elevated.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Spontaneous ICH 2022",reference:"Greenberg SM et al. Stroke. 2022;53:e282-e361. DOI: 10.1161/STR.0000000000000407",medications:["Vitamin K 10 mg IV over 20 min","4F-PCC (KCentra) 25-50 IU/kg based on INR"],conditions:e=>{var n,c;let a=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase(),i=(((c=e.telestrokeNote)==null?void 0:c.medications)||"").toLowerCase(),s=a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral"),o=i.includes("warfarin")||i.includes("coumadin");return s&&o}},reversal_dabigatran:{id:"reversal_dabigatran",category:"Reversal",title:"Dabigatran reversal in ICH",recommendation:"Administer idarucizumab (Praxbind) 5g IV (2 x 2.5g) for ICH on dabigatran.",detail:"If idarucizumab unavailable, use 4F-PCC 50 IU/kg. Reversal is immediate with idarucizumab.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Spontaneous ICH 2022",reference:"Greenberg SM et al. Stroke. 2022;53:e282-e361. DOI: 10.1161/STR.0000000000000407",medications:["Idarucizumab (Praxbind) 5g IV","Alt: 4F-PCC 50 IU/kg if unavailable"],conditions:e=>{var n,c;let a=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase(),i=(((c=e.telestrokeNote)==null?void 0:c.medications)||"").toLowerCase(),s=a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral"),o=i.includes("dabigatran")||i.includes("pradaxa");return s&&o}},reversal_xa_inhibitor:{id:"reversal_xa_inhibitor",category:"Reversal",title:"Factor Xa inhibitor reversal in ICH",recommendation:"Administer andexanet alfa or 4F-PCC 50 IU/kg for ICH on apixaban/rivaroxaban.",detail:"Andexanet alfa (Andexxa) if available: low-dose bolus 400 mg then 480 mg infusion (rivaroxaban >7h or apixaban), high-dose 800 mg then 960 mg (rivaroxaban <7h). If unavailable, use 4F-PCC 50 IU/kg.",classOfRec:"IIa",levelOfEvidence:"B-NR",guideline:"AHA/ASA Spontaneous ICH 2022",reference:"Greenberg SM et al. Stroke. 2022;53:e282-e361. DOI: 10.1161/STR.0000000000000407",medications:["Andexanet alfa (Andexxa) per dosing protocol","4F-PCC 50 IU/kg if andexanet unavailable"],conditions:e=>{var n,c;let a=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase(),i=(((c=e.telestrokeNote)==null?void 0:c.medications)||"").toLowerCase(),s=a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral"),o=i.includes("apixaban")||i.includes("eliquis")||i.includes("rivaroxaban")||i.includes("xarelto");return s&&o}},transfer_evt:{id:"transfer_evt",category:"Disposition",title:"Transfer for EVT evaluation",recommendation:"Transfer LVO patients to EVT-capable center immediately. Do NOT wait for clinical response to IV thrombolysis before initiating transfer.",detail:"Administer TNK at spoke site (if eligible) and initiate transfer simultaneously. Time-to-reperfusion is the critical metric.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.vesselOcclusion)||[]).some(n=>/ica|m1|mca|basilar/i.test(n)),i=parseInt((o=e.telestrokeNote)==null?void 0:o.nihss)||e.nihssScore||0;return a&&i>=6}},cerebellar_ich_surgery:{id:"cerebellar_ich_surgery",category:"Disposition",title:"Cerebellar ICH: surgical evacuation",recommendation:"Urgent surgical evacuation for cerebellar ICH >15 mL with neurological deterioration, brainstem compression, or obstructive hydrocephalus.",detail:"EVD alone insufficient for large cerebellar hemorrhages. Suboccipital craniectomy recommended. Transfer to neurosurgical center emergently.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Spontaneous ICH 2022",reference:"Greenberg SM et al. Stroke. 2022;53:e282-e361. DOI: 10.1161/STR.0000000000000407",conditions:e=>{var n,c;let a=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase(),i=(((c=e.telestrokeNote)==null?void 0:c.ctResults)||"").toLowerCase(),s=a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral"),o=i.includes("cerebell")||a.includes("cerebell")||i.includes("posterior fossa");return s&&o}},decompressive_craniectomy:{id:"decompressive_craniectomy",category:"Disposition",title:"Decompressive craniectomy for malignant MCA infarction",recommendation:"Consider decompressive craniectomy within 48 hours for malignant MCA infarction in patients age <60 with deteriorating neurological status despite medical therapy.",detail:"Based on pooled analysis of DECIMAL, DESTINY, HAMLET trials. Reduces mortality from ~78% to ~22%. Discuss functional outcomes and goals of care with family.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var n,c,d;let a=parseInt((n=e.telestrokeNote)==null?void 0:n.nihss)||e.nihssScore||0,i=parseInt((c=e.telestrokeNote)==null?void 0:c.age)||0,s=(((d=e.telestrokeNote)==null?void 0:d.diagnosis)||"").toLowerCase();return(s.includes("ischemic")||s.includes("mca")||s.includes("malignant"))&&a>=15&&i>0&&i<60}},carotid_intervention:{id:"carotid_intervention",category:"Secondary Prevention",title:"Carotid intervention for symptomatic stenosis",recommendation:"Carotid endarterectomy (CEA) or stenting within 2 weeks for symptomatic carotid stenosis 70-99%. Consider for 50-69% based on patient factors.",detail:"CEA preferred if age >70 and suitable anatomy. CAS reasonable if high surgical risk. Benefit diminishes if delayed beyond 2 weeks.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.ctaResults)||"").toLowerCase();return a.includes("carotid")&&(a.includes("stenosis")||a.includes("occlus"))}},pfo_closure:{id:"pfo_closure",category:"Secondary Prevention",title:"PFO closure for cryptogenic stroke",recommendation:"PFO closure is recommended for patients age 18-60 with cryptogenic ischemic stroke and high-risk PFO features (atrial septal aneurysm, large shunt).",detail:"Based on CLOSE, RESPECT, REDUCE trials. Also antiplatelet therapy. Anticoagulation if concurrent DVT/PE.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=parseInt((o=e.telestrokeNote)==null?void 0:o.age)||0;return(a.includes("cryptogenic")||a.includes("pfo")||a.includes("esus"))&&i>=18&&i<=60}},dysphagia_screen:{id:"dysphagia_screen",category:"Supportive Care",title:"Dysphagia screening",recommendation:"Keep patient NPO until formal dysphagia screening is passed. Screen before any oral intake including medications.",detail:"Use validated bedside screening tool (e.g., Yale Swallow Protocol, 3-oz water test). SLP evaluation for failed screens. Aspiration pneumonia is a leading cause of post-stroke mortality.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("hemorrhag")}},vte_prophylaxis:{id:"vte_prophylaxis",category:"Supportive Care",title:"VTE prophylaxis",recommendation:"Intermittent pneumatic compression (IPC) on admission. Add pharmacologic prophylaxis (LMWH or UFH) after 24-48 hours in immobile patients.",detail:"For ischemic stroke post-TNK: delay pharmacologic VTE prophylaxis 24 hours. For ICH: IPC immediately; consider pharmacologic prophylaxis after 24-48h if hematoma stable.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"AHA Systemic Complications of Acute Stroke 2024",reference:"AHA Scientific Statement 2024. DOI: 10.1161/STR.0000000000000477",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("hemorrhag")}},glycemic_management:{id:"glycemic_management",category:"Glycemic",title:"Glycemic management (Class III: Harm for intensive insulin)",recommendation:"Target glucose 140-180 mg/dL. Do NOT use IV insulin to target 80-130 mg/dL (Class III: Harm). Treat hypoglycemia <60 mg/dL emergently.",detail:"SHINE trial demonstrated no benefit and increased hypoglycemia with intensive glucose control (80-130). Subcutaneous insulin sliding scale preferred for mild hyperglycemia.",classOfRec:"III",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. DOI: 10.1161/STR.0000000000000513",conditions:e=>{var o,n;let a=parseInt((o=e.telestrokeNote)==null?void 0:o.glucose)||0,i=(((n=e.telestrokeNote)==null?void 0:n.diagnosis)||"").toLowerCase();return(i.includes("stroke")||i.includes("ischemic")||i.includes("ich"))&&(a>180||a<60||a===0)}},fever_management:{id:"fever_management",category:"Supportive Care",title:"Fever management",recommendation:"Treat fever (>38C) with acetaminophen and identify source. Maintain normothermia.",detail:"Fever worsens outcomes in stroke. Search for UTI, pneumonia, line infection. Induced hypothermia not recommended outside clinical trials.",classOfRec:"I",levelOfEvidence:"C-LD",guideline:"AHA Systemic Complications of Acute Stroke 2024",reference:"AHA Scientific Statement 2024. DOI: 10.1161/STR.0000000000000477",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("hemorrhag")}},goc_ich:{id:"goc_ich",category:"Goals of Care",title:"Goals-of-care discussion in ICH",recommendation:"Initiate goals-of-care discussion for ICH Score >= 3. Avoid early DNR orders that may limit aggressive care in first 24-48 hours.",detail:"Self-fulfilling prophecy of early care withdrawal is well-documented in ICH. Recommend full care for minimum 24-48 hours while prognostic picture clarifies. ICH Score is for prognostication, not to determine treatment limits.",classOfRec:"I",levelOfEvidence:"C-LD",guideline:"AHA/ASA Spontaneous ICH 2022 + AHA Palliative Care in Stroke 2024",reference:"Greenberg SM et al. Stroke. 2022. DOI: 10.1161/STR.0000000000000407; AHA 2024. DOI: 10.1161/STR.0000000000000479",conditions:e=>{var o;let a=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase(),i=a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral"),s=e.ichScore||0;return i&&s>=3}},sah_bp_presecuring:{id:"sah_bp_presecuring",category:"SAH Management",title:"SAH: BP management (pre-aneurysm securing)",recommendation:"Target SBP <160 mmHg before aneurysm is secured. Avoid SBP >160 to reduce rebleeding risk.",detail:"Use short-acting IV agents (nicardipine or labetalol) for rapid titration. Avoid nitroprusside (may increase ICP). Balance between rebleed prevention and cerebral perfusion.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Aneurysmal SAH 2023",reference:"Hoh BL et al. Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436",medications:["Nicardipine 5 mg/hr IV (titrate to 15 mg/hr)","Labetalol 10-20 mg IV bolus PRN"],conditions:e=>{var i,s;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return(a.includes("sah")||a.includes("subarachnoid"))&&!((s=e.telestrokeNote)!=null&&s.sahAneurysmSecured)}},sah_nimodipine:{id:"sah_nimodipine",category:"SAH Management",title:"SAH: Nimodipine for vasospasm prevention",recommendation:"Administer nimodipine 60 mg PO/NG q4h for 21 days. Begin as soon as possible after SAH diagnosis.",detail:"Only calcium channel blocker proven to improve outcomes after SAH. If hypotension occurs, reduce to 30 mg q2h. Do not give IV. Reduces delayed cerebral ischemia (DCI), not angiographic vasospasm.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Aneurysmal SAH 2023",reference:"Hoh BL et al. Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436",medications:["Nimodipine 60 mg PO/NG q4h x 21 days"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("sah")||a.includes("subarachnoid")}},sah_seizure:{id:"sah_seizure",category:"SAH Management",title:"SAH: Seizure management",recommendation:"Short-term (3-7 day) seizure prophylaxis may be considered. Routine long-term prophylaxis is NOT recommended.",detail:"Consider levetiracetam over phenytoin (phenytoin associated with worse cognitive outcomes). Continuous EEG monitoring for poor-grade SAH (HH 4-5). Routine prophylactic AEDs beyond 7 days are associated with harm.",classOfRec:"IIb",levelOfEvidence:"B-NR",guideline:"AHA/ASA Aneurysmal SAH 2023",reference:"Hoh BL et al. Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436",medications:["Levetiracetam 500-1000 mg IV/PO q12h (preferred)","Avoid phenytoin if possible"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("sah")||a.includes("subarachnoid")}},sah_aneurysm_securing:{id:"sah_aneurysm_securing",category:"SAH Management",title:"SAH: Early aneurysm securing (clip or coil)",recommendation:"Secure ruptured aneurysm as early as feasible, ideally within 24 hours to reduce rebleeding risk.",detail:"Endovascular coiling preferred for posterior circulation and elderly. Microsurgical clipping may be preferred for MCA aneurysms, large hematomas requiring evacuation, or wide-neck aneurysms. Multidisciplinary decision between neurovascular surgery and neurointerventional.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Aneurysmal SAH 2023",reference:"Hoh BL et al. Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436",conditions:e=>{var i,s;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return(a.includes("sah")||a.includes("subarachnoid"))&&!((s=e.telestrokeNote)!=null&&s.sahAneurysmSecured)}},sah_euvolemia:{id:"sah_euvolemia",category:"SAH Management",title:"SAH: Euvolemia maintenance",recommendation:"Maintain euvolemia with isotonic crystalloids. Avoid hypovolemia and prophylactic hypervolemia (triple-H therapy is NOT recommended).",detail:"Target euvolemia with isotonic saline. Monitor for cerebral salt wasting and SIADH. Induced hypertension may be considered as rescue for symptomatic DCI after aneurysm securing.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"AHA/ASA Aneurysmal SAH 2023",reference:"Hoh BL et al. Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("sah")||a.includes("subarachnoid")}},sah_evd:{id:"sah_evd",category:"SAH Management",title:"SAH: External ventricular drain (EVD)",recommendation:"Place EVD for acute hydrocephalus or poor-grade SAH (Hunt & Hess 3-5) with decreased level of consciousness.",detail:"CSF diversion improves outcomes in acute hydrocephalus. Monitor for ventriculitis. Consider weaning after aneurysm securing and clinical improvement.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Aneurysmal SAH 2023",reference:"Hoh BL et al. Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436",conditions:e=>{var o,n;let a=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase(),i=a.includes("sah")||a.includes("subarachnoid"),s=parseInt((n=e.telestrokeNote)==null?void 0:n.sahGrade)||0;return i&&s>=3}},cvt_anticoag_acute:{id:"cvt_anticoag_acute",category:"CVT Management",title:"CVT: Acute anticoagulation",recommendation:"Initiate therapeutic anticoagulation with LMWH or UFH, even in the presence of hemorrhagic infarction or small parenchymal hemorrhage.",detail:"LMWH preferred over UFH in most cases. Enoxaparin 1 mg/kg q12h or weight-based UFH with aPTT target 60-80s. Hemorrhagic transformation is NOT a contraindication. For large parenchymal hemorrhages, individualize decision.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA Cerebral Venous Thrombosis 2024",reference:"Saposnik G et al. Stroke. 2024. DOI: 10.1161/STR.0000000000000467",medications:["Enoxaparin 1 mg/kg SC q12h","UFH weight-based (aPTT 60-80s)"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("cvt")||a.includes("venous thrombosis")||a.includes("cerebral venous")||a.includes("dural sinus")}},cvt_anticoag_longterm:{id:"cvt_anticoag_longterm",category:"CVT Management",title:"CVT: Long-term anticoagulation",recommendation:"Transition to warfarin (INR 2-3) for 3-12 months. DOACs may be considered as alternative in provoked CVT without severe features.",detail:"Duration: 3-6 months for provoked CVT, 6-12 months for unprovoked, indefinite if recurrent VTE or severe thrombophilia. ACTION-CVT supports DOAC non-inferiority for mild-moderate CVT. Warfarin preferred for severe CVT or antiphospholipid syndrome.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA Cerebral Venous Thrombosis 2024",reference:"Saposnik G et al. Stroke. 2024. DOI: 10.1161/STR.0000000000000467",medications:["Warfarin target INR 2-3","DOAC alternative: rivaroxaban 20 mg or apixaban 5 mg BID"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("cvt")||a.includes("venous thrombosis")||a.includes("cerebral venous")||a.includes("dural sinus")}},cvt_icp_management:{id:"cvt_icp_management",category:"CVT Management",title:"CVT: Elevated ICP management",recommendation:"Assess for elevated ICP. Use acetazolamide for isolated intracranial hypertension. LP with CSF drainage for severe headache or visual impairment.",detail:"Elevated ICP is common in CVT. HOB elevation to 30 degrees. Avoid lumbar drain in large parenchymal lesions. Decompressive craniectomy for malignant CVT with impending herniation.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"AHA Cerebral Venous Thrombosis 2024",reference:"Saposnik G et al. Stroke. 2024. DOI: 10.1161/STR.0000000000000467",medications:["Acetazolamide 250-500 mg PO BID","LP with CSF drainage if severe"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("cvt")||a.includes("venous thrombosis")||a.includes("cerebral venous")||a.includes("dural sinus")}},cvt_seizure:{id:"cvt_seizure",category:"CVT Management",title:"CVT: Seizure management",recommendation:"Seizure prophylaxis is reasonable for CVT with supratentorial parenchymal lesions. Treat acute seizures with standard ASMs.",detail:"Seizures occur in ~40% of CVT patients. Supratentorial hemorrhagic or ischemic lesions increase risk. Levetiracetam preferred. Duration: typically 3-6 months, taper if seizure-free and lesion resolved.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"AHA Cerebral Venous Thrombosis 2024",reference:"Saposnik G et al. Stroke. 2024. DOI: 10.1161/STR.0000000000000467",medications:["Levetiracetam 500-1000 mg PO/IV q12h"],conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("cvt")||a.includes("venous thrombosis")||a.includes("cerebral venous")||a.includes("dural sinus")}},cvt_thrombophilia:{id:"cvt_thrombophilia",category:"CVT Management",title:"CVT: Thrombophilia workup",recommendation:"Evaluate for underlying thrombophilia in unprovoked CVT, especially in young patients. Defer testing until after acute phase if possible.",detail:"Test for: Factor V Leiden, prothrombin G20210A, antithrombin III, protein C/S, antiphospholipid antibodies. Hormonal risk factors (OCP, pregnancy) are most common provoked cause. Test timing: some assays affected by acute thrombosis and anticoagulation.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"AHA Cerebral Venous Thrombosis 2024",reference:"Saposnik G et al. Stroke. 2024. DOI: 10.1161/STR.0000000000000467",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=parseInt((o=e.telestrokeNote)==null?void 0:o.age)||0;return(a.includes("cvt")||a.includes("venous thrombosis")||a.includes("cerebral venous")||a.includes("dural sinus"))&&i<=60}},tia_admit:{id:"tia_admit",category:"TIA",title:"TIA: Hospital admission",recommendation:"Admit ALL TIA patients for urgent workup regardless of ABCD2 score.",detail:"Inpatient evaluation allows rapid completion of workup (MRI DWI, CTA, cardiac monitoring, labs) and early initiation of secondary prevention. Reduces 90-day stroke risk by 80% compared to outpatient evaluation.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Secondary Stroke Prevention 2021 + 2026 Update",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467; Powers WJ et al. Stroke. 2026.",conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase().includes("tia")}},tia_mri_dwi:{id:"tia_mri_dwi",category:"TIA",title:"TIA: MRI with DWI",recommendation:"Obtain MRI with DWI for all TIA patients to evaluate for acute infarction.",detail:"DWI-positive TIA (i.e., tissue-based minor stroke) carries higher recurrence risk. MRI also helps classify etiology. If MRI unavailable, CT is acceptable but inferior for small infarct detection.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467.",conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase().includes("tia")}},tia_vascular_imaging:{id:"tia_vascular_imaging",category:"TIA",title:"TIA: Vascular imaging (CTA/MRA)",recommendation:"Obtain CTA or MRA of head and neck for all TIA patients to evaluate for large artery stenosis or occlusion.",detail:"Identifies symptomatic carotid stenosis (CEA/CAS candidate), intracranial stenosis (DAPT candidate), or dissection. Urgent imaging within 24 hours preferred.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467.",conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase().includes("tia")}},tia_cardiac_monitoring:{id:"tia_cardiac_monitoring",category:"TIA",title:"TIA: Cardiac monitoring for AF detection",recommendation:"Perform cardiac monitoring for AF detection: 30-day ambulatory monitor preferred, 14-day patch if unavailable, ILR in select cases.",detail:"AF is found in up to 25% of cryptogenic stroke/TIA with prolonged monitoring. 30-day event monitor (e.g., Zio AT) is preferred. If unavailable, 14-day continuous patch (e.g., Zio Patch). ILR (e.g., LINQ) considered if high suspicion and no AF detected on ambulatory monitoring.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"AHA/ASA Secondary Stroke Prevention 2021 + 2026 Update",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467; CRYSTAL-AF, EMBRACE trials.",conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase().includes("tia")}},tia_echo:{id:"tia_echo",category:"TIA",title:"TIA: Echocardiography",recommendation:"Obtain echocardiography (TTE with bubble study; TEE if PFO or structural pathology suspected).",detail:"Identifies PFO, atrial septal aneurysm, valvular disease, or intracardiac thrombus. PFO closure may be indicated based on PASCAL classification in appropriate patients.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467.",conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase().includes("tia")}},tia_dapt:{id:"tia_dapt",category:"TIA",title:"TIA: DAPT for high-risk TIA",recommendation:"Start DAPT (aspirin + clopidogrel) within 24 hours for high-risk TIA, continue for 21 days, then single antiplatelet.",detail:"Loading: ASA 325 mg + clopidogrel 300 mg. Maintenance: ASA 81 mg + clopidogrel 75 mg x 21 days. Based on CHANCE/POINT/THALES trials. High-risk TIA = ABCD2 >=4 or DWI+ on MRI.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467.",medications:["ASA 325 mg load then 81 mg daily","Clopidogrel 300 mg load then 75 mg daily x 21 days"],conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase().includes("tia")}},dissection_antithrombotic:{id:"dissection_antithrombotic",category:"Dissection",title:"Cervical artery dissection: Antithrombotic therapy",recommendation:"Antiplatelet or anticoagulation for cervical artery dissection. Either approach is reasonable (no proven superiority of one over the other).",detail:"CADISS trial showed no significant difference between antiplatelet and anticoagulation. Choice depends on clinical factors: anticoagulation may be preferred for pseudoaneurysm, free-floating thrombus, or recurrent events on antiplatelet. Duration: typically 3-6 months.",classOfRec:"IIa",levelOfEvidence:"B-R",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"CADISS Trial Investigators. Lancet Neurol. 2015;14:361-367.",medications:["ASA 81-325 mg daily","OR Heparin bridge to warfarin (INR 2-3)","OR DOAC (off-label, growing evidence)"],conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("dissect")||i.includes("dissect")}},dissection_imaging_followup:{id:"dissection_imaging_followup",category:"Dissection",title:"Cervical artery dissection: Imaging follow-up",recommendation:"Repeat vascular imaging (CTA or MRA) at 3-6 months to assess for recanalization or pseudoaneurysm evolution.",detail:"Most dissections heal within 3-6 months. Persistent stenosis/occlusion or pseudoaneurysm may warrant continued antithrombotic therapy. If fully recanalized, may consider stopping anticoagulation and switching to antiplatelet.",classOfRec:"IIa",levelOfEvidence:"C-EO",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("dissect")||i.includes("dissect")}},dissection_avoid_manipulation:{id:"dissection_avoid_manipulation",category:"Dissection",title:"Cervical artery dissection: Avoid cervical manipulation",recommendation:"Advise patients to avoid cervical manipulation (chiropractic, aggressive physical therapy) during healing phase.",detail:"While causation is debated, cervical manipulation is associated with vertebral and carotid dissection. Patients should avoid high-velocity neck movements during the healing period (minimum 3 months).",classOfRec:"IIb",levelOfEvidence:"C-LD",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("dissect")||i.includes("dissect")}},dissection_no_thrombolysis_contraindication:{id:"dissection_no_thrombolysis_contraindication",category:"Dissection",title:"Dissection: TNK is NOT contraindicated",recommendation:"Cervical artery dissection is NOT an absolute contraindication to IV thrombolysis if within the treatment window.",detail:"Observational data suggests IV thrombolysis in dissection-related stroke is safe and may be beneficial. Treat according to standard TNK eligibility criteria.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026.",conditions:e=>{var o,n;let a=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase(),i=(((n=e.telestrokeNote)==null?void 0:n.ctaResults)||"").toLowerCase(),s=e.timeFromLKW;return(a.includes("dissect")||i.includes("dissect"))&&s&&s.total<=4.5}},pregnancy_stroke:{id:"pregnancy_stroke",category:"Special Populations",title:"Stroke in pregnancy",recommendation:"TNK is a relative contraindication in pregnancy but may be considered when benefit outweighs risk. Consult OB/GYN immediately. EVT is preferred for LVO.",detail:"Per 2026 AHA guidelines, pregnancy is reclassified as relative (not absolute) contraindication. For LVO, EVT is preferred (no systemic thrombolytic exposure). ASA 81 mg is safe. Avoid warfarin in first trimester. LMWH is preferred anticoagulant.",classOfRec:"IIb",levelOfEvidence:"C-LD",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026.",conditions:e=>{var i,s;return!!(((i=e.telestrokeNote)==null?void 0:i.tnkContraindicationChecklist)||{}).pregnancy||!!((s=e.telestrokeNote)!=null&&s.pregnancyStroke)}},discharge_antiplatelet:{id:"discharge_antiplatelet",category:"Discharge",title:"Discharge: Antiplatelet or anticoagulation",recommendation:"Ensure appropriate antithrombotic therapy is prescribed at discharge. Antiplatelet for non-cardioembolic stroke; anticoagulation for AF-related stroke.",detail:"ASA 81-325 mg, clopidogrel 75 mg, or DAPT based on stroke subtype. DOAC for AF (apixaban preferred). Verify no gaps in medication reconciliation.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ischemic")||a.includes("stroke")||a.includes("tia")}},discharge_statin:{id:"discharge_statin",category:"Discharge",title:"Discharge: High-intensity statin",recommendation:"Prescribe high-intensity statin at discharge with LDL target <70 mg/dL for ischemic stroke/TIA patients.",detail:"Atorvastatin 80 mg or rosuvastatin 20-40 mg. Add ezetimibe if not at goal. Verify statin is on discharge medication list.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ischemic")||a.includes("stroke")||a.includes("tia")}},discharge_bp_management:{id:"discharge_bp_management",category:"Discharge",title:"Discharge: BP optimization",recommendation:"Initiate or optimize antihypertensive therapy at discharge targeting BP <130/80 for secondary stroke prevention.",detail:"ACE inhibitor or ARB + thiazide diuretic preferred. Initiate after 24-48 hours for ischemic stroke. Individualize timing for ICH (may start earlier). SBP <120 may be considered for selected patients (Class IIa, ESPRIT 2024). Use caution with bilateral severe carotid stenosis or orthostatic symptoms.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467. DOI: 10.1161/STR.0000000000000375",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("tia")}},ich_anticoag_resumption:{id:"ich_anticoag_resumption",category:"ICH Management",title:"Anticoagulation resumption after ICH",recommendation:"Anticoagulation resumption after ICH should be individualized based on ICH location, CHA\u2082DS\u2082-VASc score, and recurrent hemorrhage risk. Non-lobar ICH with high thromboembolic risk may benefit from DOAC reinitiation at 4-8 weeks.",detail:"PRESTIGE-AF (2025): DOACs dramatically reduced ischemic stroke (HR 0.05) but increased recurrent ICH (HR 10.89). ENRICH-AF halted lobar ICH enrollment due to excess recurrent hemorrhage. For non-lobar ICH with CHA\u2082DS\u2082-VASc \u22654, DOAC reinitiation is reasonable after shared decision-making at 4-8 weeks. For lobar ICH (possible CAA), consider LAAO or avoidance of anticoagulation. DOACs preferred over warfarin when anticoagulation is chosen.",classOfRec:"IIb",levelOfEvidence:"B-R",guideline:"AHA/ASA Spontaneous ICH 2022 + PRESTIGE-AF/ENRICH-AF 2025",reference:"PRESTIGE-AF: Lancet 2025; SoSTART: Lancet Neurol 2021; APACHE-AF: Lancet Neurol 2021",conditions:e=>{var s,o,n;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.pmh)||"").toLowerCase().includes("fib")||(((n=e.telestrokeNote)==null?void 0:n.pmh)||"").toLowerCase().includes("af");return(a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral"))&&i}},carotid_symptomatic:{id:"carotid_symptomatic",category:"Carotid",title:"Symptomatic carotid stenosis management",recommendation:"For symptomatic carotid stenosis \u226550%, CEA within 2 weeks is recommended. Optimal medical management is the foundation for all patients.",detail:"Symptomatic = stroke/TIA referable to the carotid territory within 6 months. CEA remains Class I for symptomatic stenosis \u226550%. Intensive medical management includes SBP <130, LDL <70, high-intensity statin, and antiplatelet therapy. CAS is an alternative for patients at high surgical risk.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Stroke Prevention 2021",reference:"Kleindorfer DO et al. Stroke. 2021;52:e364-e467",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.ctaResults)||"").toLowerCase();return a.includes("carotid")&&(a.includes("stenosis")||a.includes("occlusion"))}},carotid_asymptomatic:{id:"carotid_asymptomatic",category:"Carotid",title:"Asymptomatic carotid stenosis (CREST-2)",recommendation:"For asymptomatic carotid stenosis \u226570%, intensive medical management alone is the primary approach. CEA is NOT superior to intensive medical management (CREST-2, 2025).",detail:"CREST-2 (NEJM 2025): CEA + intensive medical management did NOT significantly reduce stroke/death vs. intensive medical management alone. CAS + intensive medical management showed modest benefit (NNT=31 at 4 years) at high-volume centers. Intensive medical management protocol: SBP <130, LDL <70 (add PCSK9i if needed), health coaching, smoking cessation. Annual duplex surveillance recommended.",classOfRec:"IIa",levelOfEvidence:"A",guideline:"CREST-2 (NEJM 2025); ECST-2 (Lancet Neurol 2025)",reference:"CREST-2: NEJM 2025; ECST-2: Lancet Neurology 2025",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.ctaResults)||"").toLowerCase();return a.includes("carotid")&&(a.includes("stenosis")||a.includes("narrowing"))}},esus_monitoring:{id:"esus_monitoring",category:"ESUS/Cryptogenic",title:"Prolonged cardiac monitoring for cryptogenic stroke",recommendation:"For cryptogenic/ESUS stroke, prolonged cardiac monitoring (\u226514 days, ideally implantable loop recorder) is recommended to detect occult AF.",detail:"ACC 2024 ECDP: \u226514 days monitoring, especially if patient is anticoagulation candidate. ILR as initial strategy reasonable in select high-risk patients. PER-DIEM trial: ILR detected AF in 15.3% vs 4.7% with 30-day monitor at 1 year. If AF detected, transition to anticoagulation. NAVIGATE-ESUS, RE-SPECT ESUS, ATTICUS, ARCADIA: routine empiric anticoagulation NOT recommended for ESUS (Class III).",classOfRec:"I",levelOfEvidence:"B-R",guideline:"ACC Expert Consensus Decision Pathway 2024",reference:"2024 ACC ECDP; JACC 2024. PER-DIEM: Lancet Neurol 2024.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.toastClassification)||"").toLowerCase();return a.includes("cryptogenic")||a.includes("esus")||i.includes("cryptogenic")||i.includes("undetermined")}},doac_timing_af:{id:"doac_timing_af",category:"Antithrombotic",title:"Early DOAC initiation in AF-related stroke (CATALYST)",recommendation:"For AF-related ischemic stroke without large hemorrhagic transformation, DOAC initiation within 4 days reduces recurrent ischemic stroke vs. later initiation (\u22655 days).",detail:"CATALYST IPDMA (Lancet 2025, n=5,441): Early DOAC (\u22644 days) reduced primary composite (recurrent ischemic stroke, sICH, or unclassified stroke) by 30% (OR 0.70, P=0.039). No increase in sICH. Timing guidance: Mild stroke (NIHSS \u22648): start \u22644 days. Moderate stroke (NIHSS 8-15): 3-5 days. Severe stroke/large HT: 6-14 days, individualized. Reassess imaging before starting if concern for hemorrhagic transformation.",classOfRec:"IIa",levelOfEvidence:"A",guideline:"CATALYST IPDMA 2025",reference:"CATALYST: Lancet 2025. Pooled TIMING, ELAN, OPTIMAS, START.",conditions:e=>{var o,n,c;let a=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase(),i=a.includes("ischemic")||a.includes("stroke")||a.includes("lvo"),s=(((n=e.telestrokeNote)==null?void 0:n.pmh)||"").toLowerCase().includes("fib")||(((c=e.telestrokeNote)==null?void 0:c.pmh)||"").toLowerCase().includes("af");return i&&s}},hemorrhagic_transformation:{id:"hemorrhagic_transformation",category:"Complications",title:"Hemorrhagic transformation management",recommendation:"Classify hemorrhagic transformation using ECASS criteria (HI-1, HI-2, PH-1, PH-2). Symptomatic ICH (PH-2 or neurological worsening) requires emergent management.",detail:"ECASS Classification: HI-1 (small petechiae along infarct margin), HI-2 (confluent petechiae within infarct, no mass effect), PH-1 (blood clots \u226430% of infarct, mild mass effect), PH-2 (blood clots >30% of infarct with significant mass effect). For symptomatic HT post-TNK: STAT CT, cryoprecipitate 10 units (target fibrinogen >200 mg/dL), TXA 1g IV over 10 min, platelets if <100K. Hold all antithrombotics. PH-1/PH-2 require ICU admission. Repeat imaging at 24h.",classOfRec:"I",levelOfEvidence:"C-EO",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026.",conditions:e=>{var a,i,s;return!!((a=e.telestrokeNote)!=null&&a.tnkAdminTime)||!!((s=(i=e.telestrokeNote)==null?void 0:i.hemorrhagicTransformation)!=null&&s.detected)}},angioedema_post_tnk:{id:"angioedema_post_tnk",category:"Complications",title:"Post-thrombolysis orolingual angioedema",recommendation:"Monitor for orolingual angioedema after TNK, especially in patients on ACE inhibitors. Occurs in 1-5% of tPA/TNK recipients, typically within 2 hours. Immediate airway assessment is critical.",detail:"Stepwise management: 1) Stop TNK infusion if still running + hold ACEi. 2) Methylprednisolone 125 mg IV + Diphenhydramine 50 mg IV + Famotidine 20 mg IV. 3) If progressing: Epinephrine 0.3 mg IM (1:1000). 4) Refractory: Icatibant 30 mg SC (bradykinin B2 receptor antagonist) or C1 esterase inhibitor concentrate 20 U/kg IV. 5) Prepare for intubation if tongue/floor of mouth involvement. Risk factors: ACE inhibitor use (5x risk), anterior circulation infarcts involving insular cortex.",classOfRec:"I",levelOfEvidence:"C-EO",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026. Yayan J. Int J Gen Med. 2013;6:539-544.",conditions:e=>{var a,i,s,o;return!!((i=(a=e.telestrokeNote)==null?void 0:a.angioedema)!=null&&i.detected)||!!((s=e.telestrokeNote)!=null&&s.tnkAdminTime)&&(((o=e.telestrokeNote)==null?void 0:o.medications)||"").toLowerCase().match(/lisinopril|enalapril|ramipril|captopril|benazepril|fosinopril|perindopril|quinapril|trandolapril|ace.?i/)}},hyperglycemia_acute:{id:"hyperglycemia_acute",category:"Supportive Care",title:"Hyperglycemia management in acute stroke (2026 update)",recommendation:"Target glucose 140-180 mg/dL. Initiate insulin when glucose persistently >180 mg/dL. Intensive glucose lowering to 80-130 mg/dL with IV insulin is Class III (Harm).",detail:"Intensive glycemic control (80-130 mg/dL) caused symptomatic hypoglycemia in 1-in-9 patients and is explicitly recommended against. Protocol: critically ill/post-TNK patients: start IV insulin infusion with q1h glucose checks; transition to basal-bolus SC when stabilized. Sliding-scale SC insulin for less acute. Avoid glucose <70 mg/dL (neuronal injury risk). ADA 2026 aligned: 100-180 mg/dL for non-critically ill hospitalized patients.",classOfRec:"III",levelOfEvidence:"A",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026; ADA Standards of Care 2026.",caveats:"Class III: Harm applies to the intensive target of 80-130 mg/dL, NOT to treating hyperglycemia above 180.",conditions:e=>{var i;return(parseFloat((i=e.telestrokeNote)==null?void 0:i.glucose)||0)>180}},seizure_acute_stroke:{id:"seizure_acute_stroke",category:"Supportive Care",title:"Post-stroke seizure management (2025 update)",recommendation:"Prophylactic antiseizure medications are NOT recommended routinely. If seizures occur, levetiracetam or lamotrigine are preferred. Avoid phenytoin and valproic acid.",detail:"Primary prophylaxis: generally not recommended (Cochrane review: no clear benefit). Early seizures (within 7 days): low recurrence risk (10-20%), consider short-term treatment with taper. Late/unprovoked seizures (>7 days): 70% 10-year recurrence, long-term ASM recommended. Preferred agents (2025 network meta-analysis, Neurology): Levetiracetam (fewest recurrences, good tolerability), Lamotrigine (fewest adverse events), Lacosamide (favorable safety). AVOID: Phenytoin (higher mortality, drug interactions), Valproic acid (higher mortality). Start LEV 500 mg BID, titrate to 1000-1500 mg BID as needed.",classOfRec:"IIa",levelOfEvidence:"B-NR",guideline:"AHA/ASA 2022 ICH; 2025 Network Meta-analysis (Neurology)",reference:"ASM Network Meta-analysis: Neurology 2025. DOI: 10.1212/WNL.0000000000210231",conditions:e=>{var i;let a=((i=e.telestrokeNote)==null?void 0:i.screeningTools)||{};return a.seizureRisk==="high"||a.seizureRisk==="moderate"}},dysphagia_screening:{id:"dysphagia_screening",category:"Supportive Care",title:"Dysphagia screening (2026 AHA)",recommendation:"All stroke patients must undergo bedside dysphagia screening before any oral intake. Failure should trigger instrumental assessment (FEES or VFSS) by SLP.",detail:"Validated bedside tools: Gugging Swallowing Screen (GUSS), Toronto Bedside Swallowing Screening Test (TOR-BSST), 3-oz Water Swallow Test. Instrumental assessment (FEES or videofluoroscopic swallowing study) recommended when resources allow, especially for silent aspiration detection. FEES can be performed at bedside (advantage for critically ill). Early nurse-led bedside screening reduces pneumonia rates. NPO until screen passed.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("sah")}},early_mobilization:{id:"early_mobilization",category:"Supportive Care",title:"Early mobilization after stroke (AVERT)",recommendation:"Avoid very early mobilization (<24 hours) for severe strokes (NIHSS >16) and ICH. Start graduated mobilization at 24-48 hours with short, frequent sessions.",detail:"AVERT Phase III (n=2,104): Very early mobilization within 24 hours was HARMFUL (aOR 0.73, P=0.004), especially in severe strokes and ICH. Optimal: start at 24-48 hours from onset with hemodynamic stability. Recommended session: 15-45 minutes, 1-3 times daily. Short frequent sessions superior to prolonged single sessions (AVERT dose-response analysis).",classOfRec:"IIa",levelOfEvidence:"B-R",guideline:"AVERT Phase III (Lancet 2015); VA/DoD Stroke Rehab CPG 2024",reference:"AVERT: Lancet 2015;386:46-55.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")}},decompressive_craniectomy_cerebellar:{id:"decompressive_craniectomy_cerebellar",category:"Special Populations",title:"Suboccipital decompressive craniectomy for cerebellar infarction",recommendation:"Suboccipital decompressive craniectomy is a life-saving procedure for expansive cerebellar infarction with brainstem compression or hydrocephalus.",detail:"Class I, LOE B-NR. Indications: large cerebellar infarction with progressive neurological deterioration, brainstem compression, or obstructive hydrocephalus. EVD may be placed for acute hydrocephalus but alone may be insufficient if cerebellar swelling is the primary problem. Resection of necrotic cerebellar tissue may be combined with decompression. No absolute age cutoff; decision based on premorbid function, imaging, and clinical trajectory.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"Powers WJ et al. Stroke. 2026.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.ctResults)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("cerebellar")||i.includes("pica")||i.includes("sca")||i.includes("cerebellar")}},glp1ra_secondary_prevention:{id:"glp1ra_secondary_prevention",category:"Secondary Prevention",title:"GLP-1 RA for cardiovascular/stroke prevention",recommendation:"Semaglutide is recommended for stroke patients with T2DM and established ASCVD (Class I, LOE A). Consider for patients with BMI \u226527 + CVD even without diabetes (Class IIa).",detail:"SELECT (NEJM 2023, n=17,604): Semaglutide 2.4 mg weekly reduced MACE by 20% (HR 0.80, P<0.001) in overweight/obese patients with CVD but without diabetes. SUSTAIN-6: 39% reduction in nonfatal stroke (HR 0.61, P=0.04) in T2DM. SOUL (2025): 14% MACE reduction in T2DM, leading to EMA approval as first stroke management therapy. FDA approved March 2024 for MACE risk reduction in adults with overweight/obesity and established CVD. Benefit independent of baseline adiposity and weight loss.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Secondary Prevention; SELECT (NEJM 2023); SOUL (2025)",reference:"SELECT: NEJM 2023. SUSTAIN-6: NEJM 2016. SOUL: 2025.",conditions:e=>{var c,d;let a=(((c=e.telestrokeNote)==null?void 0:c.pmh)||"").toLowerCase(),i=(((d=e.telestrokeNote)==null?void 0:d.diagnosis)||"").toLowerCase(),s=i.includes("stroke")||i.includes("ischemic")||i.includes("tia"),o=a.includes("diabet")||a.includes("dm")||a.includes("a1c"),n=a.includes("obes")||a.includes("bmi");return s&&(o||n)}},ldl_aggressive_target:{id:"ldl_aggressive_target",category:"Secondary Prevention",title:"Aggressive LDL lowering for stroke prevention",recommendation:"Target LDL <55 mg/dL with \u226550% reduction from baseline for atherosclerotic stroke/TIA. Add ezetimibe, then PCSK9 inhibitor if not at goal on max statin.",detail:"TST (Lancet Neurol 2020): LDL <70 reduced composite endpoint by 22%. SPARCL: atorvastatin 80 mg reduced stroke 16%, \u226550% LDL reduction yielded 31% stroke reduction. ESC/EAS 2019: LDL <55 for very-high-risk ASCVD. FOURIER 2025 subanalysis: LDL <40 mg/dL optimal for prior stroke patients (no safety concerns, no increase in hemorrhagic stroke). Escalation ladder: high-intensity statin \u2192 add ezetimibe 10 mg \u2192 add PCSK9i (evolocumab/alirocumab) \u2192 recheck 6-8 weeks. Inclisiran (twice-yearly injection) available for adherence challenges. Oral PCSK9 agents (enlicitide) in pipeline.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA 2021; TST (Lancet Neurol 2020); FOURIER (AHA 2025)",reference:"TST: Lancet Neurol 2020. SPARCL: NEJM 2006. FOURIER subanalysis: AHA 2025.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.toastClassification)||"").toLowerCase();return(a.includes("ischemic")||a.includes("stroke")||a.includes("tia"))&&(i.includes("athero")||i===""||i.includes("undetermined"))}},cyp2c19_guided_dapt:{id:"cyp2c19_guided_dapt",category:"Antithrombotic",title:"CYP2C19-guided antiplatelet selection (CHANCE-2)",recommendation:"For minor stroke/TIA patients on DAPT, consider CYP2C19 testing. Loss-of-function carriers benefit from ticagrelor + ASA instead of clopidogrel + ASA.",detail:"CHANCE-2 (NEJM 2021, n=6,412 CYP2C19 LOF carriers): Ticagrelor + ASA \xD7 21 days then ticagrelor mono \xD7 90 days reduced 1-year stroke by 20% (HR 0.80, P=0.007) vs. clopidogrel + ASA. Benefit entirely in first 90 days. THALES: Ticagrelor + ASA \xD7 30 days reduced stroke/death (HR 0.83) regardless of genotype but with higher severe bleeding (HR 3.99). Standard DAPT (non-LOF carriers): clopidogrel 300 mg load + ASA 325 mg, then clopidogrel 75 mg + ASA 81 mg \xD7 21 days, then clopidogrel mono.",classOfRec:"IIa",levelOfEvidence:"B-R",guideline:"CHANCE-2 (NEJM 2021); THALES (NEJM 2020)",reference:"CHANCE-2: NEJM 2021. 1-year follow-up: Neurology 2024. THALES: NEJM 2020.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=parseInt((o=e.telestrokeNote)==null?void 0:o.nihss)||0;return(a.includes("ischemic")||a.includes("stroke")||a.includes("tia"))&&i<=5}},colchicine_secondary_prevention:{id:"colchicine_secondary_prevention",category:"Secondary Prevention",title:"Colchicine for stroke + coronary artery disease (emerging)",recommendation:"Colchicine 0.5 mg daily may be considered for patients with stroke AND coronary artery disease, particularly with elevated hsCRP. Evidence is emerging but not yet definitive for stroke-only patients.",detail:"CONVINCE (Lancet 2024, n=3,154): Non-cardioembolic stroke/TIA. Primary endpoint not met (HR 0.84, P=0.12) but underpowered (stopped early due to COVID). Meta-analysis (eClinicalMedicine 2024): ischemic stroke reduced 27% (RR 0.73, 95% CI 0.58-0.90) when pooled with LoDoCo2/COLCOT. CHANCE-3 (BMJ 2024): negative in minor stroke/TIA. CLEAR SYNERGY: negative. Side effects: diarrhea 12%, ~20% discontinuation. Contraindicated in severe renal impairment. Monitor CRP as biomarker of response.",classOfRec:"IIb",levelOfEvidence:"B-R",guideline:"CONVINCE (Lancet 2024); Meta-analysis (eClinicalMedicine 2024)",reference:"CONVINCE: Lancet 2024. CHANCE-3: BMJ 2024. Meta-analysis: eClinicalMedicine 2024.",conditions:e=>{var n,c;let a=(((n=e.telestrokeNote)==null?void 0:n.pmh)||"").toLowerCase(),i=(((c=e.telestrokeNote)==null?void 0:c.diagnosis)||"").toLowerCase(),s=i.includes("ischemic")||i.includes("stroke")||i.includes("tia"),o=a.includes("cad")||a.includes("coronary")||a.includes("mi")||a.includes("stent")||a.includes("cabg");return s&&o}},icad_management:{id:"icad_management",category:"Antithrombotic",title:"Intracranial atherosclerotic disease (ICAD) management",recommendation:"Aggressive medical management is first-line for intracranial stenosis: DAPT + high-intensity statin + BP <140/90. Intracranial stenting is NOT recommended routinely (Class III: Harm).",detail:"SAMMPRIS: PTAS was inferior to aggressive medical management (30-day stroke/death 14.7% vs 5.8%). CASSISS: No benefit of stenting + medical therapy. Pooled analysis (n=809): 30-day stroke/death significantly higher with PTAS (10.5% vs 4.2%, HR 2.62). Medical protocol: DAPT (ASA + clopidogrel) \xD7 90 days, then single antiplatelet. High-intensity statin (LDL <70). SBP <140/90. Stenting considered ONLY after \u22652 recurrent events on max medical therapy at experienced centers (Class IIb, LOE C).",classOfRec:"I",levelOfEvidence:"B-R",guideline:"2022 AAN Intracranial Atherosclerosis",reference:"SAMMPRIS: NEJM 2011. CASSISS: JAMA 2022. Pooled IPD: 2025.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.toastClassification)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("large artery")||i.includes("intracranial stenosis")||i.includes("intracranial atheroscler")}},mevo_evt_not_recommended:{id:"mevo_evt_not_recommended",category:"EVT",title:"MeVO/distal occlusion EVT: NOT recommended routinely",recommendation:"EVT for medium vessel (M2/M3) and distal occlusions is NOT recommended routinely based on 2025 trial data. Consider clinical trial enrollment.",detail:"ESCAPE-MeVO (NEJM 2025, n=530): No benefit of EVT for MeVO. Higher mortality in EVT group (13.3% vs 8.4%, HR 1.82). sICH higher (5.4% vs 2.2%). DISTAL (n=543): No benefit. DISCOUNT: Consistent negative results. Post-hoc: possible heterogeneity by time, earlier presenters may benefit more. Future trials needed with different devices (aspiration, intra-arterial lytics). Flag M2/M3 patients for potential clinical trial enrollment (e.g., STEP trial).",classOfRec:"III",levelOfEvidence:"B-R",guideline:"ESCAPE-MeVO (NEJM 2025); DISTAL (2025); DISCOUNT (2025)",reference:"ESCAPE-MeVO: NEJM 2025. DISTAL: 2025. DISCOUNT: 2025.",conditions:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.vesselOcclusion)||[]).some(s=>/m2|m3|m4|distal|mevo|medium vessel/i.test(s))}},bp_post_evt_drip:{id:"bp_post_evt_drip",category:"Blood Pressure",title:"Post-EVT BP drip titration protocol",recommendation:"For post-EVT BP management, use nicardipine 5-15 mg/hr or clevidipine 1-2 mg/hr. Target SBP 140-180 mmHg for recanalized patients.",detail:"Nicardipine: start 5 mg/hr, titrate by 2.5 mg/hr every 5-15 min (max 15 mg/hr). Clevidipine: start 1-2 mg/hr, double every 90 seconds initially (max 32 mg/hr). For successfully recanalized (mTICI 2b-3): target SBP 140-180 mmHg. For non-recanalized: SBP <180. ENCHANTED2/MT: SBP <120 was harmful. OPTIMAL-BP (JAMA 2024): intensive <140 showed no benefit. BP-TARGET: intensive 100-129 showed no benefit. Meta-analysis of 4 RCTs: intensive targets reduced functional independence by 23%.",classOfRec:"I",levelOfEvidence:"C-EO",guideline:"AHA/ASA Early Management of Acute Ischemic Stroke 2026",reference:"ENCHANTED2/MT: Lancet 2022. OPTIMAL-BP: JAMA 2024. BP-TARGET: Lancet Neurol 2021.",medications:["Nicardipine 5 mg/hr IV (titrate q5-15min, max 15)","Clevidipine 1-2 mg/hr IV"],conditions:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.evtRecommended)}},sglt2i_guidance:{id:"sglt2i_guidance",category:"Secondary Prevention",title:"SGLT2 inhibitors in stroke patients",recommendation:"SGLT2 inhibitors are recommended for cardiorenal benefits (HF, CKD) but NOT specifically for stroke prevention. Consider sotagliflozin if dual stroke + HF benefit is desired.",detail:"Meta-analysis (71 RCTs, n=105,914): SGLT2 inhibitors did NOT significantly reduce total stroke (RR 0.96, NS) or ischemic stroke (RR 0.89, NS). Exception: sotagliflozin (dual SGLT1/2 inhibitor) reduced all stroke types (RR 0.74, P=0.04). SGLT2i reduced hemorrhagic stroke (RR 0.62, P=0.04). Primary indications: HF (regardless of EF), CKD (eGFR 20-45), T2DM with cardiorenal comorbidity. GLP-1 RAs offer superior stroke protection in indirect comparisons.",classOfRec:"IIa",levelOfEvidence:"A",guideline:"ADA Standards 2026; SMART-C Meta-analysis (Circulation)",reference:"SGLT2i Stroke Meta-analysis: JSCVD 2024. SMART-C: Circulation 2024.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.pmh)||"").toLowerCase();return a.includes("heart failure")||a.includes("hf")||a.includes("ckd")||a.includes("kidney")}},depression_screening_schedule:{id:"depression_screening_schedule",category:"Post-Stroke Care",title:"Post-stroke depression screening schedule",recommendation:"Screen all stroke patients for depression using PHQ-2/PHQ-9 at discharge, 1 month, 3 months, 6 months, and 12 months post-stroke. SSRIs for diagnosed PSD only.",detail:"Post-stroke depression affects ~30% of survivors. SSRIs for diagnosed PSD only (Class IIa) \u2014 NOT routine for recovery (Class III per FOCUS/AFFINITY/EFFECTS: no improvement in mRS). Preferred agents: sertraline, escitalopram. Drug interaction flag: SSRIs + DAPT = 29% higher hemorrhagic stroke risk. FLAME trial (small) suggested fluoxetine enhanced motor recovery, but 3 large RCTs (FOCUS n=3,127, AFFINITY n=1,280, EFFECTS) all negative for functional recovery. SSRIs increase falls, fractures, and hyponatremia risk.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA 2021; FOCUS (Lancet 2019); AFFINITY (JAMA Neurol 2020)",reference:"FOCUS: Lancet 2019. AFFINITY: JAMA Neurology 2020.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("tia")}},sleep_apnea_screening:{id:"sleep_apnea_screening",category:"Post-Stroke Care",title:"Sleep apnea screening and management after stroke",recommendation:"Screen all stroke/TIA patients for sleep apnea (STOP-BANG or Berlin Questionnaire). CPAP benefit for vascular event prevention is uncertain (SAVE trial negative).",detail:"OSA affects ~70% of stroke patients and is an independent risk factor. SAVE trial (n=2,687, including 1,183 with prior stroke): CPAP did NOT reduce recurrent vascular events or mortality. However, adherence was poor (~3.3 h/night). Some evidence of improved neurological recovery. Class IIa for screening; Class IIb for CPAP treatment (uncertain vascular benefit; possible neurological recovery benefit). Refer for polysomnography if high-risk on screening. Track CPAP adherence if prescribed.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"AHA/ASA Secondary Prevention 2021; SAVE (NEJM 2016)",reference:"SAVE: NEJM 2016. CPAP meta-analysis: PMC 2023.",conditions:e=>{var i;let a=((i=e.telestrokeNote)==null?void 0:i.screeningTools)||{};return(parseInt(a.stopBangScore)||0)>=3||!!a.stopBangPositive}},mediterranean_diet:{id:"mediterranean_diet",category:"Secondary Prevention",title:"Mediterranean diet for stroke prevention",recommendation:"Mediterranean diet is recommended for secondary stroke prevention (Class I, LOE B). DASH diet has been downgraded due to lack of direct stroke endpoint RCT data.",detail:"PREDIMED: 42% stroke reduction (HR 0.58, 95% CI 0.42-0.82) \u2014 stronger effect than for MI or CV death. Meta-analysis of RCTs (2024): OR 0.63 for stroke incidence. 2024 AHA/ASA: Mediterranean diet upgraded; DASH diet downgraded. Italian National Guidelines 2025: high-quality evidence for Mediterranean diet + EVOO or nuts. Key components: EVOO, nuts, fish, vegetables, fruit, legumes, whole grains. Limit red meat, processed foods, added sugars. MEDAS-14 score can track adherence.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"AHA/ASA 2024; PREDIMED; Italian National Guidelines 2025",reference:"PREDIMED: NEJM 2018. Meta-analysis: Wiley 2024.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("tia")}},vte_ipc_admission:{id:"vte_ipc_admission",category:"Acute",title:"IPC at admission for immobile stroke patients",recommendation:"Intermittent pneumatic compression (IPC) should be applied immediately at admission for all immobile AIS and ICH patients (Class I, LOE A). Graduated compression stockings alone are NOT effective (Class III).",detail:"CLOTS 3 trial: IPC reduced DVT from 12.1% to 8.5% (OR 0.65). TED hose alone showed no benefit (CLOTS 1). IPC should be continued until patient is independently mobile. Pharmacologic VTE prophylaxis added after 24-48h (post-tPA: wait 24h + clear CT).",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA 2019 AIS; AHA/ASA 2022 ICH; CLOTS 3",reference:"CLOTS 3: Lancet 2013.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("hemorrhag")}},vte_enoxaparin_timing:{id:"vte_enoxaparin_timing",category:"Acute",title:"Enoxaparin preferred over UFH for VTE prophylaxis",recommendation:"Enoxaparin preferred over UFH for pharmacologic VTE prophylaxis in stroke. Post-tPA: wait 24h + CT clear. Post-ICH: wait 24-48h + hematoma stability confirmed on repeat CT.",detail:"PREVAIL trial: enoxaparin 40mg SC daily reduced VTE from 16% to 8.1% vs UFH. Duration: 10-14 days or until independently mobile. Anti-Xa monitoring (0.2-0.5 IU/mL) for BMI >40 or CrCl <30.",classOfRec:"I",levelOfEvidence:"A",guideline:"PREVAIL; AHA/ASA 2019; ACCP 9th Ed",reference:"PREVAIL: Stroke 2007.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")}},fever_management_protocol:{id:"fever_management_protocol",category:"Acute",title:"Fever management in acute stroke",recommendation:"Target temperature 36.0-37.5C. Treat fever >37.5C within 1 hour. Acetaminophen is first-line; avoid NSAIDs in stroke (Class III). Implement FeSS bundle: Fever-Sugar-Swallowing.",detail:"Stepwise protocol: (1) Infection workup + treat, (2) Scheduled acetaminophen 650-1000mg q6h, (3) Surface cooling + counter-warming, (4) IV magnesium 2g bolus, (5) Buspirone 30mg q8h. Use BSAS (0-3) to guide anti-shivering therapy. QASC trial: FeSS bundle reduced death/dependency by 16%.",classOfRec:"IIa",levelOfEvidence:"B-NR",guideline:"NTCR 2023; ESO/QASC; AHA/ASA 2019",reference:"QASC: Lancet 2011.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")||a.includes("sah")}},osmotic_therapy_protocol:{id:"osmotic_therapy_protocol",category:"Acute",title:"Osmotic therapy for cerebral edema",recommendation:"Mannitol 20% (0.5-1g/kg bolus) for euvolemic/hypervolemic patients; HTS 3% (250mL bolus) for hypotensive/hyponatremic. HTS 23.4% 30mL via central line for refractory herniation.",detail:"Mannitol: hold if osmolality >320 or osmolar gap >20. HTS: target Na 145-155 for severe edema; do not exceed 8-10 mEq/L/24h correction (ODS risk). HTS preferred in renal insufficiency (mannitol accumulates). BMP q6h with mannitol; Na q4-6h with HTS.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"NCS Guidelines; ENLS Protocol",reference:"NCS Osmotic Therapy: Neurocrit Care 2020.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ich")||a.includes("hemorrhag")||a.includes("mca")||a.includes("edema")}},nutrition_ng_peg_timing:{id:"nutrition_ng_peg_timing",category:"Acute",title:"Nutritional support after stroke",recommendation:"If dysphagia screen failed: NG tube within 24-48h. PEG consideration at day 14-21 if dysphagia persists. NG is preferred for first 2-3 weeks (FOOD trial).",detail:"FOOD trial: early PEG (within 7 days) had worse 6-month outcomes than NG feeding. Nutritional targets: 25-30 kcal/kg/day, protein 1.0-1.5 g/kg/day. Enteral nutrition within 24-48h. Antithrombotics can be continued during PEG placement (ASGE 2024).",classOfRec:"IIa",levelOfEvidence:"A",guideline:"FOOD Trial; ESPEN Guidelines; AHA/ASA 2019",reference:"FOOD Trial: Lancet 2005.",conditions:e=>{var a,i;return((i=(a=e.telestrokeNote)==null?void 0:a.dysphagiaScreening)==null?void 0:i.bedsideScreenResult)==="fail"}},platelet_transfusion_ich:{id:"platelet_transfusion_ich",category:"ICH",title:"Platelet transfusion harmful in ICH on aspirin",recommendation:"Platelet transfusion is HARMFUL in ICH patients on antiplatelet therapy unless emergency surgery is planned (Class III Harm, LOE B-R).",detail:"PATCH trial: platelet transfusion increased odds of death/dependence (OR 2.05, 95% CI 1.18-3.56). Only transfuse if emergency neurosurgery is imminent.",classOfRec:"III",levelOfEvidence:"B-R",guideline:"AHA/ASA 2022 ICH; PATCH Trial",reference:"PATCH: Lancet 2016.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ich")||a.includes("hemorrhag")}},ich_score_no_limit:{id:"ich_score_no_limit",category:"ICH",title:"ICH score must not be used to limit treatment",recommendation:"ICH severity scores must NOT be used to limit care or justify withdrawal of treatment (Class I, LOE B-NR). Postpone new DNR orders until at least hospital day 2.",detail:"Self-fulfilling prophecy of withdrawal is well-documented. Full aggressive care recommended for minimum 24-48 hours. ICH score measures severity, not prognosis.",classOfRec:"I",levelOfEvidence:"B-NR",guideline:"AHA/ASA 2022 ICH",reference:"Hemphill et al. ICH Score: Stroke 2001; 2022 ICH Guidelines.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ich")||a.includes("hemorrhag")}},permissive_hypertension:{id:"permissive_hypertension",category:"Acute",title:"Permissive hypertension in acute ischemic stroke",recommendation:"Do NOT treat BP <220/120 in acute ischemic stroke without reperfusion therapy, at least in first 24h (Class III, LOE A). Restart home antihypertensives at 24-72h if neurologically stable.",detail:"Treatment of moderate hypertension in non-reperfused AIS worsens penumbral perfusion. CSBP and AHA/ASA agree: permissive approach unless other organ damage (aortic dissection, MI, HF).",classOfRec:"III",levelOfEvidence:"A",guideline:"AHA/ASA 2019 AIS; CSBP Acute 2022",reference:"AHA/ASA AIS Guidelines 2019.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("ischemic")||a.includes("stroke")}},basilar_evt_class1:{id:"basilar_evt_class1",category:"Acute",title:"Basilar artery occlusion EVT within 24h",recommendation:"EVT is recommended for basilar artery occlusion within 24h in patients with NIHSS >=10 and mild ischemic damage on imaging (Class I, LOE A).",detail:"ATTENTION and BAOCHE trials: first Class I evidence for posterior circulation EVT. Requires CT/CTA confirming basilar occlusion. Exclude patients with extensive brainstem infarction.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA 2026 AIS Guideline; ATTENTION; BAOCHE",reference:"ATTENTION: NEJM 2022. BAOCHE: NEJM 2022.",conditions:e=>{var s,o;let a=(((s=e.telestrokeNote)==null?void 0:s.diagnosis)||"").toLowerCase(),i=(((o=e.telestrokeNote)==null?void 0:o.ctaResults)||"").toLowerCase();return a.includes("basilar")||i.includes("basilar")}},status_epilepticus_protocol:{id:"status_epilepticus_protocol",category:"Acute",title:"Status epilepticus management in stroke",recommendation:"SE first-line at 5 min: IV lorazepam 0.1 mg/kg (max 4 mg, repeat x1) or IM midazolam 10 mg if no IV access. Second-line at 20 min: fosphenytoin, LEV, or valproate (all equivalent per ESETT). Third-line at 40 min: anesthetic doses.",detail:"RAMPART trial: IM midazolam superior to IV lorazepam when no IV access. ESETT trial: LEV, fosphenytoin, and VPA equally effective for benzodiazepine-refractory SE (~45% each). Benzodiazepine underdosing occurs in >2/3 of cases.",classOfRec:"I",levelOfEvidence:"A",guideline:"AES 2016 (AAN-endorsed); ESETT",reference:"RAMPART: NEJM 2012. ESETT: NEJM 2019.",conditions:e=>{var i,s;let a=(((s=(i=e.telestrokeNote)==null?void 0:i.screeningTools)==null?void 0:s.seizureRisk)||"").toLowerCase();return a.includes("seizure")||a.includes("status")}},dapt_auto_stop:{id:"dapt_auto_stop",category:"Secondary Prevention",title:"DAPT must not continue beyond 90 days",recommendation:"Do NOT continue DAPT beyond 90 days \u2014 increased bleeding without additional benefit (Class III, LOE A). Convert to monotherapy at day 21-90.",detail:"CHANCE: 21-day DAPT optimal. POINT: 90-day DAPT had more bleeding. ESO and AHA agree: auto-stop DAPT and transition to monotherapy. Flag patients still on DAPT at 90-day visit.",classOfRec:"III",levelOfEvidence:"A",guideline:"AHA/ASA 2021; ESO DAPT 2021",reference:"CHANCE: NEJM 2013. POINT: NEJM 2018.",conditions:e=>{var i,s;return(((s=(i=e.telestrokeNote)==null?void 0:i.secondaryPrevention)==null?void 0:s.antiplateletRegimen)||"").includes("dapt")}},aed_doac_interaction:{id:"aed_doac_interaction",category:"Safety",title:"Enzyme-inducing AEDs reduce DOAC levels",recommendation:"Carbamazepine, phenytoin, and phenobarbital are contraindicated with DOACs due to CYP3A4/P-gp induction reducing DOAC plasma levels. Use LEV, lacosamide, gabapentin, or pregabalin instead.",detail:"If enzyme-inducing AED is unavoidable, switch DOAC to warfarin with INR monitoring. Safe AED options: levetiracetam, lacosamide, gabapentin, pregabalin, lamotrigine (weak inducer \u2014 monitor).",classOfRec:"III",levelOfEvidence:"B-NR",guideline:"EHRA 2018 Practical Guide",reference:"EHRA 2018; Expert Opinion Drug Safety 2024.",conditions:e=>{var i,s;let a=((s=(i=e.telestrokeNote)==null?void 0:i.secondaryPrevention)==null?void 0:s.antiplateletRegimen)||"";return a.includes("doac")||a.includes("anticoag")}},spasticity_screening:{id:"spasticity_screening",category:"Follow-up",title:"Spasticity screening and botulinum toxin referral",recommendation:"Screen for spasticity (Modified Ashworth Scale) at follow-up visits. Botulinum toxin A is first-line for focal spasticity (Class I, LOE A). Refer early (<3 months) for optimal outcomes.",detail:"Botox superior to oral tizanidine with fewer side effects. Intrathecal baclofen for refractory generalized spasticity. Also screen for hemiplegic shoulder pain \u2014 consider NMES and sling.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Rehab 2016; AAN BoNT Guideline 2016",reference:"AAN BoNT Guideline: Neurology 2016.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")}},central_pain_management:{id:"central_pain_management",category:"Follow-up",title:"Central post-stroke pain screening and treatment",recommendation:"Screen for CPSP at 3-6 months. First-line: amitriptyline 75 mg/day. Alternative: lamotrigine. Do NOT use opioids for neuropathic/central pain.",detail:"CPSP prevalence 1-12%. Burning/shooting pain in affected territory, often with allodynia. Lamotrigine uniquely effective for central (not peripheral) neuropathic pain with ~30% reduction. Gabapentin/pregabalin may also be tried.",classOfRec:"IIa",levelOfEvidence:"B",guideline:"NeuPSIG; EFNS Guidelines; AAN PDN 2022",reference:"NeuPSIG: Pain 2015.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")}},palliative_care_screening:{id:"palliative_care_screening",category:"Acute",title:"Early palliative care screening for serious stroke",recommendation:"Screen for palliative care needs in high-NIHSS AIS, large ICH, or failed EVT. Structure goals-of-care conversations at key decision points. Postpone new DNR orders until hospital day 2.",detail:"AHA 2025 Palliative Care Statement. Triggers: decompressive craniectomy decision, failed recanalization, transition to comfort care. Full aggressive care recommended for minimum 24-48h in ICH.",classOfRec:"IIa",levelOfEvidence:"C-EO",guideline:"AHA 2025 Palliative Care Statement; AHA/ASA 2022 ICH",reference:"AHA Palliative Care: Stroke 2025.",conditions:e=>{var s,o;let a=parseInt((s=e.telestrokeNote)==null?void 0:s.nihss)||0,i=(((o=e.telestrokeNote)==null?void 0:o.diagnosis)||"").toLowerCase();return a>=20||i.includes("ich")||i.includes("hemorrhag")}},alcohol_screening:{id:"alcohol_screening",category:"Secondary Prevention",title:"Alcohol screening and counseling",recommendation:"Screen all stroke patients with AUDIT-C. Counsel: limit to <=2 drinks/day (men), <=1 drink/day (women). Heavy alcohol use increases stroke risk (Class IIa, LOE C-LD).",detail:"AUDIT-C: 3-question screen, score >=4 (men) or >=3 (women) is positive. Screen for other substances (cannabis, cocaine, amphetamines). Cocaine/amphetamines are significant stroke risk factors.",classOfRec:"IIa",levelOfEvidence:"C-LD",guideline:"AHA/ASA 2021 Secondary Prevention; 2024 Primary Prevention",reference:"AHA/ASA Secondary Prevention 2021.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("tia")}},hormonal_stroke_risk:{id:"hormonal_stroke_risk",category:"Secondary Prevention",title:"Hormonal contraception and HRT stroke risk",recommendation:"Combined hormonal contraception is contraindicated in migraine with aura (Class I). Oral estrogen-containing HRT increases stroke risk in women >=60 or >10 years post-menopause (Class III Harm).",detail:"Switch combined OCP to progestin-only or nonhormonal alternative if migraine with aura. Transdermal estrogen may have lower stroke risk than oral. Discuss risk-benefit of HRT individually.",classOfRec:"I/III",levelOfEvidence:"B-NR/A",guideline:"AHA/ASA 2024 Primary Prevention",reference:"AHA/ASA Primary Prevention 2024.",conditions:e=>{var i;return((i=e.telestrokeNote)==null?void 0:i.sex)==="F"}},cvt_anticoag_phases:{id:"cvt_anticoag_phases",category:"CVT",title:"CVT three-phase anticoagulation",recommendation:"Acute: LMWH or UFH. Transition: VKA (INR 2-3) or DOAC. Duration: 3-12 months (provoked) or indefinite (APS/malignancy/thrombophilia). VKA is MANDATORY for APS (especially triple-positive).",detail:"CSBP CVT 2024: DOACs are NOT routine first-line for CVT. APS patients must use warfarin. Etiology determines duration: provoked (OCP, pregnancy, infection) \u2192 3-6 months; unprovoked \u2192 6-12 months; recurrent/prothrombotic \u2192 indefinite.",classOfRec:"I",levelOfEvidence:"B-R",guideline:"CSBP CVT 2024; ESO CVT Guidelines",reference:"CSBP CVT Module 2024.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("cvt")||a.includes("venous")||a.includes("sinus")}},pause_protocol:{id:"pause_protocol",category:"Procedure Planning",title:"PAUSE protocol for DOAC peri-procedural management",recommendation:"No heparin bridging for DOAC patients. Factor Xa inhibitors: hold 1 day (low risk) or 2 days (high risk) if CrCl >=30; add 1 day if CrCl <30. Dabigatran: hold 1-5 days based on renal function and risk.",detail:"PAUSE study (NEJM 2019): simple interruption without bridging is safe and effective. Warfarin bridging with enoxaparin indicated ONLY for: stroke/TIA within 3 months, mechanical mitral valve, or aortic valve with additional risk factors (BRIDGE Trial).",classOfRec:"I",levelOfEvidence:"A",guideline:"PAUSE Study; BRIDGE Trial; ACC 2024",reference:"PAUSE: NEJM 2019. BRIDGE: NEJM 2015.",conditions:e=>{var i,s;let a=((s=(i=e.telestrokeNote)==null?void 0:i.secondaryPrevention)==null?void 0:s.antiplateletRegimen)||"";return a.includes("doac")||a.includes("anticoag")}},falls_risk_screening:{id:"falls_risk_screening",category:"Follow-up",title:"Falls risk screening and prevention",recommendation:"Screen for falls risk at discharge and every follow-up visit. Initiate fall prevention program during hospitalization. Refer to community exercise programs with balance training (Class I, LOE A).",detail:"Stroke patients have 2-5x increased fall risk. In-hospital falls prevention: bed alarms, non-slip footwear, assist devices. Post-discharge: structured balance/exercise program reduces falls by 25-40%.",classOfRec:"I",levelOfEvidence:"A",guideline:"AHA/ASA Rehab 2016",reference:"AHA/ASA Rehab Guideline 2016.",conditions:e=>{var i;let a=(((i=e.telestrokeNote)==null?void 0:i.diagnosis)||"").toLowerCase();return a.includes("stroke")||a.includes("ischemic")||a.includes("ich")}}},yi={shared:[{id:"patient-info",label:"Patient Info",section:"patient-info-section",check:e=>{var a,i;return!!((a=e.telestrokeNote)!=null&&a.age&&((i=e.telestrokeNote)!=null&&i.symptoms))}},{id:"lkw",label:"Last Known Well",section:"lkw-section",check:e=>{var a;return!!(e.lkwTime||(a=e.telestrokeNote)!=null&&a.lkwUnknown)}},{id:"nihss",label:"NIHSS",section:"nihss-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.nihss||e.nihssComplete)}},{id:"vitals",label:"Vitals/Labs",section:"vitals-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.presentingBP)}},{id:"imaging",label:"Imaging",section:"imaging-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.ctResults)}},{id:"diagnosis",label:"Diagnosis",section:"treatment-decision",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.diagnosis)}}],ischemic:[{id:"tnk-contraindications",label:"TNK Screen",section:"tnk-contraindications",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.tnkContraindicationReviewed)},skip:e=>{let a=e.timeFromLKW;return a&&a.total>4.5}},{id:"tnk-decision",label:"TNK Decision",section:"treatment-decision",check:e=>{var a,i;return((a=e.telestrokeNote)==null?void 0:a.tnkRecommended)===!0||((i=e.telestrokeNote)==null?void 0:i.tnkRecommended)===!1},skip:e=>{let a=e.timeFromLKW;return a&&a.total>4.5}},{id:"evt-eval",label:"EVT Evaluation",section:"treatment-decision",check:e=>{var a,i;return((a=e.telestrokeNote)==null?void 0:a.evtRecommended)===!0||((i=e.telestrokeNote)==null?void 0:i.evtRecommended)===!1}},{id:"tnk-admin",label:"TNK Admin",section:"time-metrics-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.tnkAdminTime)},skip:e=>{var a;return!((a=e.telestrokeNote)!=null&&a.tnkRecommended)}},{id:"transfer",label:"Transfer",section:"transfer-section",check:e=>{var a,i;return!!((a=e.telestrokeNote)!=null&&a.transferAccepted)||!!((i=e.telestrokeNote)!=null&&i.disposition)},skip:e=>{var a,i;return!((a=e.telestrokeNote)!=null&&a.evtRecommended)&&!(((i=e.telestrokeNote)==null?void 0:i.vesselOcclusion)||[]).some(s=>/ica|m1|mca|basilar/i.test(s))}},{id:"recommendations",label:"Recommendations",section:"recommendations-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.recommendationsText)}}],ich:[{id:"ich-bp",label:"BP Management",section:"vitals-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.ichBPManaged)}},{id:"ich-reversal",label:"Anticoag Reversal",section:"treatment-decision",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.ichReversalOrdered)},skip:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.noAnticoagulants)}},{id:"ich-neurosurg",label:"Neurosurgery",section:"treatment-decision",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.ichNeurosurgeryConsulted)}},{id:"recommendations",label:"Recommendations",section:"recommendations-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.recommendationsText)}}],sah:[{id:"sah-grade",label:"SAH Grade",section:"sah-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.sahGrade)}},{id:"sah-bp",label:"BP Management",section:"sah-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.sahBPManaged)}},{id:"sah-nimodipine",label:"Nimodipine",section:"sah-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.sahNimodipine)}},{id:"sah-neurosurg",label:"Neurosurgery",section:"sah-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.sahNeurosurgeryConsulted)}},{id:"sah-aneurysm",label:"Aneurysm Securing",section:"sah-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.sahAneurysmSecured)},skip:e=>{var i;return(((i=e.telestrokeNote)==null?void 0:i.ctaResults)||"").toLowerCase().includes("no aneurysm")}},{id:"recommendations",label:"Recommendations",section:"recommendations-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.recommendationsText)}}],cvt:[{id:"cvt-anticoag",label:"Anticoagulation",section:"cvt-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.cvtAnticoagStarted)}},{id:"cvt-icp",label:"ICP Management",section:"cvt-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.cvtIcpManaged)}},{id:"cvt-seizure",label:"Seizure Mgmt",section:"cvt-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.cvtSeizureManaged)}},{id:"cvt-heme",label:"Hematology",section:"cvt-management-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.cvtHematologyConsulted)},skip:e=>{var i;return(parseInt((i=e.telestrokeNote)==null?void 0:i.age)||0)>60}},{id:"recommendations",label:"Recommendations",section:"recommendations-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.recommendationsText)}}],tia:[{id:"tia-imaging",label:"MRI DWI",section:"imaging-section",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.tiaWorkup)!=null&&i.mriDwi)}},{id:"tia-vascular",label:"CTA/MRA",section:"imaging-section",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.tiaWorkup)!=null&&i.ctaHeadNeck)}},{id:"tia-ecg",label:"ECG",section:"vitals-section",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.tiaWorkup)!=null&&i.ecg12Lead)}},{id:"tia-telemetry",label:"Telemetry",section:"vitals-section",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.tiaWorkup)!=null&&i.telemetry)}},{id:"tia-echo",label:"Echo",section:"treatment-decision",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.tiaWorkup)!=null&&i.echo)}},{id:"tia-labs",label:"Labs",section:"vitals-section",check:e=>{var a,i,s,o;return!!((i=(a=e.telestrokeNote)==null?void 0:a.tiaWorkup)!=null&&i.labsCbc&&((o=(s=e.telestrokeNote)==null?void 0:s.tiaWorkup)!=null&&o.labsLipids))}},{id:"tia-etiology",label:"TOAST Classification",section:"treatment-decision",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.toastClassification)}},{id:"tia-prevention",label:"Secondary Prevention",section:"recommendations-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.recommendationsText)}}],dissection:[{id:"dissection-imaging",label:"Vascular Imaging",section:"imaging-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.ctaResults)}},{id:"dissection-antithrombotic",label:"Antithrombotic",section:"treatment-decision",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.dissectionPathway)!=null&&i.antithromboticStarted)}},{id:"dissection-followup",label:"Imaging Follow-Up Plan",section:"recommendations-section",check:e=>{var a,i;return!!((i=(a=e.telestrokeNote)==null?void 0:a.dissectionPathway)!=null&&i.imagingFollowUp)}},{id:"recommendations",label:"Recommendations",section:"recommendations-section",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.recommendationsText)}}],mimic:[{id:"alt-workup",label:"Alternative Workup",section:"treatment-decision",check:e=>{var a;return!!((a=e.telestrokeNote)!=null&&a.diagnosis)}},{id:"disposition",label:"Disposition",section:"recommendations-section",check:e=>{var a,i;return!!((a=e.telestrokeNote)!=null&&a.disposition)||!!((i=e.telestrokeNote)!=null&&i.recommendationsText)}}]},j=e=>{if(!e)return"shared";let a=e.toLowerCase();return a.includes("mimic")||a.includes("non-stroke")||a.includes("seizure")||a.includes("migraine")||a.includes("conversion")||a.includes("bell")?"mimic":a.includes("sah")||a.includes("subarachnoid")?"sah":a.includes("cvt")||a.includes("venous thrombosis")||a.includes("cerebral venous")||a.includes("dural sinus")?"cvt":a.includes("ich")||a.includes("hemorrhag")||a.includes("intracerebral")||a.includes("bleed")?"ich":a.includes("dissect")?"dissection":a.includes("tia")||a.includes("transient ischemic")?"tia":a.includes("ischemic")||a.includes("stroke")||a.includes("lvo")||a.includes("occlusion")?"ischemic":"shared"},Ss=(e,a)=>{let i=Le[e];if(!i)return null;let s={trialId:e,trialName:i.name,category:i.category,quickDescription:i.quickDescription,lookingFor:i.lookingFor,criteria:[],exclusions:[],status:"pending",metCount:0,notMetCount:0,unknownCount:0,requiredMissing:0};return i.keyCriteria.forEach(o=>{let n="unknown",c=null;try{let d=o.evaluate(a);d===!0?(n="met",s.metCount++):d===!1?(n="not_met",s.notMetCount++,o.required&&s.requiredMissing++):(n="unknown",s.unknownCount++)}catch(d){n="unknown",s.unknownCount++}s.criteria.push({id:o.id,label:o.label,status:n,required:o.required})}),i.exclusionFlags.forEach(o=>{let n=!1;try{o.evaluate?n=o.evaluate(a):n=a[o.field]===!0}catch(c){n=!1}n&&(s.exclusions.push({id:o.id,label:o.label,triggered:!0}),s.notMetCount++,s.status="not_eligible")}),s.exclusions.some(o=>o.triggered)||s.requiredMissing>0?s.status="not_eligible":s.unknownCount>0?s.status="needs_info":s.notMetCount===0?s.status="eligible":s.status="not_eligible",s},ws=e=>{let a={};return Object.keys(Le).forEach(i=>{a[i]=Ss(i,e)}),a},[Qt,As]=b({}),[sr,Ts]=b(null),Is=e=>{let a=Le[e];if(!a)return;Ts(e),We("trials");let i=a.name.toLowerCase().replace(/\s+trial$/i,"").replace(/[^a-z0-9]/g,"-").replace(/-+/g,"-").replace(/^-|-$/g,"");setTimeout(()=>{let s=document.getElementById(`trial-${i}`);s&&(s.open=!0,s.scrollIntoView({behavior:"smooth",block:"center"}),s.classList.add("ring-4","ring-blue-400","ring-opacity-75"),setTimeout(()=>{s.classList.remove("ring-4","ring-blue-400","ring-opacity-75")},2e3))},150)},xi=({trial:e,category:a})=>{let i=n=>{switch(n){case"ischemic":return"bg-blue-600 text-white";case"ich":return"bg-red-600 text-white";case"rehab":return"bg-green-600 text-white";case"cadasil":return"bg-purple-600 text-white";default:return"bg-gray-600 text-white"}},s=n=>{switch(n){case"ischemic":return"border-blue-200";case"ich":return"border-red-200";case"rehab":return"border-green-200";case"cadasil":return"border-purple-200";default:return"border-gray-200"}},o=e.name.toLowerCase().replace(/\s+trial$/i,"").replace(/[^a-z0-9]/g,"-").replace(/-+/g,"-").replace(/^-|-$/g,"");return React.createElement("details",{id:`trial-${o}`,className:`bg-white rounded-lg shadow-md overflow-hidden border-2 ${s(a)} hover:shadow-lg transition-shadow`},React.createElement("summary",{className:`${i(a)} p-4 cursor-pointer list-none`},React.createElement("div",{className:"flex justify-between items-start"},React.createElement("div",{className:"flex-1"},React.createElement("h3",{className:"text-xl font-bold mb-2"},e.name),React.createElement("div",{className:"flex flex-wrap gap-2 mb-3"},React.createElement("span",{className:"bg-white bg-opacity-20 px-3 py-1 rounded-full text-sm font-semibold"},e.phase),e.status&&React.createElement("span",{className:"bg-white bg-opacity-20 px-3 py-1 rounded-full text-sm font-semibold"},e.status)),React.createElement("p",{className:"text-white text-opacity-95"},e.description)),React.createElement("div",{className:"ml-4"},React.createElement("svg",{className:"w-6 h-6",fill:"none",stroke:"currentColor",viewBox:"0 0 24 24"},React.createElement("path",{strokeLinecap:"round",strokeLinejoin:"round",strokeWidth:2,d:"M19 9l-7 7-7-7"})))),React.createElement("div",{className:"mt-3 flex items-center"},e.nct.startsWith("NCT")?React.createElement("button",{className:"bg-white bg-opacity-20 hover:bg-opacity-30 px-4 py-2 rounded-md text-sm font-medium transition-colors flex items-center",onClick:n=>{n.stopPropagation(),window.open(`https://clinicaltrials.gov/study/${e.nct}`,"_blank")}},React.createElement("svg",{className:"w-4 h-4 mr-2",fill:"none",stroke:"currentColor",viewBox:"0 0 24 24"},React.createElement("path",{strokeLinecap:"round",strokeLinejoin:"round",strokeWidth:2,d:"M10 6H6a2 2 0 00-2 2v10a2 2 0 002 2h10a2 2 0 002-2v-4M14 4h6m0 0v6m0-6L10 14"})),e.nct):React.createElement("span",{className:"text-sm opacity-90"},"Reference: ",e.nct))),React.createElement("div",{className:"bg-gray-50 p-4 border-t-2 border-gray-200"},React.createElement("div",{className:"grid md:grid-cols-2 gap-6"},React.createElement("div",null,React.createElement("h4",{className:"font-bold text-green-700 mb-3 text-lg"},"\u2713 Inclusion Criteria"),React.createElement("ul",{className:"space-y-2"},e.inclusion.map((n,c)=>React.createElement("li",{key:c,className:"flex items-start"},React.createElement("span",{className:"text-green-500 mr-2 mt-1"},"\u2022"),React.createElement("span",{className:"text-gray-700 text-sm"},n))))),React.createElement("div",null,React.createElement("h4",{className:"font-bold text-red-700 mb-3 text-lg"},"\u2717 Exclusion Criteria"),React.createElement("ul",{className:"space-y-2"},e.exclusion.map((n,c)=>React.createElement("li",{key:c,className:"flex items-start"},React.createElement("span",{className:"text-red-500 mr-2 mt-1"},"\u2022"),React.createElement("span",{className:"text-gray-700 text-sm"},n)))))),e.nct.startsWith("NCT")&&React.createElement("div",{className:"mt-6 pt-4 border-t border-gray-200 text-center"},React.createElement("button",{className:"bg-blue-600 hover:bg-blue-700 text-white px-6 py-3 rounded-lg font-medium transition-colors inline-flex items-center",onClick:()=>window.open(`https://clinicaltrials.gov/study/${e.nct}`,"_blank")},React.createElement("svg",{className:"w-5 h-5 mr-2",fill:"none",stroke:"currentColor",viewBox:"0 0 24 24"},React.createElement("path",{strokeLinecap:"round",strokeLinejoin:"round",strokeWidth:2,d:"M10 6H6a2 2 0 00-2 2v10a2 2 0 002 2h10a2 2 0 002-2v-4M14 4h6m0 0v6m0-6L10 14"})),"View Full Details on ClinicalTrials.gov"))))},Lt=[{id:"consciousness",name:"1a. Level of Consciousness",options:["Alert (0)","Drowsy (1)","Stuporous (2)","Coma (3)"]},{id:"loc_questions",name:"1b. LOC Questions",options:["Both correct (0)","One correct (1)","Neither correct (2)"]},{id:"loc_commands",name:"1c. LOC Commands",options:["Obeys both correctly (0)","Obeys one correctly (1)","Neither correctly (2)"]},{id:"best_gaze",name:"2. Best Gaze",options:["Normal (0)","Partial gaze palsy (1)","Forced deviation (2)"]},{id:"visual",name:"3. Visual",options:["No visual loss (0)","Partial hemianopia (1)","Complete hemianopia (2)","Bilateral hemianopia (3)"]},{id:"facial_palsy",name:"4. Facial Palsy",options:["Normal (0)","Minor asymmetry (1)","Partial facial paralysis (2)","Complete facial paralysis (3)"]},{id:"motor_arm_left",name:"5a. Motor Arm-Left",options:["No drift (0)","Drift (1)","Some effort against gravity (2)","No effort against gravity (3)","No movement (4)"]},{id:"motor_arm_right",name:"5b. Motor Arm-Right",options:["No drift (0)","Drift (1)","Some effort against gravity (2)","No effort against gravity (3)","No movement (4)"]},{id:"motor_leg_left",name:"6a. Motor Leg-Left",options:["No drift (0)","Drift (1)","Some effort against gravity (2)","No effort against gravity (3)","No movement (4)"]},{id:"motor_leg_right",name:"6b. Motor Leg-Right",options:["No drift (0)","Drift (1)","Some effort against gravity (2)","No effort against gravity (3)","No movement (4)"]},{id:"limb_ataxia",name:"7. Limb Ataxia",options:["Absent (0)","Present in upper or lower (1)","Present in both (2)"]},{id:"sensory",name:"8. Sensory",options:["Normal (0)","Partial loss (1)","Dense loss (2)"]},{id:"language",name:"9. Best Language\u2020",options:["No aphasia (0)","Mild-moderate aphasia (1)","Severe aphasia (2)","Mute, global aphasia (3)"]},{id:"dysarthria",name:"10. Dysarthria\u2020",options:["Normal articulation (0)","Mild-moderate slurring (1)","Severe dysarthria (2)","Intubated/other (2)"]},{id:"extinction",name:"11. Extinction and Inattention",options:["No neglect (0)","Visual, tactile, auditory, spatial, or personal inattention (1)","Profound hemi-inattention (2)"]}],Pa=e=>Object.values(e).reduce((a,i)=>{var o;let s=parseInt(((o=i==null?void 0:i.split("(")[1])==null?void 0:o.split(")")[0])||0);return a+s},0),or=e=>e.filter(a=>a.checked).length,Rs=e=>e.reduce((a,i)=>a+(i.checked?i.points:0),0),Mt=e=>parseInt(e.eye||0)+parseInt(e.verbal||0)+parseInt(e.motor||0),Je=e=>{let a=0;return e.gcs==="gcs34"?a+=2:e.gcs==="gcs512"&&(a+=1),e.age80&&(a+=1),e.volume30&&(a+=1),e.ivh&&(a+=1),e.infratentorial&&(a+=1),a},Ea=e=>{let a=0;return e.age60&&(a+=1),e.bp&&(a+=1),e.unilateralWeakness&&(a+=2),e.speechDisturbance&&(a+=1),e.duration==="duration10"?a+=1:e.duration==="duration60"&&(a+=2),e.diabetes&&(a+=1),a},Da=e=>{let a=0;return e.chf&&(a+=1),e.hypertension&&(a+=1),e.age75&&(a+=2),e.diabetes&&(a+=1),e.strokeTia&&(a+=2),e.vascular&&(a+=1),e.age65&&(a+=1),e.female&&(a+=1),a},ee=e=>{let a=0;e.noHypertension&&(a+=1),e.noDiabetes&&(a+=1),e.noStrokeTia&&(a+=1),e.nonsmoker&&(a+=1),e.cortical&&(a+=1);let i=parseInt(e.age)||0;return i>=18&&i<=29?a+=5:i>=30&&i<=39?a+=4:i>=40&&i<=49?a+=3:i>=50&&i<=59?a+=2:i>=60&&i<=69&&(a+=1),a},ot=e=>{let a=0;return e.hypertension&&(a+=1),e.renalDisease&&(a+=1),e.liverDisease&&(a+=1),e.stroke&&(a+=1),e.bleeding&&(a+=1),e.labileINR&&(a+=1),e.elderly&&(a+=1),e.drugs&&(a+=1),e.alcohol&&(a+=1),a},rt=e=>{let a=0;return e.recurrentTCH&&(a+=5),e.carotidInvolvement&&(a+=3),e.vasoconstrictiveTrigger&&(a+=2),e.female&&(a+=1),e.sah&&(a-=2),a},Ps=e=>{let a=parseFloat(e.lengthCm)||0,i=parseFloat(e.widthCm)||0,s=parseFloat(e.slicesCm)||0,o=a*i*s/2;return{volume:Math.round(o*10)/10,isLarge:o>=30,isExpanding:!1}},Es=(e,a)=>{let i=parseFloat(e)||0,s=parseFloat(a)||100;if(i<=0)return null;let o=Math.round(i*1),n=Math.round(i*1),c=s<30;return{dose:c?n:o,frequency:c?"daily":"BID",isRenalAdjusted:c,note:c?`CrCl <30: ${n} mg SC daily`:`${o} mg SC BID`}},Ds=(e,a)=>{let i=parseFloat(a)||0,s=(e||"").toLowerCase().includes("apixaban"),o=(e||"").toLowerCase().includes("rivaroxaban");return s?i>=8?{regimen:"low-dose",bolus:"400 mg IV over 15-30 min",infusion:"4 mg/min x 120 min (480 mg)",total:"880 mg"}:{regimen:"high-dose",bolus:"800 mg IV over 15-30 min",infusion:"8 mg/min x 120 min (960 mg)",total:"1760 mg"}:o?i>=8?{regimen:"low-dose",bolus:"400 mg IV over 15-30 min",infusion:"4 mg/min x 120 min (480 mg)",total:"880 mg"}:{regimen:"high-dose",bolus:"800 mg IV over 15-30 min",infusion:"8 mg/min x 120 min (960 mg)",total:"1760 mg"}:{regimen:"N/A",bolus:"Not applicable for this DOAC",infusion:"",total:""}},xt=(e,a,i,s)=>{let o=parseFloat(e),n=parseFloat(a),c=parseFloat(s);if(!o||!n||!c||o<=0||n<=0||c<=0)return null;let d=i==="F"?.85:1,m=(140-o)*n*d/(72*c);return{value:Math.round(m*10)/10,isLow:m<30,isBorderline:m>=30&&m<50,renalCategory:m<15?"severe-dialysis":m<30?"severe":m<50?"moderate":m<90?"mild":"normal",label:m<15?"Severe (consider dialysis)":m<30?"Severe (<30)":m<50?"Moderate (30-49)":m<90?"Mild (50-89)":"Normal (\u226590)"}},Xe=e=>{let a=parseFloat(e);if(isNaN(a)||a<=0)return null;let i=a*.25,s=Math.min(i,25),o=[{minWeight:0,maxWeight:59.9,dose:"Variable (0.25 mg/kg)",vial:"Calculate"},{minWeight:60,maxWeight:69.9,dose:"15-17.5 mg",vial:"3-3.5 mL"},{minWeight:70,maxWeight:79.9,dose:"17.5-20 mg",vial:"3.5-4 mL"},{minWeight:80,maxWeight:89.9,dose:"20-22.5 mg",vial:"4-4.5 mL"},{minWeight:90,maxWeight:99.9,dose:"22.5-25 mg",vial:"4.5-5 mL"},{minWeight:100,maxWeight:1/0,dose:"25 mg (MAX)",vial:"5 mL"}];return{weightKg:a,calculatedDose:s.toFixed(1),isMaxDose:i>=25,doseTable:o}},nt=e=>{if(!e||typeof e!="string")return{status:"unknown",systolic:null,diastolic:null};let a=e.match(/(\d+)\s*\/\s*(\d+)/);if(!a)return{status:"unknown",systolic:null,diastolic:null};let i=parseInt(a[1]),s=parseInt(a[2]);if(isNaN(i)||isNaN(s))return{status:"unknown",systolic:null,diastolic:null};let o=185,n=110,c=175,d=105,m="ok",l="OK for lysis",C="bg-green-100 text-green-800 border-green-300",k="\u2713";i>o||s>n?(m="too_high",l="Too high for TNK",C="bg-red-100 text-red-800 border-red-300",k="\uF6AB"):(i>=c&&i<=o||s>=d&&s<=n)&&(m="borderline",l="Borderline",C="bg-yellow-100 text-yellow-800 border-yellow-300",k="\u26A0");let I=Math.max(0,i-o),S=Math.max(0,s-n);return{status:m,systolic:i,diastolic:s,message:l,badgeClass:C,icon:k,sbpToLower:I,dbpToLower:S,needsLowering:I>0||S>0}},rr=(e,a)=>{let i=parseFloat(e),s=parseFloat(a);if(isNaN(i)||i<=0)return null;let o,n;isNaN(s)||s<2?(o=25,n="INR <2 or unknown"):s>=2&&s<=4?(o=25,n="INR 2-4"):s>4&&s<=6?(o=35,n="INR 4-6"):(o=50,n="INR >6");let c=Math.min(i*o,5e3);return{weightKg:i,inr:s||"unknown",unitsPerKg:o,totalDose:Math.round(c),isMaxDose:i*o>=5e3,description:n}},Oa=()=>{let e={doorToCT:null,doorToNeedle:null,ctToNeedle:null,timestamps:{}},a=t.dtnEdArrival?new Date(t.dtnEdArrival):null,i=t.dtnCtStarted?new Date(t.dtnCtStarted):null,s=t.dtnCtRead?new Date(t.dtnCtRead):null,o=t.dtnTnkAdministered?new Date(t.dtnTnkAdministered):null;if(e.timestamps={edArrival:a,strokeAlert:t.dtnStrokeAlert?new Date(t.dtnStrokeAlert):null,ctStarted:i,ctRead:s,tnkOrdered:t.dtnTnkOrdered?new Date(t.dtnTnkOrdered):null,tnkAdmin:o},a&&i){let n=i-a,c=Math.round(n/(1e3*60));e.doorToCT=c}if(a&&o){let n=o-a,c=Math.round(n/(1e3*60));e.doorToNeedle=c}if(s&&o){let n=o-s,c=Math.round(n/(1e3*60));e.ctToNeedle=c}return e},La=e=>e===null?null:e<=45?{status:"excellent",color:"green",label:"Excellent",target:45,delta:e-45}:e<=60?{status:"good",color:"yellow",label:"Good",target:60,delta:e-45}:{status:"needs_improvement",color:"red",label:"Needs Improvement",target:60,delta:e-60},Os=()=>{let e=Oa();if(!e.doorToNeedle)return"";let a=La(e.doorToNeedle),i=`
Time Metrics:
`;return e.doorToCT!==null&&(i+=`Door-to-CT: ${e.doorToCT} minutes
`),i+=`Door-to-Needle (DTN): ${e.doorToNeedle} minutes`,a&&(i+=` (${a.label}`,a.delta>0?i+=`, +${a.delta} min over ${a.target} min target`:a.delta<0&&(i+=`, ${Math.abs(a.delta)} min under ${a.target} min target`),i+=")"),i+=`
`,e.ctToNeedle!==null&&(i+=`CT-to-Needle: ${e.ctToNeedle} minutes
`),i},Ni=e=>{var k,I,S,H,f,U,V,ae,N,ge,te;let a=[],i=parseFloat((k=e.telestrokeNote)==null?void 0:k.glucose);isNaN(i)||(i<50?a.push({severity:"critical",label:"Hypoglycemia",message:`Glucose ${i} mg/dL - Correct before thrombolysis`,field:"glucose"}):i>400&&a.push({severity:"critical",label:"Hyperglycemia",message:`Glucose ${i} mg/dL - Correct before thrombolysis`,field:"glucose"}));let s=parseFloat((I=e.telestrokeNote)==null?void 0:I.inr);!isNaN(s)&&s>1.7&&a.push({severity:"critical",label:"Elevated INR",message:`INR ${s.toFixed(1)} >1.7 - tPA/TNK CONTRAINDICATED`,field:"inr"});let o=parseFloat((S=e.telestrokeNote)==null?void 0:S.plateletCount);!isNaN(o)&&o<1e5&&a.push({severity:"critical",label:"Low Platelets",message:`${o.toLocaleString()}/\u03BCL <100,000 - tPA/TNK CONTRAINDICATED`,field:"plateletCount"});let c=(((H=e.telestrokeNote)==null?void 0:H.presentingBP)||"").match(/(\d+)\s*\/\s*(\d+)/);if(c){let K=parseInt(c[1]),v=parseInt(c[2]);(K>185||v>110)&&a.push({severity:"warning",label:"Elevated BP",message:`${K}/${v} exceeds 185/110 - Must lower before TNK`,field:"presentingBP"})}if((f=e.telestrokeNote)!=null&&f.lastDOACType&&((U=e.telestrokeNote)!=null&&U.lastDOACDose)){let K=new Date(e.telestrokeNote.lastDOACDose),B=(new Date-K)/(1e3*60*60);B<48&&a.push({severity:"warning",label:"Recent DOAC",message:`${e.telestrokeNote.lastDOACType} within ${B.toFixed(0)}h - Check drug-specific assay`,field:"lastDOACDose"})}let d=parseInt((V=e.telestrokeNote)==null?void 0:V.age),m=parseInt((ae=e.telestrokeNote)==null?void 0:ae.nihss);!isNaN(d)&&!isNaN(m)&&d+m>=100&&a.push({severity:"info",label:"SPAN-100",message:`Age ${d} + NIHSS ${m} = ${d+m} \u2265100 - Higher sICH risk`,field:"nihss"});let l=(N=e.telestrokeNote)==null?void 0:N.lkwDate,C=(ge=e.telestrokeNote)==null?void 0:ge.lkwTime;if(l&&C){let K=new Date(`${l}T${C}`),B=(new Date-K)/(1e3*60*60);B>4.5&&((te=e.telestrokeNote)!=null&&te.tnkRecommended)&&a.push({severity:"warning",label:"Late Window",message:`${B.toFixed(1)}h from LKW - Verify imaging criteria`,field:"lkwTime"})}return a},nr=({icon:e,size:a=16})=>{let i=sa(null);return React.useEffect(()=>{i.current&&lucide.createIcons({root:i.current,nameAttr:"data-lucide",attrs:{class:"w-4 h-4 inline-block"}})},[e]),React.createElement("span",{ref:i,className:"inline-flex items-center justify-center"},React.createElement("i",{"data-lucide":e,className:"w-4 h-4 inline-block"}))},ki=(e,a)=>{try{Be(e,a),gt("saved"),xa(new Date)}catch(i){gt("error"),console.error("Save failed:",i)}},lr=(e,a)=>{try{return L(e,a)}catch(i){return console.warn("Load failed:",i),a}},Ls=(e,a)=>{let i;return function(...o){let n=()=>{clearTimeout(i),e(...o)};clearTimeout(i),i=setTimeout(n,a)}},F=React.useCallback(Ls((e,a)=>{gt("saving"),ki(e,a),gt("saved"),xa(Date.now())},1e3),[]),Ci=()=>`pt_${Date.now()}_${Math.random().toString(36).substr(2,9)}`,Ms=()=>{let e=t.age||"?",a=t.sex||"?",i=t.symptoms||"Stroke symptoms",s=t.nihss||h||"?",o=me(),n=o?`${o.hours}h ${o.minutes}m`:"?",c="",d=t.vesselOcclusion||[];return d.includes("M1")?c="M1":d.includes("ICA")?c="ICA":d.includes("M2")?c="M2":t.ctaResults&&(t.ctaResults.toLowerCase().includes("m1")?c="M1":t.ctaResults.toLowerCase().includes("ica")&&(c="ICA")),{age:e,sex:a,symptoms:i.substring(0,30)+(i.length>30?"...":""),nihss:s,timeFromLKW:n,vesselInfo:c,shortLabel:`${e}${a} ${c||"AIS"} NIHSS ${s}`,fullLabel:`${e}yo ${a==="M"?"M":a==="F"?"F":"?"}, ${c||"Stroke"}, NIHSS ${s}, ${n} from LKW`}},Hs=()=>{let e={eligible:0,needsInfo:0,notEligible:0,total:0};return Object.values(Qt).forEach(a=>{a&&(e.total++,a.status==="eligible"?e.eligible++:a.status==="needs_info"?e.needsInfo++:a.status==="not_eligible"&&e.notEligible++)}),e},Si=()=>{let e=je||Ci(),a=Ms(),i=Hs(),s={id:e,timestamp:Date.now(),summary:a,trialSummary:i,formState:{telestrokeNote:{...t},strokeCodeForm:{...J},lkwTime:g?g.toISOString():null,nihssScore:h,aspectsScore:A,mrsScore:M,gcsItems:{...T}}};return Ta(o=>{let n=o.findIndex(c=>c.id===e);if(n>=0){let c=[...o];return c[n]=s,c}return[...o,s]}),je||ht(e),e},cr=e=>{je&&t.age&&Si();let a=Gt.find(s=>s.id===e);if(!a)return;let{formState:i}=a;r(i.telestrokeNote),at(i.strokeCodeForm),Re(i.lkwTime?new Date(i.lkwTime):null),Ie(i.nihssScore),tt(i.aspectsScore),fe(i.mrsScore),Y(i.gcsItems),ht(e),Ia(!1)},Vs=()=>{t.age&&Si(),ao({generateNewId:!0})},dr=e=>{Ta(a=>a.filter(i=>i.id!==e)),je===e&&ht(null)},mr=e=>{if(!e)return[];let a=e.match(/{[A-Z0-9_]+}/g)||[];return[...new Set(a.map(i=>i.replace(/[{}]/g,"")))]},Fs=(e,a)=>e?e.replace(/{([A-Z0-9_]+)}/g,(i,s)=>{let o=a[s];return o==null?"":String(o)}):"",Bs=()=>{let e=t.lkwDate&&t.lkwTime?`${t.lkwDate} ${t.lkwTime}`:"";return{PATIENT_ALIAS:t.alias||"",AGE:t.age||"",SEX:t.sex||"",NIHSS:t.nihss||h||"",DIAGNOSIS:t.diagnosis||"",LVO:(t.vesselOcclusion||[]).join(", "),WEIGHT_KG:t.weight||"",LKW:e,ARRIVAL:t.arrivalTime||"",CT_TIME:t.ctTime||"",CTA_TIME:t.ctaTime||"",CT_RESULTS:t.ctResults||"",CTA_RESULTS:t.ctaResults||"",CTP_RESULTS:t.ctpResults||"",ASPECTS:A!==10?A:"",TNK_STATUS:t.tnkRecommended?t.tnkAdminTime?`Given at ${t.tnkAdminTime}`:"Recommended":"Not given",EVT_STATUS:t.evtRecommended?"Recommended":"Not recommended",DISPOSITION:t.disposition||"",TRANSFER_STATUS:t.transferAccepted?"Accepted":"",PENDING_ITEMS:"",ICH_SCORE:Je(R),GCS:Mt(T),BP:t.presentingBP||"",HEMATOMA:t.ctResults||"",IVH:t.ctResults||"",REVERSAL:""}},$s=()=>Pt.find(e=>e.id===Ra)||Pt[0]||null,_s=e=>{if(!e)return[];let a=Bs();return(e.sections||[]).filter(i=>i.enabled).map(i=>({title:i.title,body:Fs(i.template,a)}))},pr=async()=>{let e=$s();if(!e)return;let a=_s(e);await wo(a)&&z("Clipboard pack")},Me=(e,a)=>{_e(i=>({...i,shiftBoards:i.shiftBoards.map(s=>s.id!==e?s:{...a(s),updatedAt:Ze()})}))},gr=e=>{_e(a=>({...a,uiState:{...a.uiState,lastShiftBoardId:e}}))},ur=()=>{let e=prompt("Board name:","New Board");if(!e)return;let a=St("board");_e(i=>({...i,shiftBoards:[{id:a,name:e.trim()||"New Board",createdAt:Ze(),updatedAt:Ze(),archived:!1,patients:[]},...i.shiftBoards],uiState:{...i.uiState,lastShiftBoardId:a}}))},br=e=>{let a=yt.find(s=>s.id===e);if(!a)return;let i=prompt("Rename board:",a.name);i&&Me(e,s=>({...s,name:i.trim()||s.name}))},hr=(e,a=!0)=>{Me(e,i=>({...i,archived:a}))},fr=()=>{if(!Z)return;let e={id:St("pt"),alias:qs(),label:"",location:"",problemSummary:"",tasks:[],pendingResults:[],freeNotes:""};Me(Z.id,a=>({...a,patients:[e,...a.patients||[]]}))},vr=(e,a)=>{Z&&Me(Z.id,i=>({...i,patients:(i.patients||[]).map(s=>s.id===e?{...s,...a}:s)}))},yr=e=>{Z&&Me(Z.id,a=>({...a,patients:(a.patients||[]).filter(i=>i.id!==e)}))},Ws=(e,a)=>{!Z||!a||Me(Z.id,i=>({...i,patients:(i.patients||[]).map(s=>{if(s.id!==e)return s;let o={id:St("task"),text:a.trim(),priority:"med",owner:"me",dueAt:"",status:"todo",createdAt:Ze(),completedAt:null};return{...s,tasks:[o,...s.tasks||[]]}})}))},xr=()=>{if(!Z||!(Z.patients||[]).length){Ae("Add a patient before creating a task.","warning");return}let e=prompt("Task description:");if(!e)return;let a=Z.patients[0];Ws(a.id,e)},Nr=(e,a,i)=>{Z&&Me(Z.id,s=>({...s,patients:(s.patients||[]).map(o=>o.id!==e?o:{...o,tasks:(o.tasks||[]).map(n=>n.id===a?{...n,...i,completedAt:i.status==="done"?Ze():n.completedAt}:n)})}))},kr=(e,a)=>{!Z||!a||Me(Z.id,i=>({...i,patients:(i.patients||[]).map(s=>{if(s.id!==e)return s;let o={id:St("result"),label:a.trim(),status:"pending",dueAt:"",resultSummary:""};return{...s,pendingResults:[o,...s.pendingResults||[]]}})}))},Cr=(e,a,i)=>{Z&&Me(Z.id,s=>({...s,patients:(s.patients||[]).map(o=>o.id!==e?o:{...o,pendingResults:(o.pendingResults||[]).map(n=>n.id===a?{...n,...i}:n)})}))},Sr=e=>{if(!e)return"";let a=`ROUNDS CHECKLIST - ${e.name}
---
`;return(e.patients||[]).forEach(i=>{a+=`${i.alias||"Patient"}${i.label?` (${i.label})`:""}
`,i.problemSummary&&(a+=`- Summary: ${i.problemSummary}
`);let s=(i.tasks||[]).filter(n=>n.status!=="done");s.length&&(a+=`- Tasks:
`,s.forEach(n=>{a+=`  \u2022 ${n.text} (${n.priority})
`}));let o=(i.pendingResults||[]).filter(n=>n.status!=="resulted");o.length&&(a+=`- Pending:
`,o.forEach(n=>{a+=`  \u2022 ${n.label}
`})),a+=`
`}),a.trim()};React.useEffect(()=>{Gt.length>0&&ki("shiftPatients",Gt)},[Gt]),React.useEffect(()=>{je&&Be("currentPatientId",je)},[je]),React.useEffect(()=>{Po(ne)},[ne]);let Ma=React.useRef(null),Nt=React.useRef(null),wi=React.useRef(!1),Ae=(e,a="info",i={})=>{let{timeoutMs:s=4e3,persist:o=!1}=i;Ma.current&&clearTimeout(Ma.current),ca({message:e,type:a}),o||(Ma.current=setTimeout(()=>{ca(null)},s))},Ha=(e={})=>{let{resetDarkMode:a=!1}=e;la(Ft()),Tt({}),Ie(0),tt(10),Re(new Date),at(u()),Ot(y()),Jt(E()),Y({eye:"",verbal:"",motor:""}),fe(""),ve({gcs:"",age80:!1,volume30:!1,ivh:!1,infratentorial:!1}),ye({age60:!1,bp:!1,unilateralWeakness:!1,speechDisturbance:!1,duration:"",diabetes:!1}),xe({chf:!1,hypertension:!1,age75:!1,diabetes:!1,strokeTia:!1,vascular:!1,age65:!1,female:!1}),Ee({noHypertension:!1,noDiabetes:!1,noStrokeTia:!1,nonsmoker:!1,cortical:!1,age:""}),ze(""),qe(""),de({hypertension:!1,renalDisease:!1,liverDisease:!1,stroke:!1,bleeding:!1,labileINR:!1,elderly:!1,drugs:!1,alcohol:!1}),Ye({recurrentTCH:!1,carotidInvolvement:!1,vasoconstrictiveTrigger:!1,female:!1,sah:!1}),wa(0),Aa([]),Ta([]),ht(null),Ia(!1),ft(Xa().defaultConsultationType||"videoTelestroke"),vt("ich"),zt(!1),di(!1),va(null),Wt(!1),mi(0),vi(window.innerWidth<1024),r(ie()),bs(p),ha(""),Ut([]),Ge(!1),ut("header"),Na(""),Rt(!1),z(""),ps(!1),gs(!1),bi([]),Dt("ischemic"),ks({clinic:!1,map:!1}),gt("saved"),xa(null),ca(null),cs(!0),ii(!1),Ca({}),a&&(ni(!1),document.documentElement.classList.remove("dark"))},Ne=(e,a={})=>{let{clearSearch:i=!1,subTab:s=null}=a,o=e||"encounter",n=et[o],c=o;n?c="management":za.includes(c)||(c="encounter");let d=he;if(c==="management"){let m=mt(s)||n||he||"ich";d=m,vt(m)}We(c),_e(m=>({...m,uiState:{...m.uiState,lastActiveTab:c,lastManagementSubTab:c==="management"?d:m.uiState.lastManagementSubTab}})),i&&(ha(""),Ut([]),Ge(!1),ut("header"))},wr=e=>{_e(a=>({...a,uiState:{...a.uiState,searchHighlightId:e}}))},Ai=oe.allowFreeTextStorage===!0,Us=e=>{_e(a=>({...a,settings:{...a.settings,...e}}))},lt=(e,a="")=>{let i=new Date().toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"});r(s=>({...s,decisionLog:[{id:St("decision"),label:e,detail:a,time:i},...s.decisionLog||[]]}))},Ks=e=>{r(a=>{let i=(a.medications||"").trim(),s=i?`${i}, ${e}`:e;return{...a,medications:s}})},Ar=e=>{Us({contacts:e})},Tr=e=>{let a=po[e];a&&(ft(a.consultationType),si(a.showAdvanced))},Va=e=>{if(!e)return"";let a=e instanceof Date?e:new Date(e);return Number.isNaN(a.getTime())?String(e):a.toLocaleString("en-US",{month:"2-digit",day:"2-digit",hour:"2-digit",minute:"2-digit"})},Ti=(e,a="")=>{let i=t.age||"?",s=t.sex||"?",o=t.nihss||h||"?",n=Zt(),c=n?n.label:"LKW",d=n?Va(n.time):"unknown",m=e==="accept"?"Transfer accepted":"Transfer declined",l=a?`Reason: ${a}`:"Reason: clinical criteria not met";return`${m} for ${i}yo ${s}, NIHSS ${o}. ${c} ${d}. ${l}.`},Ii=()=>{let e=t.age||"--",a=t.sex||"--",i=t.nihss||h||"--",s=t.nihssDetails||"",o=t.diagnosis||(t.diagnosisCategory==="ischemic"?"Suspected acute ischemic stroke":t.diagnosisCategory==="ich"?"Intracerebral hemorrhage (ICH)":t.diagnosisCategory==="mimic"?"Stroke mimic":"Diagnosis pending"),n=Zt(),c=n?n.label:"Onset",d=n?Va(n.time):"Unknown",m=me(),l=m?`${m.hours}h ${m.minutes}m`:"Unknown",C=[`CT: ${t.ctResults||"pending"}`,`CTA: ${t.ctaResults||"pending"}`];t.ctpResults&&C.push(`CTP: ${t.ctpResults}`);let k=C.join("; "),I=t.weight?Xe(t.weight):null,S=t.tnkRecommended?`TNK recommended${I?` (${I.calculatedDose} mg)`:""}`:"TNK not recommended",H=t.evtRecommended?"EVT recommended":"EVT not recommended",f=t.disposition||"",U=t.transferAccepted?"Transfer accepted":t.transferRationale?"Transfer declined":"",V=t.transportMode?`${t.transportMode}${t.transportEta?` ETA ${Va(t.transportEta)}`:""}`:"",ae=t.transferImagingShareMethod?`${t.transferImagingShareMethod}${t.transferImagingShareLink?` (${t.transferImagingShareLink})`:""}`:"";return{age:e,sex:a,nihss:i,nihssDetails:s,diagnosis:o,onsetLabel:c,onsetTime:d,elapsed:l,imagingSummary:k,tnkStatus:S,evtStatus:H,disposition:f,transferStatus:U,transportDetails:V,imagingShare:ae}},Ri=()=>{let e=Ii(),a=["Handoff Summary",`Age/Sex: ${e.age}${e.sex?` ${e.sex}`:""}`,`Dx: ${e.diagnosis}`,`${e.onsetLabel}: ${e.onsetTime}${e.elapsed&&e.elapsed!=="Unknown"?` (${e.elapsed} elapsed)`:""}`,`NIHSS: ${e.nihss}${e.nihssDetails?` (${e.nihssDetails})`:""}`,`Imaging: ${e.imagingSummary}`,`Plan: ${e.tnkStatus}; ${e.evtStatus}`];return e.disposition&&a.push(`Disposition: ${e.disposition}`),e.transferStatus&&a.push(e.transferStatus),e.transportDetails&&a.push(`Transport: ${e.transportDetails}`),e.imagingShare&&a.push(`Imaging share: ${e.imagingShare}`),t.rationale&&a.push(`Rationale: ${t.rationale}`),t.recommendationsText&&a.push(`Recommendations: ${t.recommendationsText}`),a.filter(Boolean).join(`
`)},Gs=()=>{let e=!!Zt(),a=!!(t.nihss||h),i=!!t.presentingBP,s=!!t.glucose,o=!!t.ctResults,n=!!t.ctaResults,c=!t.tnkRecommended||!!t.weight,d=!t.tnkRecommended||t.tnkContraindicationReviewed,m=!t.tnkRecommended||t.tnkConsentDiscussed;return[{id:"onset",label:"Onset time documented",complete:e},{id:"nihss",label:"NIHSS documented",complete:a},{id:"bp",label:"BP documented",complete:i},{id:"glucose",label:"Glucose documented",complete:s},{id:"ct",label:"CT results documented",complete:o},{id:"cta",label:"CTA results documented (if obtained)",complete:n},{id:"weight",label:"Weight documented (if TNK)",complete:c},{id:"tnkChecklist",label:"TNK contraindications reviewed",complete:d},{id:"consent",label:"TNK consent discussed",complete:m}]},js=e=>Ai?e:["alias","age","sex","weight","nihss","aspects","vesselOcclusion","diagnosisCategory","lkwDate","lkwTime","lkwUnknown","discoveryDate","discoveryTime","arrivalTime","strokeAlertTime","ctDate","ctTime","ctaDate","ctaTime","tnkAdminTime","presentingBP","bpPreTNK","bpPreTNKTime","glucose","plateletCount","inr","ptt","creatinine","tnkRecommended","evtRecommended","tnkContraindicationChecklist","tnkContraindicationReviewed","tnkContraindicationReviewTime","tnkConsentDiscussed","patientFamilyConsent","presumedConsent","preTNKSafetyPause","imagingReviewed","transferAccepted","transferRationale","transferChecklist","disposition","transferImagingShareMethod","transferImagingShareLink","transportMode","transportEta","transportNotes","lastDOACType","lastDOACDose","dtnEdArrival","dtnStrokeAlert","dtnCtStarted","dtnCtRead","dtnTnkOrdered","dtnTnkAdministered","decisionLog"].reduce((i,s)=>(e&&Object.prototype.hasOwnProperty.call(e,s)&&(i[s]=e[s]),i),{}),zs=e=>Ai?e:["age","sex","lkw","lkw_date","nihss","aspects","tnk","tnk_rec","evt_rec"].reduce((i,s)=>(e&&Object.prototype.hasOwnProperty.call(e,s)&&(i[s]=e[s]),i),{}),qs=()=>{let e=["Swift","Calm","Brisk","Bright","Sable","Quiet","Sturdy","Clear"],a=["Falcon","Harbor","Quartz","Willow","Comet","Cedar","Nimbus","Aspen"],i=e[Math.floor(Math.random()*e.length)],s=a[Math.floor(Math.random()*a.length)],o=Math.floor(Math.random()*90+10);return`${i}-${s}-${o}`},Ir=e=>{let a=Math.floor(e/60),i=e%60;return`${a}:${String(i).padStart(2,"0")}`},Rr=(e,a=120,i=28)=>{if(!e.length)return"";let s=Math.max(...e,1),o=a/Math.max(e.length-1,1);return e.map((n,c)=>{let d=c*o,m=i-n/s*i;return`${c===0?"M":"L"}${d},${m}`}).join(" ")},re=(e,a)=>{navigator.clipboard.writeText(e).then(()=>{z(a),setTimeout(()=>z(""),2e3)})},Pr=async(e,a)=>{let i=window.location.origin+window.location.pathname+a;if(navigator.share)try{await navigator.share({title:`Stroke Resource: ${e}`,text:`Check out this stroke reference: ${e}`,url:i})}catch(s){s.name!=="AbortError"&&re(i,e)}else re(i,e)},X=(e,a)=>{let i=window.location.origin+window.location.pathname+a,s=encodeURIComponent(e),o=encodeURIComponent(i);window.location.href=`mailto:?subject=${s}&body=${o}`},Fa=()=>{let e=document.getElementById("root"),a={margin:.5,filename:`stroke-assessment-${new Date().toISOString().split("T")[0]}.pdf`,image:{type:"jpeg",quality:.98},html2canvas:{scale:2},jsPDF:{unit:"in",format:"letter",orientation:"portrait"}};html2pdf().set(a).from(e).save()},Ba=()=>{let e=!Ue;ni(e),Be("darkMode",e,{skipLastUpdated:!0}),e?document.documentElement.classList.add("dark"):document.documentElement.classList.remove("dark")},Pi=async()=>{let e={title:"Stroke",text:"Clinical decision support toolkit for stroke management",url:window.location.href};try{navigator.share?await navigator.share(e):(await navigator.clipboard.writeText(window.location.href),z("Link"))}catch(a){if(a.name!=="AbortError")try{await navigator.clipboard.writeText(window.location.href),z("Link")}catch(i){console.error("Share failed:",i)}}},Er=({text:e,children:a})=>React.createElement("span",{className:"tooltip"},a,React.createElement("span",{className:"tooltiptext"},e)),Ei=()=>{let e=s=>{if(!s)return"";let o=new Date(s);return`${o.getMonth()+1}/${o.getDate()}/${o.getFullYear().toString().slice(-2)}`},a=s=>{if(!s)return"";let[o,n]=s.split(":"),c=parseInt(o),d=c>=12?"pm":"am";return`${c===0?12:c>12?c-12:c}:${n} ${d}`},i=fa;if(i=i.replace(/{chiefComplaint}/g,t.chiefComplaint||""),i=i.replace(/{lkwDate}/g,e(t.lkwDate)),i=i.replace(/{lkwTime}/g,a(t.lkwTime)),i=i.replace(/{age}/g,t.age||""),i=i.replace(/{sex}/g,t.sex||""),i=i.replace(/{symptoms}/g,t.symptoms||""),i=i.replace(/{pmh}/g,t.pmh||""),i=i.replace(/{medications}/g,t.medications||""),i=i.replace(/{presentingBP}/g,t.presentingBP||""),i=i.replace(/{bpPreTNK}/g,t.bpPreTNK||""),i=i.replace(/{bpPreTNKTime}/g,a(t.bpPreTNKTime)),i=i.replace(/{glucose}/g,t.glucose||""),i=i.replace(/{plateletsCoags}/g,t.plateletsCoags||""),i=i.replace(/{creatinine}/g,t.creatinine||""),i=i.replace(/{nihss}/g,t.nihss||h||""),i=i.replace(/{nihssDetails}/g,t.nihssDetails||""),i=i.replace(/{ctTime}/g,a(t.ctTime)),i=i.replace(/{ctResults}/g,t.ctResults||""),i=i.replace(/{ctaDate}/g,e(t.ctaDate)),i=i.replace(/{ctaTime}/g,a(t.ctaTime)),i=i.replace(/{ctaResults}/g,t.ctaResults||""),i=i.replace(/{ekgResults}/g,t.ekgResults||""),i=i.replace(/{diagnosis}/g,t.diagnosis||""),i=i.replace(/{tnkAdminTime}/g,a(t.tnkAdminTime)),i=i.replace(/{recommendationsText}/g,t.recommendationsText||""),t.dtnTnkAdministered&&t.tnkRecommended&&(i+=Os()),t.tnkContraindicationReviewed){i+=`
Thrombolysis Contraindication Review: Completed at ${t.tnkContraindicationReviewTime}. `;let s=t.tnkContraindicationChecklist||{},o=["activeInternalBleeding","recentIntracranialSurgery","intracranialNeoplasm","knownBleedingDiathesis","severeUncontrolledHTN","currentICH"],n=["recentMajorSurgery","recentGIGUBleeding","recentArterialPuncture","recentLumbarPuncture","pregnancy","seizureAtOnset","lowPlatelets","elevatedINR","elevatedPTT","abnormalGlucose","recentDOAC"],c=o.filter(m=>s[m]),d=n.filter(m=>s[m]);c.length===0&&d.length===0?i+="No absolute or relative contraindications identified.":c.length>0?i+=`Absolute contraindication(s) identified: ${c.length}. TNK contraindicated.`:d.length>0&&(i+=`${d.length} relative contraindication(s) identified. Clinical judgment applied.`),i+=`
`}return i},Di=()=>{if(!t.discoveryDate||!t.discoveryTime)return null;let[e,a,i]=t.discoveryDate.split("-").map(Number),[s,o]=t.discoveryTime.split(":").map(Number);return!e||!a||!i||Number.isNaN(s)||Number.isNaN(o)?null:new Date(e,a-1,i,s,o)},Zt=()=>{if(t.lkwUnknown){let e=Di();return e?{time:e,label:"Discovery"}:null}return g?{time:g,label:"LKW"}:null},me=()=>{let e=Zt();if(!e)return null;let a=Se-e.time,i=a/(1e3*60*60),s=a/(1e3*60)%60;return{hours:Math.floor(i),minutes:Math.floor(s),total:i,label:e.label}},Ys=e=>e?e.total<=4.5?e.total<3?{color:"green",message:"Within TNK window (<3h)",urgent:!1,eligible:"tnk"}:{color:"yellow",message:"Extended TNK window (3-4.5h)",urgent:!1,eligible:"tnk"}:e.total<6?{color:"orange",message:"TNK window closed - EVT window (4.5-6h)",urgent:!0,eligible:"evt-early"}:e.total<24?{color:"red",message:"Late EVT window (6-24h - needs perfusion imaging)",urgent:!0,eligible:"evt-late"}:{color:"gray",message:"Beyond standard treatment window",urgent:!1,eligible:"none"}:null,Js=e=>{let a=document.getElementById(e);if(!a)return;let s=a.getBoundingClientRect().top+window.pageYOffset-24;window.scrollTo({top:Math.max(0,s),behavior:"smooth"}),a.hasAttribute("tabindex")||a.setAttribute("tabindex","-1"),a.focus({preventScroll:!0})},Dr=()=>{let e=me(),a=parseInt(t.nihss)||h||0,i=(t.diagnosis||"").toLowerCase(),s=j(t.diagnosis),o={telestrokeNote:t,lkwTime:g,nihssScore:h,nihssComplete:Xs(),aspectsScore:A,timeFromLKW:e,ichScore:typeof Je=="function"?Je(R):0},n=yi.shared,c=yi[s]||[],m=[...n,...c].filter(f=>!f.skip||!f.skip(o)),l=m.filter(f=>f.check(o)).length,C=m.length,k=C>0?Math.round(l/C*100):0,I="Assessment";s!=="shared"&&(l===C?I="Complete":l>n.filter(f=>!f.skip||!f.skip(o)).length?I=s==="ischemic"?"Ischemic Pathway":s==="ich"?"ICH Pathway":s==="sah"?"SAH Pathway":s==="cvt"?"CVT Pathway":s==="tia"?"TIA Pathway":s==="dissection"?"Dissection Pathway":"Workup":I="Initial Assessment");let S=m.find(f=>!f.check(o)),H=null;return S&&(H={...{"patient-info":{title:"Capture core details",detail:"Enter age and presenting symptoms to drive recommendations.",cta:"Go to Patient Info"},lkw:{title:"Set last known well",detail:"Time from onset is required to determine treatment windows.",cta:"Set LKW"},nihss:{title:"Enter NIHSS score",detail:"Use quick entry or guided NIHSS to calculate severity.",cta:"Enter NIHSS"},vitals:{title:"Add presenting BP",detail:"BP drives TNK eligibility and safety checks.",cta:"Enter BP"},imaging:{title:"Review imaging",detail:"Document CT/CTA findings to determine treatment pathway.",cta:"Add imaging"},diagnosis:{title:"Set diagnosis",detail:"Establish working diagnosis to activate type-specific pathway.",cta:"Set diagnosis"},"tnk-contraindications":{title:"Review TNK contraindications",detail:"Complete the contraindication checklist before recommending TNK.",cta:"Review contraindications"},"tnk-decision":{title:"TNK decision",detail:"Patient is within TNK window. Confirm eligibility and document decision.",cta:"Review treatment"},"evt-eval":{title:"Evaluate for EVT",detail:"Assess LVO, NIHSS, and imaging for thrombectomy candidacy.",cta:"Evaluate EVT"},"tnk-admin":{title:"Document TNK administration",detail:"Capture administration time for DTN metrics.",cta:"Add TNK time"},transfer:{title:"Arrange transfer",detail:"Coordinate transfer to EVT-capable center for LVO.",cta:"Transfer checklist"},recommendations:{title:"Finalize recommendations",detail:"Complete the recommendation summary for handoff and documentation.",cta:"Add recommendations"},"ich-bp":{title:"ICH: Manage blood pressure",detail:"Target SBP 130-150 within 2 hours (AHA/ASA 2022 ICH). Initiate nicardipine or labetalol.",cta:"Manage BP"},"ich-reversal":{title:"ICH: Anticoagulation reversal",detail:"Patient may be on anticoagulation. Review and order reversal agents.",cta:"Order reversal"},"ich-neurosurg":{title:"ICH: Neurosurgery evaluation",detail:"Document neurosurgery consultation for surgical candidacy assessment.",cta:"Consult neurosurgery"},"sah-grade":{title:"SAH: Grade severity",detail:"Enter Hunt & Hess or WFNS grade for SAH prognostication.",cta:"Grade SAH"},"sah-bp":{title:"SAH: Manage blood pressure",detail:"Target SBP <160 (pre-securing) or <140 (post-securing) per 2023 AHA/ASA SAH guidelines.",cta:"Manage BP"},"sah-nimodipine":{title:"SAH: Start nimodipine",detail:"Nimodipine 60 mg q4h x 21 days for vasospasm prevention (Class I, LOE A).",cta:"Order nimodipine"},"sah-neurosurg":{title:"SAH: Neurosurgery consult",detail:"Urgent neurosurgery consultation for aneurysm securing strategy.",cta:"Consult neurosurgery"},"sah-aneurysm":{title:"SAH: Aneurysm securing",detail:"Document plan for aneurysm securing (clip vs coil) within 24 hours.",cta:"Document plan"},"cvt-anticoag":{title:"CVT: Start anticoagulation",detail:"Initiate LMWH or UFH per 2024 AHA CVT guideline, even with hemorrhagic transformation.",cta:"Start anticoag"},"cvt-icp":{title:"CVT: ICP management",detail:"Assess and manage elevated intracranial pressure. HOB elevation, acetazolamide if needed.",cta:"Manage ICP"},"cvt-seizure":{title:"CVT: Seizure management",detail:"Assess seizure risk and initiate prophylaxis if supratentorial lesion.",cta:"Manage seizures"},"cvt-heme":{title:"CVT: Hematology consult",detail:"Thrombophilia workup for young patients or unprovoked CVT.",cta:"Consult hematology"},"alt-workup":{title:"Alternative workup",detail:"Document alternative diagnosis and appropriate workup.",cta:"Document workup"},disposition:{title:"Determine disposition",detail:"Set disposition plan for stroke mimic.",cta:"Set disposition"}}[S.id]||{title:S.label,detail:"Complete this step to advance the pathway.",cta:"Go"},action:()=>Js(S.section),stepId:S.id}),{...H,progress:{completedCount:l,totalSteps:C,percentage:k,phase:I,steps:m.map(f=>({id:f.id,label:f.label,completed:f.check(o)}))}}},$a=()=>{let e=me(),a={telestrokeNote:t,nihssScore:h,aspectsScore:A,timeFromLKW:e,ichScore:typeof Je=="function"?Je(R):0};return Object.values(Cs).filter(i=>{try{return i.conditions(a)}catch(s){return!1}})},Xs=()=>Lt.every(e=>be[e.id]!==void 0&&be[e.id]!==""),Or=()=>Lt.filter(e=>!be[e.id]).map(e=>e.name),Lr=e=>e===0?{severity:"No stroke symptoms",color:"green",guidance:"Consider stroke mimics and alternative diagnoses"}:e<=4?{severity:"Minor stroke",color:"yellow",guidance:"Consider EVT if large vessel occlusion present despite low NIHSS"}:e<=15?{severity:"Moderate stroke",color:"orange",guidance:"Candidate for both thrombolysis and EVT if eligible"}:e<=20?{severity:"Moderate-severe stroke",color:"red",guidance:"Aggressive intervention warranted - high benefit potential"}:{severity:"Severe stroke",color:"red",guidance:"All treatment options should be considered - high mortality risk without intervention"},Qs=()=>{let e={};Lt.forEach(i=>{let s=i.options.find(o=>o.includes("(0)"))||i.options[0];e[i.id]=s}),Tt(e);let a=Pa(e);Ie(a),r({...t,nihss:a.toString()})},Mr=()=>{let e=J.tnk&&J.tnk.length>0,a=J.tnk_rec==="Recommended";return e&&a?{valid:!1,message:`\u26A0\uFE0F WARNING: TNK recommended but ${J.tnk.length} contraindication(s) selected`,severity:"error"}:!e&&J.tnk_rec==="Not Recommended"?{valid:!0,message:"\u2139\uFE0F No contraindications selected. Confirm rationale for not recommending TNK.",severity:"warning"}:{valid:!0,message:null,severity:null}},He=(e,a)=>{if(!bt)return!0;let i=bt.toLowerCase();return e.toLowerCase().includes(i)?!0:a.some(s=>s.toLowerCase().includes(i))},Zs=e=>{if(!e||e.length<2){Ut([]);return}let a=[],i=e.toLowerCase();Object.entries(Xt).forEach(([n,c])=>{c.hasSubsections&&Object.entries(c.subsections).forEach(([d,m])=>{m.trials.forEach(l=>{(l.name.toLowerCase().includes(i)||l.description.toLowerCase().includes(i)||l.nct.toLowerCase().includes(i))&&a.push({type:"Clinical Trial",category:n,title:l.name,description:l.description.substring(0,100)+"...",action:()=>{Dt(n),Ne("trials",{clearSearch:!0})}})})})}),[{name:"NIHSS",keywords:["nihss","stroke scale","neurological"],tab:"encounter"},{name:"ASPECTS",keywords:["aspects","imaging","ct"],tab:"encounter"},{name:"TNK Eligibility",keywords:["tnk","tenecteplase","thrombolysis","lytic"],tab:"encounter"},{name:"EVT Eligibility",keywords:["evt","thrombectomy","mechanical","endovascular"],tab:"encounter"},{name:"ICH Management",keywords:["ich","hemorrhage","bleeding","reversal"],tab:"management",subTab:"ich"},{name:"GCS Score",keywords:["gcs","glasgow","coma","consciousness"],tab:"management",subTab:"calculators"},{name:"ICH Score",keywords:["ich score","hemorrhage score","mortality"],tab:"management",subTab:"calculators"},{name:"ABCD\xB2 Score",keywords:["abcd","tia","transient"],tab:"management",subTab:"calculators"},{name:"CHA\u2082DS\u2082-VASc",keywords:["chads","afib","atrial fibrillation","anticoagulation"],tab:"management",subTab:"calculators"},{name:"ROPE Score",keywords:["rope","pfo","paradoxical"],tab:"management",subTab:"calculators"},{name:"Modified Rankin Scale (mRS)",keywords:["mrs","rankin","disability","outcome","functional status"],tab:"management",subTab:"calculators"},{name:"Hunt and Hess Scale",keywords:["hunt","hess","sah","subarachnoid","hemorrhage","grading"],tab:"management",subTab:"calculators"},{name:"WFNS Scale",keywords:["wfns","world federation","neurosurgical","sah","subarachnoid"],tab:"management",subTab:"calculators"},{name:"HAS-BLED Score",keywords:["hasbled","has-bled","bleeding","risk","anticoagulation"],tab:"management",subTab:"calculators"},{name:"RCVS\xB2 Score",keywords:["rcvs","rcvs2","vasoconstriction","thunderclap","headache"],tab:"management",subTab:"calculators"},{name:"Blood Pressure Management",keywords:["bp","blood pressure","labetalol","nicardipine"],tab:"management",subTab:"ischemic"}].forEach(n=>{(n.name.toLowerCase().includes(i)||n.keywords.some(c=>c.includes(i)))&&a.push({type:"Tool/Protocol",title:n.name,description:`Go to ${n.name}`,action:()=>{Ne(n.tab,{clearSearch:!0,subTab:n.subTab})}})}),[{title:"DAPT Minor Stroke-TIA Trials",section:"Antiplatelet Therapy",keywords:["dapt","antiplatelet","tia","minor stroke"]},{title:"DAPT After Ischemic Stroke-TIA",section:"Antiplatelet Therapy",keywords:["dapt","antiplatelet","duration","ischemic stroke","tia","sammpris","chance","point","thales","inspires","icad"]},{title:"Timing of Anticoagulation after AF-Related Stroke",section:"Risk Factors",keywords:["anticoagulation","atrial fibrillation","afib","timing"]},{title:"Atrial Fibrillation & Secondary Stroke Prevention",section:"Risk Factors",keywords:["afib","atrial fibrillation","prevention"]},{title:"AFib Stroke EPI519",section:"Risk Factors",keywords:["afib","atrial fibrillation","epidemiology","stroke","epi","epi519"]},{title:"Diabetes and stroke",section:"Risk Factors",keywords:["diabetes","risk factor","dm"]},{title:"Lipids and Cerebrovascular Disease",section:"Risk Factors",keywords:["lipids","cholesterol","statins","ldl"]},{title:"WAKE-UP Trial",section:"Thrombolytic Therapy",keywords:["wake-up","thrombolysis","tpa","alteplase","mri"]},{title:"Thrombolytic Therapy 4.5-24h RCTs",section:"Thrombolytic Therapy",keywords:["thrombolysis","tpa","alteplase","rct","extended window","4.5-24h"]},{title:"Lacunar Stroke",section:"Cerebral Small Vessel Disease",keywords:["lacunar","small vessel","csvd"]},{title:"Symptomatic Cervical Carotid Artery Stenosis",section:"Large Artery Disease",keywords:["carotid","stenosis","endarterectomy","cea","cas"]},{title:"CREST-2 Trial",section:"Large Artery Disease",keywords:["crest","crest-2","carotid","stenting","endarterectomy","cea","cas","asymptomatic"]},{title:"Differentiating Acute Confusional State (Delirium) from Aphasia",section:"Exam",keywords:["delirium","aphasia","confusion","exam"]},{title:"Coma Exam",section:"Exam",keywords:["coma","exam","consciousness"]},{title:"Large Core Anterior Circulation LVO EVT Trials",section:"Endovascular Therapy",keywords:["large core","lvo","thrombectomy","evt"]},{title:"Basilar Artery Occlusion EVT Trials",section:"Endovascular Therapy",keywords:["basilar","posterior circulation","evt"]},{title:"MeVO & Distal Vessel Occlusion EVT Trials",section:"Endovascular Therapy",keywords:["mevo","distal","medium vessel"]},{title:"Unruptured Cerebral Aneurysms",section:"Aneurysms & Vascular Malformations",keywords:["aneurysm","unruptured","sah"]},{title:"Interpretation of Clinical Trials",section:"Critical Appraisal",keywords:["ebm","clinical trials","evidence","statistics","critical appraisal"]},{title:"CEBM Oxford Resources",section:"Critical Appraisal",keywords:["cebm","oxford","ebm","evidence-based medicine","critical appraisal","study designs","levels of evidence"]}].forEach(n=>{(n.title.toLowerCase().includes(i)||n.section.toLowerCase().includes(i)||n.keywords.some(c=>c.toLowerCase().includes(i)))&&a.push({type:"Evidence",title:n.title,description:`${n.section} section`,action:()=>{Ne("management",{clearSearch:!0,subTab:"references"})}})}),Ut(a.slice(0,10))},Oi=3e4,eo=()=>({telestrokeNote:{...t},strokeCodeForm:{...J},patientData:{...be},lkwTime:g?g.toISOString():null,nihssScore:h,aspectsScore:A,mrsScore:M,gcsItems:{...T},ichScoreItems:{...R},abcd2Items:{..._},chads2vascItems:{...W},ropeItems:{...P},huntHessGrade:De,wfnsGrade:Oe,hasbledItems:{...D},rcvs2Items:{...q},currentStep:Sa,completedSteps:Array.isArray(Kt)?[...Kt]:[],aspectsRegionState:Array.isArray(it)?it.map(e=>({...e})):[],pcAspectsRegions:Array.isArray(st)?st.map(e=>({...e})):[],consultationType:we,currentPatientId:je}),to=e=>{if(!e)return;let a=e.telestrokeNote||ie();r(a),at(e.strokeCodeForm||u()),Tt(e.patientData||{}),Re(e.lkwTime?new Date(e.lkwTime):null),Ie(e.nihssScore||0),tt(Number.isFinite(e.aspectsScore)?e.aspectsScore:10),fe(e.mrsScore||""),Y(e.gcsItems||{eye:0,verbal:0,motor:0}),ve(e.ichScoreItems||{gcs:"",age80:!1,volume30:!1,ivh:!1,infratentorial:!1}),ye(e.abcd2Items||{age60:!1,bp:!1,unilateralWeakness:!1,speechDisturbance:!1,duration:"",diabetes:!1}),xe(e.chads2vascItems||{chf:!1,hypertension:!1,age75:!1,diabetes:!1,strokeTia:!1,vascular:!1,age65:!1,female:!1}),Ee(e.ropeItems||{noHypertension:!1,noDiabetes:!1,noStrokeTia:!1,nonsmoker:!1,cortical:!1,age:""}),ze(e.huntHessGrade||""),qe(e.wfnsGrade||""),de(e.hasbledItems||{hypertension:!1,renalDisease:!1,liverDisease:!1,stroke:!1,bleeding:!1,labileINR:!1,elderly:!1,drugs:!1,alcohol:!1}),Ye(e.rcvs2Items||{recurrentTCH:!1,carotidInvolvement:!1,vasoconstrictiveTrigger:!1,female:!1,sah:!1}),wa(Number.isFinite(e.currentStep)?e.currentStep:0),Aa(Array.isArray(e.completedSteps)?e.completedSteps:[]),Ot(Array.isArray(e.aspectsRegionState)&&e.aspectsRegionState.length?e.aspectsRegionState:y()),Jt(Array.isArray(e.pcAspectsRegions)&&e.pcAspectsRegions.length?e.pcAspectsRegions:E()),ft(e.consultationType||oe.defaultConsultationType||"videoTelestroke"),ht(e.currentPatientId||null),qt.current={tnkRecommended:a.tnkRecommended,evtRecommended:a.evtRecommended,transferAccepted:a.transferAccepted,tnkContraindicationReviewed:a.tnkContraindicationReviewed,tnkConsentDiscussed:a.tnkConsentDiscussed,tnkAdminTime:a.tnkAdminTime}},Li=()=>{Tt({}),Ie(0),tt(10),Re(null),at(u()),Ot(y()),Jt(E()),Y({eye:0,verbal:0,motor:0}),fe(""),ve({gcs:"",age80:!1,volume30:!1,ivh:!1,infratentorial:!1}),ye({age60:!1,bp:!1,unilateralWeakness:!1,speechDisturbance:!1,duration:"",diabetes:!1}),xe({chf:!1,hypertension:!1,age75:!1,diabetes:!1,strokeTia:!1,vascular:!1,age65:!1,female:!1}),Ee({noHypertension:!1,noDiabetes:!1,noStrokeTia:!1,nonsmoker:!1,cortical:!1,age:""}),ze(""),qe(""),de({hypertension:!1,renalDisease:!1,liverDisease:!1,stroke:!1,bleeding:!1,labileINR:!1,elderly:!1,drugs:!1,alcohol:!1}),Ye({recurrentTCH:!1,carotidInvolvement:!1,vasoconstrictiveTrigger:!1,female:!1,sah:!1}),wa(0),Aa([]),ft(oe.defaultConsultationType||"videoTelestroke"),r(ie()),["patientData","nihssScore","aspectsScore","gcsItems","mrsScore","ichScoreItems","abcd2Items","chads2vascItems","ropeItems","huntHessGrade","wfnsGrade","hasbledItems","rcvs2Items","strokeCodeForm","lkwTime","currentStep","completedSteps","aspectsRegionState","pcAspectsRegions","telestrokeNote","consultationType"].forEach(a=>oa(a)),Ne("encounter"),gt("saved")},ao=(e={})=>{let{generateNewId:a=!1}=e;if(!confirm("Start a new case? Current inputs will be cleared. You can undo for 30 seconds."))return;let i=eo();Li(),a&&ht(Ci()),Ia(!1),da({snapshot:i,expiresAt:Date.now()+Oi}),Nt.current&&clearTimeout(Nt.current),Nt.current=setTimeout(()=>{da(null)},Oi),Ae("Case cleared. Undo available for 30 seconds.","info")},io=()=>{!Bt||!Bt.snapshot||(to(Bt.snapshot),da(null),Nt.current&&(clearTimeout(Nt.current),Nt.current=null),Ae("Case restored.","success"))},Hr=()=>{confirm("Start new patient assessment? All current data will be cleared. This cannot be undone.")&&Li()},so=()=>{confirm("This clears locally stored app data on this device.")&&(es(),Ha({resetDarkMode:!0}),Ne("encounter"),Ae("Local data cleared.","success"))},Vr=()=>{ra.forEach(e=>{try{localStorage.removeItem(e)}catch(a){console.warn("Failed to remove legacy key:",e,a)}}),Ae("Legacy keys removed.","success")},Fr=async e=>{try{let a=await Ao(e),i=a.schemaVersion?a:a.appData?a.appData:null;if(!i){Ae("Backup import failed: invalid file.","error");return}let s=na(Ft(),i),o=ts(s);la(o),Ae("Backup imported.","success")}catch(a){Ae("Backup import failed.","error")}},Br=[{id:"assessment",name:"Initial Assessment",tab:"workflow"},{id:"nihss",name:"NIHSS Score",tab:"nihss"},{id:"imaging",name:"Imaging Review",tab:"imaging"},{id:"eligibility",name:"Treatment Eligibility",tab:"lytic"},{id:"documentation",name:"Documentation",tab:"encounter"}];x(()=>{F("activeTab",Q)},[Q]),x(()=>{Be("timerSidebarCollapsed",Pe,{skipLastUpdated:!0})},[Pe]),x(()=>{Be("caseSummaryCollapsed",pt,{skipLastUpdated:!0})},[pt]),x(()=>{Be("showAdvanced",Ce,{skipLastUpdated:!0})},[Ce]),x(()=>{"serviceWorker"in navigator&&navigator.serviceWorker.register("service-worker.js").catch(e=>{console.warn("Service worker registration failed:",e)})},[]),x(()=>{qt.current={tnkRecommended:t.tnkRecommended,evtRecommended:t.evtRecommended,transferAccepted:t.transferAccepted,tnkContraindicationReviewed:t.tnkContraindicationReviewed,tnkConsentDiscussed:t.tnkConsentDiscussed,tnkAdminTime:t.tnkAdminTime}},[]),x(()=>{F("consultationType",we)},[we]),x(()=>{F("patientData",be);let e=Pa(be);e!==h&&Ie(e)},[be]),x(()=>{F("nihssScore",h)},[h]),x(()=>{F("aspectsScore",A)},[A]),x(()=>{F("gcsItems",T)},[T]),x(()=>{F("mrsScore",M)},[M]),x(()=>{F("ichScoreItems",R)},[R]),x(()=>{F("abcd2Items",_)},[_]),x(()=>{F("chads2vascItems",W)},[W]),x(()=>{F("ropeItems",P)},[P]),x(()=>{F("huntHessGrade",De)},[De]),x(()=>{F("wfnsGrade",Oe)},[Oe]),x(()=>{F("hasbledItems",D)},[D]),x(()=>{F("rcvs2Items",q)},[q]),x(()=>{F("strokeCodeForm",zs(J))},[J,oe.allowFreeTextStorage]),x(()=>{F("aspectsRegionState",it)},[it]),x(()=>{F("pcAspectsRegions",st)},[st]),x(()=>{F("telestrokeNote",js(t))},[t,oe.allowFreeTextStorage]),x(()=>{let e=qt.current;!e.tnkRecommended&&t.tnkRecommended&&lt("TNK recommended"),!e.evtRecommended&&t.evtRecommended&&lt("EVT recommended"),!e.transferAccepted&&t.transferAccepted&&lt("Transfer accepted"),!e.tnkContraindicationReviewed&&t.tnkContraindicationReviewed&&lt("TNK contraindications reviewed",t.tnkContraindicationReviewTime||""),!e.tnkConsentDiscussed&&t.tnkConsentDiscussed&&lt("TNK consent discussed"),e.tnkAdminTime!==t.tnkAdminTime&&t.tnkAdminTime&&lt("TNK administered",t.tnkAdminTime),qt.current={tnkRecommended:t.tnkRecommended,evtRecommended:t.evtRecommended,transferAccepted:t.transferAccepted,tnkContraindicationReviewed:t.tnkContraindicationReviewed,tnkConsentDiscussed:t.tnkConsentDiscussed,tnkAdminTime:t.tnkAdminTime}},[t.tnkRecommended,t.evtRecommended,t.transferAccepted,t.tnkContraindicationReviewed,t.tnkConsentDiscussed,t.tnkAdminTime]),x(()=>{(t.diagnosisCategory==="ischemic"||t.diagnosisCategory==="ich")&&Dt(t.diagnosisCategory)},[t.diagnosisCategory]),x(()=>{F("telestrokeTemplate",fa)},[fa]),x(()=>{g&&F("lkwTime",g.toISOString())},[g]),x(()=>{F("currentStep",Sa)},[Sa]),x(()=>{F("completedSteps",Kt)},[Kt]),x(()=>{if(g){let e=g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}),a=g.toLocaleDateString("en-US"),i=`${g.getFullYear()}-${String(g.getMonth()+1).padStart(2,"0")}-${String(g.getDate()).padStart(2,"0")}`;at(s=>({...s,lkw:e,lkw_date:i}))}},[g]),x(()=>{h!=null&&at(e=>({...e,nihss:h.toString()}))},[h]),x(()=>{A!=null&&at(e=>({...e,aspects:A.toString()}))},[A]),x(()=>{let e=setInterval(()=>ci(new Date),6e4);return()=>clearInterval(e)},[]);let oo=e=>{if(!Ke)try{let a=new(window.AudioContext||window.webkitAudioContext),i=a.createOscillator(),s=a.createGain();i.connect(s),s.connect(a.destination);let o={"warning-30":{freq:440,duration:.3,repeat:2},"warning-15":{freq:523,duration:.3,repeat:3},"window-closed":{freq:659,duration:.5,repeat:4}},n=o[e]||o["warning-30"],c=a.currentTime;for(let d=0;d<n.repeat;d++){let m=a.createOscillator(),l=a.createGain();m.connect(l),l.connect(a.destination),m.frequency.setValueAtTime(n.freq,c),m.type="sine",l.gain.setValueAtTime(0,c),l.gain.linearRampToValueAtTime(.3,c+.05),l.gain.linearRampToValueAtTime(.3,c+n.duration-.1),l.gain.linearRampToValueAtTime(0,c+n.duration),m.start(c),m.stop(c+n.duration),c+=n.duration+.15}}catch(a){console.log("Audio alert not supported:",a)}},ro=()=>{let e=!Ke;di(e),Be("thrombolysisAlertsMuted",e,{skipLastUpdated:!0})};x(()=>{if(!g||Q!=="encounter")return;let e=()=>{let i=new Date,s=i-g,o=s/(1e3*60),n=4.5*60-o;if(mi(Math.floor(s/1e3)),ci(i),document.hidden||!g)return;let c=[{id:"warning-30",minutesRemaining:30,played:!1},{id:"warning-15",minutesRemaining:15,played:!1},{id:"window-closed",minutesRemaining:0,played:!1}];for(let d of c)if(Math.abs(n-d.minutesRemaining)<.5&&It!==d.id&&n>=-1){va(d.id),oo(d.id),Wt(!0),setTimeout(()=>Wt(!1),1e4);break}};e();let a=setInterval(e,1e3);return()=>clearInterval(a)},[g,Ke,It,Q]),x(()=>{va(null),Wt(!1)},[g]),x(()=>{let e=me(),a=e?e.total:null,s=ws({telestrokeNote:t,strokeCodeForm:J,aspectsScore:A,nihssScore:h,mrsScore:M,hoursFromLKW:a,lkwTime:g});As(s)},[t,J,A,h,M,g]),x(()=>{let e=[];if(g){let a=me();if(!a)return;let i=a.total,s=4.5-i,o=6-i;if(s>0&&s<=.5){let n=Math.floor(s*60);e.push({id:"tnk-cutoff",level:"critical",message:`\u26A0\uFE0F URGENT: Only ${n} minutes left for TNK window!`,action:"TNK must be given before 4.5h from LKW"})}if(o>0&&o<=.5&&i>4.5){let n=Math.floor(o*60);e.push({id:"evt-cutoff",level:"critical",message:`\u26A0\uFE0F URGENT: Only ${n} minutes left for early EVT window!`,action:"Consider EVT before 6h window requires perfusion imaging"})}}bi(e)},[Se,g]),x(()=>{Zs(ba)},[ba]),x(()=>{if(!oe.deidMode){Ca({});return}let e={"Chief complaint":t.chiefComplaint,Symptoms:t.symptoms,PMH:t.pmh,Medications:t.medications,"CT results":t.ctResults,"CTA results":t.ctaResults,"EKG results":t.ekgResults,Diagnosis:t.diagnosis,Recommendations:t.recommendationsText,"Stroke code history":J.hx,"Stroke code symptoms":J.sx,"Stroke code deficits":J.def,"Stroke code HCT":J.hct,"Stroke code CTA":J.cta,"Stroke code CTP":J.ctp,"TNK rationale":J.rec_reason},a={};Object.entries(e).forEach(([i,s])=>{let o=Io(s);o.length&&(a[i]=o)}),Ca(a)},[oe.deidMode,t,J]),x(()=>{if(yt.length>0)return;let e=St("board");_e(a=>({...a,shiftBoards:[{id:e,name:"Primary Board",createdAt:Ze(),updatedAt:Ze(),archived:!1,patients:[]}],uiState:{...a.uiState,lastShiftBoardId:e}}))},[yt.length]),x(()=>{var e;Pt.find(a=>a.id===Ra)||ys(((e=Pt[0])==null?void 0:e.id)||"telestroke-consult")},[Pt,Ra]),x(()=>{let e=()=>{let i=document.getElementById("mobile-bottom-nav"),s=document.getElementById("action-bar"),o=i?i.offsetHeight:0,n=s?s.offsetHeight:0;document.documentElement.style.setProperty("--mobile-nav-offset",`${o}px`),document.documentElement.style.setProperty("--mobile-action-offset",`${n}px`)},a=()=>{window.requestAnimationFrame(e)};return a(),window.addEventListener("resize",a),window.addEventListener("orientationchange",a),()=>{window.removeEventListener("resize",a),window.removeEventListener("orientationchange",a)}},[]),x(()=>{let e=()=>{window.innerWidth>=1024&&ai(!1)};return window.addEventListener("resize",e),()=>window.removeEventListener("resize",e)},[]),x(()=>{let e=!1,i=["localhost","127.0.0.1"].includes(window.location.hostname)?"config.local.json":"config.example.json";return fetch(i,{cache:"no-store"}).then(s=>{if(s.status===404)return e||(oa("ttlHoursOverride"),ua(wt),pa(!0)),null;if(!s.ok)throw new Error("Config fetch failed");return s.json()}).then(s=>{if(e||!s)return;if(typeof s!="object"||Array.isArray(s))throw new Error("Config format invalid");let n=(Array.isArray(s.institutionLinks)?s.institutionLinks:[]).filter(d=>d&&typeof d=="object").map(d=>({label:String(d.label||"").trim(),url:String(d.url||"").trim(),note:String(d.note||"").trim()})).filter(d=>d.url),c=typeof s.ttlHoursOverride=="number"&&Number.isFinite(s.ttlHoursOverride)&&s.ttlHoursOverride>0?s.ttlHoursOverride:null;ms({institutionLinks:n,ttlHoursOverride:c}),c?(ua(c),Be("ttlHoursOverride",c,{skipLastUpdated:!0})):oa("ttlHoursOverride"),pa(!0)}).catch(s=>{e||(console.warn("Config load failed:",s),oa("ttlHoursOverride"),ua(wt),pa(!0))}),()=>{e=!0}},[]),x(()=>{$t&&(Ha({resetDarkMode:!0}),Ne("encounter"),Ae("Stored data expired and was cleared.","warning",{timeoutMs:6e3}))},[]),x(()=>{if($t||!ri||ga===wt)return;as(ga)&&(ns(!0),Ha({resetDarkMode:!0}),Ne("encounter"),Ae("Stored data expired and was cleared.","warning",{timeoutMs:6e3}))},[ga,$t,ri]),x(()=>{lucide.createIcons();let e=()=>{if($t&&!wi.current){wi.current=!0,We("encounter");return}let a=Mo(window.location.hash);if(a&&za.includes(a.tab)){if(We(a.tab),a.tab==="management"){let s=mt(a.sub)||mt(ne.uiState.lastManagementSubTab)||"ich";vt(s)}return}let i=ne.uiState.lastActiveTab||ue("activeTab",null);if(i){if(et[i]){We("management"),vt(et[i]);return}if(i==="management"){We("management"),vt(mt(ne.uiState.lastManagementSubTab)||"ich");return}if(za.includes(i)){We(i);return}}We("encounter")};return e(),rs(!0),requestAnimationFrame(()=>{us(!0),lucide.createIcons()}),window.addEventListener("hashchange",e),()=>window.removeEventListener("hashchange",e)},[]),x(()=>{if(!ti)return;let e=Ho(Q,he);window.location.hash!==e&&(window.location.hash=e)},[Q,ti,he]),x(()=>{At(!1)},[Q]),x(()=>{Q==="management"&&_e(e=>({...e,uiState:{...e.uiState,lastManagementSubTab:he}}))},[Q,he]),x(()=>{li&&lucide.createIcons()},[Q,le,Ue,Te,fi,ma,li]);let $r=()=>{let e=me(),a=e?`${e.hours}h ${e.minutes}m`:"unknown",i=g?g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}):"__",s=g?g.toLocaleDateString("en-US"):"__",o=t.sex==="M"?"male":t.sex==="F"?"female":"__",n=t.nihss||h||"__";return`HPI: ${t.age||"__"} year old ${o} with PMH of ${t.pmh||"__"} presenting with ${t.symptoms||"__"} starting at ${i} on ${s} (${a} ago). NIHSS ${n}.

IMAGING:
- Head CT: ${t.ctResults||"pending"}
- CTA Head/Neck: ${t.ctaResults||"pending"}
- CTP: ${t.ctpResults||"pending"}
- ASPECTS: ${A||"__"}

ASSESSMENT: ${t.diagnosis||"Acute ischemic stroke"}, NIHSS ${n}
${t.tnkRecommended?`
TNK: Recommended`:`
TNK: Not Recommended`}
${t.evtRecommended?"EVT: Recommended":"EVT: Not Recommended"}`},_r=()=>`ACUTE STROKE ADMISSION ORDERS:

1. Admit to Stroke Unit / Neuro ICU
2. Vital signs q1h x 24h, then q4h
3. Continuous telemetry monitoring
4. NPO until swallow evaluation completed
5. IV fluids: NS at 75 mL/hr
6. Maintain SBP <180/105 (or <185/110 if post-tPA)
7. Blood glucose 140-180 mg/dL
8. HOB elevated 30 degrees
9. DVT prophylaxis: SCDs (hold pharmacologic if tPA given)
10. Aspirin 325mg daily (hold x 24h if tPA given)
11. Statin therapy: Atorvastatin 80mg daily
12. Neurology consultation
13. PT/OT/Speech evaluation
14. Fall precautions

LABS:
- CBC, CMP, PT/INR, PTT
- Lipid panel, HbA1c
- Troponin, BNP
- Consider: ESR, CRP if indicated

IMAGING:
- MRI brain with DWI if not already done
- Carotid ultrasound
- Echocardiogram (TTE or TEE)

NIHSS: ${t.nihss||h||"__"} - reassess q4h x 24h, then daily`;React.useEffect(()=>{let e=a=>{var s,o;if(a.target.tagName==="INPUT"||a.target.tagName==="TEXTAREA"||a.target.isContentEditable)return;(a.metaKey||a.ctrlKey)&&a.key==="k"&&(a.preventDefault(),Ge(!0),ut("header"),(s=document.querySelector('input[placeholder*="Search"]'))==null||s.focus()),a.key==="/"&&!a.metaKey&&!a.ctrlKey&&!a.altKey&&(a.preventDefault(),Ge(!0),ut("header"),(o=document.querySelector('input[placeholder*="Search"]'))==null||o.focus()),a.key==="Escape"&&Ge(!1);let i={1:{tab:"encounter"},2:{tab:"management",subTab:"ischemic"},3:{tab:"management",subTab:"calculators"}};if(i[a.key]&&!a.metaKey&&!a.ctrlKey&&!a.altKey){a.preventDefault();let n=i[a.key];Ne(n.tab,{subTab:n.subTab})}(a.metaKey||a.ctrlKey)&&a.key==="e"&&(a.preventDefault(),Fa()),(a.metaKey||a.ctrlKey)&&a.key==="d"&&(a.preventDefault(),Ba()),a.key==="?"&&!a.metaKey&&!a.ctrlKey&&(a.preventDefault(),Rt(n=>!n))};return window.addEventListener("keydown",e),()=>window.removeEventListener("keydown",e)},[]);let Mi=[{label:"Regional Hospitals",url:"https://rkalani1.github.io/telestroke-expansion-map/"},{label:"Stroke Clinic Pre-Visit Questionnaire",url:"https://rkalani1.github.io/stroke-clinic-q/"}],no=[{label:"Pulsara",url:"https://us-app.pulsara.com/user/login"},{label:"Teladoc Imaging",url:"https://urldefense.com/v3/__https:/imaging.visitnow.org/studies__;!!K-Hz7m0Vt54!nECcOahuNh21d0jzlVH-mSie_Il2fvDWCKseicWktKKQwdj4xk9XfAX2s8QyVGAs0n-NvzXDLAHKDw%24"},{label:"Telestroke Provider Resources",url:"https://intranet.neurology.uw.edu/telestroke-provider-resources/"},{label:"UW Medicine",url:"https://access.uwmedicine.org/logon/LogonPoint/tmindex.html"}],lo=Array.isArray(oe.quickLinks)?oe.quickLinks:[],Hi=[...no,...lo,...oi.institutionLinks].reduce((e,a)=>{if(!a||!a.url)return e;let i=String(a.url).trim();return!i||e.seen.has(i)||(e.seen.add(i),e.items.push({label:String(a.label||"Resource").trim()||"Resource",url:i,note:a.note?String(a.note).trim():""})),e},{items:[],seen:new Set}).items,Wr=oi.ttlHoursOverride||wt,_a=!0,Ur=Q==="encounter",Kr=new Date().toISOString().slice(0,10),Gr=ra.some(e=>{try{return localStorage.getItem(e)!==null}catch(a){return!1}}),co=[{id:"encounter",name:"Encounter",icon:"activity"},{id:"management",name:"Manage",icon:"layers"},{id:"trials",name:"Trials",icon:"file-text"}],Wa=[],mo=Array.isArray(oe.contacts)&&oe.contacts.length?oe.contacts:Qi,jr=[{id:"patient-info-section",label:"Patient Info"},{id:"lkw-section",label:"LKW / Discovery"},{id:"nihss-section",label:"NIHSS"},{id:"vitals-section",label:"Vitals"},{id:"treatment-decision",label:"Treatment"},{id:"time-metrics-section",label:"DTN / DTP"},{id:"sah-management-section",label:"SAH Mgmt"},{id:"cvt-management-section",label:"CVT Mgmt"},{id:"discharge-checklist-section",label:"Discharge"},{id:"recommendations-section",label:"Recommendations"},{id:"handoff-section",label:"Handoff"},{id:"safety-section",label:"Safety"}],zr=[{value:"consult",label:"Consult"},{value:"attending",label:"Attending"},{value:"ed",label:"ED"},{value:"icu",label:"ICU"},{value:"transfer",label:"Transfer"}],po={consult:{consultationType:"videoTelestroke",showAdvanced:!0},attending:{consultationType:"videoTelestroke",showAdvanced:!0},ed:{consultationType:"telephone",showAdvanced:!1},icu:{consultationType:"telephone",showAdvanced:!0},transfer:{consultationType:"videoTelestroke",showAdvanced:!0}},pe=me(),Ua=Gs(),go=Ua.filter(e=>e.complete).length,Ka=t.lkwUnknown?{color:"gray",message:pe?"Discovery-based timing":"LKW unknown"}:Ys(pe)||{color:"gray",message:"Set LKW time"},Vi={green:"bg-emerald-100 text-emerald-800 border-emerald-200",yellow:"bg-amber-100 text-amber-800 border-amber-200",orange:"bg-orange-100 text-orange-800 border-orange-200",red:"bg-red-100 text-red-800 border-red-200",gray:"bg-slate-100 text-slate-700 border-slate-200"}[Ka.color]||"bg-slate-100 text-slate-700 border-slate-200",Fi=(pe==null?void 0:pe.label)||(t.lkwUnknown?"Discovery":"LKW"),Bi=t.lkwUnknown?pe&&`${t.discoveryDate||""} ${t.discoveryTime||""}`.trim()||"Unknown":g?g.toLocaleString("en-US",{month:"short",day:"numeric",hour:"2-digit",minute:"2-digit"}):"Not set",ea=pe?`${pe.hours}h ${pe.minutes}m`:null,uo=t.age!==void 0&&String(t.age).trim()!==""?String(t.age).trim():"--",bo=t.weight!==void 0&&String(t.weight).trim()!==""?`${String(t.weight).trim()} kg`:"--",ho=t.nihss!==void 0&&String(t.nihss).trim()!==""?String(t.nihss).trim():"",fo=Lt.some(e=>be[e.id]!==void 0&&be[e.id]!==""),$i=ho||(fo?String(h):"--");return React.createElement("div",{className:"relative"},React.createElement("div",{className:"app-shell max-w-7xl mx-auto p-4 sm:p-8 overflow-x-hidden",role:"main"},React.createElement("a",{href:"#main-content",className:"sr-only focus:not-sr-only focus:absolute focus:top-4 focus:left-4 focus:z-50 focus:px-4 focus:py-2 focus:bg-blue-600 focus:text-white focus:rounded-lg"},"Skip to main content"),React.createElement("div",{className:"mb-4 sm:mb-6 app-header",role:"banner"},React.createElement("div",{className:"flex flex-col sm:flex-row justify-between items-start gap-3"},React.createElement("div",{className:"flex-1 w-full sm:w-auto"},React.createElement("h1",{className:"text-2xl sm:text-3xl font-bold text-blue-900 mb-1 text-center sm:text-left"},"Stroke"),Mi.length>0&&React.createElement("div",{className:"mt-2 flex flex-wrap items-center gap-2 justify-center sm:justify-start"},Mi.map(e=>React.createElement("a",{key:e.url,href:e.url,target:"_blank",rel:"noopener noreferrer",className:"flex items-center gap-2 px-3 py-2 bg-indigo-600 text-white rounded-lg hover:bg-indigo-700 transition-colors text-sm font-medium"},React.createElement("i",{"data-lucide":"external-link",className:"w-4 h-4"}),React.createElement("span",null,e.label))))),React.createElement("div",{className:"flex w-full flex-col items-center justify-center gap-2 sm:w-auto sm:items-end sm:justify-end"},React.createElement("div",{className:"relative w-full sm:w-auto"},React.createElement("input",{type:"text",placeholder:"Search trials, management tools, references...",value:ba,onChange:e=>{ha(e.target.value),Ge(!0),ut("header")},onFocus:()=>{Ge(!0),ut("header")},onBlur:()=>setTimeout(()=>Ge(!1),200),className:"pl-8 pr-3 py-2 border border-gray-300 rounded-lg text-sm focus:outline-none focus:ring-2 focus:ring-blue-500 w-full sm:w-48 md:w-64","aria-label":"Search trials, management tools, and references"}),React.createElement("i",{"data-lucide":"search",className:"w-4 h-4 absolute left-2 top-3 text-gray-400"}),fi&&fs==="header"&&hi.length>0&&React.createElement("div",{className:"absolute top-12 left-0 right-0 sm:right-auto sm:w-96 bg-white shadow-lg rounded-lg border max-h-96 overflow-y-auto z-50"},Object.entries(hi.reduce((e,a)=>{let i=a.type||"Results";return e[i]||(e[i]=[]),e[i].push(a),e},{})).map(([e,a])=>React.createElement("div",{key:e},React.createElement("div",{className:"px-3 py-1 text-[11px] uppercase tracking-wider text-gray-500 bg-gray-50 border-b"},e),a.map((i,s)=>React.createElement("button",{key:`${e}-${s}`,onClick:i.action,className:"w-full text-left p-3 hover:bg-blue-50 border-b transition-colors"},React.createElement("div",{className:"flex items-start justify-between"},React.createElement("div",{className:"flex-1"},React.createElement("p",{className:"font-semibold text-sm"},i.title),i.description&&React.createElement("p",{className:"text-xs text-gray-600 mt-1"},i.description))))))))),React.createElement("div",{className:"text-xs text-gray-500 flex items-center gap-2"},React.createElement("span",{className:pi==="saving"?"text-amber-600":"text-emerald-600"},pi==="saving"?"Saving...":"Saved"),gi&&React.createElement("span",null,new Date(gi).toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}))),React.createElement("div",{className:"flex w-full flex-wrap items-center justify-center gap-2 sm:w-auto sm:justify-end"},React.createElement("button",{onClick:Vs,className:"flex items-center gap-2 px-3 py-2 bg-blue-600 text-white rounded-lg hover:bg-blue-700 transition-colors text-sm font-medium","aria-label":"Start new case",title:"Start a new case (clears current inputs)"},React.createElement("i",{"data-lucide":"user-plus",className:"w-4 h-4"}),React.createElement("span",{className:"hidden lg:inline"},"Start Case")),React.createElement("div",{className:"hidden sm:flex items-center gap-2"},_a&&React.createElement(React.Fragment,null,React.createElement("button",{onClick:Fa,className:"flex items-center gap-2 px-3 py-2 bg-green-600 text-white rounded-lg hover:bg-green-700 transition-colors text-sm font-medium","aria-label":"Export to PDF",title:"Export current view to PDF"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),React.createElement("span",{className:"hidden sm:inline"},"PDF")),React.createElement("button",{onClick:Pi,className:"flex items-center gap-1 px-3 py-2 border border-gray-300 rounded-lg hover:bg-gray-100 transition-colors","aria-label":"Share this page",title:"Share this page"},React.createElement("i",{"data-lucide":"share-2",className:"w-4 h-4"}),React.createElement("span",{className:"hidden sm:inline"},"Share"))),React.createElement("button",{onClick:Ba,className:"p-2 border border-gray-300 rounded-lg hover:bg-gray-100 dark:hover:bg-gray-700 transition-colors","aria-label":Ue?"Switch to light mode":"Switch to dark mode",title:Ue?"Switch to light mode":"Switch to dark mode"},React.createElement("i",{"data-lucide":Ue?"sun":"moon",className:"w-5 h-5"}))),React.createElement("button",{onClick:so,className:"flex items-center gap-2 px-3 py-2 bg-red-600 text-white rounded-lg hover:bg-red-700 transition-colors text-sm font-medium","aria-label":"Clear local data",title:"Clear locally stored app data"},React.createElement("i",{"data-lucide":"trash-2",className:"w-4 h-4"}),React.createElement("span",null,"Clear local data")),React.createElement("button",{onClick:()=>At(e=>!e),className:"sm:hidden flex items-center gap-2 px-3 py-2 border border-gray-300 rounded-lg text-sm font-medium","aria-expanded":ma,"aria-label":"Toggle actions menu"},React.createElement("i",{"data-lucide":"more-horizontal",className:"w-4 h-4"}),React.createElement("span",null,"Actions"))),ma&&React.createElement("div",{className:"sm:hidden w-full grid grid-cols-2 gap-2"},_a&&React.createElement("button",{onClick:()=>{Fa(),At(!1)},className:"flex items-center justify-center gap-2 px-3 py-2 bg-green-600 text-white rounded-lg text-sm font-medium","aria-label":"Export to PDF"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),React.createElement("span",null,"PDF")),_a&&React.createElement("button",{onClick:()=>{Pi(),At(!1)},className:"flex items-center justify-center gap-2 px-3 py-2 border border-gray-300 rounded-lg text-sm font-medium","aria-label":"Share this page"},React.createElement("i",{"data-lucide":"share-2",className:"w-4 h-4"}),React.createElement("span",null,"Share")),React.createElement("button",{onClick:()=>{Ba(),At(!1)},className:"flex items-center justify-center gap-2 px-3 py-2 border border-gray-300 rounded-lg text-sm font-medium","aria-label":Ue?"Switch to light mode":"Switch to dark mode"},React.createElement("i",{"data-lucide":Ue?"sun":"moon",className:"w-4 h-4"}),React.createElement("span",null,Ue?"Light":"Dark"))))),Te&&React.createElement("div",{className:`mt-2 p-3 rounded-lg border text-sm flex items-center gap-2 ${Te.type==="success"?"bg-green-100 border-green-400 text-green-700":Te.type==="warning"?"bg-yellow-100 border-yellow-400 text-yellow-800":Te.type==="error"?"bg-red-100 border-red-400 text-red-700":"bg-blue-100 border-blue-400 text-blue-700"}`},React.createElement("i",{"data-lucide":Te.type==="success"?"check-circle":Te.type==="warning"?"alert-triangle":Te.type==="error"?"x-circle":"info",className:"w-4 h-4"}),React.createElement("span",null,Te.message)),Bt&&React.createElement("div",{className:"mt-2 p-3 rounded-lg border border-blue-200 bg-blue-50 text-blue-900 text-sm flex flex-col sm:flex-row sm:items-center sm:justify-between gap-2"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"rotate-ccw",className:"w-4 h-4"}),React.createElement("span",null,"Case cleared. Undo available for 30 seconds.")),React.createElement("button",{type:"button",onClick:io,className:"px-3 py-1.5 bg-blue-600 text-white rounded-lg text-xs font-semibold hover:bg-blue-700"},"Undo")),le&&React.createElement("div",{className:"mt-2 p-2 bg-green-100 border border-green-400 text-green-700 rounded-lg text-sm flex items-center gap-2"},React.createElement("i",{"data-lucide":"check",className:"w-4 h-4"}),React.createElement("span",null,le," copied to clipboard!")),Object.keys(ka).length>0&&React.createElement("div",{className:"mt-2 p-2 bg-amber-50 border border-amber-200 text-amber-800 rounded-lg text-xs"},React.createElement("div",{className:"flex items-center gap-2 font-semibold"},React.createElement("i",{"data-lucide":"alert-triangle",className:"w-4 h-4"}),React.createElement("span",null,"Possible identifiers detected")),React.createElement("div",{className:"mt-1"},Object.entries(ka).slice(0,4).map(([e,a])=>React.createElement("div",{key:e},e,": ",a.join(", "))),Object.keys(ka).length>4&&React.createElement("div",null,"More fields flagged...")))),React.createElement("div",{className:"sticky top-2 z-40 mb-4 no-print"},React.createElement("div",{className:"bg-white/95 backdrop-blur border border-slate-200 rounded-xl shadow-sm px-3 py-3 dark:bg-slate-900/90 dark:border-slate-700"},React.createElement("div",{className:"flex items-center justify-between gap-3 lg:hidden mb-2"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"Case Summary"),React.createElement("button",{onClick:()=>ai(e=>!e),className:"text-xs font-semibold text-blue-700 dark:text-blue-300","aria-expanded":!pt,"aria-label":pt?"Expand case summary":"Collapse case summary"},pt?"Expand":"Collapse")),pt?React.createElement("div",{className:"grid grid-cols-3 gap-2"},React.createElement("div",{className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2 dark:bg-slate-800 dark:border-slate-700"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"NIHSS"),React.createElement("p",{className:"text-sm font-semibold text-slate-900 dark:text-slate-100"},$i)),React.createElement("div",{className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2 dark:bg-slate-800 dark:border-slate-700"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"LKW"),React.createElement("p",{className:"text-sm font-semibold text-slate-900 dark:text-slate-100"},Bi),ea&&React.createElement("p",{className:"text-xs text-slate-500 dark:text-slate-300"},"(",ea," from ",Fi,")")),React.createElement("div",{className:`rounded-lg border px-3 py-2 ${Vi}`},React.createElement("p",{className:"text-[11px] uppercase tracking-wide opacity-70"},"Window"),React.createElement("p",{className:"text-sm font-semibold"},Ka.message))):React.createElement("div",{className:"grid grid-cols-2 sm:grid-cols-3 lg:grid-cols-5 gap-2"},React.createElement("div",{className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2 dark:bg-slate-800 dark:border-slate-700"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"Age"),React.createElement("p",{className:"text-sm font-semibold text-slate-900 dark:text-slate-100"},uo)),React.createElement("div",{className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2 dark:bg-slate-800 dark:border-slate-700"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"Weight"),React.createElement("p",{className:"text-sm font-semibold text-slate-900 dark:text-slate-100"},bo)),React.createElement("div",{className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2 dark:bg-slate-800 dark:border-slate-700"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"NIHSS"),React.createElement("p",{className:"text-sm font-semibold text-slate-900 dark:text-slate-100"},$i)),React.createElement("div",{className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2 dark:bg-slate-800 dark:border-slate-700"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500 dark:text-slate-300"},"LKW"),React.createElement("p",{className:"text-sm font-semibold text-slate-900 dark:text-slate-100"},Bi),ea&&React.createElement("p",{className:"text-xs text-slate-500 dark:text-slate-300"},"(",ea," from ",Fi,")")),React.createElement("div",{className:`rounded-lg border px-3 py-2 ${Vi}`},React.createElement("p",{className:"text-[11px] uppercase tracking-wide opacity-70"},"Window"),React.createElement("p",{className:"text-sm font-semibold"},Ka.message))))),vs&&React.createElement("div",{className:"fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center z-50 p-4",onClick:()=>Rt(!1)},React.createElement("div",{className:"bg-white rounded-lg shadow-xl max-w-2xl w-full p-6",onClick:e=>e.stopPropagation()},React.createElement("div",{className:"flex justify-between items-center mb-4"},React.createElement("h2",{className:"text-2xl font-bold text-gray-900"},"Keyboard Shortcuts"),React.createElement("button",{onClick:()=>Rt(!1),className:"text-gray-500 hover:text-gray-700","aria-label":"Close keyboard shortcuts"},React.createElement("i",{"data-lucide":"x",className:"w-6 h-6"}))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"space-y-3"},React.createElement("h3",{className:"font-semibold text-gray-800 mb-2"},"Navigation"),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Encounter Tab"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"1")),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Management (Ischemic) Tab"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"2")),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Management (Calculators) Tab"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"3"))),React.createElement("div",{className:"space-y-3"},React.createElement("h3",{className:"font-semibold text-gray-800 mb-2"},"Actions"),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Open Search"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"\u2318K / Ctrl+K")),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Export to PDF"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"\u2318E / Ctrl+E")),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Toggle Dark Mode"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"\u2318D / Ctrl+D")),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Close Modals"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"Esc")),React.createElement("div",{className:"flex justify-between items-center"},React.createElement("span",{className:"text-gray-700"},"Show This Help"),React.createElement("kbd",{className:"px-2 py-1 bg-gray-100 border border-gray-300 rounded text-sm font-mono"},"?")))),React.createElement("div",{className:"mt-6 text-center"},React.createElement("button",{onClick:()=>Rt(!1),className:"px-4 py-2 bg-blue-600 text-white rounded-lg hover:bg-blue-700 transition-colors"},"Got it!")))),ui.length>0&&React.createElement("div",{className:"mb-4 space-y-2",role:"alert","aria-live":"assertive","aria-atomic":"true"},ui.map(e=>React.createElement("div",{key:e.id,className:`p-4 rounded-lg border-2 flex items-start gap-3 ${e.level==="critical"?"bg-red-50 border-red-500 animate-pulse":"bg-yellow-50 border-yellow-500"}`},React.createElement("i",{"data-lucide":"alert-triangle",className:`w-6 h-6 flex-shrink-0 ${e.level==="critical"?"text-red-600":"text-yellow-600"}`}),React.createElement("div",{className:"flex-1"},React.createElement("p",{className:`font-bold text-lg ${e.level==="critical"?"text-red-900":"text-yellow-900"}`},e.message),React.createElement("p",{className:`text-sm mt-1 ${e.level==="critical"?"text-red-700":"text-yellow-700"}`},e.action))))),React.createElement("div",{className:"mb-4 sm:mb-6 hidden md:block app-nav",role:"navigation","aria-label":"Main navigation"},React.createElement("nav",{className:"flex flex-wrap justify-center gap-2 md:justify-around md:gap-0",role:"tablist"},[{id:"encounter",name:"\u26A1 Encounter",icon:"activity"},{id:"management",name:"Management",icon:"layers"},{id:"trials",name:"Trials",icon:"file-text"}].map(e=>{let a=Q===e.id;return React.createElement("button",{key:e.id,onClick:()=>{Ne(e.id)},className:`tab-pill py-2 px-4 text-sm flex items-center space-x-2 transition-all ${a?"active":"inactive"}`,role:"tab","aria-selected":a},React.createElement("i",{"data-lucide":e.icon,className:"w-4 h-4"}),React.createElement("span",null,e.name))}))),React.createElement("div",{id:"main-content",className:"space-y-6 sm:space-y-8 mobile-nav-padding",role:"region","aria-label":"Main content area"},Q==="encounter"&&React.createElement("div",{key:"encounter-tab",className:"space-y-4"},React.createElement("div",{className:"bg-gradient-to-r from-slate-50 to-slate-100 border border-slate-200 rounded-lg p-4"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("label",{className:"block font-semibold text-slate-700 text-sm uppercase tracking-wide"},"Consultation Type"),React.createElement("button",{onClick:()=>si(e=>!e),className:`text-xs font-semibold px-3 py-1 rounded-full border ${Ce?"bg-blue-600 text-white border-blue-600":"bg-white text-slate-600 border-slate-300"}`,type:"button","aria-pressed":Ce,title:Ce?"Hide advanced sections":"Show advanced sections"},Ce?"Advanced On":"Advanced Off")),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("button",{onClick:()=>ft("telephone"),className:`flex-1 min-w-[120px] px-4 py-3 rounded-lg font-medium transition-all ${we==="telephone"?"bg-amber-600 text-white shadow-md":"bg-white text-slate-700 border border-slate-300 hover:bg-amber-50 hover:border-amber-300"}`},React.createElement("i",{"data-lucide":"phone",className:"w-4 h-4 inline mr-2"}),"Telephone"),React.createElement("button",{onClick:()=>ft("videoTelestroke"),className:`flex-1 min-w-[120px] px-4 py-3 rounded-lg font-medium transition-all ${we==="videoTelestroke"?"bg-blue-600 text-white shadow-md":"bg-white text-slate-700 border border-slate-300 hover:bg-blue-50 hover:border-blue-300"}`},React.createElement("i",{"data-lucide":"video",className:"w-4 h-4 inline mr-2"}),"Video Telestroke"))),Hi.length>0&&React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-4"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-sm font-semibold text-blue-900 uppercase tracking-wide"},"Quick Links")),React.createElement("div",{className:"flex flex-col sm:flex-row gap-3 flex-wrap"},Hi.map((e,a)=>React.createElement("a",{key:`${e.label}-${a}`,href:e.url,target:"_blank",rel:"noopener noreferrer",className:"flex items-center gap-2 px-4 py-3 bg-white border border-blue-300 rounded-lg hover:bg-blue-100 transition-colors text-blue-700 font-medium"},React.createElement("i",{"data-lucide":"external-link",className:"w-5 h-5"}),React.createElement("div",{className:"flex flex-col"},React.createElement("span",null,e.label),e.note&&React.createElement("span",{className:"text-xs text-blue-700"},e.note)))))),we==="videoTelestroke"&&React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-4"},React.createElement("label",{className:"block text-sm font-medium text-blue-900 mb-1"},React.createElement("i",{"data-lucide":"map-pin",className:"w-4 h-4 inline mr-1"}),"Calling Site"),React.createElement("select",{value:t.callingSite,onChange:e=>r({...t,callingSite:e.target.value,callingSiteOther:e.target.value==="Other"?t.callingSiteOther:""}),className:"w-full px-3 py-2 border border-blue-300 rounded-lg focus:ring-2 focus:ring-blue-500"},React.createElement("option",{value:""},"-- Select Site --"),React.createElement("optgroup",{label:"UW Sites"},React.createElement("option",{value:"UWM Northwest"},"UWM Northwest")),React.createElement("optgroup",{label:"Video Partner Sites"},React.createElement("option",{value:"Astria Sunnyside"},"Astria Sunnyside"),React.createElement("option",{value:"Cascade Medical \u2013 Leavenworth"},"Cascade Medical \u2013 Leavenworth"),React.createElement("option",{value:"Columbia Basin-Ephrata"},"Columbia Basin-Ephrata"),React.createElement("option",{value:"Confluence Health \u2013 Wenatchee"},"Confluence Health \u2013 Wenatchee"),React.createElement("option",{value:"Island Health \u2013 Anacortes"},"Island Health \u2013 Anacortes"),React.createElement("option",{value:"Lourdes Health \u2013 Pasco"},"Lourdes Health \u2013 Pasco"),React.createElement("option",{value:"Mason General Hospital \u2013 Shelton"},"Mason General Hospital \u2013 Shelton"),React.createElement("option",{value:"Snoqualmie Valley \u2013 Snoqualmie"},"Snoqualmie Valley \u2013 Snoqualmie"),React.createElement("option",{value:"St. Joseph Regional Medical Center \u2013 Lewiston, Idaho"},"St. Joseph Regional Medical Center \u2013 Lewiston, Idaho")),React.createElement("optgroup",{label:"PeaceHealth Sites"},React.createElement("option",{value:"PeaceHealth Island - Friday Harbor"},"PeaceHealth Island - Friday Harbor"),React.createElement("option",{value:"PeaceHealth Ketchikan Medical Center \u2013 Ketchikan, Alaska"},"PeaceHealth Ketchikan Medical Center \u2013 Ketchikan, Alaska"),React.createElement("option",{value:"PeaceHealth St. Joseph Medical Center \u2013 Bellingham"},"PeaceHealth St. Joseph Medical Center \u2013 Bellingham"),React.createElement("option",{value:"PeaceHealth United General Medical Center \u2013 Sedro Woolley"},"PeaceHealth United General Medical Center \u2013 Sedro Woolley")),React.createElement("optgroup",{label:"Alaska Sites"},React.createElement("option",{value:"Petersburg, AK"},"Petersburg, AK")),React.createElement("optgroup",{label:"Tri-Cities"},React.createElement("option",{value:"Trios Health \u2013 Kennewick"},"Trios Health \u2013 Kennewick")),React.createElement("option",{value:"Other"},"Other (specify below)")),t.callingSite==="Other"&&React.createElement("input",{type:"text",value:t.callingSiteOther,onChange:e=>r({...t,callingSiteOther:e.target.value}),className:"w-full mt-2 px-3 py-2 border border-blue-300 rounded-lg focus:ring-2 focus:ring-blue-500",placeholder:"Enter site name..."})),we==="videoTelestroke"&&React.createElement("div",{id:"lkw-section",className:"bg-blue-50 border-2 border-blue-300 rounded-lg p-4"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"block font-semibold text-blue-900"},React.createElement("i",{"data-lucide":"clock",className:"w-4 h-4 inline mr-1"}),"Last Known Well Time *"),React.createElement("button",{type:"button",onClick:()=>{Re(new Date)},className:"text-xs font-semibold text-blue-700 hover:text-blue-900"},"Use Now")),React.createElement("div",{className:"grid grid-cols-1 sm:grid-cols-2 gap-3"},React.createElement("div",{className:"min-w-0"},React.createElement("label",{className:"block text-sm font-medium text-blue-900 mb-1"},"Date"),React.createElement("input",{type:"date",value:g?`${g.getFullYear()}-${String(g.getMonth()+1).padStart(2,"0")}-${String(g.getDate()).padStart(2,"0")}`:"",onChange:e=>{if(e.target.value){let[a,i,s]=e.target.value.split("-").map(Number),o=new Date(a,i-1,s);g&&o.setHours(g.getHours(),g.getMinutes()),Re(o)}},max:`${Se.getFullYear()}-${String(Se.getMonth()+1).padStart(2,"0")}-${String(Se.getDate()).padStart(2,"0")}`,className:"w-full px-2 sm:px-4 py-3 border-2 border-blue-300 rounded-lg text-base sm:text-lg font-semibold focus:outline-none focus:ring-2 focus:ring-blue-500 max-w-full",style:{boxSizing:"border-box"}})),React.createElement("div",{className:"min-w-0"},React.createElement("label",{className:"block text-sm font-medium text-blue-900 mb-1"},"Time"),React.createElement("input",{type:"time",value:g?g.toTimeString().slice(0,5):"",onChange:e=>{if(e.target.value){let[a,i]=e.target.value.split(":"),s=g?new Date(g):new Date;s.setHours(parseInt(a),parseInt(i)),Re(s)}},className:"w-full px-2 sm:px-4 py-3 border-2 border-blue-300 rounded-lg text-base sm:text-lg font-semibold focus:outline-none focus:ring-2 focus:ring-blue-500 max-w-full",style:{boxSizing:"border-box"}}))),React.createElement("div",{className:"mt-3"},React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.lkwUnknown,onChange:e=>{let a=e.target.checked;r({...t,lkwUnknown:a,discoveryDate:a?t.discoveryDate||new Date().toISOString().split("T")[0]:t.discoveryDate,discoveryTime:a?t.discoveryTime||new Date().toTimeString().slice(0,5):t.discoveryTime})},className:"w-5 h-5 rounded border-2 border-purple-400 text-purple-600 focus:ring-purple-500"}),React.createElement("span",{className:"font-semibold text-purple-800"},"Wake-up Stroke / Unknown LKW"))),t.lkwUnknown&&React.createElement("div",{className:"mt-3 bg-purple-50 border border-purple-200 rounded-lg p-3"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("span",{className:"text-sm font-semibold text-purple-800"},"Discovery Time"),React.createElement("button",{onClick:()=>r({...t,discoveryDate:new Date().toISOString().split("T")[0],discoveryTime:new Date().toTimeString().slice(0,5)}),className:"text-xs font-semibold text-purple-700 hover:text-purple-900",type:"button"},"Use Now")),React.createElement("div",{className:"grid grid-cols-1 sm:grid-cols-2 gap-2"},React.createElement("input",{type:"date",value:t.discoveryDate,onChange:e=>r({...t,discoveryDate:e.target.value}),className:"w-full px-3 py-2 border border-purple-300 rounded-lg focus:ring-2 focus:ring-purple-500"}),React.createElement("input",{type:"time",value:t.discoveryTime,onChange:e=>r({...t,discoveryTime:e.target.value}),className:"w-full px-3 py-2 border border-purple-300 rounded-lg focus:ring-2 focus:ring-purple-500"})),pe&&React.createElement("p",{className:"text-xs text-purple-700 mt-2"},pe.hours,"h ",pe.minutes,"m from discovery")),t.lkwUnknown&&React.createElement("div",{className:"mt-3 bg-purple-50 border-2 border-purple-300 rounded-lg p-4 space-y-4"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"text-lg font-bold text-purple-900"},"\u{1F319} Wake-up Stroke Evaluation")),React.createElement("div",{className:"space-y-2"},React.createElement("div",{className:"font-semibold text-purple-800"},"Is MRI with DWI-FLAIR available?"),React.createElement("div",{className:"flex gap-2"},React.createElement("button",{onClick:()=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,mriAvailable:!0}}),className:`px-4 py-2 rounded-lg font-medium transition-all ${t.wakeUpStrokeWorkflow.mriAvailable===!0?"bg-purple-600 text-white":"bg-white border-2 border-purple-300 text-purple-700 hover:bg-purple-100"}`},"Yes - MRI Available"),React.createElement("button",{onClick:()=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,mriAvailable:!1}}),className:`px-4 py-2 rounded-lg font-medium transition-all ${t.wakeUpStrokeWorkflow.mriAvailable===!1?"bg-orange-600 text-white":"bg-white border-2 border-orange-300 text-orange-700 hover:bg-orange-100"}`},"No - Use CTP"))),t.wakeUpStrokeWorkflow.mriAvailable===!0&&React.createElement("div",{className:"bg-white border border-purple-200 rounded-lg p-3 space-y-2"},React.createElement("div",{className:"font-bold text-purple-800 flex items-center gap-2"},React.createElement("span",null,"\u{1F52C}"),React.createElement("span",null,"WAKE-UP Trial Criteria (MRI-guided)"),React.createElement("a",{href:"https://www.nejm.org/doi/full/10.1056/NEJMoa1804355",target:"_blank",rel:"noopener noreferrer",className:"text-xs text-purple-600 hover:underline"},"[NEJM 2018]")),React.createElement("div",{className:"grid gap-2 text-sm"},React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.dwi.positiveForLesion,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,dwi:{...t.wakeUpStrokeWorkflow.dwi,positiveForLesion:e.target.checked}}}),className:"w-4 h-4 rounded border-purple-400 text-purple-600"}),React.createElement("span",null,"DWI positive lesion visible")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.flair.noMarkedHyperintensity,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,flair:{...t.wakeUpStrokeWorkflow.flair,noMarkedHyperintensity:e.target.checked}}}),className:"w-4 h-4 rounded border-purple-400 text-purple-600"}),React.createElement("span",null,"No marked parenchymal hyperintensity on FLAIR")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.ageEligible,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,ageEligible:e.target.checked}}),className:"w-4 h-4 rounded border-purple-400 text-purple-600"}),React.createElement("span",null,"Age 18-80 years")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.nihssEligible,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,nihssEligible:e.target.checked}}),className:"w-4 h-4 rounded border-purple-400 text-purple-600"}),React.createElement("span",null,"NIHSS \u226425"))),t.wakeUpStrokeWorkflow.dwi.positiveForLesion&&t.wakeUpStrokeWorkflow.flair.noMarkedHyperintensity&&t.wakeUpStrokeWorkflow.ageEligible&&t.wakeUpStrokeWorkflow.nihssEligible&&React.createElement("div",{className:"bg-green-100 border border-green-300 rounded-lg p-2 text-green-800 font-semibold text-sm flex items-center gap-2"},React.createElement("span",null,"\u2713"),React.createElement("span",null,"Meets WAKE-UP criteria - Consider IV thrombolysis"))),t.wakeUpStrokeWorkflow.mriAvailable===!1&&React.createElement("div",{className:"bg-white border border-orange-200 rounded-lg p-3 space-y-2"},React.createElement("div",{className:"font-bold text-orange-800 flex items-center gap-2"},React.createElement("span",null,"\u{1F9E0}"),React.createElement("span",null,"EXTEND Trial Criteria (Perfusion Imaging)"),React.createElement("a",{href:"https://www.nejm.org/doi/full/10.1056/NEJMoa1813046",target:"_blank",rel:"noopener noreferrer",className:"text-xs text-orange-600 hover:underline"},"[NEJM 2019]")),React.createElement("div",{className:"grid gap-2 text-sm"},React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.extendCriteria.nihss4to26,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,extendCriteria:{...t.wakeUpStrokeWorkflow.extendCriteria,nihss4to26:e.target.checked}}}),className:"w-4 h-4 rounded border-orange-400 text-orange-600"}),React.createElement("span",null,"NIHSS 4-26")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.extendCriteria.premorbidMRSLt2,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,extendCriteria:{...t.wakeUpStrokeWorkflow.extendCriteria,premorbidMRSLt2:e.target.checked}}}),className:"w-4 h-4 rounded border-orange-400 text-orange-600"}),React.createElement("span",null,"Pre-morbid mRS <2")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.extendCriteria.ischemicCoreLte70,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,extendCriteria:{...t.wakeUpStrokeWorkflow.extendCriteria,ischemicCoreLte70:e.target.checked}}}),className:"w-4 h-4 rounded border-orange-400 text-orange-600"}),React.createElement("span",null,"Ischemic core \u226470mL")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.extendCriteria.mismatchRatioGte1_2,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,extendCriteria:{...t.wakeUpStrokeWorkflow.extendCriteria,mismatchRatioGte1_2:e.target.checked}}}),className:"w-4 h-4 rounded border-orange-400 text-orange-600"}),React.createElement("span",null,"Mismatch ratio \u22651.2")),React.createElement("label",{className:"flex items-center gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.wakeUpStrokeWorkflow.extendCriteria.timeWindow4_5to9h,onChange:e=>r({...t,wakeUpStrokeWorkflow:{...t.wakeUpStrokeWorkflow,extendCriteria:{...t.wakeUpStrokeWorkflow.extendCriteria,timeWindow4_5to9h:e.target.checked}}}),className:"w-4 h-4 rounded border-orange-400 text-orange-600"}),React.createElement("span",null,"Time 4.5-9 hours OR wake-up stroke"))),t.wakeUpStrokeWorkflow.extendCriteria.nihss4to26&&t.wakeUpStrokeWorkflow.extendCriteria.premorbidMRSLt2&&t.wakeUpStrokeWorkflow.extendCriteria.ischemicCoreLte70&&t.wakeUpStrokeWorkflow.extendCriteria.mismatchRatioGte1_2&&t.wakeUpStrokeWorkflow.extendCriteria.timeWindow4_5to9h&&React.createElement("div",{className:"bg-green-100 border border-green-300 rounded-lg p-2 text-green-800 font-semibold text-sm flex items-center gap-2"},React.createElement("span",null,"\u2713"),React.createElement("span",null,"Meets EXTEND criteria - Consider IV thrombolysis"))),t.wakeUpStrokeWorkflow.mriAvailable!==null&&React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3"},React.createElement("div",{className:"font-semibold text-blue-800 mb-2"},"\u{1F4CB} Suggested Imaging Recommendation:"),React.createElement("div",{className:"text-sm text-blue-900 bg-white rounded p-2 border border-blue-200"},t.wakeUpStrokeWorkflow.mriAvailable===!0?"Obtain MRI brain with DWI/FLAIR to assess for DWI-FLAIR mismatch (WAKE-UP trial criteria). If positive DWI lesion with no corresponding FLAIR hyperintensity, patient may be candidate for IV thrombolysis.":"Obtain CT Perfusion to assess for perfusion mismatch (EXTEND trial criteria). If ischemic core \u226470mL with mismatch ratio \u22651.2, patient may be candidate for IV thrombolysis in extended window.")))),we==="telephone"&&React.createElement("div",{className:"space-y-4"},React.createElement("div",{className:"bg-gradient-to-r from-amber-500 to-orange-500 text-white rounded-lg p-4 shadow-lg"},React.createElement("div",{className:"flex flex-col md:flex-row md:items-center md:justify-between gap-4"},React.createElement("h3",{className:"text-xl font-bold"},"\u{1F4DE} Telephone Consult"),g&&React.createElement("div",{className:"bg-white/20 rounded-lg px-4 py-2 text-center"},React.createElement("span",{className:"text-2xl font-bold"},(()=>{let e=me();return e?`${e.hours}h ${e.minutes}m`:"--:--"})()),React.createElement("span",{className:"text-sm ml-2 opacity-90"},"from LKW")))),React.createElement("div",{className:"bg-blue-50 border-2 border-blue-300 rounded-lg p-4 shadow-md"},React.createElement("label",{className:"block text-sm font-medium text-blue-900 mb-1"},React.createElement("i",{"data-lucide":"map-pin",className:"w-4 h-4 inline mr-1"}),"Calling Site"),React.createElement("select",{value:t.callingSite,onChange:e=>r({...t,callingSite:e.target.value,callingSiteOther:e.target.value==="Other"?t.callingSiteOther:""}),className:"w-full px-3 py-2 border border-blue-300 rounded-lg focus:ring-2 focus:ring-blue-500"},React.createElement("option",{value:""},"-- Select Site --"),React.createElement("optgroup",{label:"UW Sites"},React.createElement("option",{value:"HMC"},"HMC"),React.createElement("option",{value:"UWMC-ML"},"UWMC-ML"),React.createElement("option",{value:"UWM Northwest"},"UWM Northwest")),React.createElement("optgroup",{label:"Partner Sites"},React.createElement("option",{value:"Astria Sunnyside"},"Astria Sunnyside"),React.createElement("option",{value:"Cascade Medical \u2013 Leavenworth"},"Cascade Medical \u2013 Leavenworth"),React.createElement("option",{value:"Columbia Basin-Ephrata"},"Columbia Basin-Ephrata"),React.createElement("option",{value:"Confluence Health \u2013 Wenatchee"},"Confluence Health \u2013 Wenatchee"),React.createElement("option",{value:"Island Health \u2013 Anacortes"},"Island Health \u2013 Anacortes"),React.createElement("option",{value:"Lourdes Health \u2013 Pasco"},"Lourdes Health \u2013 Pasco"),React.createElement("option",{value:"Mason General Hospital \u2013 Shelton"},"Mason General Hospital \u2013 Shelton"),React.createElement("option",{value:"Snoqualmie Valley \u2013 Snoqualmie"},"Snoqualmie Valley \u2013 Snoqualmie"),React.createElement("option",{value:"St. Joseph Regional Medical Center \u2013 Lewiston, Idaho"},"St. Joseph Regional Medical Center \u2013 Lewiston, Idaho"),React.createElement("option",{value:"PeaceHealth Island - Friday Harbor"},"PeaceHealth Island - Friday Harbor"),React.createElement("option",{value:"PeaceHealth Ketchikan Medical Center \u2013 Ketchikan, Alaska"},"PeaceHealth Ketchikan Medical Center \u2013 Ketchikan, Alaska"),React.createElement("option",{value:"PeaceHealth St. Joseph Medical Center \u2013 Bellingham"},"PeaceHealth St. Joseph Medical Center \u2013 Bellingham"),React.createElement("option",{value:"PeaceHealth United General Medical Center \u2013 Sedro Woolley"},"PeaceHealth United General Medical Center \u2013 Sedro Woolley"),React.createElement("option",{value:"Petersburg, AK"},"Petersburg, AK"),React.createElement("option",{value:"Trios Health \u2013 Kennewick"},"Trios Health \u2013 Kennewick")),React.createElement("option",{value:"Other"},"Other (specify below)")),t.callingSite==="Other"&&React.createElement("input",{type:"text",value:t.callingSiteOther,onChange:e=>r({...t,callingSiteOther:e.target.value}),className:"w-full mt-2 px-3 py-2 border border-blue-300 rounded-lg focus:ring-2 focus:ring-blue-500",placeholder:"Enter site name..."})),React.createElement("div",{className:"bg-amber-50 border-2 border-amber-300 rounded-lg p-4 shadow-md"},React.createElement("label",{className:"block text-sm font-medium text-amber-900 mb-1"},React.createElement("i",{"data-lucide":"clock",className:"w-4 h-4 inline mr-1"}),"Last Known Well"),React.createElement("div",{className:"grid grid-cols-2 gap-2"},React.createElement("input",{type:"date",value:g?`${g.getFullYear()}-${String(g.getMonth()+1).padStart(2,"0")}-${String(g.getDate()).padStart(2,"0")}`:"",onChange:e=>{if(e.target.value){let[a,i,s]=e.target.value.split("-").map(Number),o=new Date(a,i-1,s);g&&o.setHours(g.getHours(),g.getMinutes()),Re(o)}},max:`${Se.getFullYear()}-${String(Se.getMonth()+1).padStart(2,"0")}-${String(Se.getDate()).padStart(2,"0")}`,className:"w-full px-2 py-2 border border-amber-300 rounded-lg focus:ring-2 focus:ring-amber-500"}),React.createElement("input",{type:"time",value:g?g.toTimeString().slice(0,5):"",onChange:e=>{if(e.target.value){let[a,i]=e.target.value.split(":"),s=g?new Date(g):new Date;s.setHours(parseInt(a),parseInt(i)),Re(s)}},className:"w-full px-2 py-2 border border-amber-300 rounded-lg focus:ring-2 focus:ring-amber-500"}))),React.createElement("div",{id:"patient-info-section",className:"bg-white border-2 border-purple-300 rounded-lg p-4 shadow-md"},React.createElement("h4",{className:"text-md font-bold text-purple-900 mb-3 flex items-center gap-2"},React.createElement("i",{"data-lucide":"user",className:"w-4 h-4"}),"Patient Info & History"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-4 gap-3 mb-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Age"),React.createElement("input",{type:"number",value:t.age,onChange:e=>r({...t,age:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Sex"),React.createElement("select",{value:t.sex,onChange:e=>r({...t,sex:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"},React.createElement("option",{value:"M"},"M"),React.createElement("option",{value:"F"},"F"))),React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Weight (kg)"),React.createElement("input",{type:"number",value:t.weight,onChange:e=>r({...t,weight:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Cr (mg/dL)"),React.createElement("input",{type:"number",step:"0.1",value:t.creatinine,onChange:e=>r({...t,creatinine:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500",placeholder:"e.g. 1.2"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Pre-stroke mRS"),React.createElement("select",{value:t.premorbidMRS,onChange:e=>r({...t,premorbidMRS:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"},React.createElement("option",{value:""},"--"),React.createElement("option",{value:"0"},"0"),React.createElement("option",{value:"1"},"1"),React.createElement("option",{value:"2"},"2"),React.createElement("option",{value:"3"},"3"),React.createElement("option",{value:"4"},"4"),React.createElement("option",{value:"5"},"5")))),(()=>{let e=xt(t.age,t.weight,t.sex,t.creatinine);if(!e)return null;let a=e.isLow?"bg-red-50 border-red-200 text-red-800":e.isBorderline?"bg-amber-50 border-amber-200 text-amber-800":"bg-green-50 border-green-200 text-green-800";return React.createElement("div",{className:`mb-3 border rounded-lg p-2 flex items-center justify-between text-sm ${a}`},React.createElement("span",{className:"font-medium"},"CrCl (Cockcroft-Gault): ",React.createElement("span",{className:"font-bold"},e.value," mL/min")," \u2014 ",e.label),e.isLow&&React.createElement("span",{className:"text-xs font-semibold px-2 py-0.5 bg-red-200 rounded-full"},"Renal dose adjustment required"),e.isBorderline&&React.createElement("span",{className:"text-xs font-semibold px-2 py-0.5 bg-amber-200 rounded-full"},"Check DOAC dosing"))})(),t.weight&&Xe(t.weight)&&React.createElement("div",{className:"mb-3 bg-orange-50 border border-orange-200 rounded-lg p-2 flex items-center justify-between text-sm"},React.createElement("span",{className:"text-orange-800 font-medium"},"\u{1F489} TNK Dose: ",React.createElement("span",{className:"font-bold"},Xe(t.weight).calculatedDose," mg")),React.createElement("span",{className:"text-xs text-orange-600"},Xe(t.weight).volume)),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 mb-3"},React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("label",{className:"block text-xs font-medium text-gray-600"},"Presenting Symptoms")),React.createElement("textarea",{value:t.symptoms,onChange:e=>r({...t,symptoms:e.target.value}),rows:"2",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("label",{className:"block text-xs font-medium text-gray-600"},"Relevant PMH")),React.createElement("textarea",{value:t.pmh,onChange:e=>r({...t,pmh:e.target.value}),rows:"2",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"}))),React.createElement("div",{className:"mb-3"},React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Medications"),React.createElement("input",{type:"text",value:t.medications,onChange:e=>r({...t,medications:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"}),React.createElement("div",{className:"flex flex-wrap gap-2 mt-2"},["Aspirin","Clopidogrel","Warfarin","Apixaban"].map(e=>React.createElement("button",{key:e,type:"button",onClick:()=>Ks(e),className:"px-2 py-1 text-xs font-semibold rounded-full border border-purple-200 text-purple-700 hover:bg-purple-50"},"+ ",e)))),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3"},React.createElement("span",{className:"text-sm font-medium text-amber-800"},"\u{1F48A} Anticoagulation Status"),React.createElement("div",{className:"grid grid-cols-2 gap-3 mt-2"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Anticoagulant Type"),React.createElement("select",{value:t.lastDOACType,onChange:e=>r({...t,lastDOACType:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-amber-500"},React.createElement("option",{value:""},"None / Unknown"),React.createElement("option",{value:"apixaban"},"Apixaban (Eliquis)"),React.createElement("option",{value:"rivaroxaban"},"Rivaroxaban (Xarelto)"),React.createElement("option",{value:"dabigatran"},"Dabigatran (Pradaxa)"),React.createElement("option",{value:"warfarin"},"Warfarin (check INR)"),React.createElement("option",{value:"heparin"},"Heparin UFH (check PTT)"),React.createElement("option",{value:"lmwh"},"LMWH / Enoxaparin"))),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Last Dose"),React.createElement("input",{type:"datetime-local",value:t.lastDOACDose,onChange:e=>r({...t,lastDOACDose:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-amber-500"}),React.createElement("div",{className:"flex flex-wrap gap-2 mt-2"},React.createElement("button",{type:"button",onClick:()=>r({...t,lastDOACDose:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 text-xs font-semibold rounded-full border border-amber-200 text-amber-700 hover:bg-amber-50"},"Dose now"),React.createElement("button",{type:"button",onClick:()=>{let e=new Date(Date.now()-1764e5);r({...t,lastDOACDose:e.toISOString().slice(0,16)})},className:"px-2 py-1 text-xs font-semibold rounded-full border border-amber-200 text-amber-700 hover:bg-amber-50"},">48h ago"),React.createElement("button",{type:"button",onClick:()=>r({...t,lastDOACDose:""}),className:"px-2 py-1 text-xs font-semibold rounded-full border border-amber-200 text-amber-700 hover:bg-amber-50"},"Unknown")))),t.lastDOACType&&G[t.lastDOACType]&&React.createElement("div",{className:"mt-2 bg-orange-50 border border-orange-200 rounded p-2 text-xs"},React.createElement("div",{className:"flex justify-between"},React.createElement("span",{className:"font-medium"},G[t.lastDOACType].name),React.createElement("span",{className:"text-orange-700"},"t\xBD: ",G[t.lastDOACType].halfLife)),React.createElement("div",{className:"text-orange-700 mt-1"},"TNK: ",G[t.lastDOACType].thrombolysisThreshold)))),React.createElement("div",{id:"nihss-section",className:"bg-white border-2 border-red-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h4",{className:"text-md font-bold text-red-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"brain",className:"w-4 h-4"}),"NIHSS Examination"),React.createElement("span",{className:"text-2xl font-bold text-red-600"},"Score: ",h)),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"NIHSS Score (0-42)"),React.createElement("input",{type:"number",value:t.nihss,onChange:e=>{let a=e.target.value;r({...t,nihss:a}),Ie(parseInt(a)||0)},min:"0",max:"42",className:"w-full px-3 py-2 border-2 border-gray-300 rounded-lg text-xl font-bold text-center focus:ring-2 focus:ring-red-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Neurologic Deficits"),React.createElement("input",{type:"text",value:t.nihssDetails,onChange:e=>r({...t,nihssDetails:e.target.value}),placeholder:"e.g., R hemiparesis, aphasia, gaze deviation",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-red-500"}))),h>0&&React.createElement("div",{className:`mt-2 p-2 rounded-lg text-center text-sm font-medium ${h<=4?"bg-green-100 text-green-800":h<=15?"bg-yellow-100 text-yellow-800":h<=20?"bg-orange-100 text-orange-800":"bg-red-100 text-red-800"}`},h<=4?"Minor Stroke":h<=15?"Moderate Stroke":h<=20?"Moderate-Severe Stroke":"Severe Stroke")),React.createElement("div",{id:"vitals-section",className:"bg-white border-2 border-green-300 rounded-lg p-4 shadow-md"},React.createElement("h4",{className:"text-md font-bold text-green-900 mb-3 flex items-center gap-2"},React.createElement("i",{"data-lucide":"activity",className:"w-4 h-4"}),"Vitals & Labs"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-4 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"BP"),React.createElement("input",{type:"text",value:t.presentingBP,onChange:e=>r({...t,presentingBP:e.target.value}),placeholder:"120/80",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-green-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Glucose"),React.createElement("input",{type:"text",value:t.glucose,onChange:e=>r({...t,glucose:e.target.value}),placeholder:"mg/dL",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-green-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"INR"),React.createElement("input",{type:"text",value:t.inr,onChange:e=>r({...t,inr:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-green-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Platelets"),React.createElement("input",{type:"text",value:t.platelets,onChange:e=>r({...t,platelets:e.target.value}),placeholder:"K/uL",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-green-500"})))),React.createElement("div",{className:"bg-white border-2 border-cyan-300 rounded-lg p-4 shadow-md"},React.createElement("h4",{className:"text-md font-bold text-cyan-900 mb-3 flex items-center gap-2"},React.createElement("i",{"data-lucide":"scan",className:"w-4 h-4"}),"Imaging Review"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"CT Head"),React.createElement("textarea",{value:t.ctResults,onChange:e=>r({...t,ctResults:e.target.value}),rows:"2",placeholder:"No acute hemorrhage, early ischemic changes...",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-cyan-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"CTA Head/Neck"),React.createElement("textarea",{value:t.ctaResults,onChange:e=>r({...t,ctaResults:e.target.value}),rows:"2",placeholder:"LVO location, vessel patency...",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-cyan-500"}))),React.createElement("div",{className:"grid grid-cols-2 gap-3 mt-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"ASPECTS"),React.createElement("input",{type:"number",value:A,onChange:e=>tt(parseInt(e.target.value)||0),min:"0",max:"10",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-cyan-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"CTP"),React.createElement("input",{type:"text",value:t.ctpResults,onChange:e=>r({...t,ctpResults:e.target.value}),placeholder:"Core/penumbra, mismatch...",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-cyan-500"})))),React.createElement("div",{className:"bg-white border-2 border-purple-300 rounded-lg p-4 shadow-md"},React.createElement("h4",{className:"text-md font-bold text-purple-900 mb-3 flex items-center gap-2"},React.createElement("i",{"data-lucide":"stethoscope",className:"w-4 h-4"}),"Treatment Decision"),React.createElement("div",{className:"space-y-3"},React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Suspected Diagnosis"),React.createElement("select",{value:t.diagnosis,onChange:e=>{let a=e.target.value,i=a.toLowerCase().includes("ich")||a.toLowerCase().includes("hemorrhag")?"ich":a.toLowerCase().includes("ischemic")||a.toLowerCase().includes("lvo")?"ischemic":"";r({...t,diagnosis:a,diagnosisCategory:i})},className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-purple-500"},React.createElement("option",{value:""},"-- Select Diagnosis --"),React.createElement("optgroup",{label:"Ischemic Stroke"},React.createElement("option",{value:"Acute Ischemic Stroke"},"Acute Ischemic Stroke"),React.createElement("option",{value:"Acute Ischemic Stroke - LVO"},"Acute Ischemic Stroke - LVO"),React.createElement("option",{value:"Minor Ischemic Stroke"},"Minor Ischemic Stroke"),React.createElement("option",{value:"TIA"},"TIA")),React.createElement("optgroup",{label:"Hemorrhagic"},React.createElement("option",{value:"Intracerebral Hemorrhage (ICH)"},"Intracerebral Hemorrhage (ICH)"),React.createElement("option",{value:"Subarachnoid Hemorrhage (SAH)"},"Subarachnoid Hemorrhage (SAH)")),React.createElement("optgroup",{label:"Other"},React.createElement("option",{value:"Cerebral Venous Thrombosis (CVT)"},"Cerebral Venous Thrombosis (CVT)"),React.createElement("option",{value:"Cervical Artery Dissection"},"Cervical Artery Dissection"),React.createElement("option",{value:"Stroke Mimic"},"Stroke Mimic"),React.createElement("option",{value:"Other"},"Other")))),React.createElement("div",{className:"grid grid-cols-2 gap-3"},React.createElement("label",{className:"flex items-center gap-2 p-2 bg-green-50 border border-green-200 rounded-lg cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.tnkRecommended,onChange:e=>r({...t,tnkRecommended:e.target.checked}),className:"w-4 h-4 text-green-600"}),React.createElement("span",{className:"text-sm font-medium text-green-800"},"TNK Recommended")),React.createElement("label",{className:"flex items-center gap-2 p-2 bg-blue-50 border border-blue-200 rounded-lg cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t.evtRecommended,onChange:e=>r({...t,evtRecommended:e.target.checked}),className:"w-4 h-4 text-blue-600"}),React.createElement("span",{className:"text-sm font-medium text-blue-800"},"EVT Recommended"))),t.tnkRecommended&&React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"TNK Admin Time"),React.createElement("input",{type:"time",value:t.tnkAdminTime||"",onChange:e=>r({...t,tnkAdminTime:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-green-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Rationale"),React.createElement("textarea",{value:t.rationale,onChange:e=>r({...t,rationale:e.target.value}),rows:"2",placeholder:"Clinical rationale for treatment recommendation...",className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Disposition"),React.createElement("select",{value:t.disposition||"",onChange:e=>r({...t,disposition:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-purple-500"},React.createElement("option",{value:""},"-- Select --"),React.createElement("option",{value:"Admit to Neuro ICU"},"Admit to Neuro ICU"),React.createElement("option",{value:"Admit to Stroke Unit"},"Admit to Stroke Unit"),React.createElement("option",{value:"Admit to Floor"},"Admit to Floor"),React.createElement("option",{value:"Transfer to CSC"},"Transfer to Comprehensive Stroke Center"),React.createElement("option",{value:"Transfer to PSC"},"Transfer to Primary Stroke Center"),React.createElement("option",{value:"Observation"},"Observation"),React.createElement("option",{value:"Discharge"},"Discharge"))))),React.createElement("div",{className:"bg-white border-2 border-teal-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h4",{className:"text-md font-bold text-teal-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"clipboard-check",className:"w-4 h-4"}),"Recommendations"),React.createElement("button",{type:"button",onClick:()=>{let e=$a(),a=t.age||"[Age]",i=t.sex==="M"?"male":t.sex==="F"?"female":"[sex]",s=t.diagnosis||"[Diagnosis]",o=`TELEPHONE CONSULTATION NOTE
Date: ${new Date().toLocaleDateString()}

`;o+=`HPI: ${a} year old ${i}`,t.pmh&&(o+=` with PMH of ${t.pmh}`),o+=` presenting with ${t.symptoms||"[symptoms]"}.
`,g&&(o+=`Last known well: ${g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"})} on ${g.toLocaleDateString()}.
`),o+=`
NIHSS: ${t.nihss||h||"N/A"}
`,t.presentingBP&&(o+=`BP: ${t.presentingBP}
`),o+=`
IMAGING:
`,t.ctResults&&(o+=`CT Head: ${t.ctResults}
`),t.ctaResults&&(o+=`CTA: ${t.ctaResults}
`),t.ctpResults&&(o+=`CTP: ${t.ctpResults}
`),A&&(o+=`ASPECTS: ${A}
`),o+=`
ASSESSMENT: ${s}

PLAN:
`,t.tnkRecommended?(o+="- TNK 0.25 mg/kg IV bolus (max 25 mg) recommended",t.tnkAdminTime&&(o+=` at ${t.tnkAdminTime}`),o+=`.
`):o+=`- IV TNK: Not recommended.
`,t.evtRecommended&&(o+=`- EVT: Recommended.
`),t.rationale&&(o+=`- Rationale: ${t.rationale}
`),t.disposition&&(o+=`
DISPOSITION: ${t.disposition}
`),e.length>0&&(o+=`
GUIDELINE-BASED RECOMMENDATIONS:
`,e.forEach(m=>{o+=`- ${m.title}: ${m.recommendation} [Class ${m.classOfRec}, LOE ${m.levelOfEvidence}]
`}));let n=Object.values(Qt).filter(Boolean),c=n.filter(m=>m.status==="eligible"),d=n.filter(m=>m.status==="needs_info");(c.length>0||d.length>0)&&(o+=`
CLINICAL TRIAL ELIGIBILITY:
`,c.forEach(m=>{let l=Le[m.trialId];o+=`- ELIGIBLE: ${m.trialName} (${(l==null?void 0:l.nct)||""}) \u2014 ${m.quickDescription}. Criteria met: ${m.metCount}/${m.criteria.length}.
`}),d.forEach(m=>{let l=Le[m.trialId],C=m.criteria.filter(k=>k.status==="unknown").map(k=>k.label).join(", ");o+=`- NEEDS INFO: ${m.trialName} (${(l==null?void 0:l.nct)||""}) \u2014 missing: ${C}.
`})),r({...t,recommendationsText:o})},className:"flex items-center gap-2 px-3 py-1.5 bg-teal-600 text-white text-xs font-medium rounded-lg hover:bg-teal-700 transition-colors"},React.createElement("i",{"data-lucide":"file-text",className:"w-3 h-3"}),"Generate Auto-Note")),React.createElement("textarea",{value:t.recommendationsText,onChange:e=>r({...t,recommendationsText:e.target.value}),placeholder:"Click 'Generate Auto-Note' or type recommendations...",rows:"5",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-teal-500 text-sm"})),React.createElement("div",{className:"bg-gray-50 border-2 border-gray-300 rounded-lg p-4 shadow-md space-y-3"},React.createElement("h4",{className:"text-md font-bold text-gray-800 mb-3"},"\u{1F4CB} Copy Notes"),React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-3"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("span",{className:"font-semibold text-indigo-800 text-sm"},"Pulsara Summary"),React.createElement("button",{onClick:()=>{let e=t.age||"[Age]",a=t.sex,i=a==="M"?"male":a==="F"?"female":"[sex]",s=t.pmh||"no PMH",o=t.symptoms||"[symptoms]",n=g?g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}):"[time]",c=g?g.toLocaleDateString("en-US"):"[date]",d=t.nihss||h||"[score]",m=t.nihssDetails?` (${t.nihssDetails})`:"",l=t.ctResults||"[CT findings]",C=t.ctaResults||"[CTA findings]",k=t.ctpResults||"N/A",I=A?` ASPECTS: ${A}.`:"",S=t.tnkRecommended?"Recommended":"Not Recommended",H=t.evtRecommended?"Recommended":"Not Recommended",f=t.rationale||"[rationale]",U=`${e} year old ${i} with ${s} who presents with ${o}. Last known well is ${n} ${c}. NIHSS score: ${d}${m}. Head CT: ${l}.${I} CTA Head/Neck: ${C}. CTP: ${k}. TNK Treatment: ${S}. EVT: ${H}. Rationale for Treatment Recommendation: ${f}.`;navigator.clipboard.writeText(U),z("tel-pulsara"),setTimeout(()=>z(""),2e3)},className:"flex items-center gap-2 px-3 py-1.5 bg-indigo-600 text-white text-sm rounded-lg hover:bg-indigo-700 transition-colors"},React.createElement("i",{"data-lucide":le==="tel-pulsara"?"check":"copy",className:"w-4 h-4"}),le==="tel-pulsara"?"Copied!":"Copy Pulsara")),React.createElement("p",{className:"text-xs text-gray-600 whitespace-pre-wrap"},(()=>{let e=t.age||"[Age]",a=t.sex,i=a==="M"?"male":a==="F"?"female":"[sex]",s=t.pmh||"no PMH",o=t.symptoms||"[symptoms]",n=g?g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}):"[time]",c=g?g.toLocaleDateString("en-US"):"[date]",d=t.nihss||h||"[score]",m=t.nihssDetails?` (${t.nihssDetails})`:"",l=t.ctResults||"[CT findings]",C=t.ctaResults||"[CTA findings]",k=t.ctpResults||"N/A",I=A?` ASPECTS: ${A}.`:"",S=t.tnkRecommended?"Recommended":"Not Recommended",H=t.evtRecommended?"Recommended":"Not Recommended",f=t.rationale||"[rationale]";return`${e} year old ${i} with ${s} who presents with ${o}. Last known well is ${n} ${c}. NIHSS score: ${d}${m}. Head CT: ${l}.${I} CTA Head/Neck: ${C}. CTP: ${k}. TNK Treatment: ${S}. EVT: ${H}. Rationale: ${f}.`})())),React.createElement("button",{onClick:()=>{let e=t.callingSite==="Other"?t.callingSiteOther:t.callingSite,a=me(),i=a?`${a.hours}h ${a.minutes}m from LKW`:"",s=`TELEPHONE CONSULT

Site: ${e||"Not specified"}
Patient: ${t.age||"?"}yo ${t.sex||"?"}
LKW: ${g?g.toLocaleString():"Not specified"}${i?` (${i})`:""}

PRESENTATION:
${t.symptoms||"Not documented"}
PMH: ${t.pmh||"Not documented"}
Medications: ${t.medications||"Not documented"}
`+(t.lastDOACType?`Anticoagulation: ${t.lastDOACType}${t.lastDOACDose?`, last dose: ${new Date(t.lastDOACDose).toLocaleString()}`:""}
`:"")+`
NIHSS: ${t.nihss||h||"N/A"}${t.nihssDetails?` (${t.nihssDetails})`:""}

VITALS/LABS:
BP: ${t.presentingBP||"N/A"}, Glucose: ${t.glucose||"N/A"}, INR: ${t.inr||"N/A"}, Plt: ${t.platelets||"N/A"}

IMAGING:
CT Head: ${t.ctResults||"Not documented"}
CTA: ${t.ctaResults||"Not documented"}
`+(A?`ASPECTS: ${A}
`:"")+(t.ctpResults?`CTP: ${t.ctpResults}
`:"")+`
TREATMENT DECISION:
TNK: ${t.tnkRecommended?"RECOMMENDED":"Not recommended"}
EVT: ${t.evtRecommended?"RECOMMENDED":"Not recommended"}

RATIONALE/RECOMMENDATIONS:
${t.rationale||"None documented"}

Clinician Name
${new Date().toLocaleString()}`;navigator.clipboard.writeText(s),z("telephone-note"),setTimeout(()=>z(""),2e3)},className:"w-full px-4 py-3 bg-amber-600 text-white rounded-lg hover:bg-amber-700 transition-colors font-medium flex items-center justify-center gap-2"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4"}),le==="telephone-note"?"Copied!":"Copy Full Telephone Note"))),we==="videoTelestroke"&&React.createElement(React.Fragment,null,React.createElement("div",{className:"grid grid-cols-1 lg:grid-cols-3 gap-4"},React.createElement("div",{className:"lg:col-span-2 space-y-4"},React.createElement("div",{id:"patient-info-section",className:"bg-white border-2 border-blue-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-blue-900"},"1. Patient Info"),React.createElement("i",{"data-lucide":"user",className:"w-5 h-5 text-blue-600"})),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-4 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Age"),React.createElement("input",{type:"number",value:t.age,onChange:e=>r({...t,age:e.target.value}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500",placeholder:""})),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Sex"),React.createElement("select",{value:t.sex,onChange:e=>r({...t,sex:e.target.value}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"},React.createElement("option",{value:"M"},"M"),React.createElement("option",{value:"F"},"F"))),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Weight",React.createElement("span",{className:"ml-1 text-xs text-orange-600 font-normal"},"(TNK dosing)")),React.createElement("div",{className:"flex items-center"},React.createElement("input",{type:"number",value:t.weight,onChange:e=>r({...t,weight:e.target.value}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500",placeholder:"",min:"0"}),React.createElement("span",{className:"ml-1 text-xs text-gray-500"},"kg"))),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Pre-stroke mRS",React.createElement("span",{className:"ml-1 text-xs text-blue-600 font-normal"},"(trials)")),React.createElement("select",{value:t.premorbidMRS,onChange:e=>r({...t,premorbidMRS:e.target.value}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"},React.createElement("option",{value:""},"Select..."),React.createElement("option",{value:"0"},"0 - No symptoms"),React.createElement("option",{value:"1"},"1 - No significant disability"),React.createElement("option",{value:"2"},"2 - Slight disability"),React.createElement("option",{value:"3"},"3 - Moderate disability"),React.createElement("option",{value:"4"},"4 - Moderately severe disability"),React.createElement("option",{value:"5"},"5 - Severe disability")))),t.weight&&Xe(t.weight)&&React.createElement("div",{className:"mt-2 bg-orange-50 border border-orange-200 rounded-lg p-2 flex items-center justify-between"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"text-orange-800 font-medium"},"\u{1F489} TNK Dose:"),React.createElement("span",{className:"text-lg font-bold text-orange-700"},Xe(t.weight).calculatedDose," mg"),React.createElement("span",{className:"text-sm text-orange-600"},"(",Xe(t.weight).volume,")")),React.createElement("span",{className:"text-xs text-orange-500"},"0.25 mg/kg, max 25 mg")),React.createElement("div",{className:"mt-3"},React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Chief Complaint"),React.createElement("input",{type:"text",value:t.chiefComplaint,onChange:e=>r({...t,chiefComplaint:e.target.value}),placeholder:"",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}))),React.createElement("div",{className:"bg-white border-2 border-purple-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-purple-900"},"2. History & Medications"),React.createElement("i",{"data-lucide":"file-text",className:"w-5 h-5 text-purple-600"})),React.createElement("div",{className:"space-y-3"},React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Presenting Symptoms"),React.createElement("textarea",{value:t.symptoms,onChange:e=>r({...t,symptoms:e.target.value}),placeholder:"",rows:"2",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Relevant PMH"),React.createElement("input",{type:"text",value:t.pmh,onChange:e=>r({...t,pmh:e.target.value}),placeholder:"",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Medications"),React.createElement("textarea",{value:t.medications,onChange:e=>r({...t,medications:e.target.value}),placeholder:"",rows:"2",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3 space-y-2"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"text-sm font-medium text-amber-800"},"\u{1F48A} Anticoagulation Status")),React.createElement("div",{className:"grid grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Anticoagulant Type"),React.createElement("select",{value:t.lastDOACType,onChange:e=>r({...t,lastDOACType:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-blue-500"},React.createElement("option",{value:""},"None / Unknown"),React.createElement("option",{value:"apixaban"},"Apixaban (Eliquis)"),React.createElement("option",{value:"rivaroxaban"},"Rivaroxaban (Xarelto)"),React.createElement("option",{value:"dabigatran"},"Dabigatran (Pradaxa)"),React.createElement("option",{value:"warfarin"},"Warfarin (check INR)"),React.createElement("option",{value:"heparin"},"Heparin UFH (check PTT)"),React.createElement("option",{value:"lmwh"},"LMWH / Enoxaparin"))),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-600 mb-1"},"Last Dose (date/time)"),React.createElement("input",{type:"datetime-local",value:t.lastDOACDose,onChange:e=>r({...t,lastDOACDose:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-blue-500"}))),t.lastDOACType&&G[t.lastDOACType]&&React.createElement("div",{className:"bg-orange-50 border-2 border-orange-300 rounded-lg p-3 space-y-2"},React.createElement("div",{className:"flex items-center justify-between"},React.createElement("span",{className:"font-bold text-orange-800"},G[t.lastDOACType].name),React.createElement("span",{className:"text-xs bg-orange-200 text-orange-800 px-2 py-0.5 rounded-full"},G[t.lastDOACType].class)),React.createElement("div",{className:"grid grid-cols-2 gap-2 text-xs"},React.createElement("div",{className:"bg-white rounded p-2 border border-orange-200"},React.createElement("div",{className:"text-gray-500 mb-0.5"},"Half-Life"),React.createElement("div",{className:"font-semibold text-gray-800"},G[t.lastDOACType].halfLife)),React.createElement("div",{className:"bg-white rounded p-2 border border-orange-200"},React.createElement("div",{className:"text-gray-500 mb-0.5"},"tPA/TNK Threshold"),React.createElement("div",{className:"font-semibold text-gray-800"},G[t.lastDOACType].thrombolysisThreshold))),G[t.lastDOACType].thrombolysisNote&&React.createElement("div",{className:"text-xs text-orange-700 bg-orange-100 p-2 rounded flex items-start gap-1"},React.createElement("span",null,"\u26A0\uFE0F"),React.createElement("span",null,G[t.lastDOACType].thrombolysisNote)),React.createElement("details",{className:"group"},React.createElement("summary",{className:"cursor-pointer text-sm font-semibold text-red-700 hover:text-red-900 flex items-center gap-1"},React.createElement("span",{className:"group-open:rotate-90 transition-transform"},"\u25B6"),"ICH Reversal Protocol"),React.createElement("div",{className:"mt-2 bg-red-50 border border-red-200 rounded-lg p-2 text-xs space-y-1"},React.createElement("div",{className:"flex items-start gap-2"},React.createElement("span",{className:"font-bold text-red-700 shrink-0"},"1st Line:"),React.createElement("span",{className:"text-red-900 font-medium"},G[t.lastDOACType].ichReversal.primary)),G[t.lastDOACType].ichReversal.pccDosing&&React.createElement("div",{className:"flex items-start gap-2"},React.createElement("span",{className:"font-bold text-red-700 shrink-0"},"PCC Dose:"),React.createElement("span",{className:"text-red-800"},G[t.lastDOACType].ichReversal.pccDosing)),G[t.lastDOACType].ichReversal.alternative&&React.createElement("div",{className:"flex items-start gap-2"},React.createElement("span",{className:"font-bold text-gray-600 shrink-0"},"Alt:"),React.createElement("span",{className:"text-gray-700"},G[t.lastDOACType].ichReversal.alternative)),G[t.lastDOACType].ichReversal.maxDose&&React.createElement("div",{className:"text-gray-600 italic"},G[t.lastDOACType].ichReversal.maxDose),G[t.lastDOACType].ichReversal.note&&React.createElement("div",{className:"text-gray-600 italic mt-1 pt-1 border-t border-red-200"},G[t.lastDOACType].ichReversal.note))),React.createElement("div",{className:"text-xs text-gray-600"},React.createElement("span",{className:"font-medium"},"Monitor:")," ",G[t.lastDOACType].monitoring))))),React.createElement("div",{className:"bg-white border-2 border-red-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-red-900"},"3. NIHSS Examination"),React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"text-2xl font-bold text-red-600"},"Score: ",h),React.createElement("i",{"data-lucide":"brain",className:"w-5 h-5 text-red-600"}))),React.createElement("div",{className:"bg-yellow-50 border border-yellow-200 rounded-lg p-3 mb-3"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("p",{className:"text-sm font-medium text-gray-700"},"Quick Entry:"),React.createElement("button",{type:"button",onClick:Qs,className:"text-xs font-semibold text-blue-700 hover:text-blue-900"},"All normal (0)")),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 mb-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-500 mb-1"},"NIHSS Score (0-42)"),React.createElement("input",{type:"number",value:t.nihss,onChange:e=>{let a=e.target.value;r({...t,nihss:a}),Ie(parseInt(a)||0)},min:"0",max:"42",className:"w-full px-3 py-2 border-2 border-gray-300 rounded-lg text-2xl font-bold text-center focus:ring-2 focus:ring-blue-500"})),React.createElement("div",null,React.createElement("label",{className:"block text-xs text-gray-500 mb-1"},"Neurologic Deficits"),React.createElement("input",{type:"text",value:t.nihssDetails,onChange:e=>r({...t,nihssDetails:e.target.value}),placeholder:"e.g., R hemiparesis, aphasia",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}))),(t.nihss||h>0)&&React.createElement("div",{className:`p-2 rounded-lg text-center text-sm font-medium ${h===0?"bg-green-100 text-green-800":h<=4?"bg-blue-100 text-blue-800":h<=15?"bg-yellow-100 text-yellow-800":h<=20?"bg-orange-100 text-orange-800":"bg-red-100 text-red-800"}`},h===0?"0 = No stroke symptoms":h<=4?`${h} = Minor stroke`:h<=15?`${h} = Moderate stroke`:h<=20?`${h} = Moderate-Severe stroke`:`${h} = Severe stroke`,h>=6&&h<=24&&" | Consider TNK if within window",h>=6&&" | Consider LVO screening")),React.createElement("details",{className:"bg-gray-50 border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-gray-800 hover:bg-gray-100 rounded-lg"},"\u{1F4CA} Full NIHSS Calculator (Click to expand)"),React.createElement("div",{className:"p-4 space-y-3"},Lt.map(e=>React.createElement("div",{key:e.id,className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-sm mb-2"},e.name),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-2"},e.options.map((a,i)=>React.createElement("label",{key:i,className:"flex items-center space-x-2 cursor-pointer text-sm"},React.createElement("input",{type:"radio",name:e.id,value:a,checked:be[e.id]===a,onChange:s=>{let o={...be,[e.id]:s.target.value};Tt(o);let n=Pa(o);Ie(n),r({...t,nihss:n.toString()})},className:"text-blue-600"}),React.createElement("span",null,a))))))))),React.createElement("div",{className:"bg-white border-2 border-green-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-green-900"},"4. Vitals & Labs"),React.createElement("i",{"data-lucide":"activity",className:"w-5 h-5 text-green-600"})),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Presenting BP"),React.createElement("div",{className:"flex items-center gap-2"},React.createElement("input",{type:"text",value:t.presentingBP,onChange:e=>r({...t,presentingBP:e.target.value}),placeholder:"185/110",className:`flex-1 px-3 py-2 border-2 rounded-lg focus:ring-2 focus:ring-blue-500 ${(()=>{let e=nt(t.presentingBP);return e.status==="too_high"?"border-red-400 bg-red-50":e.status==="borderline"?"border-yellow-400 bg-yellow-50":e.status==="ok"?"border-green-400 bg-green-50":"border-gray-300"})()}`}),(()=>{let e=nt(t.presentingBP);return e.status==="unknown"?null:React.createElement("span",{className:`px-2 py-1 rounded text-xs font-bold border whitespace-nowrap ${e.badgeClass}`},e.icon," ",e.message)})()),(()=>{let e=nt(t.presentingBP);return e.needsLowering?React.createElement("div",{className:"mt-1 px-2 py-1 bg-red-100 border border-red-300 rounded text-xs text-red-800 font-medium"},"Need to lower by ",e.sbpToLower,"/",e.dbpToLower," mmHg to reach 185/110"):null})(),nt(t.presentingBP).status!=="too_high"?null:React.createElement("div",{className:"mt-2 px-2 py-1 bg-red-50 border border-red-200 rounded text-xs text-red-700"},"TNK should be held until BP is controlled below 185/110.")),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Current BP (prior to TNK, if applicable)"),React.createElement("div",{className:"flex items-center gap-2"},React.createElement("input",{type:"text",value:t.bpPreTNK,onChange:e=>r({...t,bpPreTNK:e.target.value}),placeholder:"185/110",className:`flex-1 px-3 py-2 border-2 rounded-lg focus:ring-2 focus:ring-blue-500 ${(()=>{let e=nt(t.bpPreTNK);return e.status==="too_high"?"border-red-400 bg-red-50":e.status==="borderline"?"border-yellow-400 bg-yellow-50":e.status==="ok"?"border-green-400 bg-green-50":"border-gray-300"})()}`}),React.createElement("input",{type:"time",value:t.bpPreTNKTime,onChange:e=>r({...t,bpPreTNKTime:e.target.value}),className:"w-24 px-2 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}),(()=>{let e=nt(t.bpPreTNK);return e.status==="unknown"?null:React.createElement("span",{className:`px-2 py-1 rounded text-xs font-bold border whitespace-nowrap ${e.badgeClass}`},e.icon," ",e.message)})()),(()=>{let e=nt(t.bpPreTNK);return e.needsLowering?React.createElement("div",{className:"mt-1 px-2 py-1 bg-red-100 border border-red-300 rounded text-xs text-red-800 font-medium"},"Need to lower by ",e.sbpToLower,"/",e.dbpToLower," mmHg to reach 185/110"):null})())),(t.tnkRecommended||t.dtnTnkAdministered)&&React.createElement("div",{className:"mt-2 px-3 py-2 bg-blue-50 border-l-4 border-blue-500 rounded-r text-sm"},React.createElement("span",{className:"font-bold text-blue-800"},"Post-TNK Target:"),React.createElement("span",{className:"text-blue-700 ml-2"},"<180/105 for 24 hours after thrombolysis")),React.createElement("div",{className:"grid grid-cols-3 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Glucose"),React.createElement("div",{className:"flex items-center"},React.createElement("input",{type:"number",value:t.glucose,onChange:e=>r({...t,glucose:e.target.value}),placeholder:"",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500",min:"0"}),React.createElement("span",{className:"ml-1 text-xs text-gray-500"},"mg/dL"))),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"INR"),React.createElement("input",{type:"number",value:t.inr,onChange:e=>r({...t,inr:e.target.value}),placeholder:"",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500",step:"0.1",min:"0"})),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Platelets"),React.createElement("div",{className:"flex items-center"},React.createElement("input",{type:"number",value:t.plateletCount,onChange:e=>r({...t,plateletCount:e.target.value}),placeholder:"",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500",min:"0"}),React.createElement("span",{className:"ml-1 text-xs text-gray-500"},"/\u03BCL")))),React.createElement("div",{className:"bg-yellow-50 border border-yellow-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-yellow-800 mb-2"},"\u23F1\uFE0F Critical Timestamps"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-4 gap-3"},React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("label",{className:"block text-xs font-medium text-gray-600"},"Door Time (ED Arrival)"),React.createElement("button",{type:"button",onClick:()=>r({...t,doorTime:new Date().toTimeString().slice(0,5)}),className:"text-[10px] font-semibold text-yellow-800 hover:text-yellow-900"},"Now")),React.createElement("input",{type:"time",value:t.doorTime||"",onChange:e=>r({...t,doorTime:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-yellow-500"})),React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("label",{className:"block text-xs font-medium text-gray-600"},"CT Time"),React.createElement("button",{type:"button",onClick:()=>r({...t,ctTime:new Date().toTimeString().slice(0,5)}),className:"text-[10px] font-semibold text-yellow-800 hover:text-yellow-900"},"Now")),React.createElement("input",{type:"time",value:t.ctTime||"",onChange:e=>r({...t,ctTime:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-yellow-500"})),React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("label",{className:"block text-xs font-medium text-gray-600"},"Needle Time (TNK)"),React.createElement("button",{type:"button",onClick:()=>r({...t,needleTime:new Date().toTimeString().slice(0,5)}),className:"text-[10px] font-semibold text-yellow-800 hover:text-yellow-900"},"Now")),React.createElement("input",{type:"time",value:t.needleTime||"",onChange:e=>r({...t,needleTime:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-yellow-500"})),React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("label",{className:"block text-xs font-medium text-gray-600"},"Puncture Time (EVT)"),React.createElement("button",{type:"button",onClick:()=>r({...t,punctureTime:new Date().toTimeString().slice(0,5)}),className:"text-[10px] font-semibold text-yellow-800 hover:text-yellow-900"},"Now")),React.createElement("input",{type:"time",value:t.punctureTime||"",onChange:e=>r({...t,punctureTime:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-yellow-500"}))),t.doorTime&&(t.needleTime||t.punctureTime)&&React.createElement("div",{className:"mt-3 grid grid-cols-2 gap-3"},t.needleTime&&(()=>{let[e,a]=t.doorTime.split(":").map(Number),[i,s]=t.needleTime.split(":").map(Number),o=i*60+s-(e*60+a);o<0&&(o+=1440);let n=o<=60;return React.createElement("div",{className:`p-2 rounded text-center ${n?"bg-green-100 border border-green-300":"bg-red-100 border border-red-300"}`},React.createElement("span",{className:"block text-xs text-gray-600"},"Door-to-Needle"),React.createElement("span",{className:`text-xl font-bold ${n?"text-green-800":"text-red-800"}`},o," min"),React.createElement("span",{className:"block text-xs text-gray-500"},n?"\u2713 Goal \u226460 min":"\u26A0 Goal \u226460 min"))})(),t.punctureTime&&(()=>{let[e,a]=t.doorTime.split(":").map(Number),[i,s]=t.punctureTime.split(":").map(Number),o=i*60+s-(e*60+a);o<0&&(o+=1440);let n=o<=90;return React.createElement("div",{className:`p-2 rounded text-center ${n?"bg-green-100 border border-green-300":"bg-red-100 border border-red-300"}`},React.createElement("span",{className:"block text-xs text-gray-600"},"Door-to-Puncture"),React.createElement("span",{className:`text-xl font-bold ${n?"text-green-800":"text-red-800"}`},o," min"),React.createElement("span",{className:"block text-xs text-gray-500"},n?"\u2713 Goal \u226490 min":"\u26A0 Goal \u226490 min"))})()),t.doorTime&&(()=>{let[e,a]=t.doorTime.split(":").map(Number),i=Se.getHours(),s=Se.getMinutes(),o=i*60+s-(e*60+a);o<0&&(o+=1440);let n=60-o,c=90-o;return React.createElement("div",{className:"mt-3 bg-white border border-yellow-200 rounded-lg p-3"},React.createElement("p",{className:"text-xs font-semibold text-yellow-800 mb-2"},"Live Timers (from door time)"),React.createElement("div",{className:"grid grid-cols-1 sm:grid-cols-2 gap-2 text-center"},React.createElement("div",{className:`p-2 rounded border ${n>=0?"bg-green-50 border-green-200 text-green-700":"bg-red-50 border-red-200 text-red-700"}`},React.createElement("p",{className:"text-xs font-medium"},"TNK goal (60 min)"),React.createElement("p",{className:"text-lg font-bold"},n>=0?`${n} min left`:`${Math.abs(n)} min over`)),React.createElement("div",{className:`p-2 rounded border ${c>=0?"bg-green-50 border-green-200 text-green-700":"bg-red-50 border-red-200 text-red-700"}`},React.createElement("p",{className:"text-xs font-medium"},"EVT goal (90 min)"),React.createElement("p",{className:"text-lg font-bold"},c>=0?`${c} min left`:`${Math.abs(c)} min over`))))})()))),React.createElement("div",{className:"bg-white border-2 border-indigo-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-indigo-900"},"5. Imaging Review"),React.createElement("i",{"data-lucide":"image",className:"w-5 h-5 text-indigo-600"})),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"bg-gray-50 p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"Non-contrast Head CT"),React.createElement("div",{className:"grid grid-cols-2 gap-2 mb-2"},React.createElement("input",{type:"date",value:t.ctDate,onChange:e=>r({...t,ctDate:e.target.value}),className:"px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}),React.createElement("input",{type:"time",value:t.ctTime,onChange:e=>r({...t,ctTime:e.target.value}),placeholder:"Time reviewed",className:"px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})),React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("span",{className:"text-xs font-medium text-gray-600"},"CT Results")),React.createElement("textarea",{value:t.ctResults,onChange:e=>r({...t,ctResults:e.target.value}),placeholder:"",rows:"2",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3 mb-3"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-medium text-blue-800"},"ASPECTS Score"),React.createElement("span",{className:"text-2xl font-bold text-blue-600"},A,"/10")),React.createElement("div",{className:"flex flex-wrap gap-2 mb-2"},[10,9,8,7,6,5,4,3,2,1,0].map(e=>React.createElement("button",{key:e,onClick:()=>{tt(e);let a=it.map((i,s)=>({...i,checked:s<e}));Ot(a)},className:`w-8 h-8 rounded-lg text-sm font-bold transition ${A===e?"ring-2 ring-offset-1 ring-blue-500":""} ${e>=7?"bg-green-100 hover:bg-green-200 text-green-800":e>=6?"bg-yellow-100 hover:bg-yellow-200 text-yellow-800":e>=3?"bg-orange-100 hover:bg-orange-200 text-orange-800":"bg-red-100 hover:bg-red-200 text-red-800"}`},e))),React.createElement("div",{className:`p-2 rounded-lg text-center text-xs font-medium ${A>=7?"bg-green-100 text-green-800":A>=6?"bg-yellow-100 text-yellow-800":A>=3?"bg-orange-100 text-orange-800":"bg-red-100 text-red-800"}`},A>=7?`ASPECTS ${A} = Favorable for EVT (most trials)`:A===6?"ASPECTS 6 = Standard EVT candidate; late window if perfusion mismatch or good collaterals":A>=3?`ASPECTS ${A} = Large core \u2014 EVT may benefit (SELECT2/ANGEL-ASPECT/RESCUE-Japan); discuss GOC with family`:`ASPECTS ${A} = Very large core, poor EVT candidate`)),React.createElement("details",{className:"bg-blue-50 border border-blue-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-blue-800 hover:bg-blue-100 rounded-lg"},"\u{1F9EE} Full ASPECTS Calculator (Click to expand)"),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"text-center mb-3"},React.createElement("span",{className:"text-3xl font-bold text-blue-600"},"ASPECTS: ",A)),React.createElement("div",{className:"space-y-2"},it.map(e=>React.createElement("label",{key:e.id,className:"flex items-center gap-2 p-2 hover:bg-blue-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",checked:e.checked,onChange:()=>{let a=it.map(i=>i.id===e.id?{...i,checked:!i.checked}:i);Ot(a),tt(a.filter(i=>i.checked).length)},className:"w-4 h-4"}),React.createElement("span",{className:"text-sm"},e.name)))))),React.createElement("details",{className:"bg-purple-50 border border-purple-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-purple-800 hover:bg-purple-100 rounded-lg"},"\u{1F9EE} PC-ASPECTS Calculator (Posterior Circulation)"),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-between items-center mb-3"},React.createElement("p",{className:"text-sm text-gray-700"},"Start at 10 points, subtract points for affected regions:"),React.createElement("div",{className:"text-center"},React.createElement("span",{className:"text-3xl font-bold text-purple-600"},"PC-ASPECTS: ",Rs(st)))),React.createElement("div",{className:"space-y-2"},st.map((e,a)=>React.createElement("label",{key:e.id,className:"flex items-center gap-2 p-2 hover:bg-purple-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",checked:e.checked,onChange:i=>{let s=[...st];s[a].checked=i.target.checked,Jt(s)},className:"w-4 h-4"}),React.createElement("span",{className:"text-sm flex-1"},e.name),React.createElement("span",{className:"text-xs font-semibold text-purple-700 bg-purple-100 px-2 py-1 rounded"},e.points," ",e.points===1?"point":"points")))))),React.createElement("div",{className:"bg-gray-50 p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"CTA Head & Neck"),React.createElement("div",{className:"grid grid-cols-2 gap-2 mb-2"},React.createElement("input",{type:"date",value:t.ctaDate,onChange:e=>r({...t,ctaDate:e.target.value}),className:"px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}),React.createElement("input",{type:"time",value:t.ctaTime,onChange:e=>r({...t,ctaTime:e.target.value}),placeholder:"Time reviewed",className:"px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})),React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("span",{className:"text-xs font-medium text-gray-600"},"CTA Results")),React.createElement("textarea",{value:t.ctaResults,onChange:e=>r({...t,ctaResults:e.target.value}),placeholder:"",rows:"3",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}),React.createElement("div",{className:"mt-3 p-2 bg-blue-50 border border-blue-200 rounded-lg"},React.createElement("p",{className:"text-xs font-semibold text-blue-800 mb-2"},"\u{1F52C} Vessel Occlusion ",React.createElement("span",{className:"font-normal"},"(for trial screening)")),React.createElement("div",{className:"flex flex-wrap gap-2"},["ICA","M1","M2","M3","M4","A1","A2","A3","P1","P2","P3"].map(e=>React.createElement("label",{key:e,className:"flex items-center gap-1 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:(t.vesselOcclusion||[]).includes(e),onChange:a=>{let i=t.vesselOcclusion||[],s=a.target.checked?[...i,e]:i.filter(o=>o!==e);r({...t,vesselOcclusion:s})},className:"w-3 h-3"}),React.createElement("span",{className:`text-xs px-2 py-0.5 rounded ${(t.vesselOcclusion||[]).includes(e)?"bg-blue-600 text-white font-semibold":"bg-gray-200 text-gray-700"}`},e))),(t.vesselOcclusion||[]).length===0&&React.createElement("span",{className:"text-xs text-gray-500 italic"},"None selected")))),React.createElement("div",{className:"bg-gray-50 p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"CT Perfusion"),React.createElement("textarea",{value:t.ctpResults,onChange:e=>r({...t,ctpResults:e.target.value}),placeholder:"",rows:"3",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})))),React.createElement("div",{id:"treatment-decision",ref:Ns,className:"bg-white border-2 border-orange-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-orange-900"},"6. Treatment Decision"),React.createElement("i",{"data-lucide":"zap",className:"w-5 h-5 text-orange-600"})),(()=>{let e=me(),a=e?e.total:null,i=parseInt(t.nihss)||h||0,s=A,o=parseInt(t.age)||0,c=Ni({telestrokeNote:t}).filter(l=>l.severity==="critical"),d={eligible:!1,reason:"",confidence:"low"},m={eligible:!1,reason:"",confidence:"low"};return c.length>0?d={eligible:!1,reason:"Absolute contraindication(s) present",confidence:"high"}:a?i<4&&!t.nihssDetails?d={eligible:!1,reason:`NIHSS ${i} - minor stroke, TNK not typically indicated`,confidence:"medium"}:a<=4.5?(i>=4||t.nihssDetails)&&(d={eligible:!0,reason:`Within 4.5h window, NIHSS ${i}`,confidence:"high"}):a>4.5&&a<=24?d={eligible:!0,reason:`Extended window (${a.toFixed(1)}h) \u2014 TNK may be given if perfusion mismatch present (TIMELESS criteria: core <70 mL, ratio >1.2). Obtain CTP/MRI.`,confidence:"medium"}:a>24&&(d={eligible:!1,reason:"Outside all TNK windows (>24h)",confidence:"high"}):d={eligible:!1,reason:"Set LKW time to evaluate",confidence:"low"},a?i>=6&&a<=24?s>=7&&a<=6?m={eligible:!0,reason:`Early window, NIHSS ${i}, ASPECTS ${s}`,confidence:"high"}:s>=6&&a>6&&a<=24?m={eligible:!0,reason:"Late window eligible (DAWN/DEFUSE criteria likely met)",confidence:"medium"}:s>=3&&a<=24?m={eligible:!0,reason:"Large core - may qualify under SELECT2/RESCUE-Japan",confidence:"medium"}:s<3&&(m={eligible:!1,reason:`ASPECTS ${s} too low for EVT`,confidence:"high"}):i<6?m={eligible:!1,reason:`NIHSS ${i} - consider if LVO present (STEP trial)`,confidence:"medium"}:a>24&&(m={eligible:!1,reason:"Outside EVT window (>24h)",confidence:"high"}):m={eligible:!1,reason:"Set LKW time to evaluate",confidence:"low"},!o&&!i&&!a?null:React.createElement("div",{className:"bg-gradient-to-r from-blue-50 to-green-50 border-2 border-blue-300 rounded-lg p-4 mb-4"},React.createElement("div",{className:"flex items-center gap-2 mb-3"},React.createElement("span",{className:"text-lg font-bold text-blue-900"},"Recommendation")),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:`p-3 rounded-lg border-2 ${d.eligible?"bg-green-100 border-green-400":d.confidence==="low"?"bg-gray-100 border-gray-300":"bg-red-50 border-red-300"}`},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("span",{className:"font-bold text-gray-800"},"TNK (Thrombolysis)"),d.eligible?React.createElement("span",{className:"px-2 py-1 bg-green-500 text-white text-xs font-bold rounded"},"CONSIDER"):d.confidence==="low"?React.createElement("span",{className:"px-2 py-1 bg-gray-400 text-white text-xs font-bold rounded"},"PENDING"):React.createElement("span",{className:"px-2 py-1 bg-red-500 text-white text-xs font-bold rounded"},"NOT INDICATED")),React.createElement("p",{className:"text-sm text-gray-700"},d.reason)),React.createElement("div",{className:`p-3 rounded-lg border-2 ${m.eligible?"bg-purple-100 border-purple-400":m.confidence==="low"?"bg-gray-100 border-gray-300":"bg-red-50 border-red-300"}`},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("span",{className:"font-bold text-gray-800"},"EVT (Thrombectomy)"),m.eligible?React.createElement("span",{className:"px-2 py-1 bg-purple-500 text-white text-xs font-bold rounded"},"CONSIDER"):m.confidence==="low"?React.createElement("span",{className:"px-2 py-1 bg-gray-400 text-white text-xs font-bold rounded"},"PENDING"):React.createElement("span",{className:"px-2 py-1 bg-red-500 text-white text-xs font-bold rounded"},"NOT INDICATED")),React.createElement("p",{className:"text-sm text-gray-700"},m.reason))))})(),(()=>{let e=Ni({telestrokeNote:t});if(e.length===0)return null;let a=e.filter(o=>o.severity==="critical"),i=e.filter(o=>o.severity==="warning"),s=e.filter(o=>o.severity==="info");return React.createElement("div",{className:"mb-3 space-y-2"},a.length>0&&React.createElement("div",{className:"bg-red-100 border-2 border-red-400 rounded-lg p-3"},React.createElement("div",{className:"flex items-center gap-2 mb-2"},React.createElement("span",{className:"text-red-700 font-bold"},"\u{1F6A8} CRITICAL CONTRAINDICATION",a.length>1?"S":"")),React.createElement("ul",{className:"space-y-1"},a.map((o,n)=>React.createElement("li",{key:n,className:"text-sm text-red-800 flex items-start gap-2"},React.createElement("span",{className:"text-red-500"},"\u2022"),React.createElement("span",null,React.createElement("strong",null,o.label,":")," ",o.message))))),i.length>0&&React.createElement("div",{className:"bg-amber-50 border-2 border-amber-400 rounded-lg p-3"},React.createElement("div",{className:"flex items-center gap-2 mb-2"},React.createElement("span",{className:"text-amber-700 font-bold"},"\u26A0\uFE0F CAUTION",i.length>1?"S":"")),React.createElement("ul",{className:"space-y-1"},i.map((o,n)=>React.createElement("li",{key:n,className:"text-sm text-amber-800 flex items-start gap-2"},React.createElement("span",{className:"text-amber-500"},"\u2022"),React.createElement("span",null,React.createElement("strong",null,o.label,":")," ",o.message))))),s.length>0&&React.createElement("div",{className:"bg-blue-50 border border-blue-300 rounded-lg p-2"},React.createElement("ul",{className:"space-y-1"},s.map((o,n)=>React.createElement("li",{key:n,className:"text-sm text-blue-800 flex items-start gap-2"},React.createElement("span",{className:"text-blue-500"},"\u2139\uFE0F"),React.createElement("span",null,o.message))))))})(),React.createElement("div",{className:"bg-slate-50 border border-slate-200 rounded-lg p-3"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("h4",{className:"text-sm font-semibold text-slate-700"},"Decision Log"),React.createElement("button",{type:"button",onClick:()=>{let e=prompt("Decision label (e.g., TNK held, transfer declined)");e&&lt(e.trim())},className:"text-xs font-semibold text-blue-700 hover:text-blue-900"},"Add timestamp")),(t.decisionLog||[]).length>0?React.createElement("ul",{className:"space-y-1 text-xs text-slate-700"},t.decisionLog.slice(0,6).map(e=>React.createElement("li",{key:e.id,className:"flex items-center justify-between"},React.createElement("span",{className:"font-medium"},e.label,e.detail?` \u2014 ${e.detail}`:""),React.createElement("span",{className:"text-slate-500"},e.time)))):React.createElement("p",{className:"text-xs text-slate-500"},"No decisions logged yet.")),React.createElement("div",{className:"space-y-3"},React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-2"},"Diagnosis"),React.createElement("div",{className:"flex flex-wrap gap-2 mb-2"},[{value:"ischemic",label:"Ischemic Stroke or TIA",color:"blue",icon:"activity"},{value:"ich",label:"Intracranial Hemorrhage",color:"red",icon:"alert-triangle"},{value:"sah",label:"SAH",color:"purple",icon:"zap"},{value:"cvt",label:"CVT",color:"indigo",icon:"git-branch"},{value:"mimic",label:"Stroke Mimic/Other",color:"amber",icon:"eye-off"}].map(e=>{let a=t.diagnosisCategory===e.value,i={blue:"bg-blue-500 text-white border-blue-500",red:"bg-red-500 text-white border-red-500",purple:"bg-purple-500 text-white border-purple-500",indigo:"bg-indigo-500 text-white border-indigo-500",amber:"bg-amber-500 text-white border-amber-500"};return React.createElement("button",{key:e.value,type:"button",onClick:()=>{let s=e.value,o="";s==="ischemic"?o="Suspected acute ischemic stroke":s==="ich"?o="Intracerebral hemorrhage (ICH)":s==="sah"?o="Subarachnoid hemorrhage (SAH)":s==="cvt"?o="Cerebral venous thrombosis (CVT)":s==="mimic"&&(o="Stroke mimic"),r({...t,diagnosisCategory:s,diagnosis:o})},className:`flex items-center gap-2 px-4 py-2 rounded-lg text-sm font-medium transition-all border-2 ${a?i[e.color]||"bg-gray-500 text-white border-gray-500":"bg-white text-gray-700 border-gray-300 hover:border-gray-400"}`},React.createElement("i",{"data-lucide":e.icon,className:"w-4 h-4"}),e.label)})),t.diagnosisCategory==="other"&&React.createElement("input",{type:"text",value:t.diagnosis,onChange:e=>r({...t,diagnosis:e.target.value}),placeholder:"Specify diagnosis...",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}),t.diagnosisCategory&&t.diagnosisCategory!=="other"&&React.createElement("div",{className:`px-3 py-2 rounded-lg text-sm ${t.diagnosisCategory==="ischemic"?"bg-blue-50 text-blue-800 border border-blue-200":t.diagnosisCategory==="ich"?"bg-red-50 text-red-800 border border-red-200":t.diagnosisCategory==="mimic"?"bg-amber-50 text-amber-800 border border-amber-200":"bg-gray-50 text-gray-800 border border-gray-200"}`},React.createElement("strong",null,"Dx:")," ",t.diagnosis),Ce&&t.diagnosisCategory==="ischemic"&&React.createElement("div",{className:"mt-3 text-sm"},React.createElement("div",{className:"font-medium text-gray-700 mb-1"},"Active Ischemic Stroke Trials:"),React.createElement("ul",{className:"text-gray-600 space-y-0.5 ml-4"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"SISTER")," \u2013 Late thrombolysis (4.5-24h), no TNK/EVT"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"STEP-EVT")," \u2013 Mild LVO or medium/distal vessel occlusions"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"PICASSO")," \u2013 Tandem lesion (carotid + intracranial LVO)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"TESTED")," \u2013 EVT in pre-existing disability (mRS 3-4)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"VERIFY")," \u2013 TMS/MRI to predict motor recovery"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"DISCOVERY")," \u2013 Cognitive trajectories post-stroke"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"ESUS Imaging")," \u2013 Cardiac/vessel wall MRI for ESUS"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"MOCHA Imaging")," \u2013 Intracranial vessel-wall analysis for ICAD"))),Ce&&t.diagnosisCategory==="ich"&&React.createElement("div",{className:"mt-3 text-sm"},React.createElement("div",{className:"font-medium text-gray-700 mb-1"},"Active ICH Trials:"),React.createElement("ul",{className:"text-gray-600 space-y-0.5 ml-4"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"FASTEST")," \u2013 rFVIIa within 2h for hematoma expansion"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"SATURN")," \u2013 Statin continuation vs stop after lobar ICH"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"ASPIRE")," \u2013 Apixaban vs aspirin post-ICH with AF"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"cAPPricorn-1")," \u2013 Intrathecal mivelsiran for CAA"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"MIRROR Registry")," \u2013 Minimally invasive ICH evacuation"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"DISCOVERY")," \u2013 Cognitive trajectories post-ICH")))),t.diagnosisCategory==="ich"&&React.createElement("div",{className:"bg-red-50 border border-red-300 rounded-lg p-3"},React.createElement("h4",{className:"text-sm font-bold text-red-800 mb-2 uppercase tracking-wide"},"ICH Pathway Checklist"),React.createElement("div",{className:"space-y-2"},[{field:"ichBPManaged",label:"BP managed (SBP 130-150 target)",detail:"AHA/ASA ICH 2022"},{field:"ichReversalOrdered",label:"Anticoag reversal ordered (if applicable)",detail:"Skip if no anticoagulants",skipIf:t.noAnticoagulants},{field:"ichNeurosurgeryConsulted",label:"Neurosurgery consulted/evaluated",detail:"Surgical candidacy assessed"}].filter(e=>!e.skipIf).map(e=>React.createElement("label",{key:e.field,className:"flex items-start gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:t[e.field]||!1,onChange:a=>r({...t,[e.field]:a.target.checked}),className:"mt-0.5 rounded border-red-300 text-red-600 focus:ring-red-500"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-medium text-red-900"},e.label),React.createElement("span",{className:"text-xs text-red-600 block"},e.detail)))))),Ce&&React.createElement("details",{className:"bg-green-50 border border-green-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-green-800 hover:bg-green-100 rounded-lg"},"\u2713 TNK Eligibility Criteria (Click to expand)"),React.createElement("div",{className:"p-4 space-y-3 text-sm"},React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-green-700 mb-2"},"Standard Window (\u22644.5h) \u2014 TNK 0.25 mg/kg IV bolus (max 25 mg):"),React.createElement("ul",{className:"space-y-1 ml-4"},React.createElement("li",null,"\u2022 Diagnosis of ischemic stroke causing measurable neurologic deficit"),React.createElement("li",null,"\u2022 Age \u226518 years"),React.createElement("li",null,"\u2022 Onset of symptoms <4.5 hours from LKW"),React.createElement("li",null,"\u2022 Class I, LOE A (AHA/ASA 2026)"))),React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-teal-700 mb-2"},"Extended Window (4.5-24h) \u2014 TIMELESS Criteria:"),React.createElement("ul",{className:"space-y-1 ml-4"},React.createElement("li",null,"\u2022 TNK 0.25 mg/kg IV bolus (max 25 mg) in 4.5-24h window"),React.createElement("li",null,"\u2022 Requires CT Perfusion or MRI DWI/perfusion"),React.createElement("li",null,"\u2022 Ischemic core <70 mL with mismatch ratio >1.2"),React.createElement("li",null,"\u2022 No hemorrhage on imaging"),React.createElement("li",null,"\u2022 Class IIa, LOE B-R (TIMELESS 2025, EXTEND, WAKE-UP)"))),React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-teal-700 mb-2"},"WAKE-UP Stroke:"),React.createElement("ul",{className:"space-y-1 ml-4"},React.createElement("li",null,"\u2022 LKW unclear + NO LVO"),React.createElement("li",null,"\u2022 MRI with DWI-FLAIR mismatch (DWI+, FLAIR-)"),React.createElement("li",null,"\u2022 TNK 0.25 mg/kg IV bolus (max 25 mg)"),React.createElement("li",null,"\u2022 Discuss lower certainty of benefit and hemorrhage risk"))),React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-amber-700 mb-2"},"2026 Relaxed Contraindication Notes:"),React.createElement("ul",{className:"space-y-1 ml-4"},React.createElement("li",null,"\u2022 Pregnancy is a relative (not absolute) contraindication \u2014 consult OB/GYN"),React.createElement("li",null,"\u2022 Prior stroke <90 days: relative CI; weigh severity of current vs prior"),React.createElement("li",null,"\u2022 Extra-axial intracranial neoplasm: NOT a contraindication"),React.createElement("li",null,"\u2022 Seizure at onset: may treat if deficit clearly from stroke, not postictal"),React.createElement("li",null,"\u2022 Lecanemab / anti-amyloid therapy: relative CI due to ARIA risk"),React.createElement("li",null,"\u2022 DOAC within 48h: check drug-specific assay; if below threshold, may treat"))))),(()=>{let e=t.tnkContraindicationChecklist||{},a=[{id:"currentICH",label:"CT with evidence of hemorrhage",note:null},{id:"extensiveHypoattenuation",label:"CT with extensive regions of clear hypoattenuation",note:null},{id:"largeInfarct",label:"Ischemic injury >1/3 of MCA territory",note:null},{id:"intracranialTumor",label:"Intra-axial intracranial tumor",note:"extra-axial not absolute"},{id:"aorticDissection",label:"Aortic arch dissection",note:null},{id:"recentStroke",label:"Recent stroke",note:"<90 days"},{id:"recentHeadTrauma",label:"Recent severe head trauma",note:"<90 days"},{id:"recentIntracranialSurgery",label:"Recent intracranial/intraspinal surgery",note:"<60 days"},{id:"activeInternalBleeding",label:"Active internal bleeding",note:null},{id:"giMalignancy",label:"GI malignancy",note:null},{id:"sahPresentation",label:"Clinical presentation suggestive of SAH",note:"even if CT normal"},{id:"infectiveEndocarditis",label:"Presentation consistent with infective endocarditis",note:null},{id:"severeUncontrolledHTN",label:"SBP >185 or DBP >110 mmHg",note:"unresponsive to treatment"},{id:"lowPlatelets",label:"Platelet count <100,000",note:null},{id:"lowGlucose",label:"Blood glucose <50 mg/dL",note:null},{id:"warfarinElevatedINR",label:"Warfarin use with PT >15s, INR >1.7, or aPTT >40s",note:null},{id:"recentDOAC",label:"Recent DOAC use",note:"<48h"},{id:"recentHeparin",label:"Treatment-dose heparin/LMWH",note:"<24 hours"}],i=[{id:"priorICH",label:"Prior known non-traumatic intracranial hemorrhage",note:null},{id:"vascularMalformation",label:"Intracranial vascular malformation",note:"unless severe neuro sx"},{id:"intracranialAneurysm",label:"Intracranial aneurysm",note:null},{id:"knownBleedingDiathesis",label:"Known bleeding diathesis",note:null},{id:"pregnancy",label:"Pregnancy",note:"consult OB/GYN ASAP"},{id:"recentMajorSurgery",label:"Major extracranial surgery or trauma",note:"<14 days"},{id:"recentGIGUBleeding",label:"Recent GI/urinary tract hemorrhage",note:"<21 days"},{id:"recentMI",label:"Acute or recent MI",note:"<3 months, depends on type"},{id:"acutePericarditis",label:"Acute pericarditis",note:null},{id:"recentArterialPuncture",label:"Recent arterial puncture at non-compressible site",note:"<7 days"},{id:"recentLumbarPuncture",label:"Recent lumbar puncture",note:"<7 days"},{id:"seizureAtOnset",label:"Seizure at onset with postictal deficits",note:"consider stroke mimic"},{id:"abnormalCoagUnknown",label:"Abnormal aPTT, TT, or anti-Xa with unknown anticoagulant use",note:null},{id:"cerebralMicrobleeds",label:"Cerebral microbleeds >10 on prior MRI",note:"increased ICH risk"},{id:"lecanemab",label:"Lecanemab or other Alzheimer medications",note:"ARIA risk"},{id:"highGlucose",label:"Blood glucose >400 mg/dL",note:"correct before treatment"},{id:"severeRenalFailure",label:"Severe renal failure (Cr >3 or CrCl <25)",note:"increased bleeding risk"}],s={},o=parseFloat(t.glucose);!isNaN(o)&&o<50&&(s.lowGlucose=!0),!isNaN(o)&&o>400&&(s.highGlucose=!0);let n=parseFloat(t.inr);!isNaN(n)&&n>1.7&&(s.warfarinElevatedINR=!0);let c=parseFloat(t.ptt);!isNaN(c)&&c>40&&(s.warfarinElevatedINR=!0);let d=parseFloat(t.plateletCount);!isNaN(d)&&d<1e5&&(s.lowPlatelets=!0);let l=(t.presentingBP||"").match(/(\d+)\s*\/\s*(\d+)/);l&&(parseInt(l[1])>185||parseInt(l[2])>110)&&(s.severeUncontrolledHTN=!0),t.lastDOACType&&t.lastDOACType!==""&&t.lastDOACType!=="none"&&t.lastDOACType!=="warfarin"&&t.lastDOACType!=="heparin"&&(t.lastDOACDose?(new Date-new Date(t.lastDOACDose))/36e5<48&&(s.recentDOAC=!0):s.recentDOAC=!0),t.lastDOACType==="heparin"&&(t.lastDOACDose?(new Date-new Date(t.lastDOACDose))/36e5<24&&(s.recentHeparin=!0):s.recentHeparin=!0),t.lastDOACType==="warfarin"&&!isNaN(n)&&n>1.7&&(s.warfarinElevatedINR=!0);let C=parseFloat(t.creatinine),k=xt(t.age,t.weight,t.sex,t.creatinine);(!isNaN(C)&&C>3||k&&k.value<25)&&(s.severeRenalFailure=!0),t.pregnancyStroke&&(s.pregnancy=!0);let I=(t.medications||"").toLowerCase();/warfarin|coumadin|jantoven/.test(I)&&!isNaN(n)&&n>1.7&&(s.warfarinElevatedINR=!0),/apixaban|eliquis|rivaroxaban|xarelto|dabigatran|pradaxa|edoxaban|savaysa/.test(I)&&(s.recentDOAC=!0),/enoxaparin|lovenox|heparin/.test(I)&&(s.recentHeparin=!0);let S=a.filter(v=>e[v.id]||s[v.id]),H=i.filter(v=>e[v.id]||s[v.id]),f,U,V;S.length>0?(f="bg-red-500 text-white",U="Absolute CI ("+S.length+")",V="X"):H.length>0?(f="bg-amber-500 text-white",U=H.length+" relative",V="!"):t.tnkContraindicationReviewed?(f="bg-green-500 text-white",U="No contraindications",V="check"):(f="bg-gray-400 text-white",U="Not reviewed",V="?");let ae=(v,B)=>r({...t,tnkContraindicationChecklist:{...t.tnkContraindicationChecklist,[v]:B}}),N=()=>{let v={};[...a,...i].forEach(B=>{v[B.id]=!1}),r({...t,tnkContraindicationChecklist:v,tnkContraindicationReviewed:!0,tnkContraindicationReviewTime:new Date().toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}),tnkRecommended:!0})},ge=Object.keys(s),te=a.filter(v=>s[v.id]),K=i.filter(v=>s[v.id]);return React.createElement(React.Fragment,null,te.length>0&&React.createElement("div",{className:"bg-red-100 border-2 border-red-400 rounded-lg p-3 animate-pulse"},React.createElement("div",{className:"flex items-center gap-2 mb-1"},React.createElement("span",{className:"bg-red-600 text-white px-2 py-0.5 rounded text-xs font-bold"},"AUTO-DETECTED"),React.createElement("span",{className:"text-sm font-bold text-red-900"},"TNK Contraindication",te.length>1?"s":""," Found From Patient Data")),React.createElement("ul",{className:"text-xs text-red-800 space-y-0.5 ml-2"},te.map(v=>React.createElement("li",{key:v.id},"\u2717 ",React.createElement("strong",null,v.label),v.note?` (${v.note})`:"")))),te.length===0&&K.length>0&&React.createElement("div",{className:"bg-amber-100 border-2 border-amber-400 rounded-lg p-3"},React.createElement("div",{className:"flex items-center gap-2 mb-1"},React.createElement("span",{className:"bg-amber-500 text-white px-2 py-0.5 rounded text-xs font-bold"},"AUTO-DETECTED"),React.createElement("span",{className:"text-sm font-bold text-amber-900"},K.length," Relative Contraindication",K.length>1?"s":""," \u2014 Use Clinical Judgment")),React.createElement("ul",{className:"text-xs text-amber-800 space-y-0.5 ml-2"},K.map(v=>React.createElement("li",{key:v.id},"\u26A0 ",v.label,v.note?` (${v.note})`:"")))),React.createElement("details",{id:"tnk-contraindications",className:"bg-gradient-to-r from-orange-50 to-red-50 border-2 border-orange-300 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-orange-900 hover:bg-orange-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"TNK Contraindications"),React.createElement("span",{className:"px-3 py-1 rounded-full text-xs font-bold "+f},V==="check"&&React.createElement("span",null,"\u2713 "),V==="!"&&React.createElement("span",null,"\u26A0 "),V==="X"&&React.createElement("span",null,"\u2717 "),U)),React.createElement("div",{className:"p-4 space-y-4"},S.length>0&&React.createElement("div",{className:"bg-red-50 border border-red-300 rounded-lg p-3 text-sm text-red-800"},React.createElement("strong",null,"Absolute contraindications detected.")," TNK should not be given unless these are ruled out or overridden."),t.tnkRecommended&&S.length>0&&React.createElement("div",{className:"bg-red-100 border border-red-300 rounded-lg p-3 text-sm text-red-800"},React.createElement("strong",null,"Warning:")," TNK is marked recommended while absolute contraindications are present."),React.createElement("div",{className:"flex flex-wrap items-center justify-between gap-2 bg-white border border-orange-200 rounded-lg px-3 py-2"},React.createElement("div",{className:"text-sm text-orange-800"},React.createElement("strong",null,"Review status:")," ",t.tnkContraindicationReviewed?`Reviewed at ${t.tnkContraindicationReviewTime||"\u2014"}`:"Not reviewed"),React.createElement("button",{type:"button",onClick:()=>r({...t,tnkContraindicationReviewed:!0,tnkContraindicationReviewTime:new Date().toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"})}),className:"px-3 py-1.5 bg-orange-600 text-white rounded-lg text-xs font-semibold hover:bg-orange-700"},"Mark Reviewed")),React.createElement("div",{className:"bg-red-100 border border-red-300 rounded-lg p-3"},React.createElement("h4",{className:"font-bold text-red-800 mb-3 flex items-center gap-2"},React.createElement("span",{className:"bg-red-600 text-white px-2 py-0.5 rounded text-xs"},"ABSOLUTE"),"Contraindications - TNK is contraindicated if ANY checked"),React.createElement("div",{className:"space-y-2"},a.map(v=>{let B=s[v.id],se=e[v.id]||B;return React.createElement("label",{key:v.id,className:"flex items-start gap-2 p-2 rounded cursor-pointer transition "+(se?"bg-red-200":"hover:bg-red-50")},React.createElement("input",{type:"checkbox",checked:se,onChange:ce=>ae(v.id,ce.target.checked),className:"w-4 h-4 mt-0.5 accent-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("span",{className:"text-sm "+(se?"text-red-900 font-semibold":"text-gray-800")},v.label),v.note&&React.createElement("span",{className:"text-xs text-red-600 ml-1"},"(",v.note,")"),B&&React.createElement("span",{className:"ml-2 text-xs bg-red-500 text-white px-1.5 py-0.5 rounded"},"Auto-detected")))}))),React.createElement("div",{className:"bg-amber-50 border border-amber-300 rounded-lg p-3"},React.createElement("h4",{className:"font-bold text-amber-800 mb-3 flex items-center gap-2"},React.createElement("span",{className:"bg-amber-500 text-white px-2 py-0.5 rounded text-xs"},"RELATIVE"),"Contraindications - Use clinical judgment"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-2"},i.map(v=>{let B=s[v.id],se=e[v.id]||B;return React.createElement("label",{key:v.id,className:"flex items-start gap-2 p-2 rounded cursor-pointer transition "+(se?"bg-amber-200":"hover:bg-amber-100")},React.createElement("input",{type:"checkbox",checked:se,onChange:ce=>ae(v.id,ce.target.checked),className:"w-4 h-4 mt-0.5 accent-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("span",{className:"text-sm "+(se?"text-amber-900 font-semibold":"text-gray-800")},v.label),v.note&&React.createElement("span",{className:"text-xs text-amber-600 block"},"(",v.note,")"),B&&React.createElement("span",{className:"ml-2 text-xs bg-amber-500 text-white px-1.5 py-0.5 rounded"},"Auto-detected")))}))),React.createElement("div",{className:"flex items-center justify-between pt-2 border-t border-orange-200"},React.createElement("div",{className:"text-sm text-gray-600"},t.tnkContraindicationReviewed&&React.createElement("span",{className:"text-green-700"},"Reviewed at ",t.tnkContraindicationReviewTime)),React.createElement("div",{className:"flex gap-2"},S.length===0&&React.createElement("button",{onClick:N,className:"px-4 py-2 bg-green-600 text-white rounded-lg font-semibold hover:bg-green-700 transition flex items-center gap-2"},React.createElement("span",null,"\u2713")," All reviewed - Proceed with TNK"),S.length>0&&React.createElement("div",{className:"px-4 py-2 bg-red-100 text-red-800 rounded-lg font-semibold border border-red-300"},"\u2717 TNK Contraindicated - ",S.length," absolute CI",S.length>1?"s":""))))))})(),React.createElement("label",{className:"flex items-center gap-2 text-sm font-medium text-gray-700"},React.createElement("input",{type:"checkbox",checked:t.tnkRecommended,onChange:e=>r({...t,tnkRecommended:e.target.checked}),className:"w-4 h-4"}),"TNK Recommended"),t.tnkRecommended&&React.createElement("div",{className:"bg-green-50 border border-green-200 rounded-lg p-3 space-y-3"},React.createElement("div",{className:"bg-white border border-green-300 rounded-lg p-3 space-y-2"},React.createElement("div",{className:"flex items-center justify-between"},React.createElement("span",{className:"text-sm font-semibold text-green-800"},"\u{1F489} TNK Dosing Calculator"),React.createElement("span",{className:"text-xs text-gray-500"},"0.25 mg/kg, max 25 mg")),React.createElement("div",{className:"flex items-center gap-3"},React.createElement("label",{className:"text-sm text-gray-700"},"Weight:"),React.createElement("input",{type:"number",value:t.weight,onChange:e=>r({...t,weight:e.target.value}),placeholder:"kg",className:"w-20 px-2 py-1 border border-gray-300 rounded text-sm",min:"0",step:"0.1"}),React.createElement("span",{className:"text-xs text-gray-500"},"kg")),(()=>{let e=Xe(t.weight);if(!e)return React.createElement("div",{className:"text-sm text-amber-600 bg-amber-50 px-3 py-2 rounded-lg border border-amber-200"},"\u26A0\uFE0F Enter patient weight to calculate TNK dose");let a=(parseFloat(e.calculatedDose)/5).toFixed(1);return React.createElement("div",{className:`rounded-xl shadow-lg overflow-hidden ${e.isMaxDose?"ring-2 ring-amber-400":"ring-2 ring-green-400"}`},React.createElement("div",{className:`px-4 py-2 ${e.isMaxDose?"bg-gradient-to-r from-amber-500 to-amber-600":"bg-gradient-to-r from-green-500 to-emerald-600"}`},React.createElement("div",{className:"flex items-center justify-between"},React.createElement("span",{className:"text-white font-bold text-lg flex items-center gap-2"},React.createElement("span",{className:"text-2xl"},"\u{1F489}"),"TNK DOSING"),e.isMaxDose&&React.createElement("span",{className:"bg-white/20 text-white px-3 py-1 rounded-full text-xs font-bold uppercase tracking-wide"},"MAX DOSE"))),React.createElement("div",{className:`px-4 py-4 ${e.isMaxDose?"bg-gradient-to-br from-amber-50 to-amber-100":"bg-gradient-to-br from-green-50 to-emerald-100"}`},React.createElement("div",{className:"grid grid-cols-3 gap-3 text-center"},React.createElement("div",{className:`p-3 rounded-lg ${e.isMaxDose?"bg-amber-200/50":"bg-green-200/50"}`},React.createElement("div",{className:"text-3xl font-black text-gray-900"},e.calculatedDose),React.createElement("div",{className:"text-sm font-medium text-gray-600"},"mg")),React.createElement("div",{className:`p-3 rounded-lg ${e.isMaxDose?"bg-amber-200/50":"bg-green-200/50"}`},React.createElement("div",{className:"text-3xl font-black text-gray-900"},a),React.createElement("div",{className:"text-sm font-medium text-gray-600"},"mL")),React.createElement("div",{className:`p-3 rounded-lg ${e.isMaxDose?"bg-amber-200/50":"bg-green-200/50"}`},React.createElement("div",{className:"text-3xl font-black text-gray-900"},e.weightKg),React.createElement("div",{className:"text-sm font-medium text-gray-600"},"kg"))),React.createElement("div",{className:"text-xs text-gray-500 text-center mt-2"},e.weightKg," kg \xD7 0.25 mg/kg = ",(e.weightKg*.25).toFixed(1)," mg",e.isMaxDose&&" \u2192 capped at 25 mg max"),React.createElement("div",{className:"text-xs text-gray-400 text-center mt-1"},"Reconstitute: 50mg vial + 10mL sterile water = 5 mg/mL")))})()),React.createElement("label",{className:"flex items-center gap-2 text-sm font-medium text-gray-700"},React.createElement("input",{type:"checkbox",checked:t.tnkConsentDiscussed,onChange:e=>r({...t,tnkConsentDiscussed:e.target.checked}),className:"w-4 h-4"}),"Risks/benefits discussed with patient and family"),t.tnkConsentDiscussed&&React.createElement("div",{className:"bg-white border border-purple-200 rounded-lg p-3 space-y-2"},React.createElement("p",{className:"text-sm text-gray-700"},`We recommend a medication called Tenecteplase (TNK), which is a "clot-buster" drug. TNK reduces the risk of being disabled; people who get TNK have an improved chance of recovering without disability than people who don't get the medication. All medications have risks \u2013 the main risk is bleeding, up to 4% of people develop bleeding in the brain that leads to new symptoms. Very rarely, people have an allergic reaction. The potential benefits are thought to be higher than the potential risks and we recommend TNK is administered. Time is very important here - the sooner the treatment is started, the higher the likelihood of benefit.`),React.createElement("div",{className:"mt-3 space-y-2"},React.createElement("label",{className:"flex items-center gap-2 text-sm font-medium text-gray-700"},React.createElement("input",{type:"checkbox",checked:t.patientFamilyConsent,onChange:e=>r({...t,patientFamilyConsent:e.target.checked}),className:"w-4 h-4"}),"Patient/family provides consent"),React.createElement("label",{className:"flex items-center gap-2 text-sm font-medium text-gray-700"},React.createElement("input",{type:"checkbox",checked:t.presumedConsent,onChange:e=>r({...t,presumedConsent:e.target.checked}),className:"w-4 h-4"}),"Presumed consent"),React.createElement("label",{className:"flex items-center gap-2 text-sm font-medium text-gray-700"},React.createElement("input",{type:"checkbox",checked:t.preTNKSafetyPause,onChange:e=>r({...t,preTNKSafetyPause:e.target.checked}),className:"w-4 h-4"}),"Pre-TNK safety pause completed"))),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"TNK Administration Time"),React.createElement("input",{type:"time",value:t.tnkAdminTime,onChange:e=>r({...t,tnkAdminTime:e.target.value}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}))),React.createElement("details",{id:"time-metrics-section",className:"bg-purple-50 border-2 border-purple-300 rounded-lg",open:t.tnkRecommended},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-purple-800 hover:bg-purple-100 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"timer",className:"w-4 h-4"}),"Time Metrics (DTN Tracker)"),(()=>{let e=Oa();if(e.doorToNeedle!==null){let a=La(e.doorToNeedle);return React.createElement("span",{className:`px-2 py-1 rounded text-xs font-bold ${a.color==="green"?"bg-green-500 text-white":a.color==="yellow"?"bg-yellow-500 text-white":"bg-red-500 text-white"}`},"DTN: ",e.doorToNeedle," min")}return null})()),React.createElement("div",{className:"p-4 space-y-4"},React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"bg-white p-3 rounded-lg border border-purple-200"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-medium text-gray-700"},"ED Arrival (Door)"),React.createElement("button",{type:"button",onClick:()=>r({...t,dtnEdArrival:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 bg-purple-600 text-white text-xs rounded hover:bg-purple-700 transition-colors"},"Now")),React.createElement("input",{type:"datetime-local",value:t.dtnEdArrival||"",onChange:e=>r({...t,dtnEdArrival:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",{className:"bg-white p-3 rounded-lg border border-purple-200"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-medium text-gray-700"},"Stroke Alert Called"),React.createElement("button",{type:"button",onClick:()=>r({...t,dtnStrokeAlert:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 bg-purple-600 text-white text-xs rounded hover:bg-purple-700 transition-colors"},"Now")),React.createElement("input",{type:"datetime-local",value:t.dtnStrokeAlert||"",onChange:e=>r({...t,dtnStrokeAlert:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",{className:"bg-white p-3 rounded-lg border border-purple-200"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-medium text-gray-700"},"CT Scan Started"),React.createElement("button",{type:"button",onClick:()=>r({...t,dtnCtStarted:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 bg-purple-600 text-white text-xs rounded hover:bg-purple-700 transition-colors"},"Now")),React.createElement("input",{type:"datetime-local",value:t.dtnCtStarted||"",onChange:e=>r({...t,dtnCtStarted:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",{className:"bg-white p-3 rounded-lg border border-purple-200"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-medium text-gray-700"},"CT Read/Cleared for TNK"),React.createElement("button",{type:"button",onClick:()=>r({...t,dtnCtRead:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 bg-purple-600 text-white text-xs rounded hover:bg-purple-700 transition-colors"},"Now")),React.createElement("input",{type:"datetime-local",value:t.dtnCtRead||"",onChange:e=>r({...t,dtnCtRead:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",{className:"bg-white p-3 rounded-lg border border-purple-200"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-medium text-gray-700"},"TNK Ordered"),React.createElement("button",{type:"button",onClick:()=>r({...t,dtnTnkOrdered:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 bg-purple-600 text-white text-xs rounded hover:bg-purple-700 transition-colors"},"Now")),React.createElement("input",{type:"datetime-local",value:t.dtnTnkOrdered||"",onChange:e=>r({...t,dtnTnkOrdered:e.target.value}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm focus:ring-2 focus:ring-purple-500"})),React.createElement("div",{className:"bg-white p-3 rounded-lg border-2 border-green-400"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("label",{className:"text-sm font-bold text-green-700"},"TNK Administered (Needle)"),React.createElement("button",{type:"button",onClick:()=>r({...t,dtnTnkAdministered:new Date().toISOString().slice(0,16)}),className:"px-2 py-1 bg-green-600 text-white text-xs rounded hover:bg-green-700 transition-colors"},"Now")),React.createElement("input",{type:"datetime-local",value:t.dtnTnkAdministered||"",onChange:e=>r({...t,dtnTnkAdministered:e.target.value}),className:"w-full px-2 py-1 border border-green-300 rounded text-sm focus:ring-2 focus:ring-green-500"}))),(()=>{let e=Oa();return e.doorToCT!==null||e.doorToNeedle!==null||e.ctToNeedle!==null?React.createElement("div",{className:"bg-gradient-to-r from-purple-100 to-blue-100 rounded-lg p-4 border-2 border-purple-300"},React.createElement("h5",{className:"font-bold text-purple-900 mb-3 flex items-center gap-2"},React.createElement("i",{"data-lucide":"bar-chart-2",className:"w-4 h-4"}),"Calculated Intervals"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("div",{className:"bg-white p-3 rounded-lg border border-blue-200 text-center"},React.createElement("p",{className:"text-xs text-gray-600 mb-1"},"Door-to-CT"),React.createElement("p",{className:"text-2xl font-bold text-blue-600"},e.doorToCT!==null?`${e.doorToCT} min`:"--"),React.createElement("p",{className:"text-xs text-gray-500"},"Target: <25 min")),e.doorToNeedle!==null&&(()=>{let i=La(e.doorToNeedle);return React.createElement("div",{className:`p-3 rounded-lg border-2 text-center ${i.color==="green"?"bg-green-100 border-green-500":i.color==="yellow"?"bg-yellow-100 border-yellow-500":"bg-red-100 border-red-500"}`},React.createElement("p",{className:"text-xs text-gray-700 mb-1 font-semibold"},"Door-to-Needle (DTN)"),React.createElement("p",{className:`text-3xl font-bold ${i.color==="green"?"text-green-700":i.color==="yellow"?"text-yellow-700":"text-red-700"}`},e.doorToNeedle," min"),React.createElement("p",{className:`text-sm font-semibold ${i.color==="green"?"text-green-600":i.color==="yellow"?"text-yellow-600":"text-red-600"}`},i.label),i.delta!==0&&React.createElement("p",{className:"text-xs text-gray-600 mt-1"},i.delta>0?`+${i.delta} min over ${i.target} min target`:`${Math.abs(i.delta)} min under target`))})(),e.doorToNeedle===null&&React.createElement("div",{className:"bg-white p-3 rounded-lg border border-gray-200 text-center"},React.createElement("p",{className:"text-xs text-gray-600 mb-1"},"Door-to-Needle (DTN)"),React.createElement("p",{className:"text-2xl font-bold text-gray-400"},"--"),React.createElement("p",{className:"text-xs text-gray-500"},"Target: <45 min")),React.createElement("div",{className:"bg-white p-3 rounded-lg border border-blue-200 text-center"},React.createElement("p",{className:"text-xs text-gray-600 mb-1"},"CT-to-Needle"),React.createElement("p",{className:"text-2xl font-bold text-blue-600"},e.ctToNeedle!==null?`${e.ctToNeedle} min`:"--"),React.createElement("p",{className:"text-xs text-gray-500"},"Target: <20 min"))),React.createElement("div",{className:"mt-3 pt-3 border-t border-purple-200"},React.createElement("p",{className:"text-xs text-gray-600 text-center"},"DTN Benchmarks:",React.createElement("span",{className:"ml-2 px-2 py-0.5 bg-green-500 text-white rounded"},"\u226445 min = Excellent"),React.createElement("span",{className:"ml-1 px-2 py-0.5 bg-yellow-500 text-white rounded"},"46-60 min = Good"),React.createElement("span",{className:"ml-1 px-2 py-0.5 bg-red-500 text-white rounded"},">60 min = Needs Improvement")))):React.createElement("div",{className:"text-center text-gray-500 text-sm py-2"},"Enter timestamps above to calculate time metrics")})())),React.createElement("details",{className:"bg-blue-50 border border-blue-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-blue-800 hover:bg-blue-100 rounded-lg"},"\u{1F527} EVT Eligibility Criteria (Click to expand)"),React.createElement("div",{className:"p-4 space-y-3 text-sm"},React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-blue-700 mb-2"},"Basilar Artery Occlusion:"),React.createElement("ul",{className:"space-y-1 ml-4"},React.createElement("li",null,"\u2022 Last known well \u226424 hours"),React.createElement("li",null,"\u2022 NIHSS score \u226510"),React.createElement("li",null,"\u2022 pc-ASPECTS \u22656"))),React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-green-700 mb-2"},"Anterior Circulation Large Vessel Occlusion:"),React.createElement("p",{className:"text-xs text-gray-600 mb-2"},"Trial evidence principally supports efficacy among adults \u226560 years of age, baseline mRS 0-1, NIHSS\u22656 with disabling symptoms"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 mt-2"},React.createElement("div",{className:"bg-white p-2 rounded border"},React.createElement("p",{className:"font-semibold text-green-700 text-xs mb-1"},"Early Window (0-6h):"),React.createElement("ul",{className:"space-y-1 ml-2 text-xs"},React.createElement("li",null,"\u2022 ASPECTS 3-10: Generally eligible for EVT"),React.createElement("li",null,"\u2022 ASPECTS 0-2: Consider in very select cases; Consider CTP to evaluate if estimated core volume is <70-100cc"))),React.createElement("div",{className:"bg-white p-2 rounded border"},React.createElement("p",{className:"font-semibold text-purple-700 text-xs mb-1"},"Late Window (6-24h):"),React.createElement("ul",{className:"space-y-1 ml-2 text-xs"},React.createElement("li",null,"\u2022 ASPECTS 6-10: Generally eligible for EVT"),React.createElement("li",null,"\u2022 ASPECTS 3-5: Generally eligible; Consider CTP to evaluate if estimated core volume is \u2264100cc + mismatch is present"),React.createElement("li",null,"\u2022 ASPECTS 0-2: EVT benefit is unclear"))))),React.createElement("div",null,React.createElement("h4",{className:"font-semibold text-orange-700 mb-2"},"Medium Vessel Occlusion:"),React.createElement("ul",{className:"space-y-1 ml-4"},React.createElement("li",null,"\u2022 Consider in select cases of proximal or dominant M2 segment MCA occlusion within \u22641cm of bifurcation in horizontal segment when there is evidence of salvageable tissue + last known well is \u226424 hours"),React.createElement("li",null,"\u2022 Not recommended for M2-M4 MCA, ACA, and PCA occlusions"))))),React.createElement("label",{className:"flex items-center gap-2 text-sm font-medium text-gray-700"},React.createElement("input",{type:"checkbox",checked:t.evtRecommended,onChange:e=>r({...t,evtRecommended:e.target.checked}),className:"w-4 h-4"}),"EVT Recommended"),React.createElement("div",null,React.createElement("div",{className:"flex flex-wrap items-center justify-between gap-2 mb-1"},React.createElement("label",{className:"block text-sm font-medium text-gray-700"},"Rationale for Recommendation")),React.createElement("textarea",{value:t.rationale,onChange:e=>r({...t,rationale:e.target.value}),placeholder:"",rows:"3",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"})))),(()=>{let e=$a();if(e.length===0)return null;let a={};e.forEach(s=>{a[s.category]||(a[s.category]=[]),a[s.category].push(s)});let i={I:"bg-green-600 text-white",IIa:"bg-blue-500 text-white",IIb:"bg-amber-500 text-white",III:"bg-red-600 text-white"};return React.createElement("div",{className:"bg-white border-2 border-indigo-300 rounded-lg shadow-md"},React.createElement("details",{open:ds,onToggle:s=>ii(s.target.open)},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-indigo-900 hover:bg-indigo-50 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"book-open",className:"w-5 h-5 text-indigo-600"}),"Guideline Recommendations (",e.length,")"),React.createElement("span",{className:"text-xs text-indigo-500 font-normal"},"Evidence-based, auto-matched to patient data")),React.createElement("div",{className:"p-4 pt-0 space-y-4"},Object.entries(a).map(([s,o])=>React.createElement("div",{key:s},React.createElement("h4",{className:"text-sm font-bold text-indigo-800 uppercase tracking-wide mb-2 border-b border-indigo-100 pb-1"},s),React.createElement("div",{className:"space-y-2"},o.map(n=>React.createElement("div",{key:n.id,className:"bg-indigo-50/50 border border-indigo-100 rounded-lg p-3"},React.createElement("div",{className:"flex items-start gap-2"},React.createElement("span",{className:`inline-flex items-center px-1.5 py-0.5 rounded text-xs font-bold shrink-0 ${i[n.classOfRec]||"bg-gray-500 text-white"}`},n.classOfRec,"/",n.levelOfEvidence),React.createElement("div",{className:"flex-1 min-w-0"},React.createElement("p",{className:"text-sm font-semibold text-gray-900"},n.title),React.createElement("p",{className:"text-sm text-gray-700 mt-0.5"},n.recommendation),n.medications&&n.medications.length>0&&React.createElement("div",{className:"mt-1.5 flex flex-wrap gap-1"},n.medications.map((c,d)=>React.createElement("span",{key:d,className:"inline-block px-2 py-0.5 bg-white border border-indigo-200 rounded text-xs text-indigo-800"},c))),n.caveats&&React.createElement("p",{className:"text-xs text-amber-700 mt-1 italic"},n.caveats),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},n.guideline)))))))))))})(),(()=>{if(Object.keys(Le).length===0)return null;let a=Object.values(Qt).filter(Boolean);if(a.length===0)return null;let i=a.filter(d=>d.status==="eligible"),s=a.filter(d=>d.status==="needs_info"),o=a.filter(d=>d.status==="not_eligible"),n=[...i,...s,...o],c=i.length>0||s.length>0;return React.createElement("details",{className:"border-2 rounded-lg "+(i.length>0?"bg-green-50 border-green-300":s.length>0?"bg-purple-50 border-purple-300":"bg-gray-50 border-gray-300"),open:c},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold hover:bg-opacity-70 rounded-lg flex items-center justify-between"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"flask-conical",className:"w-5 h-5 text-purple-600"}),React.createElement("span",{className:i.length>0?"text-green-900":"text-purple-900"},"Trial Eligibility Auto-Matcher")),React.createElement("div",{className:"flex items-center gap-2"},i.length>0&&React.createElement("span",{className:"px-2 py-0.5 bg-green-600 text-white rounded-full text-xs font-bold"},i.length," eligible"),s.length>0&&React.createElement("span",{className:"px-2 py-0.5 bg-amber-500 text-white rounded-full text-xs font-bold"},s.length," needs info"),o.length>0&&React.createElement("span",{className:"px-2 py-0.5 bg-gray-400 text-white rounded-full text-xs font-bold"},o.length," not eligible"))),React.createElement("div",{className:"p-3 space-y-2"},React.createElement("p",{className:"text-xs text-gray-600 mb-2"},"Auto-compared against patient data (age, NIHSS, LKW, imaging, diagnosis). Criteria update in real-time as you enter data."),n.map(d=>{let m=Le[d.trialId];if(!m)return null;let l=d.status==="eligible"?"border-green-400 bg-green-50":d.status==="needs_info"?"border-amber-400 bg-amber-50":"border-gray-300 bg-gray-50",C=d.status==="eligible"?"bg-green-600 text-white":d.status==="needs_info"?"bg-amber-500 text-white":"bg-gray-400 text-white",k=d.status==="eligible"?"&#10003; Eligible":d.status==="needs_info"?"? Needs Info":"&#10007; Not Eligible",I=d.criteria.filter(f=>f.status==="unknown"),S=d.criteria.filter(f=>f.status==="met"),H=d.criteria.filter(f=>f.status==="not_met");return React.createElement("details",{key:d.trialId,className:"border rounded-lg "+l,open:d.status==="eligible"||d.status==="needs_info"},React.createElement("summary",{className:"cursor-pointer px-3 py-2 flex items-center justify-between text-sm"},React.createElement("div",{className:"flex items-center gap-2 min-w-0"},React.createElement("span",{className:"px-2 py-0.5 rounded text-xs font-bold whitespace-nowrap "+C,dangerouslySetInnerHTML:{__html:k}}),React.createElement("span",{className:"font-semibold truncate"},m.name),React.createElement("span",{className:"text-xs text-gray-500 hidden sm:inline"},"(",m.nct,")")),React.createElement("span",{className:"text-xs text-gray-500 whitespace-nowrap ml-2"},S.length,"/",d.criteria.length," met")),React.createElement("div",{className:"px-3 pb-3 space-y-2"},React.createElement("p",{className:"text-xs text-gray-700 italic"},m.quickDescription),React.createElement("div",{className:"space-y-1"},d.criteria.map(f=>React.createElement("div",{key:f.id,className:"flex items-center gap-2 text-xs"},f.status==="met"&&React.createElement("span",{className:"text-green-600 font-bold w-4 text-center"},"\u2713"),f.status==="not_met"&&React.createElement("span",{className:"text-red-600 font-bold w-4 text-center"},"\u2717"),f.status==="unknown"&&React.createElement("span",{className:"text-gray-400 font-bold w-4 text-center"},"\u25CF"),React.createElement("span",{className:f.status==="met"?"text-green-800":f.status==="not_met"?"text-red-800 line-through":"text-gray-600"},f.label,f.required?"":" (optional)")))),d.exclusions.length>0&&React.createElement("div",{className:"bg-red-50 border border-red-200 rounded px-2 py-1"},React.createElement("span",{className:"text-xs font-bold text-red-700"},"Exclusion triggered:"),d.exclusions.map(f=>React.createElement("span",{key:f.id,className:"text-xs text-red-700 ml-1"},"\u2717 ",f.label))),I.length>0&&React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded px-2 py-1.5"},React.createElement("span",{className:"text-xs font-semibold text-amber-800"},"Missing data to determine eligibility:"),React.createElement("div",{className:"flex flex-wrap gap-1 mt-1"},I.map(f=>React.createElement("span",{key:f.id,className:"text-xs bg-amber-200 text-amber-900 px-1.5 py-0.5 rounded"},f.label)))),React.createElement("div",{className:"flex gap-2 pt-1"},React.createElement("button",{type:"button",onClick:()=>Is(d.trialId),className:"text-xs font-semibold text-purple-700 hover:text-purple-900 underline"},"View full trial details \u2192"))))}),i.length>0&&React.createElement("div",{className:"bg-green-100 border border-green-300 rounded-lg p-2 mt-2"},React.createElement("p",{className:"text-xs font-bold text-green-800 mb-1"},"\u2713 Patient may qualify for ",i.length," trial",i.length>1?"s":""," \u2014 consider discussing enrollment"),i.map(d=>React.createElement("p",{key:d.trialId,className:"text-xs text-green-700"},"\u2022 ",React.createElement("strong",null,d.trialName,":")," ",d.quickDescription)))))})(),(t.diagnosisCategory==="sah"||(t.diagnosis||"").toLowerCase().includes("sah")||(t.diagnosis||"").toLowerCase().includes("subarachnoid"))&&React.createElement("div",{id:"sah-management-section",className:"bg-white border-2 border-purple-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-purple-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"zap",className:"w-5 h-5"}),"SAH Management (2023 AHA/ASA)")),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"grid grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Grading Scale"),React.createElement("select",{value:t.sahGradeScale||"",onChange:e=>r({...t,sahGradeScale:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm"},React.createElement("option",{value:""},"-- Select --"),React.createElement("option",{value:"huntHess"},"Hunt & Hess"),React.createElement("option",{value:"wfns"},"WFNS"))),React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Grade"),React.createElement("select",{value:t.sahGrade||"",onChange:e=>r({...t,sahGrade:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm"},React.createElement("option",{value:""},"-- Select --"),t.sahGradeScale==="huntHess"?React.createElement(React.Fragment,null,React.createElement("option",{value:"1"},"Grade 1 - Asymptomatic or mild headache"),React.createElement("option",{value:"2"},"Grade 2 - Moderate to severe headache, nuchal rigidity"),React.createElement("option",{value:"3"},"Grade 3 - Drowsy, confused, mild focal deficit"),React.createElement("option",{value:"4"},"Grade 4 - Stupor, moderate to severe hemiparesis"),React.createElement("option",{value:"5"},"Grade 5 - Deep coma, decerebrate posturing")):t.sahGradeScale==="wfns"?React.createElement(React.Fragment,null,React.createElement("option",{value:"1"},"Grade I - GCS 15, no motor deficit"),React.createElement("option",{value:"2"},"Grade II - GCS 13-14, no motor deficit"),React.createElement("option",{value:"3"},"Grade III - GCS 13-14, with motor deficit"),React.createElement("option",{value:"4"},"Grade IV - GCS 7-12"),React.createElement("option",{value:"5"},"Grade V - GCS 3-6")):React.createElement(React.Fragment,null,React.createElement("option",{value:"1"},"1"),React.createElement("option",{value:"2"},"2"),React.createElement("option",{value:"3"},"3"),React.createElement("option",{value:"4"},"4"),React.createElement("option",{value:"5"},"5"))))),parseInt(t.sahGrade)>=4&&React.createElement("div",{className:"bg-red-50 border border-red-300 rounded-lg p-2 text-sm text-red-800"},React.createElement("strong",null,"Poor-grade SAH (Grade ",t.sahGrade,"):")," Consider EVD placement, ICU admission, and early goals-of-care discussion. Avoid premature limitations of care."),React.createElement("div",{className:"bg-purple-50 rounded-lg p-3"},React.createElement("div",{className:"text-sm font-semibold text-purple-800 mb-2"},"SAH ICU Bundle"),React.createElement("div",{className:"space-y-2"},[{key:"sahBPManaged",label:"BP managed (SBP <160 pre-securing)",detail:"Nicardipine or labetalol IV"},{key:"sahNimodipine",label:"Nimodipine started (60 mg q4h x 21d)",detail:"Class I, LOE A for DCI prevention"},{key:"sahEVDPlaced",label:"EVD placed (if hydrocephalus/poor-grade)",detail:"For acute hydrocephalus or HH 3-5"},{key:"sahNeurosurgeryConsulted",label:"Neurosurgery consulted",detail:"For aneurysm securing strategy"},{key:"sahAneurysmSecured",label:"Aneurysm securing plan documented",detail:"Clip vs coil within 24h"},{key:"sahSeizureProphylaxis",label:"Seizure prophylaxis addressed",detail:"Short-term (3-7d) levetiracetam if indicated"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-start gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!t[e.key],onChange:a=>r({...t,[e.key]:a.target.checked}),className:"mt-0.5 rounded border-purple-300 text-purple-600"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-medium text-gray-800"},e.label),React.createElement("span",{className:"block text-xs text-gray-500"},e.detail)))))))),(t.diagnosisCategory==="cvt"||(t.diagnosis||"").toLowerCase().includes("cvt")||(t.diagnosis||"").toLowerCase().includes("venous thrombosis")||(t.diagnosis||"").toLowerCase().includes("cerebral venous"))&&React.createElement("div",{id:"cvt-management-section",className:"bg-white border-2 border-indigo-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-indigo-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"git-branch",className:"w-5 h-5"}),"CVT Management (2024 AHA)")),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"bg-indigo-50 rounded-lg p-3"},React.createElement("div",{className:"text-sm font-semibold text-indigo-800 mb-2"},"CVT Treatment Checklist"),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-start gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!t.cvtAnticoagStarted,onChange:e=>r({...t,cvtAnticoagStarted:e.target.checked}),className:"mt-0.5 rounded border-indigo-300 text-indigo-600"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-medium text-gray-800"},"Anticoagulation initiated"),React.createElement("span",{className:"block text-xs text-gray-500"},"LMWH or UFH, even with hemorrhagic infarction (Class I)"))),t.cvtAnticoagStarted&&React.createElement("div",{className:"ml-6"},React.createElement("select",{value:t.cvtAnticoagType||"",onChange:e=>r({...t,cvtAnticoagType:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm"},React.createElement("option",{value:""},"-- Select agent --"),React.createElement("option",{value:"enoxaparin"},"Enoxaparin 1 mg/kg SC q12h"),React.createElement("option",{value:"ufh"},"UFH weight-based (aPTT 60-80s)"),React.createElement("option",{value:"other"},"Other"))),React.createElement("label",{className:"flex items-start gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!t.cvtIcpManaged,onChange:e=>r({...t,cvtIcpManaged:e.target.checked}),className:"mt-0.5 rounded border-indigo-300 text-indigo-600"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-medium text-gray-800"},"ICP assessment/management"),React.createElement("span",{className:"block text-xs text-gray-500"},"HOB 30\xB0, acetazolamide if needed, LP drainage for visual impairment"))),React.createElement("label",{className:"flex items-start gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!t.cvtSeizureManaged,onChange:e=>r({...t,cvtSeizureManaged:e.target.checked}),className:"mt-0.5 rounded border-indigo-300 text-indigo-600"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-medium text-gray-800"},"Seizure management addressed"),React.createElement("span",{className:"block text-xs text-gray-500"},"Prophylaxis for supratentorial lesions; levetiracetam preferred"))),React.createElement("label",{className:"flex items-start gap-2 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!t.cvtHematologyConsulted,onChange:e=>r({...t,cvtHematologyConsulted:e.target.checked}),className:"mt-0.5 rounded border-indigo-300 text-indigo-600"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-medium text-gray-800"},"Hematology consult / thrombophilia workup"),React.createElement("span",{className:"block text-xs text-gray-500"},"Factor V Leiden, prothrombin mutation, protein C/S, APLA"))))),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-2 text-xs text-blue-800"},React.createElement("strong",null,"Long-term plan:")," Transition to VKA (INR 2-3) for 3-12 months. DOAC may be considered for mild provoked CVT per ACTION-CVT data. Indefinite anticoagulation if recurrent VTE or severe thrombophilia."))),j(t.diagnosis)==="tia"&&React.createElement("div",{className:"bg-white border-2 border-orange-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-orange-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"clipboard-check",className:"w-5 h-5"}),"TIA Rapid Workup Checklist"),React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"text-xs text-orange-600 font-medium"},Object.values(t.tiaWorkup||{}).filter(Boolean).length,"/",Object.keys(t.tiaWorkup||{}).length," complete"),React.createElement("button",{type:"button",onClick:()=>r({...t,tiaWorkupReviewed:!t.tiaWorkupReviewed}),className:`text-xs px-2 py-1 rounded-lg font-medium ${t.tiaWorkupReviewed?"bg-green-500 text-white":"bg-gray-200 text-gray-700 hover:bg-gray-300"}`},t.tiaWorkupReviewed?"Reviewed":"Mark Reviewed"))),React.createElement("div",{className:"bg-orange-50 border border-orange-200 rounded-lg p-3 mb-3 text-sm text-orange-800"},React.createElement("strong",null,"Admit ALL TIAs")," for urgent inpatient workup (Class I, LOE B-NR). Do not use ABCD2 score for disposition decisions."),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-x-4 gap-y-1"},[{key:"mriDwi",label:"MRI Brain with DWI",category:"Imaging"},{key:"ctaHeadNeck",label:"CTA Head & Neck (or MRA)",category:"Imaging"},{key:"ecg12Lead",label:"12-Lead ECG",category:"Cardiac"},{key:"telemetry",label:"Continuous telemetry monitoring",category:"Cardiac"},{key:"echo",label:"Echocardiography (TTE +/- bubble)",category:"Cardiac"},{key:"labsCbc",label:"CBC with differential",category:"Labs"},{key:"labsBmp",label:"BMP + glucose",category:"Labs"},{key:"labsA1c",label:"HbA1c",category:"Labs"},{key:"labsLipids",label:"Fasting lipid panel",category:"Labs"},{key:"labsTsh",label:"TSH",category:"Labs"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-2 py-1 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!(t.tiaWorkup||{})[e.key],onChange:a=>r({...t,tiaWorkup:{...t.tiaWorkup||{},[e.key]:a.target.checked}}),className:"rounded border-orange-300 text-orange-600"}),React.createElement("span",{className:"text-sm text-gray-700"},e.label))))),(j(t.diagnosis)==="ischemic"||j(t.diagnosis)==="tia")&&React.createElement("div",{className:"bg-white border-2 border-violet-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-violet-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"layers",className:"w-5 h-5"}),"TOAST Etiologic Classification")),React.createElement("div",{className:"grid grid-cols-1 sm:grid-cols-2 gap-2"},[{value:"large-artery",label:"Large Artery Atherosclerosis",desc:"Carotid/intracranial stenosis >=50%, or plaque with ulceration"},{value:"cardioembolism",label:"Cardioembolism",desc:"AF, PFO, valvular disease, LV thrombus, endocarditis"},{value:"small-vessel",label:"Small Vessel Occlusion (Lacunar)",desc:"Subcortical infarct <15mm, classic lacunar syndrome"},{value:"other-determined",label:"Other Determined Etiology",desc:"Dissection, vasculitis, hypercoagulable, sickle cell, etc."},{value:"cryptogenic",label:"Cryptogenic / ESUS",desc:"No cause found despite complete evaluation, or >1 competing cause"}].map(e=>React.createElement("label",{key:e.value,className:`flex items-start gap-2 p-2 rounded cursor-pointer border transition ${t.toastClassification===e.value?"bg-violet-100 border-violet-400":"hover:bg-violet-50 border-gray-200"}`},React.createElement("input",{type:"radio",name:"toastClassification",value:e.value,checked:t.toastClassification===e.value,onChange:a=>r({...t,toastClassification:a.target.value}),className:"mt-1 text-violet-600"}),React.createElement("div",null,React.createElement("span",{className:"text-sm font-semibold text-gray-800"},e.label),React.createElement("p",{className:"text-xs text-gray-500"},e.desc)))))),(j(t.diagnosis)==="ischemic"||j(t.diagnosis)==="tia"||t.toastClassification==="cardioembolism"||t.toastClassification==="cryptogenic")&&t.diagnosis&&React.createElement("div",{className:"bg-white border-2 border-pink-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-pink-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"heart",className:"w-5 h-5"}),"Cardiac Workup")),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("label",{className:"flex items-center gap-2 p-2 bg-pink-50 rounded border border-pink-200"},React.createElement("input",{type:"checkbox",checked:!!(t.cardiacWorkup||{}).ecgComplete,onChange:e=>r({...t,cardiacWorkup:{...t.cardiacWorkup||{},ecgComplete:e.target.checked}}),className:"text-pink-600"}),React.createElement("span",{className:"text-sm"},"12-Lead ECG")),React.createElement("label",{className:"flex items-center gap-2 p-2 bg-pink-50 rounded border border-pink-200"},React.createElement("input",{type:"checkbox",checked:!!(t.cardiacWorkup||{}).telemetryOrdered,onChange:e=>r({...t,cardiacWorkup:{...t.cardiacWorkup||{},telemetryOrdered:e.target.checked}}),className:"text-pink-600"}),React.createElement("span",{className:"text-sm"},"Inpatient Telemetry")),React.createElement("label",{className:"flex items-center gap-2 p-2 bg-pink-50 rounded border border-pink-200"},React.createElement("input",{type:"checkbox",checked:!!(t.cardiacWorkup||{}).echoOrdered,onChange:e=>r({...t,cardiacWorkup:{...t.cardiacWorkup||{},echoOrdered:e.target.checked}}),className:"text-pink-600"}),React.createElement("span",{className:"text-sm"},"Echo (TTE +/- Bubble)"))),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Extended Cardiac Monitoring (post-discharge)"),React.createElement("select",{value:(t.cardiacWorkup||{}).extendedMonitoringType||"",onChange:e=>r({...t,cardiacWorkup:{...t.cardiacWorkup||{},extendedMonitoringType:e.target.value,extendedMonitoring:e.target.value?"ordered":""}}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-pink-500"},React.createElement("option",{value:""},"-- Select monitoring plan --"),React.createElement("option",{value:"30-day-monitor"},"30-Day Ambulatory Monitor (Preferred)"),React.createElement("option",{value:"14-day-patch"},"14-Day Continuous Patch (if 30-day unavailable)"),React.createElement("option",{value:"ilr"},"Implantable Loop Recorder (select cases)"),React.createElement("option",{value:"none-af-known"},"Not needed \u2014 AF already documented"),React.createElement("option",{value:"none-other"},"Not indicated (clear etiology identified)")),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"Hierarchy: 30-day monitor preferred; 14-day patch if unavailable; ILR in select cases with high suspicion and negative ambulatory monitoring.")),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"PFO Evaluation"),React.createElement("select",{value:(t.cardiacWorkup||{}).pfoEvaluation||"",onChange:e=>r({...t,cardiacWorkup:{...t.cardiacWorkup||{},pfoEvaluation:e.target.value}}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-pink-500"},React.createElement("option",{value:""},"-- Select PFO status --"),React.createElement("option",{value:"no-pfo"},"No PFO detected"),React.createElement("option",{value:"pfo-no-closure"},"PFO present \u2014 closure not indicated"),React.createElement("option",{value:"pfo-closure-candidate"},"PFO present \u2014 closure candidate (PASCAL: probable/definite)"),React.createElement("option",{value:"pfo-further-eval"},"PFO present \u2014 needs further evaluation"))),(t.cardiacWorkup||{}).pfoEvaluation==="pfo-closure-candidate"&&React.createElement("div",{className:"bg-pink-50 border border-pink-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-pink-800 mb-2"},"PASCAL Classification for PFO Closure"),React.createElement("select",{value:(t.cardiacWorkup||{}).pascalClassification||"",onChange:e=>r({...t,cardiacWorkup:{...t.cardiacWorkup||{},pascalClassification:e.target.value}}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-pink-500"},React.createElement("option",{value:""},"-- Select PASCAL grade --"),React.createElement("option",{value:"definite"},"Definite \u2014 High probability PFO-attributable stroke (closure recommended)"),React.createElement("option",{value:"probable"},"Probable \u2014 Moderate probability (closure reasonable)"),React.createElement("option",{value:"possible"},"Possible \u2014 Low probability (closure uncertain benefit)"),React.createElement("option",{value:"unlikely"},"Unlikely \u2014 Very low probability (closure not recommended)")),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"PASCAL integrates: PFO anatomy (shunt size, ASA), age, clot/DVT source, Alternative etiologies, Lacunar vs cortical pattern. Closure recommended for definite/probable in patients age 18-60.")),(t.toastClassification==="cryptogenic"||t.toastClassification==="cardioembolism")&&React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3 text-sm"},React.createElement("h4",{className:"font-semibold text-blue-800 mb-1"},"sICAS Management (AAN 2022)"),React.createElement("ul",{className:"space-y-1 ml-4 text-blue-700"},React.createElement("li",null,"\u2022 Severe symptomatic intracranial stenosis (70-99%): DAPT x 90 days, then ASA 325 mg"),React.createElement("li",null,"\u2022 High-intensity statin with LDL target <70 mg/dL"),React.createElement("li",null,"\u2022 SBP target <140/90 (ideally <130/80)"),React.createElement("li",null,"\u2022 Do NOT offer intracranial stenting as initial treatment (Class III)"))))),j(t.diagnosis)==="dissection"&&React.createElement("div",{className:"bg-white border-2 border-rose-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-rose-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"git-branch",className:"w-5 h-5"}),"Cervical Artery Dissection Pathway")),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"bg-rose-50 border border-rose-200 rounded-lg p-3 text-sm text-rose-800"},React.createElement("strong",null,"Key:")," Cervical dissection is NOT a contraindication to IV TNK if within treatment window. Antithrombotic therapy (antiplatelet or anticoagulation) is indicated; neither is proven superior (CADISS)."),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Antithrombotic Selection"),React.createElement("select",{value:(t.dissectionPathway||{}).antithromboticType||"",onChange:e=>r({...t,dissectionPathway:{...t.dissectionPathway||{},antithromboticType:e.target.value,antithromboticStarted:!!e.target.value}}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-rose-500"},React.createElement("option",{value:""},"-- Select antithrombotic --"),React.createElement("option",{value:"antiplatelet-asa"},"Antiplatelet: ASA 81-325 mg daily"),React.createElement("option",{value:"antiplatelet-dapt"},"Antiplatelet: DAPT (ASA + clopidogrel)"),React.createElement("option",{value:"anticoag-heparin"},"Anticoagulation: Heparin bridge to warfarin"),React.createElement("option",{value:"anticoag-doac"},"Anticoagulation: DOAC (off-label)"))),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Vascular Imaging Follow-Up Plan"),React.createElement("select",{value:(t.dissectionPathway||{}).imagingFollowUp||"",onChange:e=>r({...t,dissectionPathway:{...t.dissectionPathway||{},imagingFollowUp:e.target.value}}),className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-rose-500"},React.createElement("option",{value:""},"-- Select follow-up plan --"),React.createElement("option",{value:"3-month"},"Repeat CTA/MRA at 3 months"),React.createElement("option",{value:"6-month"},"Repeat CTA/MRA at 6 months"),React.createElement("option",{value:"3-and-6-month"},"Repeat at 3 and 6 months")),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"Most dissections heal in 3-6 months. If recanalized, consider switching anticoagulation to antiplatelet. Persistent pseudoaneurysm may warrant continued treatment.")),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3 text-sm"},React.createElement("h4",{className:"font-semibold text-amber-800 mb-1"},"Dissection Counseling Points"),React.createElement("ul",{className:"space-y-1 ml-4 text-amber-700"},React.createElement("li",null,"\u2022 Avoid cervical manipulation (chiropractic) during healing"),React.createElement("li",null,"\u2022 Avoid heavy lifting/straining for 4-6 weeks"),React.createElement("li",null,"\u2022 Report any new headache, neck pain, or neurological symptoms immediately"),React.createElement("li",null,"\u2022 Duration of antithrombotic therapy: typically 3-6 months, reassess with imaging"))))),t.diagnosis&&j(t.diagnosis)!=="mimic"&&React.createElement("details",{className:"bg-white border-2 border-teal-300 rounded-lg shadow-md"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-teal-900 hover:bg-teal-50 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"scan",className:"w-5 h-5 text-teal-600"}),"Post-Stroke Screening Tools"),React.createElement("span",{className:"text-xs text-teal-500 font-normal"},"PHQ-2, MoCA, STOP-BANG, Seizure Risk")),React.createElement("div",{className:"p-4 pt-0 space-y-4"},React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-blue-800 mb-2"},"PHQ-2 Depression Screening"),React.createElement("p",{className:"text-xs text-gray-600 mb-2"},"Over the past 2 weeks, how often has the patient been bothered by:"),React.createElement("div",{className:"space-y-2"},React.createElement("div",null,React.createElement("label",{className:"text-sm text-gray-700"},"1. Little interest or pleasure in doing things?"),React.createElement("select",{value:(t.screeningTools||{}).phq2_q1||"",onChange:e=>{let a={...t.screeningTools||{},phq2_q1:e.target.value},i=(parseInt(a.phq2_q1)||0)+(parseInt(a.phq2_q2)||0);a.phq2Score=i.toString(),a.phq2Positive=i>=3,r({...t,screeningTools:a})},className:"w-full px-2 py-1 border border-gray-300 rounded text-sm mt-1"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"0"},"Not at all (0)"),React.createElement("option",{value:"1"},"Several days (1)"),React.createElement("option",{value:"2"},"More than half the days (2)"),React.createElement("option",{value:"3"},"Nearly every day (3)"))),React.createElement("div",null,React.createElement("label",{className:"text-sm text-gray-700"},"2. Feeling down, depressed, or hopeless?"),React.createElement("select",{value:(t.screeningTools||{}).phq2_q2||"",onChange:e=>{let a={...t.screeningTools||{},phq2_q2:e.target.value},i=(parseInt(a.phq2_q1)||0)+(parseInt(a.phq2_q2)||0);a.phq2Score=i.toString(),a.phq2Positive=i>=3,r({...t,screeningTools:a})},className:"w-full px-2 py-1 border border-gray-300 rounded text-sm mt-1"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"0"},"Not at all (0)"),React.createElement("option",{value:"1"},"Several days (1)"),React.createElement("option",{value:"2"},"More than half the days (2)"),React.createElement("option",{value:"3"},"Nearly every day (3)")))),(t.screeningTools||{}).phq2Score&&React.createElement("div",{className:`mt-2 p-2 rounded text-sm font-medium ${(t.screeningTools||{}).phq2Positive?"bg-red-100 text-red-800":"bg-green-100 text-green-800"}`},"PHQ-2 Score: ",(t.screeningTools||{}).phq2Score,"/6",(t.screeningTools||{}).phq2Positive?" \u2014 POSITIVE: Consider full PHQ-9, psychiatry/psychology referral":" \u2014 Negative screen")),React.createElement("div",{className:"bg-purple-50 border border-purple-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-purple-800 mb-2"},"MoCA Cognitive Screening"),React.createElement("div",{className:"flex items-center gap-3"},React.createElement("div",{className:"flex-1"},React.createElement("label",{className:"text-sm text-gray-700"},"MoCA Score (0-30):"),React.createElement("input",{type:"number",min:"0",max:"30",value:(t.screeningTools||{}).mocaScore||"",onChange:e=>{let a={...t.screeningTools||{},mocaScore:e.target.value};r({...t,screeningTools:a})},className:"w-full px-2 py-1 border border-gray-300 rounded text-sm mt-1",placeholder:"Enter score"})),React.createElement("label",{className:"flex items-center gap-2 mt-4"},React.createElement("input",{type:"checkbox",checked:!!(t.screeningTools||{}).mocaReferral,onChange:e=>r({...t,screeningTools:{...t.screeningTools||{},mocaReferral:e.target.checked}}),className:"text-purple-600"}),React.createElement("span",{className:"text-sm"},"Neuropsych referral"))),parseInt((t.screeningTools||{}).mocaScore)>0&&React.createElement("div",{className:`mt-2 p-2 rounded text-sm ${parseInt((t.screeningTools||{}).mocaScore)>=26?"bg-green-100 text-green-800":"bg-amber-100 text-amber-800"}`},parseInt((t.screeningTools||{}).mocaScore)>=26?"Normal cognition (>=26)":`Below normal (${(t.screeningTools||{}).mocaScore}/30) \u2014 consider neuropsych referral`),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"Administer MoCA at follow-up (not acute phase). Add 1 point if education \u226412 years. ",React.createElement("a",{href:"https://mocatest.org",target:"_blank",rel:"noopener noreferrer",className:"text-purple-600 underline"},"mocatest.org"))),React.createElement("div",{className:"bg-cyan-50 border border-cyan-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-cyan-800 mb-2"},"STOP-BANG OSA Screening"),React.createElement("div",{className:"grid grid-cols-2 gap-1"},[{key:"sb_snoring",label:"Snoring (loud)"},{key:"sb_tired",label:"Tired/sleepy during day"},{key:"sb_observed",label:"Observed apneas"},{key:"sb_pressure",label:"Treated for high BP"},{key:"sb_bmi",label:"BMI > 35"},{key:"sb_age",label:"Age > 50"},{key:"sb_neck",label:"Neck circumference > 40cm"},{key:"sb_gender",label:"Male gender"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-2 py-0.5"},React.createElement("input",{type:"checkbox",checked:!!(t.screeningTools||{})[e.key],onChange:a=>{let i={...t.screeningTools||{},[e.key]:a.target.checked},s=["sb_snoring","sb_tired","sb_observed","sb_pressure","sb_bmi","sb_age","sb_neck","sb_gender"].filter(o=>i[o]).length;i.stopBangScore=s.toString(),i.stopBangPositive=s>=3,r({...t,screeningTools:i})},className:"text-cyan-600"}),React.createElement("span",{className:"text-xs text-gray-700"},e.label)))),(t.screeningTools||{}).stopBangScore&&React.createElement("div",{className:`mt-2 p-2 rounded text-sm font-medium ${parseInt((t.screeningTools||{}).stopBangScore)>=5?"bg-red-100 text-red-800":parseInt((t.screeningTools||{}).stopBangScore)>=3?"bg-amber-100 text-amber-800":"bg-green-100 text-green-800"}`},"STOP-BANG: ",(t.screeningTools||{}).stopBangScore,"/8",parseInt((t.screeningTools||{}).stopBangScore)>=5?" \u2014 HIGH risk OSA: order sleep study":parseInt((t.screeningTools||{}).stopBangScore)>=3?" \u2014 INTERMEDIATE risk: consider sleep study":" \u2014 Low risk")),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-amber-800 mb-2"},"Post-Stroke Seizure Management"),React.createElement("select",{value:(t.screeningTools||{}).seizureRisk||"",onChange:e=>r({...t,screeningTools:{...t.screeningTools||{},seizureRisk:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"-- Seizure status --"),React.createElement("option",{value:"no-seizure"},"No seizure activity"),React.createElement("option",{value:"acute-seizure"},"Acute symptomatic seizure (within 7 days)"),React.createElement("option",{value:"late-seizure"},"Late seizure (after 7 days)"),React.createElement("option",{value:"status-epilepticus"},"Status epilepticus")),React.createElement("div",{className:"text-xs text-gray-600 mt-2 space-y-1"},React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"Acute symptomatic seizure:")," Short-term ASM (7 days for ICH; case-by-case for ischemic). No routine prophylaxis."),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"Late seizure (>7 days):")," Start ASM; risk of recurrence is high (~70%). Levetiracetam or lacosamide preferred."),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"Routine prophylactic ASM:")," NOT recommended (Class III) for ischemic stroke. May consider 7-day prophylaxis for lobar ICH (Class IIb)."))))),t.diagnosis&&j(t.diagnosis)!=="mimic"&&React.createElement("details",{className:"bg-white border-2 border-green-300 rounded-lg shadow-md"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-green-900 hover:bg-green-50 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"shield",className:"w-5 h-5 text-green-600"}),"Secondary Prevention Dashboard"),React.createElement("span",{className:"text-xs text-green-500 font-normal"},"BP, LDL, Diabetes, Smoking, Exercise, Diet")),React.createElement("div",{className:"p-4 pt-0 space-y-4"},React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-red-800 mb-2"},"Blood Pressure Target"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Current BP Meds"),React.createElement("input",{type:"text",value:(t.secondaryPrevention||{}).bpMeds||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},bpMeds:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"e.g., lisinopril 10mg, amlodipine 5mg"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Target"),React.createElement("select",{value:(t.secondaryPrevention||{}).bpTarget||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},bpTarget:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"<130/80"},"<130/80 (standard, Class I)"),React.createElement("option",{value:"<120/80"},"<120/80 (intensive \u2014 SPS3, RESPECT-ESUS subgroup)"),React.createElement("option",{value:"<140/90"},"<140/90 (if tolerability concern)"))),React.createElement("div",null,React.createElement("label",{className:"flex items-center gap-1 text-xs mt-4"},React.createElement("input",{type:"checkbox",checked:!!(t.secondaryPrevention||{}).bpIntensiveCandidate,onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},bpIntensiveCandidate:e.target.checked}})}),"Intensive BP candidate (lacunar/small vessel)")))),React.createElement("div",{className:"bg-yellow-50 border border-yellow-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-yellow-800 mb-2"},"LDL Target: <55 mg/dL optimal, <70 minimum (TST, SPARCL)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Current LDL"),React.createElement("input",{type:"text",value:(t.secondaryPrevention||{}).ldlCurrent||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},ldlCurrent:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"mg/dL"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Statin"),React.createElement("select",{value:(t.secondaryPrevention||{}).statinDose||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},statinDose:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select statin"),React.createElement("option",{value:"atorvastatin-80"},"Atorvastatin 80mg"),React.createElement("option",{value:"atorvastatin-40"},"Atorvastatin 40mg"),React.createElement("option",{value:"rosuvastatin-20"},"Rosuvastatin 20mg"),React.createElement("option",{value:"rosuvastatin-40"},"Rosuvastatin 40mg"))),React.createElement("div",{className:"flex flex-col gap-1"},React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.secondaryPrevention||{}).ezetimibeAdded,onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},ezetimibeAdded:e.target.checked}})}),"+ Ezetimibe 10mg"),React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.secondaryPrevention||{}).pcsk9Added,onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},pcsk9Added:e.target.checked}})}),"+ PCSK9i (evolocumab/alirocumab)"),React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.secondaryPrevention||{}).inclisiranConsidered,onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},inclisiranConsidered:e.target.checked}})}),"+ Inclisiran (siRNA, q6mo injection)"))),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"Ladder: High-intensity statin \u2192 add ezetimibe \u2192 add PCSK9i or inclisiran. TST trial: LDL <70 reduced recurrent stroke by 22%. FOURIER subanalysis supports LDL <40 in high-risk ASCVD.")),React.createElement("div",{className:"bg-green-50 border border-green-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-green-800 mb-2"},"Antiplatelet / Antithrombotic Selection"),React.createElement("select",{value:(t.secondaryPrevention||{}).antiplateletRegimen||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},antiplateletRegimen:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"-- Select regimen --"),React.createElement("option",{value:"dapt-21"},"DAPT x 21 days (minor stroke/TIA, NIHSS \u22643)"),React.createElement("option",{value:"asa-mono"},"ASA 81-325 mg monotherapy"),React.createElement("option",{value:"clopidogrel-mono"},"Clopidogrel 75 mg monotherapy"),React.createElement("option",{value:"asa-er-dipyridamole"},"ASA/ER-Dipyridamole (Aggrenox)"),React.createElement("option",{value:"doac-af"},"DOAC for AF (per CATALYST timing)"),React.createElement("option",{value:"anticoag-other"},"Anticoagulation (other indication)"))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"bg-orange-50 border border-orange-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-orange-800 mb-2 text-sm"},"Diabetes"),React.createElement("select",{value:(t.secondaryPrevention||{}).diabetesManagement||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},diabetesManagement:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"no-diabetes"},"No diabetes"),React.createElement("option",{value:"well-controlled"},"Diabetes \u2014 well controlled (A1c <7%)"),React.createElement("option",{value:"needs-optimization"},"Diabetes \u2014 needs optimization"),React.createElement("option",{value:"new-diagnosis"},"New diabetes diagnosis"))),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-blue-800 mb-2 text-sm"},"Smoking"),React.createElement("select",{value:(t.secondaryPrevention||{}).smokingStatus||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},smokingStatus:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"never"},"Never smoker"),React.createElement("option",{value:"former"},"Former smoker"),React.createElement("option",{value:"current"},"Current smoker \u2014 cessation counseled"),React.createElement("option",{value:"current-rx"},"Current smoker \u2014 pharmacotherapy started"))),React.createElement("div",{className:"bg-teal-50 border border-teal-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-teal-800 mb-2 text-sm"},"Exercise"),React.createElement("select",{value:(t.secondaryPrevention||{}).exercisePlan||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},exercisePlan:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"active"},"Already physically active (\u2265150 min/wk)"),React.createElement("option",{value:"counseled"},"Exercise counseling provided (target 150 min/wk)"),React.createElement("option",{value:"limited"},"Limited by disability \u2014 PT/OT referral")),React.createElement("div",{className:"mt-1"},React.createElement("label",{className:"text-xs text-gray-500"},"Current min/week:"),React.createElement("input",{type:"number",value:(t.secondaryPrevention||{}).exerciseMinPerWeek||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},exerciseMinPerWeek:e.target.value}}),className:"w-20 ml-1 px-1 py-0.5 border border-gray-300 rounded text-xs",placeholder:"0"}))),React.createElement("div",{className:"bg-lime-50 border border-lime-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-lime-800 mb-2 text-sm"},"Diet"),React.createElement("select",{value:(t.secondaryPrevention||{}).dietPlan||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},dietPlan:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"mediterranean"},"Mediterranean diet (Class I \u2014 PREDIMED, 2024 AHA upgrade)"),React.createElement("option",{value:"dash"},"DASH diet"),React.createElement("option",{value:"sodium-restriction"},"Sodium restriction (<2.3g/day)"),React.createElement("option",{value:"dietitian"},"Dietitian referral placed")),React.createElement("select",{value:(t.secondaryPrevention||{}).dietAdherence||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},dietAdherence:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs mt-1"},React.createElement("option",{value:""},"Adherence"),React.createElement("option",{value:"good"},"Good adherence"),React.createElement("option",{value:"partial"},"Partial adherence"),React.createElement("option",{value:"poor"},"Poor adherence \u2014 reinforce counseling")))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"bg-violet-50 border border-violet-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-violet-800 mb-2 text-sm"},"GLP-1 Receptor Agonist"),React.createElement("select",{value:(t.secondaryPrevention||{}).glp1ra||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},glp1ra:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"semaglutide-2.4"},"Semaglutide 2.4 mg SC weekly"),React.createElement("option",{value:"semaglutide-1.0"},"Semaglutide 1.0 mg SC weekly"),React.createElement("option",{value:"liraglutide"},"Liraglutide 1.8 mg SC daily"),React.createElement("option",{value:"dulaglutide"},"Dulaglutide 1.5 mg SC weekly"),React.createElement("option",{value:"not-indicated"},"Not indicated")),React.createElement("select",{value:(t.secondaryPrevention||{}).glp1raIndication||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},glp1raIndication:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs mt-1"},React.createElement("option",{value:""},"Indication"),React.createElement("option",{value:"overweight-ascvd"},"Overweight/obesity + ASCVD (SELECT trial)"),React.createElement("option",{value:"t2dm"},"T2DM (SUSTAIN-6, SOUL)"),React.createElement("option",{value:"both"},"Both obesity + T2DM")),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"SELECT: semaglutide 2.4mg reduced MACE 20% in overweight/obese patients with ASCVD (HR 0.80). SOUL: stroke reduction with oral semaglutide in T2DM.")),React.createElement("div",{className:"bg-sky-50 border border-sky-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-sky-800 mb-2 text-sm"},"SGLT2 Inhibitor"),React.createElement("select",{value:(t.secondaryPrevention||{}).sglt2i||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},sglt2i:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"empagliflozin"},"Empagliflozin 10mg daily"),React.createElement("option",{value:"dapagliflozin"},"Dapagliflozin 10mg daily"),React.createElement("option",{value:"sotagliflozin"},"Sotagliflozin 200mg daily"),React.createElement("option",{value:"not-indicated"},"Not indicated")),React.createElement("select",{value:(t.secondaryPrevention||{}).sglt2iIndication||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},sglt2iIndication:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs mt-1"},React.createElement("option",{value:""},"Indication"),React.createElement("option",{value:"hf"},"Heart failure (HFrEF or HFpEF)"),React.createElement("option",{value:"ckd"},"CKD (eGFR 20-60)"),React.createElement("option",{value:"t2dm-ascvd"},"T2DM + ASCVD"),React.createElement("option",{value:"sotagliflozin-af-hf-dm"},"Sotagliflozin for AF + HF + DM (SCORED/SOLOIST)")),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"SGLT2i primarily for cardiorenal protection; not direct stroke prevention. Sotagliflozin exception: reduced stroke in DM + HF.")),React.createElement("div",{className:"bg-rose-50 border border-rose-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-rose-800 mb-2 text-sm"},"Colchicine"),React.createElement("label",{className:"flex items-center gap-2 mb-1"},React.createElement("input",{type:"checkbox",checked:!!(t.secondaryPrevention||{}).colchicineConsidered,onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},colchicineConsidered:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Colchicine 0.5 mg daily considered")),React.createElement("select",{value:(t.secondaryPrevention||{}).colchicineIndication||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},colchicineIndication:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Indication"),React.createElement("option",{value:"atherosclerotic-stroke"},"Atherosclerotic stroke with hsCRP elevation"),React.createElement("option",{value:"recurrent-ascvd"},"Recurrent ASCVD events"),React.createElement("option",{value:"not-indicated"},"Not indicated")),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"CONVINCE: reduced recurrent vascular events post-stroke. CHANCE-3: colchicine + DAPT for minor stroke/TIA. Avoid if eGFR <30.")),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-amber-800 mb-2 text-sm"},"CYP2C19 Pharmacogenomics"),React.createElement("label",{className:"flex items-center gap-2 mb-1"},React.createElement("input",{type:"checkbox",checked:!!(t.secondaryPrevention||{}).cyp2c19Tested,onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},cyp2c19Tested:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"CYP2C19 genotyping ordered/available")),(t.secondaryPrevention||{}).cyp2c19Tested&&React.createElement("select",{value:(t.secondaryPrevention||{}).cyp2c19Result||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},cyp2c19Result:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Result"),React.createElement("option",{value:"normal-metabolizer"},"Normal metabolizer (*1/*1) \u2014 clopidogrel OK"),React.createElement("option",{value:"intermediate"},"Intermediate metabolizer (*1/*2, *1/*3)"),React.createElement("option",{value:"poor-metabolizer"},"Poor metabolizer (*2/*2, *2/*3, *3/*3) \u2014 avoid clopidogrel"),React.createElement("option",{value:"rapid-metabolizer"},"Rapid/ultra-rapid metabolizer"),React.createElement("option",{value:"pending"},"Result pending")),(t.secondaryPrevention||{}).cyp2c19Result==="poor-metabolizer"&&React.createElement("div",{className:"mt-1 p-1 bg-red-100 rounded text-xs text-red-700"},"CYP2C19 LOF: Switch to ticagrelor 90mg BID or prasugrel 10mg daily (CHANCE-2: ticagrelor + ASA superior to clopidogrel + ASA in LOF carriers)."),(t.secondaryPrevention||{}).cyp2c19Result==="intermediate"&&React.createElement("div",{className:"mt-1 p-1 bg-yellow-100 rounded text-xs text-yellow-700"},"Intermediate metabolizer: Consider ticagrelor 90mg BID. CHANCE-2 showed benefit in both intermediate and poor metabolizers."))),React.createElement("div",{className:"bg-red-50 border border-red-300 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-red-800 mb-2"},"Drug Interaction Safety Panel"),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"bg-white border border-red-200 rounded p-2"},React.createElement("h5",{className:"text-xs font-semibold text-red-700 mb-1"},"AED\u2013DOAC Interaction Check"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-2"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Antiepileptic Drug"),React.createElement("select",{value:(t.drugInteractions||{}).aedType||"",onChange:e=>r({...t,drugInteractions:{...t.drugInteractions||{},aedType:e.target.value,aedDoacInteraction:["phenytoin","carbamazepine","phenobarbital"].includes(e.target.value)}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"None / Select"),React.createElement("option",{value:"levetiracetam"},"Levetiracetam (no interaction)"),React.createElement("option",{value:"lacosamide"},"Lacosamide (no interaction)"),React.createElement("option",{value:"valproate"},"Valproate (minimal)"),React.createElement("option",{value:"phenytoin"},"Phenytoin (STRONG CYP3A4/P-gp inducer)"),React.createElement("option",{value:"carbamazepine"},"Carbamazepine (STRONG CYP3A4/P-gp inducer)"),React.createElement("option",{value:"phenobarbital"},"Phenobarbital (STRONG CYP3A4 inducer)"),React.createElement("option",{value:"oxcarbazepine"},"Oxcarbazepine (moderate inducer)"))),React.createElement("div",null,React.createElement("label",{className:"flex items-center gap-1 text-xs mt-3"},React.createElement("input",{type:"checkbox",checked:!!(t.drugInteractions||{}).doacDoseAppropriate,onChange:e=>r({...t,drugInteractions:{...t.drugInteractions||{},doacDoseAppropriate:e.target.checked}})}),"DOAC dose verified appropriate"))),(t.drugInteractions||{}).aedDoacInteraction&&React.createElement("div",{className:"mt-1 p-2 bg-red-100 border border-red-300 rounded text-xs text-red-800"},React.createElement("strong",null,"WARNING:")," Enzyme-inducing AED significantly reduces DOAC levels. Consider: (1) Switch AED to non-inducing agent, (2) Use warfarin with INR monitoring instead, or (3) Check drug levels if available. ",React.createElement("em",null,"EHRA 2021 Practical Guide."))),React.createElement("div",{className:"bg-white border border-amber-200 rounded p-2"},React.createElement("h5",{className:"text-xs font-semibold text-amber-700 mb-1"},"Statin Interaction Check"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-2"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Interacting Drug"),React.createElement("select",{value:(t.drugInteractions||{}).statinInteractionDrug||"",onChange:e=>r({...t,drugInteractions:{...t.drugInteractions||{},statinInteractionDrug:e.target.value,statinInteraction:!!e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"None"),React.createElement("option",{value:"diltiazem"},"Diltiazem (CYP3A4 inhibitor)"),React.createElement("option",{value:"verapamil"},"Verapamil (CYP3A4 inhibitor)"),React.createElement("option",{value:"amiodarone"},"Amiodarone (CYP3A4 inhibitor)"),React.createElement("option",{value:"cyclosporine"},"Cyclosporine"),React.createElement("option",{value:"clarithromycin"},"Clarithromycin (CYP3A4 inhibitor)"),React.createElement("option",{value:"fluconazole"},"Fluconazole (CYP2C9 inhibitor)")))),(t.drugInteractions||{}).statinInteraction&&React.createElement("div",{className:"mt-1 p-2 bg-amber-100 rounded text-xs text-amber-800"},React.createElement("strong",null,"Statin dose adjustment needed:")," With CYP3A4 inhibitors, limit simvastatin to 20mg, atorvastatin to 40mg. Consider rosuvastatin (minimal CYP3A4 metabolism). Monitor for myopathy.")),(()=>{let e=xt(t.age,t.weight,t.sex,t.creatinine),a=e?e.value:null,i=parseFloat(t.age)||0,s=parseFloat(t.weight)||0,o=parseFloat(t.creatinine)||0,n=(t.drugInteractions||{}).doacDoseReductionCriteria||"",c=(i>=80?1:0)+(s>0&&s<=60?1:0)+(o>=1.5?1:0),d=c>=2;return React.createElement("div",{className:"bg-white border border-blue-200 rounded p-2"},React.createElement("h5",{className:"text-xs font-semibold text-blue-700 mb-1"},"DOAC Dose Reduction Checker ",a!==null&&React.createElement("span",{className:"font-normal text-gray-500"},"(Patient CrCl: ",a," mL/min)")),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-2"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"DOAC Agent"),React.createElement("select",{value:n,onChange:m=>r({...t,drugInteractions:{...t.drugInteractions||{},doacDoseReductionCriteria:m.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Select DOAC"),React.createElement("option",{value:"apixaban"},"Apixaban"),React.createElement("option",{value:"rivaroxaban"},"Rivaroxaban"),React.createElement("option",{value:"dabigatran"},"Dabigatran"),React.createElement("option",{value:"edoxaban"},"Edoxaban")))),n==="apixaban"&&React.createElement("div",{className:`mt-1 p-2 rounded text-xs ${d?"bg-red-100 border border-red-300 text-red-800":"bg-green-50 border border-green-200 text-green-800"}`},d?React.createElement(React.Fragment,null,React.createElement("strong",null,"DOSE REDUCTION REQUIRED:")," Apixaban ",React.createElement("strong",null,"2.5mg BID"),". Patient meets \u22652 of 3 criteria: ",i>=80?"age \u226580":"",s>0&&s<=60?`${i>=80?", ":""}wt \u226460kg`:"",o>=1.5?`${i>=80||s>0&&s<=60?", ":""}Cr \u22651.5`:""," (",c,"/3 criteria met). ARISTOTLE."):i>0||s>0||o>0?React.createElement(React.Fragment,null,React.createElement("strong",null,"Standard dose: Apixaban 5mg BID.")," Patient has ",c,"/3 reduction criteria",c===1?" \u2014 do NOT reduce for single criterion":"",". (ARISTOTLE)"):React.createElement(React.Fragment,null,"Apixaban 2.5mg BID if \u22652 of: age \u226580, weight \u226460kg, Cr \u22651.5. ",React.createElement("strong",null,"Do NOT reduce dose for single criterion")," (ARISTOTLE).")),n==="rivaroxaban"&&React.createElement("div",{className:`mt-1 p-2 rounded text-xs ${a!==null&&a<15?"bg-red-100 border border-red-300 text-red-800":a!==null&&a<=50?"bg-amber-100 border border-amber-200 text-amber-800":"bg-green-50 border border-green-200 text-green-800"}`},a!==null&&a<15?React.createElement(React.Fragment,null,React.createElement("strong",null,"AVOID:")," Rivaroxaban contraindicated with CrCl <15 mL/min (patient: ",a,")."):a!==null&&a<=50?React.createElement(React.Fragment,null,React.createElement("strong",null,"DOSE REDUCTION:")," Rivaroxaban ",React.createElement("strong",null,"15mg daily")," (CrCl ",a," mL/min, range 15-50). Take with evening meal. (ROCKET-AF)"):a!==null?React.createElement(React.Fragment,null,React.createElement("strong",null,"Standard dose: Rivaroxaban 20mg daily")," with evening meal (CrCl ",a," mL/min). (ROCKET-AF)"):React.createElement(React.Fragment,null,"Rivaroxaban 15mg daily if CrCl 15-50. Avoid if CrCl <15. Take with evening meal (ROCKET-AF).")),n==="dabigatran"&&React.createElement("div",{className:`mt-1 p-2 rounded text-xs ${a!==null&&a<15?"bg-red-100 border border-red-300 text-red-800":a!==null&&a<30?"bg-amber-100 border border-amber-200 text-amber-800":"bg-green-50 border border-green-200 text-green-800"}`},a!==null&&a<15?React.createElement(React.Fragment,null,React.createElement("strong",null,"AVOID:")," Dabigatran not recommended with CrCl <15 mL/min (patient: ",a,")."):a!==null&&a<30?React.createElement(React.Fragment,null,React.createElement("strong",null,"DOSE REDUCTION:")," Dabigatran ",React.createElement("strong",null,"75mg BID")," (CrCl ",a," mL/min). Idarucizumab available for reversal. (RE-LY, RE-VERSE AD)"):a!==null&&a<50?React.createElement(React.Fragment,null,React.createElement("strong",null,"Consider reduced dose:")," Dabigatran 75mg BID per FDA labeling for CrCl 30-49 with high bleed risk, or 150mg BID if standard risk (CrCl ",a," mL/min). (RE-LY)"):a!==null?React.createElement(React.Fragment,null,React.createElement("strong",null,"Standard dose: Dabigatran 150mg BID")," (CrCl ",a," mL/min). (RE-LY)"):React.createElement(React.Fragment,null,"Dabigatran 75mg BID if CrCl 15-30. Avoid if CrCl <15. Idarucizumab for reversal (RE-LY, RE-VERSE AD).")),n==="edoxaban"&&React.createElement("div",{className:`mt-1 p-2 rounded text-xs ${a!==null&&a>95||a!==null&&a<15?"bg-red-100 border border-red-300 text-red-800":a!==null&&a<=50?"bg-amber-100 border border-amber-200 text-amber-800":"bg-green-50 border border-green-200 text-green-800"}`},a!==null&&a>95?React.createElement(React.Fragment,null,React.createElement("strong",null,"AVOID:")," Edoxaban has ",React.createElement("strong",null,"reduced efficacy")," with CrCl >95 mL/min (patient: ",a,"). Use alternative DOAC. (ENGAGE AF-TIMI 48)"):a!==null&&a<15?React.createElement(React.Fragment,null,React.createElement("strong",null,"AVOID:")," Edoxaban not recommended with CrCl <15 mL/min (patient: ",a,")."):a!==null&&a<=50?React.createElement(React.Fragment,null,React.createElement("strong",null,"DOSE REDUCTION:")," Edoxaban ",React.createElement("strong",null,"30mg daily")," (CrCl ",a," mL/min). Also reduce if wt \u226460kg or concomitant P-gp inhibitor. (ENGAGE AF-TIMI 48)"):a!==null?React.createElement(React.Fragment,null,React.createElement("strong",null,"Standard dose: Edoxaban 60mg daily")," (CrCl ",a," mL/min). (ENGAGE AF-TIMI 48)"):React.createElement(React.Fragment,null,"Edoxaban 30mg daily if CrCl 15-50 or weight \u226460kg or concomitant P-gp inhibitor. Avoid if CrCl >95 (reduced efficacy, ENGAGE AF-TIMI 48).")))})())),React.createElement("div",{className:"bg-orange-50 border border-orange-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-orange-800 mb-2 text-sm"},"DAPT Duration & Auto-Stop"),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",null,React.createElement("strong",null,"Minor stroke/TIA (NIHSS \u22643):")," DAPT (ASA + clopidogrel) x 21 days, then monotherapy (CHANCE/POINT)."),React.createElement("p",null,React.createElement("strong",null,"CYP2C19 LOF carrier:")," ASA + ticagrelor x 30 days, then monotherapy (CHANCE-2)."),React.createElement("p",{className:"text-red-600 font-medium"},"Class III (Harm): DAPT beyond 90 days increases bleeding risk without benefit (MATCH)."),React.createElement("p",null,React.createElement("strong",null,"ICAD-specific:")," ASA 325mg + clopidogrel 75mg x 90 days, then ASA 325mg monotherapy (SAMMPRIS)."))),React.createElement("div",{className:"bg-purple-50 border border-purple-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-purple-800 mb-2 text-sm"},"Anticoagulant Bridging (PAUSE Protocol)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"DOAC Type"),React.createElement("select",{value:(t.anticoagBridging||{}).doacType||"",onChange:e=>r({...t,anticoagBridging:{...t.anticoagBridging||{},doacType:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"apixaban"},"Apixaban"),React.createElement("option",{value:"rivaroxaban"},"Rivaroxaban"),React.createElement("option",{value:"dabigatran"},"Dabigatran"),React.createElement("option",{value:"edoxaban"},"Edoxaban"),React.createElement("option",{value:"warfarin"},"Warfarin (see bridging below)"))),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"CrCl (mL/min)"),React.createElement("input",{type:"number",value:(t.anticoagBridging||{}).crCl||"",onChange:e=>r({...t,anticoagBridging:{...t.anticoagBridging||{},crCl:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs",placeholder:"mL/min"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Procedure Risk"),React.createElement("select",{value:(t.anticoagBridging||{}).procedureRisk||"",onChange:e=>r({...t,anticoagBridging:{...t.anticoagBridging||{},procedureRisk:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"low"},"Low bleed risk"),React.createElement("option",{value:"high"},"High bleed risk"))),React.createElement("div",null,React.createElement("label",{className:"flex items-center gap-1 text-xs mt-3"},React.createElement("input",{type:"checkbox",checked:!!(t.anticoagBridging||{}).warfarinBridgeIndication,onChange:e=>r({...t,anticoagBridging:{...t.anticoagBridging||{},warfarinBridgeIndication:e.target.checked}})}),"Warfarin bridging indicated (mechanical valve / APS only)"))),(t.anticoagBridging||{}).doacType&&(t.anticoagBridging||{}).doacType!=="warfarin"&&React.createElement("div",{className:"mt-2 p-2 bg-purple-100 rounded text-xs text-purple-800"},React.createElement("strong",null,"PAUSE Protocol:")," DOACs \u2014 NO heparin bridging needed (Class I, LOE A). Hold ",(t.anticoagBridging||{}).procedureRisk==="high"?"2-3 days":"1-2 days"," pre-procedure",(t.anticoagBridging||{}).crCl&&parseInt((t.anticoagBridging||{}).crCl)<50&&(t.anticoagBridging||{}).doacType==="dabigatran"?" (extend to 4-5 days for dabigatran with CrCl <50)":"",". Resume 24-48h post-procedure (24h low risk, 48-72h high risk). BRIDGE trial: bridging with LMWH for warfarin increases bleeding without reducing thromboembolism."),(t.anticoagBridging||{}).doacType==="warfarin"&&React.createElement("div",{className:"mt-2 p-2 bg-amber-100 rounded text-xs text-amber-800"},React.createElement("strong",null,"Warfarin periprocedural:")," Hold 5 days pre-procedure (target INR <1.5). Bridge with LMWH ONLY if: mechanical mitral valve, mechanical aortic valve with additional risk factors, or antiphospholipid syndrome (Class I). For AF alone, do NOT bridge (BRIDGE trial).")),React.createElement("div",{className:"bg-teal-50 border border-teal-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-teal-800 mb-2 text-sm"},"Additional Considerations"),React.createElement("div",{className:"text-xs text-gray-700 space-y-2"},React.createElement("div",{className:"p-2 bg-white border border-teal-100 rounded"},React.createElement("strong",null,"Statin After ICH:")," AHA 2022 ICH guidelines \u2014 statins may be continued or started for patients with compelling cardiovascular indication (Class IIb, LOE B-NR). Avoid in lobar ICH with probable CAA unless strong ASCVD indication."),React.createElement("div",{className:"p-2 bg-white border border-teal-100 rounded"},React.createElement("strong",null,"Pioglitazone (IRIS trial):")," For non-diabetic patients with insulin resistance (HOMA-IR >3.0) and ischemic stroke/TIA, pioglitazone 15-45mg reduces recurrent stroke/MI (HR 0.76, NNT ~17 over 5y). Monitor weight, edema, fracture risk. Contraindicated in HF, bladder cancer. ",React.createElement("em",null,"Class IIa, LOE B-R.")))),React.createElement("div",{className:"bg-gray-50 border border-gray-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-gray-800 mb-2"},"Follow-Up Timeline"),React.createElement("select",{value:(t.secondaryPrevention||{}).followUpTimeline||"",onChange:e=>r({...t,secondaryPrevention:{...t.secondaryPrevention||{},followUpTimeline:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"-- Select follow-up plan --"),React.createElement("option",{value:"1-2wk"},"1-2 weeks (high risk, post-TNK, carotid surgery)"),React.createElement("option",{value:"3mo"},"3 months (standard)"),React.createElement("option",{value:"6mo"},"6 months"),React.createElement("option",{value:"12mo"},"12 months"),React.createElement("option",{value:"custom"},"Custom (specify in notes)")),React.createElement("div",{className:"text-xs text-gray-500 mt-1"},"Recommended schedule: 1-2 wk post-discharge, then 3 mo, 6 mo, 12 mo. Adjust based on severity and risk factors.")))),t.diagnosis&&(j(t.diagnosis)==="ischemic"||j(t.diagnosis)==="ich")&&React.createElement("details",{className:"bg-white border-2 border-orange-300 rounded-lg shadow-md"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-orange-900 hover:bg-orange-50 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"clipboard-list",className:"w-5 h-5 text-orange-600"}),"Acute Care Protocols"),React.createElement("span",{className:"text-xs text-orange-500 font-normal"},"HT, Angioedema, Dysphagia, Mobilization, Hyperglycemia, DOAC Timing, Carotid, ESUS, ICH Anticoag")),React.createElement("div",{className:"p-4 pt-0 space-y-4"},j(t.diagnosis)==="ischemic"&&React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-red-800 mb-2"},"Hemorrhagic Transformation (HT) Monitoring"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"flex items-center gap-2 mb-2"},React.createElement("input",{type:"checkbox",checked:!!(t.hemorrhagicTransformation||{}).detected,onChange:e=>r({...t,hemorrhagicTransformation:{...t.hemorrhagicTransformation||{},detected:e.target.checked}})}),React.createElement("span",{className:"text-sm font-medium"},"HT detected on imaging")),(t.hemorrhagicTransformation||{}).detected&&React.createElement("div",{className:"space-y-2 ml-6"},React.createElement("select",{value:(t.hemorrhagicTransformation||{}).classification||"",onChange:e=>r({...t,hemorrhagicTransformation:{...t.hemorrhagicTransformation||{},classification:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"ECASS Classification"),React.createElement("option",{value:"HI-1"},"HI-1: Small petechiae along margin"),React.createElement("option",{value:"HI-2"},"HI-2: Confluent petechiae, no mass effect"),React.createElement("option",{value:"PH-1"},"PH-1: Hematoma \u226430% infarct, mild mass effect"),React.createElement("option",{value:"PH-2"},"PH-2: Hematoma >30% infarct, significant mass effect")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.hemorrhagicTransformation||{}).symptomatic,onChange:e=>r({...t,hemorrhagicTransformation:{...t.hemorrhagicTransformation||{},symptomatic:e.target.checked}})}),React.createElement("span",{className:"text-xs text-red-700 font-medium"},"Symptomatic (sICH): NIHSS increase \u22654 points")))),React.createElement("div",null,(t.hemorrhagicTransformation||{}).detected&&React.createElement("div",{className:"space-y-2"},React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},((t.hemorrhagicTransformation||{}).classification||"").startsWith("HI")&&React.createElement("p",{className:"text-green-700"},"HI-1/2: Generally benign. May continue antiplatelets. Repeat imaging in 24h."),(t.hemorrhagicTransformation||{}).classification==="PH-1"&&React.createElement("p",{className:"text-amber-700"},"PH-1: Hold antithrombotics 24-48h. Repeat CT. Consider reversal if post-TNK and symptomatic."),(t.hemorrhagicTransformation||{}).classification==="PH-2"&&React.createElement("p",{className:"text-red-700"},"PH-2: Hold all antithrombotics. STAT labs (fibrinogen, platelets, INR). If post-TNK: cryoprecipitate 10U + TXA 1g. Neurosurgery consult.")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.hemorrhagicTransformation||{}).antithromboticHeld,onChange:e=>r({...t,hemorrhagicTransformation:{...t.hemorrhagicTransformation||{},antithromboticHeld:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Antithrombotics held")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.hemorrhagicTransformation||{}).reimagingPlanned,onChange:e=>r({...t,hemorrhagicTransformation:{...t.hemorrhagicTransformation||{},reimagingPlanned:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Repeat imaging planned")))))),j(t.diagnosis)==="ischemic"&&(t.tnkRecommended||t.tnkAdminTime)&&React.createElement("div",{className:"border rounded-lg p-3 "+((t.angioedema||{}).detected?"bg-red-50 border-red-300":"bg-orange-50 border-orange-200")},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("h4",{className:"font-semibold text-orange-800 flex items-center gap-2"},"Post-TNK Angioedema Protocol",(t.medications||"").toLowerCase().match(/lisinopril|enalapril|ramipril|captopril|benazepril|fosinopril|perindopril|quinapril|trandolapril|ace.?i/)&&React.createElement("span",{className:"px-2 py-0.5 bg-red-100 text-red-700 rounded-full text-xs font-bold"},"ACEi detected \u2014 5x risk")),React.createElement("span",{className:"text-xs text-gray-500"},"Incidence: 1-5% post-thrombolysis")),React.createElement("label",{className:"flex items-center gap-2 mb-2"},React.createElement("input",{type:"checkbox",checked:!!(t.angioedema||{}).detected,onChange:e=>r({...t,angioedema:{...t.angioedema||{},detected:e.target.checked}}),className:"w-4 h-4"}),React.createElement("span",{className:"text-sm font-medium text-red-800"},"Angioedema detected")),(t.angioedema||{}).detected?React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"flex gap-3 items-center"},React.createElement("label",{className:"text-xs font-medium text-gray-700"},"Onset time:"),React.createElement("input",{type:"time",value:(t.angioedema||{}).onsetTime||"",onChange:e=>r({...t,angioedema:{...t.angioedema||{},onsetTime:e.target.value}}),className:"px-2 py-1 border border-gray-300 rounded text-sm"}),React.createElement("select",{value:(t.angioedema||{}).severity||"",onChange:e=>r({...t,angioedema:{...t.angioedema||{},severity:e.target.value}}),className:"px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Severity"),React.createElement("option",{value:"mild"},"Mild \u2014 lip/facial swelling only"),React.createElement("option",{value:"moderate"},"Moderate \u2014 tongue swelling, no airway compromise"),React.createElement("option",{value:"severe"},"Severe \u2014 tongue/floor of mouth, airway compromise"))),React.createElement("div",{className:"bg-white border border-red-200 rounded-lg p-3"},React.createElement("p",{className:"text-xs font-bold text-red-800 mb-2"},"Stepwise Management (execute in order):"),React.createElement("div",{className:"space-y-2"},[{id:"stopTnk",step:1,label:"Stop TNK if still infusing + Hold ACE inhibitor",detail:"Discontinue immediately. ACEi increases bradykinin \u2014 primary mediator."},{id:"steroids",step:2,label:"Methylprednisolone 125 mg IV + Diphenhydramine 50 mg IV + Famotidine 20 mg IV",detail:"Standard antihistamine/steroid protocol. Onset 15-30 min."},{id:"epinephrine",step:3,label:"Epinephrine 0.3 mg IM (1:1000) if progressing",detail:"For moderate-severe or any airway compromise. May repeat q5-15 min."},{id:"icatibant",step:4,label:"Icatibant 30 mg SC OR C1 esterase inhibitor 20 U/kg IV",detail:"Bradykinin B2 receptor antagonist. For refractory angioedema not responding to steps 1-3. Consider early if ACEi-related mechanism suspected."},{id:"airway",step:5,label:"Prepare for intubation \u2014 call anesthesia/ENT",detail:"Fiberoptic intubation preferred. Surgical airway backup if tongue/floor of mouth massive. Do NOT delay if stridor or desaturation."}].map(e=>{let a=(t.angioedema||{}).stepsTaken||{},i=!!a[e.id],s=(t.angioedema||{}).severity,o=e.step<=2||s==="moderate"&&e.step<=3||s==="severe";return React.createElement("div",{key:e.id,className:"flex items-start gap-2 p-2 rounded "+(i?"bg-green-50":o?"bg-red-50":"bg-gray-50")},React.createElement("input",{type:"checkbox",checked:i,onChange:n=>r({...t,angioedema:{...t.angioedema||{},stepsTaken:{...a,[e.id]:n.target.checked}}}),className:"w-4 h-4 mt-0.5 flex-shrink-0"}),React.createElement("div",{className:"min-w-0"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"text-xs font-bold text-gray-500"},"Step ",e.step),React.createElement("span",{className:"text-sm font-medium "+(i?"text-green-800 line-through":"text-gray-900")},e.label)),React.createElement("p",{className:"text-xs text-gray-600 mt-0.5"},e.detail)))}))),React.createElement("div",{className:"flex gap-4"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.angioedema||{}).intubated,onChange:e=>r({...t,angioedema:{...t.angioedema||{},intubated:e.target.checked}})}),React.createElement("span",{className:"text-xs font-medium text-red-700"},"Patient intubated")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.angioedema||{}).resolved,onChange:e=>r({...t,angioedema:{...t.angioedema||{},resolved:e.target.checked}})}),React.createElement("span",{className:"text-xs font-medium text-green-700"},"Angioedema resolved"))),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.angioedema||{}).aceInhibitorUse,onChange:e=>r({...t,angioedema:{...t.angioedema||{},aceInhibitorUse:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Patient was on ACE inhibitor (permanently discontinue)"))):React.createElement("div",{className:"text-xs text-gray-600 space-y-1"},React.createElement("p",null,React.createElement("strong",null,"Monitor for:")," Lip, tongue, or oropharyngeal swelling within 2 hours of TNK. Higher risk with ACE inhibitor use (5x), anterior circulation infarcts involving insular cortex."),React.createElement("p",null,React.createElement("strong",null,"If detected:")," Check the box above to activate the stepwise management protocol."))),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-blue-800 mb-2"},"Dysphagia Screening Protocol"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.dysphagiaScreening||{}).bedsideScreenPerformed,onChange:e=>r({...t,dysphagiaScreening:{...t.dysphagiaScreening||{},bedsideScreenPerformed:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Bedside swallow screen performed")),(t.dysphagiaScreening||{}).bedsideScreenPerformed&&React.createElement("select",{value:(t.dysphagiaScreening||{}).bedsideScreenResult||"",onChange:e=>r({...t,dysphagiaScreening:{...t.dysphagiaScreening||{},bedsideScreenResult:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm ml-6"},React.createElement("option",{value:""},"Result"),React.createElement("option",{value:"pass"},"Pass \u2014 regular diet"),React.createElement("option",{value:"fail"},"Fail \u2014 NPO, SLP consult"),React.createElement("option",{value:"modified"},"Modified diet recommended"))),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.dysphagiaScreening||{}).npoStatus,onChange:e=>r({...t,dysphagiaScreening:{...t.dysphagiaScreening||{},npoStatus:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"NPO until screened")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.dysphagiaScreening||{}).slpConsultOrdered,onChange:e=>r({...t,dysphagiaScreening:{...t.dysphagiaScreening||{},slpConsultOrdered:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"SLP consult ordered")),React.createElement("select",{value:(t.dysphagiaScreening||{}).instrumentalAssessment||"",onChange:e=>r({...t,dysphagiaScreening:{...t.dysphagiaScreening||{},instrumentalAssessment:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Instrumental assessment"),React.createElement("option",{value:"vfss"},"VFSS (modified barium swallow)"),React.createElement("option",{value:"fees"},"FEES (fiberoptic endoscopic evaluation)"),React.createElement("option",{value:"not-needed"},"Not needed")))),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"Class I: All stroke patients must have dysphagia screening before oral intake. Failed screen \u2192 NPO + SLP within 24h. Aspiration pneumonia risk increases 3x without screening.")),React.createElement("div",{className:"bg-green-50 border border-green-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-green-800 mb-2"},"Early Mobilization (AVERT-Informed)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("select",{value:(t.earlyMobilization||{}).timingDecision||"",onChange:e=>r({...t,earlyMobilization:{...t.earlyMobilization||{},timingDecision:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Mobilization timing"),React.createElement("option",{value:"24-48h"},"24-48h post-onset (recommended)"),React.createElement("option",{value:"deferred"},"Deferred >48h (severe stroke, hemodynamic instability)"),React.createElement("option",{value:"contraindicated"},"Contraindicated (active ICH expansion, unstable)"))),React.createElement("div",{className:"space-y-1"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.earlyMobilization||{}).mobilizationStarted,onChange:e=>r({...t,earlyMobilization:{...t.earlyMobilization||{},mobilizationStarted:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Mobilization initiated")),React.createElement("select",{value:(t.earlyMobilization||{}).sessionFrequency||"",onChange:e=>r({...t,earlyMobilization:{...t.earlyMobilization||{},sessionFrequency:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Session frequency"),React.createElement("option",{value:"short-frequent"},"Short, frequent sessions (AVERT protocol)"),React.createElement("option",{value:"standard-pt"},"Standard PT schedule"),React.createElement("option",{value:"intensive"},"Intensive rehab (\u22653h/day)")))),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"AVERT: Very early mobilization (<24h) is harmful (Class III). Graduated approach starting 24-48h preferred. Short, frequent sessions better than prolonged single sessions.")),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-amber-800 mb-2"},"Acute Hyperglycemia Management"),React.createElement("div",{className:"text-sm text-gray-700 space-y-1"},React.createElement("p",null,React.createElement("strong",null,"Target glucose: 140-180 mg/dL")," (Class I, LOE A)"),React.createElement("p",{className:"text-red-700 font-semibold"},"Intensive glucose control (80-130 mg/dL) is CLASS III: HARM"),React.createElement("p",null,"\u2022 Treat glucose >180 mg/dL with insulin"),React.createElement("p",null,"\u2022 Avoid hypoglycemia (<60 mg/dL) \u2014 associated with worse outcomes"),React.createElement("p",null,"\u2022 Continuous glucose monitoring may be considered"),React.createElement("p",{className:"text-xs text-gray-500 italic"},"SHINE trial, AHA/ASA 2019 + 2026 update"))),j(t.diagnosis)==="ischemic"&&React.createElement("div",{className:"bg-purple-50 border border-purple-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-purple-800 mb-2"},"DOAC Timing Algorithm (AF-Stroke)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.doacTiming||{}).strokeSeverity||"",onChange:e=>r({...t,doacTiming:{...t.doacTiming||{},strokeSeverity:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Stroke severity"),React.createElement("option",{value:"minor"},"Minor (NIHSS <8, small infarct)"),React.createElement("option",{value:"moderate"},"Moderate (NIHSS 8-15)"),React.createElement("option",{value:"severe"},"Severe (NIHSS >15 or large infarct)")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.doacTiming||{}).hemorrhagicTransformation,onChange:e=>r({...t,doacTiming:{...t.doacTiming||{},hemorrhagicTransformation:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Hemorrhagic transformation present")),React.createElement("select",{value:(t.doacTiming||{}).doacAgent||"",onChange:e=>r({...t,doacTiming:{...t.doacTiming||{},doacAgent:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"DOAC agent"),React.createElement("option",{value:"apixaban"},"Apixaban 5mg BID"),React.createElement("option",{value:"apixaban-reduced"},"Apixaban 2.5mg BID (dose reduction criteria met)"),React.createElement("option",{value:"rivaroxaban"},"Rivaroxaban 20mg daily"),React.createElement("option",{value:"rivaroxaban-reduced"},"Rivaroxaban 15mg daily (CrCl 15-50)"),React.createElement("option",{value:"dabigatran"},"Dabigatran 150mg BID"),React.createElement("option",{value:"edoxaban"},"Edoxaban 60mg daily"))),React.createElement("div",null,(t.doacTiming||{}).strokeSeverity&&React.createElement("div",{className:`p-2 rounded border text-sm ${(t.doacTiming||{}).hemorrhagicTransformation?"bg-red-100 border-red-300":(t.doacTiming||{}).strokeSeverity==="minor"?"bg-green-100 border-green-300":(t.doacTiming||{}).strokeSeverity==="moderate"?"bg-amber-100 border-amber-300":"bg-red-100 border-red-300"}`},React.createElement("p",{className:"font-semibold mb-1"},(t.doacTiming||{}).hemorrhagicTransformation?"Delay DOAC \u2014 repeat imaging first":(t.doacTiming||{}).strokeSeverity==="minor"?"Start DOAC within 48 hours":(t.doacTiming||{}).strokeSeverity==="moderate"?"Start DOAC Day 3-5":"Start DOAC Day 6-14"),React.createElement("p",{className:"text-xs text-gray-600"},"CATALYST meta-analysis (ELAN, OPTIMAS, TIMING, START). Early initiation is safe and non-inferior to delayed."),(t.doacTiming||{}).hemorrhagicTransformation&&React.createElement("p",{className:"text-xs text-red-700 mt-1"},"HT present: Repeat CT before DOAC initiation. If PH-2, delay until stable and consult.")),React.createElement("input",{type:"text",value:(t.doacTiming||{}).doacInitiationDay||"",onChange:e=>r({...t,doacTiming:{...t.doacTiming||{},doacInitiationDay:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs mt-2",placeholder:"Planned initiation day (e.g., Day 3)"})))),j(t.diagnosis)==="ischemic"&&React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-indigo-800 mb-2"},"Carotid Stenosis Management"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Side"),React.createElement("select",{value:(t.carotidManagement||{}).stenosisSide||"",onChange:e=>r({...t,carotidManagement:{...t.carotidManagement||{},stenosisSide:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"left"},"Left"),React.createElement("option",{value:"right"},"Right"),React.createElement("option",{value:"bilateral"},"Bilateral"))),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Degree of Stenosis"),React.createElement("select",{value:(t.carotidManagement||{}).stenosisDegree||"",onChange:e=>r({...t,carotidManagement:{...t.carotidManagement||{},stenosisDegree:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"<50"},"<50% (mild)"),React.createElement("option",{value:"50-69"},"50-69% (moderate)"),React.createElement("option",{value:"70-99"},"70-99% (severe)"),React.createElement("option",{value:"occlusion"},"Complete occlusion"))),React.createElement("div",null,React.createElement("label",{className:"flex items-center gap-2 mt-4"},React.createElement("input",{type:"checkbox",checked:!!(t.carotidManagement||{}).symptomatic,onChange:e=>r({...t,carotidManagement:{...t.carotidManagement||{},symptomatic:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Symptomatic (ipsilateral to stroke)")))),(t.carotidManagement||{}).stenosisDegree&&React.createElement("div",{className:"mt-2"},React.createElement("select",{value:(t.carotidManagement||{}).intervention||"",onChange:e=>r({...t,carotidManagement:{...t.carotidManagement||{},intervention:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Intervention plan"),React.createElement("option",{value:"cea"},"CEA (within 2 weeks if symptomatic \u226550%)"),React.createElement("option",{value:"cas"},"CAS (if high surgical risk)"),React.createElement("option",{value:"tcar"},"TCAR (transcarotid artery revascularization)"),React.createElement("option",{value:"medical-only"},"Medical management only")),(t.carotidManagement||{}).symptomatic&&((t.carotidManagement||{}).stenosisDegree==="50-69"||(t.carotidManagement||{}).stenosisDegree==="70-99")&&React.createElement("div",{className:"mt-1 p-2 bg-green-100 rounded text-xs text-green-800"},React.createElement("strong",null,"Symptomatic ",(t.carotidManagement||{}).stenosisDegree,"%:")," CEA within 2 weeks recommended (Class I, LOE A). Benefit greatest when performed early (NNT = 5 for \u226570%)."),!(t.carotidManagement||{}).symptomatic&&(t.carotidManagement||{}).stenosisDegree==="70-99"&&React.createElement("div",{className:"mt-1 p-2 bg-yellow-100 rounded text-xs text-yellow-800"},React.createElement("strong",null,"Asymptomatic \u226570%:")," CREST-2 showed CEA + medical NOT superior to medical management alone. Optimize medical therapy first (high-intensity statin, BP control, antiplatelet)."))),j(t.diagnosis)==="ischemic"&&React.createElement("div",{className:"bg-cyan-50 border border-cyan-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-cyan-800 mb-2"},"ESUS / Cryptogenic Stroke Workup"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.esusWorkup||{}).cardiacMonitoringType||"",onChange:e=>r({...t,esusWorkup:{...t.esusWorkup||{},cardiacMonitoringType:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Cardiac monitoring plan"),React.createElement("option",{value:"30-day-monitor"},"30-day ambulatory monitor (preferred)"),React.createElement("option",{value:"14-day-patch"},"14-day continuous patch"),React.createElement("option",{value:"ilr"},"Implantable loop recorder"),React.createElement("option",{value:"telemetry-only"},"Inpatient telemetry only")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.esusWorkup||{}).teePerformed,onChange:e=>r({...t,esusWorkup:{...t.esusWorkup||{},teePerformed:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"TEE performed/ordered")),(t.esusWorkup||{}).teePerformed&&React.createElement("input",{type:"text",value:(t.esusWorkup||{}).teeFindings||"",onChange:e=>r({...t,esusWorkup:{...t.esusWorkup||{},teeFindings:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs",placeholder:"TEE findings (PFO, ASA, valve, LAA thrombus)"})),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.esusWorkup||{}).afDetected,onChange:e=>r({...t,esusWorkup:{...t.esusWorkup||{},afDetected:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"AF detected on monitoring")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.esusWorkup||{}).hypercoagWorkup,onChange:e=>r({...t,esusWorkup:{...t.esusWorkup||{},hypercoagWorkup:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Hypercoagulable workup ordered")),React.createElement("select",{value:(t.esusWorkup||{}).esusAntiplatelet||"",onChange:e=>r({...t,esusWorkup:{...t.esusWorkup||{},esusAntiplatelet:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"ESUS antithrombotic"),React.createElement("option",{value:"antiplatelet"},"Antiplatelet (NAVIGATE-ESUS, RE-SPECT ESUS: no DOAC benefit)"),React.createElement("option",{value:"doac-af-found"},"DOAC \u2014 AF discovered on monitoring")))),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"ACC 2024 ECDP: Extended cardiac monitoring is reasonable for all cryptogenic stroke. PER-DIEM trial supports early prolonged monitoring. NAVIGATE-ESUS and RE-SPECT ESUS showed no benefit of DOAC over antiplatelet for ESUS without AF.")),j(t.diagnosis)==="ich"&&React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-red-800 mb-2"},"ICH: Anticoagulation Resumption Decision"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.ichAnticoagResumption||{}).ichLocation||"",onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},ichLocation:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"ICH location"),React.createElement("option",{value:"deep"},"Deep (basal ganglia, thalamus, pons)"),React.createElement("option",{value:"lobar"},"Lobar"),React.createElement("option",{value:"cerebellar"},"Cerebellar"),React.createElement("option",{value:"brainstem"},"Brainstem")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.ichAnticoagResumption||{}).caaFeatures,onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},caaFeatures:e.target.checked}})}),React.createElement("span",{className:"text-sm text-red-700"},"CAA features on MRI (cortical siderosis, multiple lobar microbleeds)")),React.createElement("div",{className:"grid grid-cols-2 gap-2"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"CHA2DS2-VASc"),React.createElement("input",{type:"number",value:(t.ichAnticoagResumption||{}).chadsVascScore||"",onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},chadsVascScore:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",min:"0",max:"9"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"HAS-BLED"),React.createElement("input",{type:"number",value:(t.ichAnticoagResumption||{}).hasbledScore||"",onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},hasbledScore:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",min:"0",max:"9"})))),React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.ichAnticoagResumption||{}).decision||"",onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},decision:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Decision"),React.createElement("option",{value:"resume-doac"},"Resume DOAC (after 4-8 weeks)"),React.createElement("option",{value:"resume-doac-early"},"Resume DOAC early (high CHA2DS2-VASc, deep ICH)"),React.createElement("option",{value:"laao"},"LAAO (Watchman) referral \u2014 high bleed risk"),React.createElement("option",{value:"no-anticoag"},"No anticoagulation \u2014 high recurrent ICH risk"),React.createElement("option",{value:"defer"},"Defer decision \u2014 multidisciplinary discussion")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.ichAnticoagResumption||{}).laaoConsidered,onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},laaoConsidered:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"LAAO evaluation considered")),React.createElement("textarea",{value:(t.ichAnticoagResumption||{}).rationale||"",onChange:e=>r({...t,ichAnticoagResumption:{...t.ichAnticoagResumption||{},rationale:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs",rows:"2",placeholder:"Rationale for decision..."}),(t.ichAnticoagResumption||{}).caaFeatures&&React.createElement("div",{className:"p-1 bg-red-100 rounded text-xs text-red-700"},"CAA + AF: High risk of both recurrent ICH and stroke. LAAO may be preferred. PRESTIGE-AF: DOAC had higher ICH recurrence in CAA patients."))),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"PRESTIGE-AF, SoSTART, APACHE-AF: Resuming OAC after ICH may be reasonable in selected patients (Class IIb). Deep ICH with high CHA2DS2-VASc favors resumption. Lobar ICH with CAA features favors LAAO or no anticoagulation.")),React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-indigo-800 mb-2"},"VTE Prophylaxis Protocol"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.vteProphylaxis||{}).ipcApplied,onChange:e=>r({...t,vteProphylaxis:{...t.vteProphylaxis||{},ipcApplied:e.target.checked}})}),React.createElement("span",{className:"text-sm font-medium"},"IPC applied at admission (Class I, LOE A)")),React.createElement("select",{value:(t.vteProphylaxis||{}).pharmacoProphylaxis||"",onChange:e=>r({...t,vteProphylaxis:{...t.vteProphylaxis||{},pharmacoProphylaxis:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Pharmacologic prophylaxis"),React.createElement("option",{value:"enoxaparin-40"},"Enoxaparin 40mg SC daily (preferred \u2014 PREVAIL)"),React.createElement("option",{value:"enoxaparin-30"},"Enoxaparin 30mg SC daily (CrCl <30)"),React.createElement("option",{value:"ufh-5000"},"UFH 5000u SC q8-12h (alternative)"),React.createElement("option",{value:"held-post-tpa"},"Held \u2014 post-tPA (24h wait + CT clear)"),React.createElement("option",{value:"held-post-ich"},"Held \u2014 post-ICH (24-48h + hematoma stability)"),React.createElement("option",{value:"contraindicated"},"Contraindicated")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.vteProphylaxis||{}).antiXaMonitoring,onChange:e=>r({...t,vteProphylaxis:{...t.vteProphylaxis||{},antiXaMonitoring:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Anti-Xa monitoring (BMI >40 or CrCl <30)"))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",{className:"font-semibold text-red-700"},"TED hose alone are NOT effective (Class III)"),React.createElement("p",null,"\u2022 IPC immediately for all immobile stroke patients (CLOTS 3)"),React.createElement("p",null,"\u2022 Post-tPA: no enoxaparin for 24h + CT clear"),React.createElement("p",null,"\u2022 Post-ICH: enoxaparin safe at 24-48h after hematoma stability"),React.createElement("p",null,"\u2022 Duration: 10-14 days or until independently mobile"),React.createElement("p",null,"\u2022 Combined IPC + LMWH for highest-risk patients (prior VTE, malignancy)")))),React.createElement("div",{className:"bg-orange-50 border border-orange-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-orange-800 mb-2"},"Fever Management Protocol (FeSS Bundle)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.feverManagement||{}).feverDetected,onChange:e=>r({...t,feverManagement:{...t.feverManagement||{},feverDetected:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Fever detected (>37.5C)")),(t.feverManagement||{}).feverDetected&&React.createElement("div",{className:"space-y-2 ml-4"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.feverManagement||{}).infectionWorkupSent,onChange:e=>r({...t,feverManagement:{...t.feverManagement||{},infectionWorkupSent:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Infection workup sent (blood cx, UA, CXR)")),React.createElement("select",{value:(t.feverManagement||{}).escalationLevel||"",onChange:e=>r({...t,feverManagement:{...t.feverManagement||{},escalationLevel:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Escalation level"),React.createElement("option",{value:"acetaminophen"},"1. Acetaminophen 650-1000mg q6h"),React.createElement("option",{value:"surface-cooling"},"2. Surface cooling + counter-warming"),React.createElement("option",{value:"iv-mag"},"3. IV magnesium 2g bolus"),React.createElement("option",{value:"buspirone"},"4. Buspirone 30mg q8h"),React.createElement("option",{value:"meperidine"},"5. Meperidine 25-50mg IV q4-6h PRN"),React.createElement("option",{value:"sedation"},"6. Sedation (intubated patients)")),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"BSAS score (0-3)"),React.createElement("select",{value:(t.feverManagement||{}).bsasScore||"",onChange:e=>r({...t,feverManagement:{...t.feverManagement||{},bsasScore:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"BSAS"),React.createElement("option",{value:"0"},"0 \u2014 No shivering"),React.createElement("option",{value:"1"},"1 \u2014 Mild (neck/thorax only)"),React.createElement("option",{value:"2"},"2 \u2014 Moderate (upper extremities)"),React.createElement("option",{value:"3"},"3 \u2014 Severe (whole body/sustained)"))))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",{className:"font-semibold"},"FeSS Bundle (QASC: 16% reduction in death/dependency):"),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"Fe"),"ver: target 36.0-37.5C, temp q4h, treat within 1h"),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"S"),"ugar: target 140-180 mg/dL (see Hyperglycemia section)"),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"S"),"wallowing: mandatory dysphagia screen before oral intake"),React.createElement("p",{className:"text-red-700 font-semibold mt-1"},"Avoid NSAIDs in stroke (bleeding risk, renal, antiplatelet interference)"),React.createElement("p",null,"\u2022 Acetaminophen is first-line antipyretic")))),React.createElement("div",{className:"bg-slate-50 border border-slate-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-slate-800 mb-2"},"Osmotic Therapy Decision Tree"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.osmoticTherapy||{}).agentUsed||"",onChange:e=>r({...t,osmoticTherapy:{...t.osmoticTherapy||{},agentUsed:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Agent"),React.createElement("option",{value:"mannitol-20"},"Mannitol 20% (0.5-1 g/kg bolus)"),React.createElement("option",{value:"hts-3"},"HTS 3% (250 mL or 5 mL/kg bolus)"),React.createElement("option",{value:"hts-23.4"},"HTS 23.4% (30 mL via central line \u2014 herniation)"),React.createElement("option",{value:"none"},"No osmotic therapy")),React.createElement("select",{value:(t.osmoticTherapy||{}).indication||"",onChange:e=>r({...t,osmoticTherapy:{...t.osmoticTherapy||{},indication:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Indication"),React.createElement("option",{value:"cerebral-edema"},"Cerebral edema"),React.createElement("option",{value:"herniation"},"Impending/active herniation"),React.createElement("option",{value:"icp-elevation"},"ICP elevation"))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",null,React.createElement("strong",null,"Mannitol:")," hold if osmolality >320 or gap >20; BMP q6h"),React.createElement("p",null,React.createElement("strong",null,"HTS 3%:")," Na q4-6h; target 145-155; max 8-10 mEq/L/24h"),React.createElement("p",null,React.createElement("strong",null,"HTS preferred")," if renal insufficiency (mannitol accumulates)"),React.createElement("p",null,React.createElement("strong",null,"HTS 23.4%:")," central line only; for refractory herniation")))),React.createElement("div",{className:"bg-lime-50 border border-lime-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-lime-800 mb-2"},"Nutritional Support Pathway"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.nutritionalSupport||{}).feedingRoute||"",onChange:e=>r({...t,nutritionalSupport:{...t.nutritionalSupport||{},feedingRoute:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Feeding route"),React.createElement("option",{value:"oral-regular"},"Oral \u2014 regular diet"),React.createElement("option",{value:"oral-modified"},"Oral \u2014 modified texture"),React.createElement("option",{value:"ngt"},"NG tube"),React.createElement("option",{value:"npo-pending"},"NPO \u2014 pending swallow evaluation"),React.createElement("option",{value:"peg"},"PEG tube")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.nutritionalSupport||{}).nutritionConsultOrdered,onChange:e=>r({...t,nutritionalSupport:{...t.nutritionalSupport||{},nutritionConsultOrdered:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Nutrition consult ordered"))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",null,"\u2022 Failed swallow: NG within 24-48h; SLP within 72h"),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"PEG at day 14-21")," if dysphagia persists (FOOD trial: early PEG worse)"),React.createElement("p",null,"\u2022 Target: 25-30 kcal/kg/day, protein 1.0-1.5 g/kg/day"),React.createElement("p",null,"\u2022 Start enteral nutrition within 24-48h"),React.createElement("p",null,"\u2022 Antithrombotics can continue during PEG (ASGE 2024)")))),React.createElement("div",{className:"bg-gray-50 border border-gray-300 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-gray-800 mb-2"},"Palliative Care & Goals of Care"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.palliativeCare||{}).goalsOfCareDiscussed,onChange:e=>r({...t,palliativeCare:{...t.palliativeCare||{},goalsOfCareDiscussed:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Goals-of-care conversation held")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.palliativeCare||{}).consultOrdered,onChange:e=>r({...t,palliativeCare:{...t.palliativeCare||{},consultOrdered:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Palliative care consult ordered")),React.createElement("select",{value:(t.palliativeCare||{}).goalsOfCareOutcome||"",onChange:e=>r({...t,palliativeCare:{...t.palliativeCare||{},goalsOfCareOutcome:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Outcome"),React.createElement("option",{value:"full-code"},"Full code \u2014 aggressive care"),React.createElement("option",{value:"limited-intervention"},"Limited intervention (no intubation)"),React.createElement("option",{value:"comfort-focused"},"Comfort-focused care"))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",{className:"text-red-700 font-semibold"},"Postpone new DNR until hospital day 2 (AHA/ASA 2022 ICH)"),React.createElement("p",null,"\u2022 Triggers: high NIHSS (\u226520), large ICH, failed EVT"),React.createElement("p",null,"\u2022 ICH score must NOT limit treatment"),React.createElement("p",null,"\u2022 Full aggressive care x 24-48h minimum for ICH"),React.createElement("p",null,"\u2022 Structured GOC at: craniectomy decision, failed recanalization, transitions")))))),t.diagnosis&&j(t.diagnosis)!=="mimic"&&React.createElement("details",{className:"bg-white border-2 border-violet-300 rounded-lg shadow-md"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-violet-900 hover:bg-violet-50 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"calendar",className:"w-5 h-5 text-violet-600"}),"Follow-Up Clinic Tools"),React.createElement("span",{className:"text-xs text-violet-500 font-normal"},"mRS, Driving, RTW, Spasticity, Pain, Fatigue, Alcohol, Travel")),React.createElement("div",{className:"p-4 pt-0 space-y-4"},React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-blue-800 mb-2"},"Modified Rankin Scale (mRS) Tracking"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-5 gap-2"},[{key:"discharge",label:"Discharge"},{key:"day30",label:"30 days"},{key:"day90",label:"90 days"},{key:"month6",label:"6 months"},{key:"month12",label:"12 months"}].map(e=>React.createElement("div",{key:e.key},React.createElement("label",{className:"text-xs text-gray-600"},e.label),React.createElement("select",{value:(t.mrsAssessment||{})[e.key]||"",onChange:a=>r({...t,mrsAssessment:{...t.mrsAssessment||{},[e.key]:a.target.value}}),className:"w-full px-1 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"--"),React.createElement("option",{value:"0"},"0 \u2014 No symptoms"),React.createElement("option",{value:"1"},"1 \u2014 No significant disability"),React.createElement("option",{value:"2"},"2 \u2014 Slight disability"),React.createElement("option",{value:"3"},"3 \u2014 Moderate disability"),React.createElement("option",{value:"4"},"4 \u2014 Moderately severe"),React.createElement("option",{value:"5"},"5 \u2014 Severe disability"),React.createElement("option",{value:"6"},"6 \u2014 Dead")))))),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-amber-800 mb-2"},"Driving Restrictions"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.drivingRestrictions||{}).counselingProvided,onChange:e=>r({...t,drivingRestrictions:{...t.drivingRestrictions||{},counselingProvided:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Driving cessation counseling provided")),React.createElement("select",{value:(t.drivingRestrictions||{}).restrictionDuration||"",onChange:e=>r({...t,drivingRestrictions:{...t.drivingRestrictions||{},restrictionDuration:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Restriction period"),React.createElement("option",{value:"1-month"},"1 month minimum (stroke/single TIA)"),React.createElement("option",{value:"3-months"},"3 months (multiple TIAs, commercial driver)"),React.createElement("option",{value:"6-months"},"6 months (severe stroke with residual deficits)"),React.createElement("option",{value:"1-year"},"1 year (commercial \u2014 FMCSA)"),React.createElement("option",{value:"indefinite"},"Indefinite (unresolved deficits)")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.drivingRestrictions||{}).drivingEvalReferral,onChange:e=>r({...t,drivingRestrictions:{...t.drivingRestrictions||{},drivingEvalReferral:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Driving evaluation referral (cognitive/visual/on-road)")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.drivingRestrictions||{}).commercialDriver,onChange:e=>r({...t,drivingRestrictions:{...t.drivingRestrictions||{},commercialDriver:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Commercial driver (CDL \u2014 FMCSA 1-year min)"))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",null,"\u2022 Acute symptomatic seizure within 24h does NOT trigger epilepsy driving rules"),React.createElement("p",null,"\u2022 Refer for formal evaluation if: visual field defect, cognitive deficit, limb impairment"),React.createElement("p",null,"\u2022 US: varies by state (no uniform federal standard for private vehicles)"),React.createElement("p",null,"\u2022 Document counseling in note for medicolegal purposes")))),React.createElement("div",{className:"bg-teal-50 border border-teal-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-teal-800 mb-2"},"Return to Work"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.returnToWork||{}).workingAge,onChange:e=>r({...t,returnToWork:{...t.returnToWork||{},workingAge:e.target.checked}})}),React.createElement("span",{className:"text-sm"},"Working-age patient")),(t.returnToWork||{}).workingAge&&React.createElement("div",{className:"space-y-2"},React.createElement("select",{value:(t.returnToWork||{}).expectedTimeline||"",onChange:e=>r({...t,returnToWork:{...t.returnToWork||{},expectedTimeline:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Expected timeline"),React.createElement("option",{value:"2-4-weeks"},"2-4 weeks (TIA/minor stroke)"),React.createElement("option",{value:"2-6-months"},"2-6 months (moderate stroke)"),React.createElement("option",{value:"6-12-months"},"6-12+ months (severe stroke)"),React.createElement("option",{value:"unable"},"Unable to return")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.returnToWork||{}).vocationalRehabReferral,onChange:e=>r({...t,returnToWork:{...t.returnToWork||{},vocationalRehabReferral:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Vocational rehab / OT referral for RTW")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.returnToWork||{}).phasedReturnPlan,onChange:e=>r({...t,returnToWork:{...t.returnToWork||{},phasedReturnPlan:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Phased return plan recommended")))),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",null,"\u2022 Address at every follow-up visit (<50% of working-age survivors return)"),React.createElement("p",null,"\u2022 Top barriers: fatigue, cognitive deficits, emotional changes"),React.createElement("p",null,"\u2022 RETAKE trial: structured OT + vocational rehab improves outcomes")))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-red-800 mb-2 text-sm"},"Spasticity"),React.createElement("label",{className:"flex items-center gap-2 mb-1"},React.createElement("input",{type:"checkbox",checked:!!(t.spasticity||{}).screenPerformed,onChange:e=>r({...t,spasticity:{...t.spasticity||{},screenPerformed:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Screened (Modified Ashworth)")),React.createElement("select",{value:(t.spasticity||{}).treatment||"",onChange:e=>r({...t,spasticity:{...t.spasticity||{},treatment:e.target.value}}),className:"w-full px-1 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Treatment"),React.createElement("option",{value:"none"},"No spasticity"),React.createElement("option",{value:"stretching"},"Stretching/ROM program"),React.createElement("option",{value:"botox"},"Botox referral (Class I, LOE A)"),React.createElement("option",{value:"oral-meds"},"Oral agents (baclofen/tizanidine)"),React.createElement("option",{value:"itb"},"ITB pump evaluation"))),React.createElement("div",{className:"bg-purple-50 border border-purple-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-purple-800 mb-2 text-sm"},"Central Pain (CPSP)"),React.createElement("label",{className:"flex items-center gap-2 mb-1"},React.createElement("input",{type:"checkbox",checked:!!(t.centralPain||{}).painPresent,onChange:e=>r({...t,centralPain:{...t.centralPain||{},painPresent:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"CPSP present (burning/shooting)")),React.createElement("select",{value:(t.centralPain||{}).treatment||"",onChange:e=>r({...t,centralPain:{...t.centralPain||{},treatment:e.target.value}}),className:"w-full px-1 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Treatment"),React.createElement("option",{value:"amitriptyline"},"Amitriptyline 75mg/day (1st line)"),React.createElement("option",{value:"lamotrigine"},"Lamotrigine (central pain-specific)"),React.createElement("option",{value:"gabapentin"},"Gabapentin/pregabalin"),React.createElement("option",{value:"duloxetine"},"Duloxetine")),React.createElement("p",{className:"text-xs text-red-600 mt-1"},"No opioids for CPSP")),React.createElement("div",{className:"bg-cyan-50 border border-cyan-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-cyan-800 mb-2 text-sm"},"Post-Stroke Fatigue"),React.createElement("label",{className:"flex items-center gap-2 mb-1"},React.createElement("input",{type:"checkbox",checked:!!(t.fatigue||{}).fatiguePresent,onChange:e=>r({...t,fatigue:{...t.fatigue||{},fatiguePresent:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Fatigue present (screen separately from depression)")),React.createElement("select",{value:(t.fatigue||{}).management||"",onChange:e=>r({...t,fatigue:{...t.fatigue||{},management:e.target.value}}),className:"w-full px-1 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Management"),React.createElement("option",{value:"energy-conservation"},"Energy conservation strategies"),React.createElement("option",{value:"graded-exercise"},"Graded exercise program"),React.createElement("option",{value:"sleep-hygiene"},"Sleep hygiene optimization"),React.createElement("option",{value:"treat-comorbid"},"Treat comorbid (OSA, depression, pain)")))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",{className:"bg-orange-50 border border-orange-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-orange-800 mb-2 text-sm"},"Alcohol & Substance Screening"),React.createElement("div",{className:"space-y-1"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("label",{className:"text-xs text-gray-600"},"AUDIT-C:"),React.createElement("input",{type:"number",min:"0",max:"12",value:(t.substanceScreening||{}).alcoholAuditC||"",onChange:e=>r({...t,substanceScreening:{...t.substanceScreening||{},alcoholAuditC:e.target.value}}),className:"w-16 px-1 py-0.5 border border-gray-300 rounded text-xs",placeholder:"/12"}),parseInt((t.substanceScreening||{}).alcoholAuditC)>=4&&React.createElement("span",{className:"text-xs text-red-600 font-semibold"},"POSITIVE \u2014 brief intervention")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.substanceScreening||{}).substanceUseScreen,onChange:e=>r({...t,substanceScreening:{...t.substanceScreening||{},substanceUseScreen:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Substance use screened (cocaine, amphetamines, cannabis)")))),React.createElement("div",{className:"bg-pink-50 border border-pink-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-pink-800 mb-2 text-sm"},"Hormonal Risk Assessment"),React.createElement("div",{className:"space-y-1"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.hormonalRisk||{}).combinedOCPUse,onChange:e=>r({...t,hormonalRisk:{...t.hormonalRisk||{},combinedOCPUse:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"On combined OCP")),(t.hormonalRisk||{}).combinedOCPUse&&React.createElement("p",{className:"text-xs text-red-600 ml-5"},"Discontinue combined OCP. Switch to progestin-only or nonhormonal (esp. if migraine with aura \u2014 Class I)."),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.hormonalRisk||{}).hrtUse,onChange:e=>r({...t,hormonalRisk:{...t.hormonalRisk||{},hrtUse:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"On oral estrogen HRT")),(t.hormonalRisk||{}).hrtUse&&React.createElement("p",{className:"text-xs text-red-600 ml-5"},"Oral estrogen HRT increases stroke risk (Class III Harm if age \u226560 or >10yr post-menopause). Consider transdermal."))),React.createElement("div",{className:"bg-green-50 border border-green-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-green-800 mb-2 text-sm"},"Sexual Activity Counseling"),React.createElement("label",{className:"flex items-center gap-2 mb-1"},React.createElement("input",{type:"checkbox",checked:!!(t.sexualHealthCounseling||{}).discussed,onChange:e=>r({...t,sexualHealthCounseling:{...t.sexualHealthCounseling||{},discussed:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Sexual health discussed")),React.createElement("p",{className:"text-xs text-gray-600"},"Safe when BP controlled + tolerates moderate activity (climb 1-2 flights stairs). Typically 2-4 weeks post minor stroke. Review meds causing dysfunction (beta-blockers, SSRIs, thiazides).")),React.createElement("div",{className:"bg-sky-50 border border-sky-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-sky-800 mb-2 text-sm"},"Air Travel Restrictions"),React.createElement("select",{value:(t.airTravelRestrictions||{}).restrictionDuration||"",onChange:e=>r({...t,airTravelRestrictions:{...t.airTravelRestrictions||{},restrictionDuration:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Restriction"),React.createElement("option",{value:"1-2-weeks"},"1-2 weeks (TIA)"),React.createElement("option",{value:"2-weeks"},"2 weeks min (minor ischemic stroke)"),React.createElement("option",{value:"1-3-months"},"1-3 months (major ischemic stroke)"),React.createElement("option",{value:"6-8-weeks"},"6-8 weeks (ICH)"),React.createElement("option",{value:"1-week-post-crani"},"1 week min post-craniotomy (trapped air risk)")),React.createElement("p",{className:"text-xs text-gray-600 mt-1"},"Flights >4h: compression stockings, ambulate q1-2h, hydrate, avoid alcohol. Supplemental O2 if SpO2 <95%."))),React.createElement("div",{className:"bg-yellow-50 border border-yellow-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-yellow-800 mb-2 text-sm"},"Falls Risk"),React.createElement("div",{className:"flex flex-wrap gap-3"},React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.fallsRisk||{}).screenPerformed,onChange:e=>r({...t,fallsRisk:{...t.fallsRisk||{},screenPerformed:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Falls risk screened")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.fallsRisk||{}).preventionPlanInitiated,onChange:e=>r({...t,fallsRisk:{...t.fallsRisk||{},preventionPlanInitiated:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Prevention plan initiated")),React.createElement("label",{className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.fallsRisk||{}).balanceProgramReferral,onChange:e=>r({...t,fallsRisk:{...t.fallsRisk||{},balanceProgramReferral:e.target.checked}})}),React.createElement("span",{className:"text-xs"},"Balance/exercise program referral (Class I)")))),parseInt(t.age)>0&&parseInt(t.age)<=50&&React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-indigo-800 mb-2"},"Young Adult Stroke Workup (Age \u226450)"),React.createElement("div",{className:"space-y-3"},React.createElement("div",null,React.createElement("p",{className:"text-xs font-semibold text-indigo-700 mb-1"},"Tier 1 \u2014 All patients:"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-1"},[{key:"ctaMra",label:"CTA/MRA head+neck"},{key:"tteBubble",label:"TTE with bubble study"},{key:"ecg",label:"ECG"},{key:"telemetry",label:"Telemetry >=24h"},{key:"drugScreen",label:"Urine drug screen"},{key:"basicLabs",label:"Basic labs (CBC, BMP, A1c, lipids)"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-1"},React.createElement("input",{type:"checkbox",checked:!!((t.youngAdultWorkup||{}).tier1Items||{})[e.key],onChange:a=>r({...t,youngAdultWorkup:{...t.youngAdultWorkup||{},tier1Items:{...(t.youngAdultWorkup||{}).tier1Items||{},[e.key]:a.target.checked}}})}),React.createElement("span",{className:"text-xs"},e.label))))),React.createElement("div",null,React.createElement("p",{className:"text-xs font-semibold text-indigo-700 mb-1"},"Tier 2 \u2014 If cryptogenic after Tier 1:"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-1"},[{key:"tee",label:"TEE"},{key:"extendedMonitoring",label:"Extended cardiac monitoring (>=14d)"},{key:"aplPanel",label:"Antiphospholipid antibody panel"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-1"},React.createElement("input",{type:"checkbox",checked:!!((t.youngAdultWorkup||{}).tier2Items||{})[e.key],onChange:a=>r({...t,youngAdultWorkup:{...t.youngAdultWorkup||{},tier2Items:{...(t.youngAdultWorkup||{}).tier2Items||{},[e.key]:a.target.checked}}})}),React.createElement("span",{className:"text-xs"},e.label))))),React.createElement("div",null,React.createElement("p",{className:"text-xs font-semibold text-indigo-700 mb-1"},"Tier 3 \u2014 Suspicion-driven:"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-1"},[{key:"rcvsWorkup",label:"RCVS workup"},{key:"thrombophilia",label:"Thrombophilia panel (only if PFO/VTE)"},{key:"fabry",label:"Fabry disease (alpha-gal A)"},{key:"cadasil",label:"CADASIL (NOTCH3)"},{key:"vasculitis",label:"Vasculitis workup (ESR, CRP, ANA)"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-1"},React.createElement("input",{type:"checkbox",checked:!!((t.youngAdultWorkup||{}).tier3Items||{})[e.key],onChange:a=>r({...t,youngAdultWorkup:{...t.youngAdultWorkup||{},tier3Items:{...(t.youngAdultWorkup||{}).tier3Items||{},[e.key]:a.target.checked}}})}),React.createElement("span",{className:"text-xs"},e.label))))),React.createElement("p",{className:"text-xs text-gray-500"},"Do NOT routinely test inherited thrombophilias for arterial stroke (Class III). Test only if PFO with suspected paradoxical embolism, VTE history, or family hx. Cervical artery dissection is #1 cause of stroke in young adults."))))),t.diagnosis&&j(t.diagnosis)!=="mimic"&&React.createElement("details",{className:"bg-white border-2 border-amber-300 rounded-lg shadow-md"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-amber-900 hover:bg-amber-50 rounded-lg flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"users",className:"w-5 h-5 text-amber-600"}),"Special Populations & Rehab"),React.createElement("span",{className:"text-xs text-amber-500 font-normal"},"Pregnancy, Craniectomy, Rehab Referral")),React.createElement("div",{className:"p-4 pt-0 space-y-4"},React.createElement("div",{className:"bg-pink-50 border border-pink-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-pink-800 mb-2"},"Stroke in Pregnancy (AHA 2026)"),React.createElement("label",{className:"flex items-center gap-2 mb-2"},React.createElement("input",{type:"checkbox",checked:!!t.pregnancyStroke,onChange:e=>r({...t,pregnancyStroke:e.target.checked}),className:"text-pink-600"}),React.createElement("span",{className:"text-sm font-medium"},"Patient is pregnant or postpartum")),t.pregnancyStroke&&React.createElement("div",{className:"text-xs text-pink-700 space-y-1 ml-6"},React.createElement("p",null,"\u2022 TNK is a ",React.createElement("strong",null,"relative")," contraindication \u2014 weigh benefit vs risk, consult OB/GYN"),React.createElement("p",null,"\u2022 EVT is preferred for LVO (no systemic thrombolytic exposure)"),React.createElement("p",null,"\u2022 ASA 81 mg is safe in pregnancy"),React.createElement("p",null,"\u2022 Avoid warfarin in first trimester; LMWH preferred"),React.createElement("p",null,"\u2022 Consider preeclampsia/eclampsia, RCVS, and CVT in differential"))),React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-red-800 mb-2"},"Decompressive Craniectomy Decision Support"),React.createElement("label",{className:"flex items-center gap-2 mb-2"},React.createElement("input",{type:"checkbox",checked:!!(t.decompressiveCraniectomy||{}).considered,onChange:e=>r({...t,decompressiveCraniectomy:{...t.decompressiveCraniectomy||{},considered:e.target.checked}}),className:"text-red-600"}),React.createElement("span",{className:"text-sm font-medium"},"Malignant MCA infarction \u2014 craniectomy being considered")),(t.decompressiveCraniectomy||{}).considered&&React.createElement("div",{className:"space-y-2 ml-6"},React.createElement("div",{className:"text-xs text-red-700 space-y-1"},React.createElement("p",null,React.createElement("strong",null,"DECIMAL/DESTINY/HAMLET criteria:")),React.createElement("p",null,"\u2022 Age 18-60: strong benefit (NNT ~2 for survival, ~4 for mRS 0-3)"),React.createElement("p",null,"\u2022 Age >60 (DESTINY II): survival benefit but higher rate of severe disability"),React.createElement("p",null,"\u2022 NIHSS >15, infarct >50% MCA territory on imaging"),React.createElement("p",null,"\u2022 Surgery within 48 hours of symptom onset (ideally <24h)"),React.createElement("p",null,"\u2022 ",React.createElement("strong",null,"Goals-of-care discussion is critical")," \u2014 discuss functional outcomes")),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded p-2 mt-2"},React.createElement("p",{className:"text-xs font-semibold text-blue-800 mb-1"},"Cerebellar Infarction / Hemorrhage:"),React.createElement("div",{className:"text-xs text-blue-700 space-y-0.5"},React.createElement("p",null,"\u2022 Suboccipital decompressive craniectomy for cerebellar swelling with brainstem compression (Class I, LOE B-NR)"),React.createElement("p",null,"\u2022 EVD for acute obstructive hydrocephalus"),React.createElement("p",null,"\u2022 Imaging: posterior fossa CT/MRI, assess 4th ventricle compression"),React.createElement("p",null,"\u2022 Earlier surgery (<24h) associated with better outcomes"))),React.createElement("select",{value:(t.decompressiveCraniectomy||{}).timing||"",onChange:e=>r({...t,decompressiveCraniectomy:{...t.decompressiveCraniectomy||{},timing:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm mt-2"},React.createElement("option",{value:""},"-- Decision --"),React.createElement("option",{value:"proceeding-supra"},"Proceeding \u2014 supratentorial craniectomy"),React.createElement("option",{value:"proceeding-posterior"},"Proceeding \u2014 suboccipital decompression"),React.createElement("option",{value:"monitoring"},"Close monitoring \u2014 may proceed if deterioration"),React.createElement("option",{value:"not-candidate"},"Not a candidate (age, goals-of-care, timing)")))),(t.decompressiveCraniectomy||{}).considered&&React.createElement("div",{className:"bg-gray-50 border border-gray-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-gray-800 mb-2 text-sm"},"DESTINY II Outcomes Data (Age >60) \u2014 For Shared Decision-Making"),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("div",{className:"grid grid-cols-2 gap-2"},React.createElement("div",{className:"bg-white p-2 rounded border"},React.createElement("p",{className:"font-semibold"},"With Surgery:"),React.createElement("p",null,"\u2022 6-mo survival: 63%"),React.createElement("p",null,"\u2022 mRS 0-3: 6%"),React.createElement("p",null,"\u2022 mRS 4: 32%"),React.createElement("p",null,"\u2022 mRS 5: 25%")),React.createElement("div",{className:"bg-white p-2 rounded border"},React.createElement("p",{className:"font-semibold"},"Without Surgery:"),React.createElement("p",null,"\u2022 6-mo survival: 24%"),React.createElement("p",null,"\u2022 mRS 0-3: 3%"),React.createElement("p",null,"\u2022 mRS 4: 15%"),React.createElement("p",null,"\u2022 mRS 5: 6%"))),React.createElement("p",{className:"text-amber-700 font-medium mt-1"},"Surgery improves survival but most survivors have moderate-to-severe disability. Discuss functional outcomes and patient values prior to consent."))),(j(t.diagnosis)==="cvt"||t.diagnosis==="cvt")&&React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-indigo-800 mb-2"},"CVT Anticoagulation Phases (CSBP 2024)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Acute Phase (0-14 days)"),React.createElement("select",{value:(t.cvtAnticoag||{}).acutePhase||"",onChange:e=>r({...t,cvtAnticoag:{...t.cvtAnticoag||{},acutePhase:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"ufh-infusion"},"UFH infusion (if HIT concern or surgery likely)"),React.createElement("option",{value:"lmwh"},"LMWH (preferred \u2014 enoxaparin 1mg/kg BID)"))),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Transition Agent"),React.createElement("select",{value:(t.cvtAnticoag||{}).transitionAgent||"",onChange:e=>r({...t,cvtAnticoag:{...t.cvtAnticoag||{},transitionAgent:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"warfarin"},"Warfarin INR 2-3 (MANDATORY for APS)"),React.createElement("option",{value:"doac"},"DOAC (non-APS, after acute phase stabilization)"))),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Duration"),React.createElement("select",{value:(t.cvtAnticoag||{}).duration||"",onChange:e=>r({...t,cvtAnticoag:{...t.cvtAnticoag||{},duration:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-xs"},React.createElement("option",{value:""},"Select"),React.createElement("option",{value:"3-6mo"},"3-6 months (provoked \u2014 OCP, pregnancy, surgery)"),React.createElement("option",{value:"6-12mo"},"6-12 months (unprovoked)"),React.createElement("option",{value:"indefinite"},"Indefinite (recurrent VTE, APS, severe thrombophilia)")))),React.createElement("div",{className:"mt-2 grid grid-cols-2 gap-2"},React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.cvtAnticoag||{}).apsStatus,onChange:e=>r({...t,cvtAnticoag:{...t.cvtAnticoag||{},apsStatus:e.target.checked}})}),"APS confirmed/suspected (use WARFARIN only, DOACs contraindicated)"),React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.cvtAnticoag||{}).etiologyProvoked,onChange:e=>r({...t,cvtAnticoag:{...t.cvtAnticoag||{},etiologyProvoked:e.target.checked}})}),"Provoked etiology identified")),(t.cvtAnticoag||{}).apsStatus&&(t.cvtAnticoag||{}).transitionAgent==="doac"&&React.createElement("div",{className:"mt-1 p-2 bg-red-100 border border-red-300 rounded text-xs text-red-800"},React.createElement("strong",null,"CONTRAINDICATED:")," DOACs are inferior to warfarin in APS (TRAPS trial, ASTRO-APS). Switch to warfarin INR 2-3.")),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-blue-800 mb-2"},"Rehabilitation Intensity Prescription (ESO/CSBP 2024)"),React.createElement("div",{className:"text-xs text-gray-700 space-y-1"},React.createElement("p",null,React.createElement("strong",null,"Recommended intensity:")," Minimum 3 hours/day, 5 days/week of active task-specific therapy (Class I, LOE A \u2014 AVERT, CSBP 2024)."),React.createElement("p",null,React.createElement("strong",null,"Early mobilization:")," Begin within 24-48h post-stroke. Avoid very early high-dose mobilization within 24h (AVERT \u2014 increased odds of poor outcome at 3 months)."),React.createElement("p",null,React.createElement("strong",null,"Aphasia referral:")," Refer to SLP within 30 days. RELEASE: higher-intensity aphasia therapy (8+ hours/week) is associated with greater improvement.")),React.createElement("div",{className:"mt-2 grid grid-cols-1 md:grid-cols-2 gap-2"},React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{}).intensityPrescribed,onChange:e=>r({...t,rehabReferral:{...t.rehabReferral||{},intensityPrescribed:e.target.checked}})}),"3h/day \xD7 5d/wk rehab intensity prescribed"),React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{}).aphasiaReferral30d,onChange:e=>r({...t,rehabReferral:{...t.rehabReferral||{},aphasiaReferral30d:e.target.checked}})}),"Aphasia SLP referral within 30 days"))),React.createElement("div",{className:"bg-purple-50 border border-purple-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-purple-800 mb-2 text-sm"},"Vascular Cognitive Impairment (VCI) Screening"),React.createElement("div",{className:"text-xs text-gray-700 space-y-1 mb-2"},React.createElement("p",null,React.createElement("strong",null,"Screen at:")," Pre-discharge, 3 months, and 12 months (AHA/ASA 2021 VCI Scientific Statement)."),React.createElement("p",null,React.createElement("strong",null,"Tools:")," MoCA (primary \u2014 sensitive for executive/attention), NINDS-CSN 5-min protocol, or Addenbrooke's Cognitive Exam (ACE-III)."),React.createElement("p",null,React.createElement("strong",null,"Triggers for expanded testing:")," MoCA <22, patient/family cognitive concerns, multiple vascular risk factors, strategic infarct location (thalamic, angular gyrus, caudate).")),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-2"},React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{}).cognitiveScreenDischarge,onChange:e=>r({...t,rehabReferral:{...t.rehabReferral||{},cognitiveScreenDischarge:e.target.checked}})}),"Screened at discharge"),React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{}).cognitiveScreen3mo,onChange:e=>r({...t,rehabReferral:{...t.rehabReferral||{},cognitiveScreen3mo:e.target.checked}})}),"Screened at 3 months"),React.createElement("label",{className:"flex items-center gap-1 text-xs"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{}).neuropsychReferral,onChange:e=>r({...t,rehabReferral:{...t.rehabReferral||{},neuropsychReferral:e.target.checked}})}),"Neuropsych referral placed"))),React.createElement("div",{className:"bg-amber-50 border border-amber-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-amber-800 mb-2 text-sm"},"Caregiver Training Checklist"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-2"},[{key:"strokeSigns",label:"Stroke warning signs (BE-FAST)"},{key:"medicationAdmin",label:"Medication administration"},{key:"bpMonitoring",label:"Home BP monitoring"},{key:"safeTransfers",label:"Safe transfers & fall prevention"},{key:"dysphagiaDiet",label:"Modified diet / swallowing precautions"},{key:"emergencyPlan",label:"When to call 911"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{})[`caregiver_${e.key}`],onChange:a=>r({...t,rehabReferral:{...t.rehabReferral||{},[`caregiver_${e.key}`]:a.target.checked}}),className:"text-amber-600"}),React.createElement("span",{className:"text-xs text-gray-700"},e.label))))),React.createElement("div",{className:"bg-green-50 border border-green-200 rounded-lg p-3"},React.createElement("h4",{className:"font-semibold text-green-800 mb-2"},"Rehabilitation Referral Checklist"),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-2"},[{key:"pt",label:"Physical Therapy (PT)"},{key:"ot",label:"Occupational Therapy (OT)"},{key:"slp",label:"Speech-Language Pathology (SLP)"},{key:"neuropsych",label:"Neuropsychology"},{key:"socialWork",label:"Social Work / Case Mgmt"},{key:"vocationalRehab",label:"Vocational Rehabilitation"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-2"},React.createElement("input",{type:"checkbox",checked:!!(t.rehabReferral||{})[e.key],onChange:a=>r({...t,rehabReferral:{...t.rehabReferral||{},[e.key]:a.target.checked}}),className:"text-green-600"}),React.createElement("span",{className:"text-xs text-gray-700"},e.label))))))),t.diagnosis&&React.createElement("div",{id:"discharge-checklist-section",className:"bg-white border-2 border-emerald-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-emerald-900 flex items-center gap-2"},React.createElement("i",{"data-lucide":"clipboard-list",className:"w-5 h-5"}),"Discharge Checklist"),React.createElement("div",{className:"flex items-center gap-2"},(()=>{let e=t.dischargeChecklist||{},a=Object.keys(e).length,i=Object.values(e).filter(Boolean).length;return React.createElement("span",{className:`text-xs font-semibold px-2 py-0.5 rounded-full ${i===a?"bg-green-100 text-green-800":"bg-amber-100 text-amber-800"}`},i,"/",a)})(),React.createElement("button",{type:"button",onClick:()=>r({...t,dischargeChecklistReviewed:!t.dischargeChecklistReviewed}),className:`text-xs px-2 py-1 rounded-lg font-medium ${t.dischargeChecklistReviewed?"bg-green-500 text-white":"bg-gray-200 text-gray-700 hover:bg-gray-300"}`},t.dischargeChecklistReviewed?"Reviewed":"Mark Reviewed"))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-x-4 gap-y-1"},[{key:"antiplateletOrAnticoag",label:"Antiplatelet or anticoagulation prescribed",category:"Medications"},{key:"statinPrescribed",label:"High-intensity statin prescribed",category:"Medications"},{key:"bpMedOptimized",label:"BP medications optimized (target <130/80)",category:"Medications"},{key:"diabetesManaged",label:"Diabetes management addressed",category:"Risk Factors"},{key:"smokingCessation",label:"Smoking cessation counseled",category:"Risk Factors"},{key:"dietCounseling",label:"Diet counseling (Mediterranean/DASH)",category:"Lifestyle"},{key:"exerciseCounseling",label:"Exercise counseling (150 min/wk)",category:"Lifestyle"},{key:"followUpNeurology",label:"Neurology follow-up scheduled",category:"Follow-up"},{key:"followUpPCP",label:"PCP follow-up scheduled",category:"Follow-up"},{key:"rehabilitationOrdered",label:"Rehabilitation services ordered",category:"Rehab"},{key:"patientEducation",label:"Stroke education provided",category:"Education"},{key:"drivingRestrictions",label:"Driving restrictions discussed",category:"Education"}].map(e=>React.createElement("label",{key:e.key,className:"flex items-center gap-2 py-1 cursor-pointer"},React.createElement("input",{type:"checkbox",checked:!!(t.dischargeChecklist||{})[e.key],onChange:a=>r({...t,dischargeChecklist:{...t.dischargeChecklist||{},[e.key]:a.target.checked}}),className:"rounded border-emerald-300 text-emerald-600"}),React.createElement("span",{className:"text-sm text-gray-700"},e.label)))),React.createElement("div",{className:"mt-2 text-xs text-gray-500 italic"},"Based on AHA/ASA Secondary Stroke Prevention 2021 guidelines (Kleindorfer DO et al. Stroke. 2021;52:e364-e467)")),React.createElement("div",{id:"recommendations-section",className:"bg-white border-2 border-teal-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h3",{className:"text-lg font-bold text-teal-900"},"7. Recommendations"),React.createElement("i",{"data-lucide":"clipboard-check",className:"w-5 h-5 text-teal-600"})),React.createElement("div",{className:"mb-3"},React.createElement("button",{type:"button",onClick:()=>{let e=$a(),a=j(t.diagnosis),i=t.age||"[Age]",s=t.sex==="M"?"male":t.sex==="F"?"female":"[sex]",o=t.diagnosis||"[Diagnosis]",n=t.nihss||h||"",c=t.presentingBP||"",d=t.ctResults||"",m=t.ctaResults||"",l="";if(l+=`TELESTROKE CONSULTATION NOTE
`,l+=`Date: ${new Date().toLocaleDateString()}

`,l+=`HPI: ${i} year old ${s}`,t.pmh&&(l+=` with PMH of ${t.pmh}`),l+=` presenting with ${t.symptoms||"[symptoms]"}.
`,g&&(l+=`Last known well: ${g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"})} on ${g.toLocaleDateString()}.
`),l+=`
`,l+=`EXAMINATION:
`,n&&(l+=`NIHSS: ${n}`),t.nihssDetails&&(l+=` (${t.nihssDetails})`),n&&(l+=`
`),c&&(l+=`Presenting BP: ${c}
`),l+=`
`,l+=`IMAGING:
`,d&&(l+=`Head CT: ${d}
`),m&&(l+=`CTA Head/Neck: ${m}
`),t.ctpResults&&(l+=`CTP: ${t.ctpResults}
`),A&&(l+=`ASPECTS: ${A}
`),l+=`
`,l+=`ASSESSMENT: ${o}

`,a==="ischemic")l+=`PLAN:
`,t.tnkRecommended?(l+="- TNK 0.25 mg/kg IV bolus (max 25 mg) recommended and administered",t.tnkAdminTime&&(l+=` at ${t.tnkAdminTime}`),l+=`.
`):l+=`- IV TNK: Not recommended.
`,t.evtRecommended&&(l+=`- EVT: Recommended. Transfer to EVT-capable center.
`);else if(a==="ich")l+=`PLAN:
`,t.ichBPManaged&&(l+=`- BP management initiated (target SBP 130-150).
`),t.ichReversalOrdered&&(l+=`- Anticoagulation reversal ordered.
`),t.ichNeurosurgeryConsulted&&(l+=`- Neurosurgery consulted.
`);else if(a==="sah")l+=`PLAN:
`,t.sahGrade&&(l+=`- SAH Grade: ${t.sahGrade} (${t.sahGradeScale==="huntHess"?"Hunt & Hess":t.sahGradeScale==="wfns"?"WFNS":"scale not specified"})
`),t.sahBPManaged&&(l+=`- BP management initiated (target SBP <160 pre-securing).
`),t.sahNimodipine&&(l+=`- Nimodipine 60 mg q4h started for DCI prevention.
`),t.sahEVDPlaced&&(l+=`- EVD placed for hydrocephalus management.
`),t.sahNeurosurgeryConsulted&&(l+=`- Neurosurgery consulted for aneurysm securing.
`),t.sahAneurysmSecured&&(l+=`- Aneurysm securing plan documented.
`);else if(a==="cvt")l+=`PLAN:
`,t.cvtAnticoagStarted&&(l+=`- Anticoagulation initiated (${t.cvtAnticoagType||"agent selected"}).
`),t.cvtIcpManaged&&(l+=`- ICP management addressed.
`),t.cvtSeizureManaged&&(l+=`- Seizure management addressed.
`),t.cvtHematologyConsulted&&(l+=`- Hematology consulted for thrombophilia workup.
`);else if(a==="tia"){l+=`PLAN:
`,l+=`- Admit for urgent inpatient TIA workup (Class I, LOE B-NR).
`;let w=t.tiaWorkup||{},O=Object.values(w).filter(Boolean).length,Fe=Object.keys(w).length;l+=`- TIA workup: ${O}/${Fe} items completed.
`,w.mriDwi&&(l+=`- MRI DWI obtained.
`),w.ctaHeadNeck&&(l+=`- CTA Head/Neck obtained.
`)}else if(a==="dissection"){l+=`PLAN:
`;let w=t.dissectionPathway||{};w.antithromboticType&&(l+=`- Antithrombotic therapy: ${w.antithromboticType.replace(/-/g," ")}.
`),w.imagingFollowUp&&(l+=`- Vascular imaging follow-up: ${w.imagingFollowUp}.
`),l+=`- Cervical manipulation avoidance counseled.
`}t.toastClassification&&(l+=`
ETIOLOGIC CLASSIFICATION (TOAST): ${{"large-artery":"Large Artery Atherosclerosis",cardioembolism:"Cardioembolism","small-vessel":"Small Vessel Occlusion (Lacunar)","other-determined":"Other Determined Etiology",cryptogenic:"Cryptogenic / ESUS"}[t.toastClassification]||t.toastClassification}
`);let C=t.cardiacWorkup||{};(C.ecgComplete||C.telemetryOrdered||C.echoOrdered||C.extendedMonitoringType)&&(l+=`
CARDIAC WORKUP:
`,C.ecgComplete&&(l+=`- 12-Lead ECG completed.
`),C.telemetryOrdered&&(l+=`- Inpatient telemetry ordered.
`),C.echoOrdered&&(l+=`- Echo ordered.
`),C.extendedMonitoringType&&(l+=`- Extended monitoring: ${{"30-day-monitor":"30-day ambulatory monitor","14-day-patch":"14-day continuous patch",ilr:"Implantable loop recorder","none-af-known":"Not needed (AF known)","none-other":"Not indicated"}[C.extendedMonitoringType]||C.extendedMonitoringType}.
`),C.pfoEvaluation&&(l+=`- PFO evaluation: ${C.pfoEvaluation.replace(/-/g," ")}.
`),C.pascalClassification&&(l+=`- PASCAL classification: ${C.pascalClassification}.
`));let k=t.screeningTools||{};(k.phq2Score||k.mocaScore||k.stopBangScore||k.seizureRisk)&&(l+=`
SCREENING:
`,k.phq2Score&&(l+=`- PHQ-2: ${k.phq2Score}/6 (${k.phq2Positive?"POSITIVE":"negative"}).
`),k.mocaScore&&(l+=`- MoCA: ${k.mocaScore}/30${k.mocaReferral?" \u2014 neuropsych referral placed":""}.
`),k.stopBangScore&&(l+=`- STOP-BANG: ${k.stopBangScore}/8 (${parseInt(k.stopBangScore)>=5?"HIGH risk":parseInt(k.stopBangScore)>=3?"INTERMEDIATE risk":"low risk"} OSA).
`),k.seizureRisk&&(l+=`- Seizure status: ${k.seizureRisk.replace(/-/g," ")}.
`));let I=t.hemorrhagicTransformation||{};I.detected&&(l+=`
HEMORRHAGIC TRANSFORMATION:
`,I.classification&&(l+=`- ECASS classification: ${I.classification}.
`),I.symptomatic&&(l+=`- Symptomatic ICH (sICH).
`),I.antithromboticHeld&&(l+=`- Antithrombotics held.
`),I.reimagingPlanned&&(l+=`- Repeat imaging planned.
`));let S=t.dysphagiaScreening||{};(S.bedsideScreenPerformed||S.npoStatus||S.slpConsultOrdered)&&(l+=`
DYSPHAGIA:
`,S.bedsideScreenPerformed&&(l+=`- Bedside swallow screen: ${S.bedsideScreenResult||"performed"}.
`),S.npoStatus&&(l+=`- NPO status.
`),S.slpConsultOrdered&&(l+=`- SLP consult ordered.
`),S.instrumentalAssessment&&S.instrumentalAssessment!=="not-needed"&&(l+=`- Instrumental assessment: ${S.instrumentalAssessment.toUpperCase()}.
`));let H=t.earlyMobilization||{};H.timingDecision&&(l+=`
MOBILIZATION: ${H.timingDecision.replace(/-/g," ")}${H.mobilizationStarted?" \u2014 initiated":""}.
`);let f=t.doacTiming||{};(f.strokeSeverity||f.doacAgent)&&(l+=`
DOAC TIMING:
`,f.strokeSeverity&&(l+=`- Severity: ${f.strokeSeverity}. Recommended: ${f.strokeSeverity==="minor"?"within 48h":f.strokeSeverity==="moderate"?"Day 3-5":"Day 6-14"}.
`),f.doacAgent&&(l+=`- Agent: ${f.doacAgent.replace(/-/g," ")}.
`),f.doacInitiationDay&&(l+=`- Planned initiation: ${f.doacInitiationDay}.
`),f.hemorrhagicTransformation&&(l+=`- Note: HT present \u2014 repeat imaging before DOAC.
`));let U=t.carotidManagement||{};U.stenosisDegree&&(l+=`
CAROTID: ${U.stenosisSide||""} ${U.stenosisDegree}% stenosis${U.symptomatic?" (symptomatic)":" (asymptomatic)"}.
`,U.intervention&&(l+=`- Plan: ${U.intervention.replace(/-/g," ")}.
`));let V=t.esusWorkup||{};(V.cardiacMonitoringType||V.teePerformed||V.hypercoagWorkup)&&(l+=`
ESUS/CRYPTOGENIC WORKUP:
`,V.cardiacMonitoringType&&(l+=`- Cardiac monitoring: ${V.cardiacMonitoringType.replace(/-/g," ")}.
`),V.teePerformed&&(l+=`- TEE: performed${V.teeFindings?` \u2014 ${V.teeFindings}`:""}.
`),V.afDetected&&(l+=`- AF DETECTED on monitoring.
`),V.hypercoagWorkup&&(l+=`- Hypercoagulable workup ordered.
`),V.esusAntiplatelet&&(l+=`- Antithrombotic: ${V.esusAntiplatelet.replace(/-/g," ")}.
`));let ae=t.ichAnticoagResumption||{};ae.decision&&(l+=`
ICH ANTICOAG RESUMPTION:
`,ae.ichLocation&&(l+=`- Location: ${ae.ichLocation}.
`),ae.caaFeatures&&(l+=`- CAA features present.
`),l+=`- Decision: ${ae.decision.replace(/-/g," ")}.
`,ae.rationale&&(l+=`- Rationale: ${ae.rationale}.
`),ae.laaoConsidered&&(l+=`- LAAO evaluation considered.
`));let N=t.secondaryPrevention||{};(N.statinDose||N.antiplateletRegimen||N.bpTarget)&&(l+=`
SECONDARY PREVENTION:
`,N.antiplateletRegimen&&(l+=`- Antithrombotic: ${N.antiplateletRegimen.replace(/-/g," ")}.
`),N.statinDose&&(l+=`- Statin: ${N.statinDose.replace(/-/g," ")}${N.ezetimibeAdded?" + ezetimibe":""}${N.pcsk9Added?" + PCSK9i":""}${N.inclisiranConsidered?" + inclisiran":""}.
`),N.bpTarget&&(l+=`- BP target: ${N.bpTarget}${N.bpIntensiveCandidate?" (intensive candidate)":""}.
`),N.diabetesManagement&&(l+=`- Diabetes: ${N.diabetesManagement.replace(/-/g," ")}.
`),N.glp1ra&&N.glp1ra!=="not-indicated"&&(l+=`- GLP-1 RA: ${N.glp1ra.replace(/-/g," ")}${N.glp1raIndication?` (${N.glp1raIndication.replace(/-/g," ")})`:""}.
`),N.sglt2i&&N.sglt2i!=="not-indicated"&&(l+=`- SGLT2i: ${N.sglt2i}${N.sglt2iIndication?` (${N.sglt2iIndication.replace(/-/g," ")})`:""}.
`),N.colchicineConsidered&&(l+=`- Colchicine 0.5 mg daily${N.colchicineIndication?` \u2014 ${N.colchicineIndication.replace(/-/g," ")}`:""}.
`),N.cyp2c19Tested&&(l+=`- CYP2C19: ${N.cyp2c19Result?N.cyp2c19Result.replace(/-/g," "):"tested, result pending"}.
`),N.smokingStatus&&(l+=`- Smoking: ${N.smokingStatus}.
`),N.exercisePlan&&(l+=`- Exercise: ${N.exercisePlan}${N.exerciseMinPerWeek?` (${N.exerciseMinPerWeek} min/wk)`:""}.
`),N.dietPlan&&(l+=`- Diet: ${N.dietPlan}${N.dietAdherence?` \u2014 adherence: ${N.dietAdherence}`:""}.
`),N.followUpTimeline&&(l+=`- Follow-up: ${N.followUpTimeline}.
`));let ge=t.vteProphylaxis||{};(ge.ipcApplied||ge.pharmacoProphylaxis)&&(l+=`
VTE PROPHYLAXIS:
`,ge.ipcApplied&&(l+=`- IPC applied on admission.
`),ge.pharmacoProphylaxis&&(l+=`- Pharmacologic: ${ge.pharmacoProphylaxis}${ge.enoxaparinDose?` ${ge.enoxaparinDose}`:""}.
`),ge.hematoStabilityConfirmed&&(l+=`- Hemostatic stability confirmed.
`));let te=t.angioedema||{};if(te.detected){l+=`
POST-TNK ANGIOEDEMA:
`,te.severity&&(l+=`- Severity: ${te.severity}.
`),te.onsetTime&&(l+=`- Onset: ${te.onsetTime}.
`),te.aceInhibitorUse&&(l+=`- ACE inhibitor use: Yes (discontinued).
`);let w=te.stepsTaken||{},O={stopTnk:"TNK stopped + ACEi held",steroids:"Methylprednisolone/Diphenhydramine/Famotidine given",epinephrine:"Epinephrine 0.3 mg IM administered",icatibant:"Icatibant 30 mg SC or C1 esterase inhibitor given",airway:"Airway intervention/intubation"},Fe=Object.entries(w).filter(([ke,No])=>No).map(([ke])=>O[ke]||ke);Fe.length>0&&Fe.forEach(ke=>{l+=`- ${ke}.
`}),te.intubated&&(l+=`- Patient intubated for airway protection.
`),te.resolved&&(l+=`- Angioedema resolved.
`)}let K=t.feverManagement||{};(K.feverDetected||K.feverProtocolInitiated)&&(l+=`
FEVER MANAGEMENT:
`,K.maxTemp&&(l+=`- Max temp: ${K.maxTemp}\xB0C.
`),K.feverProtocolInitiated&&(l+=`- FeSS bundle initiated.
`),K.bsasScore&&(l+=`- BSAS score: ${K.bsasScore}.
`),K.infectionWorkupSent&&(l+=`- Infection workup sent.
`),K.escalationLevel&&(l+=`- Escalation: ${K.escalationLevel.replace(/-/g," ")}.
`));let v=t.osmoticTherapy||{};v.agentUsed&&(l+=`
OSMOTIC THERAPY:
`,l+=`- Agent: ${v.agentUsed}${v.indication?` for ${v.indication.replace(/-/g," ")}`:""}.
`,v.serumSodium&&(l+=`- Na: ${v.serumSodium}, target: ${v.sodiumTarget||"not set"}.
`),v.serumOsmolality&&(l+=`- Osm: ${v.serumOsmolality}.
`));let B=t.nutritionalSupport||{};B.feedingRoute&&(l+=`
NUTRITION: Route: ${B.feedingRoute}.
`,B.ngPlacementDay&&(l+=`- NG placed day ${B.ngPlacementDay}.
`),B.pegConsiderationDay&&(l+=`- PEG consideration day ${B.pegConsiderationDay}.
`),B.nutritionConsultOrdered&&(l+=`- Nutrition consult ordered.
`));let se=t.palliativeCare||{};(se.goalsOfCareDiscussed||se.consultOrdered)&&(l+=`
PALLIATIVE CARE / GOALS OF CARE:
`,se.goalsOfCareDiscussed&&(l+=`- GOC discussed${se.goalsOfCareOutcome?`: ${se.goalsOfCareOutcome.replace(/-/g," ")}`:""}.
`),se.consultOrdered&&(l+=`- Palliative care consult ordered.
`),se.dnrPostponementAlert&&(l+=`- Note: DNR orders deferred per guideline (full care x 24-48h for ICH).
`));let ce=t.drugInteractions||{};(ce.aedDoacInteraction||ce.statinInteraction||ce.doacDoseReductionCriteria)&&(l+=`
DRUG INTERACTION ALERTS:
`,ce.aedDoacInteraction&&(l+=`- WARNING: ${ce.aedType} reduces DOAC efficacy \u2014 consider warfarin or AED switch.
`),ce.statinInteraction&&(l+=`- Statin interaction with ${ce.statinInteractionDrug} \u2014 dose adjustment may be needed.
`),ce.doacDoseReductionCriteria&&(l+=`- DOAC (${ce.doacDoseReductionCriteria}) \u2014 dose reduction criteria reviewed.
`));let ct=t.anticoagBridging||{};ct.doacType&&(l+=`
PERIPROCEDURAL ANTICOAG (PAUSE): ${ct.doacType}${ct.crCl?`, CrCl ${ct.crCl}`:""}${ct.procedureRisk?`, ${ct.procedureRisk} bleed risk`:""}.
`,ct.warfarinBridgeIndication&&(l+=`- Heparin bridging indicated (mechanical valve/APS).
`));let Ve=t.cvtAnticoag||{};(Ve.acutePhase||Ve.transitionAgent)&&(l+=`
CVT ANTICOAGULATION:
`,Ve.acutePhase&&(l+=`- Acute: ${Ve.acutePhase.replace(/-/g," ")}.
`),Ve.transitionAgent&&(l+=`- Transition: ${Ve.transitionAgent}.
`),Ve.duration&&(l+=`- Duration: ${Ve.duration}.
`),Ve.apsStatus&&(l+=`- APS confirmed \u2014 warfarin mandatory.
`));let vo=t.mrsAssessment||{},Ui=Object.entries(vo).filter(([w,O])=>O);Ui.length>0&&(l+=`
mRS TRACKING: ${Ui.map(([w,O])=>`${w}: ${O}`).join(", ")}.
`);let ta=t.drivingRestrictions||{};ta.counselingProvided&&(l+=`
DRIVING: Cessation counseling provided${ta.restrictionDuration?`, restriction: ${ta.restrictionDuration}`:""}${ta.commercialDriver?" (commercial driver \u2014 DMV notification)":""}.
`);let kt=t.returnToWork||{};(kt.priorOccupation||kt.vocationalRehabReferral)&&(l+=`
RETURN TO WORK:${kt.priorOccupation?` Prior occupation: ${kt.priorOccupation}.`:""}${kt.vocationalRehabReferral?" Vocational rehab referred.":""}${kt.phasedReturnPlan?" Phased return plan discussed.":""}
`);let Ht=t.spasticity||{},Ct=t.centralPain||{},aa=t.fatigue||{};(Ht.screenPerformed||Ct.screenPerformed||aa.screenPerformed)&&(l+=`
POST-STROKE SCREENING:
`,Ht.screenPerformed&&(l+=`- Spasticity: ${Ht.ashworthScore?`Ashworth ${Ht.ashworthScore}`:"screened"}${Ht.botoxReferral?", botox referral placed":""}.
`),Ct.screenPerformed&&(l+=`- Central pain: ${Ct.painPresent?`present (${Ct.painType||"type unspecified"})${Ct.treatment?`, Rx: ${Ct.treatment}`:""}`:"not present"}.
`),aa.screenPerformed&&(l+=`- Fatigue: ${aa.fatiguePresent?`present, severity: ${aa.severity||"unrated"}`:"not present"}.
`));let Qe=t.substanceScreening||{};(Qe.alcoholAuditC||Qe.substanceUseScreen)&&(l+=`
SUBSTANCE SCREENING:${Qe.alcoholAuditC?` AUDIT-C: ${Qe.alcoholAuditC}${parseInt(Qe.alcoholAuditC)>=4?" (POSITIVE)":""}.`:""}${Qe.alcoholCounseling?" Brief intervention provided.":""}${Qe.substanceUseScreen?` Substances: ${Qe.substancesIdentified||"screened"}.`:""}
`);let dt=t.hormonalRisk||{};(dt.combinedOCPUse||dt.hrtUse||dt.migraineWithAura)&&(l+=`HORMONAL RISK:${dt.combinedOCPUse?" Combined OCP use \u2014 discontinue (Class III).":""}${dt.hrtUse?" HRT use \u2014 review risk/benefit.":""}${dt.migraineWithAura?" Migraine with aura \u2014 avoid estrogen-containing contraceptives.":""}${dt.counselingProvided?" Counseling provided.":""}
`);let ia=t.fallsRisk||{};ia.screenPerformed&&(l+=`FALLS RISK: Screened${ia.highRisk?" \u2014 HIGH RISK":""}${ia.preventionPlanInitiated?", prevention plan initiated":""}${ia.balanceProgramReferral?", balance program referred":""}.
`);let Vt=t.youngAdultWorkup||{};if(Vt.tier1Complete||Vt.tier2Complete){l+=`
YOUNG ADULT WORKUP:
`,Vt.tier1Complete&&(l+=`- Tier 1 complete (CTA/MRA, TTE+bubble, ECG, telemetry, tox screen, basic labs).
`),Vt.tier2Complete&&(l+=`- Tier 2 complete (TEE, extended monitoring, APL panel).
`);let w=Vt.tier3Items||{},O=Object.entries(w).filter(([Fe,ke])=>ke).map(([Fe])=>Fe.replace(/([A-Z])/g," $1").trim());O.length>0&&(l+=`- Tier 3: ${O.join(", ")}.
`)}t.pregnancyStroke&&(l+=`
SPECIAL: Pregnant/postpartum patient \u2014 see pregnancy-specific management above.
`),(t.decompressiveCraniectomy||{}).considered&&(l+=`DECOMPRESSIVE CRANIECTOMY: ${(t.decompressiveCraniectomy||{}).timing||"being considered"}.
`);let yo=t.rehabReferral||{},Ki=Object.entries(yo).filter(([w,O])=>O&&typeof O=="boolean");Ki.length>0&&(l+=`
REHAB: ${Ki.map(([w])=>w.replace(/([A-Z])/g," $1").replace(/caregiver_/g,"Caregiver: ").trim()).join(", ")}.
`),e.length>0&&(l+=`
GUIDELINE-BASED RECOMMENDATIONS:
`,e.forEach(w=>{l+=`- ${w.title}: ${w.recommendation} [Class ${w.classOfRec}, LOE ${w.levelOfEvidence}] (${w.guideline})
`})),t.disposition&&(l+=`
DISPOSITION: ${t.disposition}
`),t.admitLocation&&(l+=`Admit to: ${t.admitLocation}
`);let xo=t.dischargeChecklist||{},Gi=Object.entries(xo).filter(([w,O])=>O);if(Gi.length>0){l+=`
DISCHARGE CHECKLIST ITEMS COMPLETED:
`;let w={antiplateletOrAnticoag:"Antiplatelet/anticoagulation prescribed",statinPrescribed:"High-intensity statin prescribed",bpMedOptimized:"BP medications optimized",diabetesManaged:"Diabetes management addressed",smokingCessation:"Smoking cessation counseled",dietCounseling:"Diet counseling provided",exerciseCounseling:"Exercise counseling provided",followUpNeurology:"Neurology follow-up scheduled",followUpPCP:"PCP follow-up scheduled",rehabilitationOrdered:"Rehabilitation ordered",patientEducation:"Stroke education provided",drivingRestrictions:"Driving restrictions discussed"};Gi.forEach(([O])=>{l+=`- ${w[O]||O}
`})}let ji=Object.values(Qt).filter(Boolean),zi=ji.filter(w=>w.status==="eligible"),qi=ji.filter(w=>w.status==="needs_info");(zi.length>0||qi.length>0)&&(l+=`
CLINICAL TRIAL ELIGIBILITY:
`,zi.forEach(w=>{let O=Le[w.trialId];l+=`- ELIGIBLE: ${w.trialName} (${(O==null?void 0:O.nct)||""}) \u2014 ${w.quickDescription}. Criteria met: ${w.metCount}/${w.criteria.length}.
`}),qi.forEach(w=>{let O=Le[w.trialId],Fe=w.criteria.filter(ke=>ke.status==="unknown").map(ke=>ke.label).join(", ");l+=`- NEEDS INFO: ${w.trialName} (${(O==null?void 0:O.nct)||""}) \u2014 missing: ${Fe}.
`})),r({...t,recommendationsText:l})},className:"flex items-center gap-2 px-4 py-2 bg-teal-600 text-white text-sm font-medium rounded-lg hover:bg-teal-700 transition-colors"},React.createElement("i",{"data-lucide":"file-text",className:"w-4 h-4"}),"Generate Auto-Note"),React.createElement("span",{className:"text-xs text-gray-500 ml-2"},"Populates note from patient data + guideline citations")),React.createElement("div",null,React.createElement("div",{className:"flex items-center justify-between mb-1"},React.createElement("span",{className:"text-sm font-medium text-gray-700"},"Recommendation Summary")),React.createElement("textarea",{value:t.recommendationsText,onChange:e=>r({...t,recommendationsText:e.target.value}),placeholder:"",rows:"6",className:"w-full px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500"}))),React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-3 mt-4"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("span",{className:"font-semibold text-indigo-800 text-sm"},"Pulsara Summary"),React.createElement("button",{onClick:()=>{let e=t.age||"[Age]",a=t.sex,i=a==="M"?"male":a==="F"?"female":"[sex]",s=t.pmh||"no PMH",o=t.symptoms||"[symptoms]",n=g?g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}):"[time]",c=g?g.toLocaleDateString("en-US"):"[date]",d=t.nihss||h||"[score]",m=t.nihssDetails?` (${t.nihssDetails})`:"",l=t.ctResults||"[CT findings]",C=t.ctaResults||"[CTA findings]",k=t.ctpResults||"N/A",I=A?` ASPECTS: ${A}.`:"",S=t.tnkRecommended?"Recommended":"Not Recommended",H=t.evtRecommended?"Recommended":"Not Recommended",f=t.rationale||"[rationale]",U=`${e} year old ${i} with ${s} who presents with ${o}. Last known well is ${n} ${c}. NIHSS score: ${d}${m}. Head CT: ${l}.${I} CTA Head/Neck: ${C}. CTP: ${k}. TNK Treatment: ${S}. EVT: ${H}. Rationale for Treatment Recommendation: ${f}.`;navigator.clipboard.writeText(U),z("tel-pulsara"),setTimeout(()=>z(""),2e3)},className:"flex items-center gap-2 px-3 py-1.5 bg-indigo-600 text-white text-sm rounded-lg hover:bg-indigo-700 transition-colors"},React.createElement("i",{"data-lucide":le==="tel-pulsara"?"check":"copy",className:"w-4 h-4"}),le==="tel-pulsara"?"Copied!":"Copy Pulsara")),React.createElement("p",{className:"text-xs text-gray-600 whitespace-pre-wrap"},(()=>{let e=t.age||"[Age]",a=t.sex,i=a==="M"?"male":a==="F"?"female":"[sex]",s=t.pmh||"no PMH",o=t.symptoms||"[symptoms]",n=g?g.toLocaleTimeString("en-US",{hour:"2-digit",minute:"2-digit"}):"[time]",c=g?g.toLocaleDateString("en-US"):"[date]",d=t.nihss||h||"[score]",m=t.nihssDetails?` (${t.nihssDetails})`:"",l=t.ctResults||"[CT findings]",C=t.ctaResults||"[CTA findings]",k=t.ctpResults||"N/A",I=A?` ASPECTS: ${A}.`:"",S=t.tnkRecommended?"Recommended":"Not Recommended",H=t.evtRecommended?"Recommended":"Not Recommended",f=t.rationale||"[rationale]";return`${e} year old ${i} with ${s} who presents with ${o}. Last known well is ${n} ${c}. NIHSS score: ${d}${m}. Head CT: ${l}.${I} CTA Head/Neck: ${C}. CTP: ${k}. TNK Treatment: ${S}. EVT: ${H}. Rationale: ${f}.`})())),React.createElement("div",{className:"bg-gray-50 border border-gray-300 rounded-lg p-4 mt-4"},React.createElement("h3",{className:"text-lg font-semibold text-gray-800 mb-4"},"Telestroke"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4 mb-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"Transfer"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3"},React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Transport mode"),React.createElement("select",{value:t.transportMode||"",onChange:e=>r({...t,transportMode:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-blue-500"},React.createElement("option",{value:""},"-- Select --"),React.createElement("option",{value:"Ground"},"Ground"),React.createElement("option",{value:"Air"},"Air"),React.createElement("option",{value:"Private"},"Private"),React.createElement("option",{value:"Pending"},"Pending"))),React.createElement("div",null,React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"ETA (time)"),React.createElement("input",{type:"datetime-local",value:t.transportEta||"",onChange:e=>r({...t,transportEta:e.target.value}),className:"w-full px-2 py-1.5 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-blue-500"}))),React.createElement("div",{className:"mt-3"},React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Transport notes"),React.createElement("textarea",{value:t.transportNotes||"",onChange:e=>r({...t,transportNotes:e.target.value}),rows:"2",className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-blue-500",placeholder:"Air/ground contact, staging, or special considerations"})),React.createElement("div",{className:"mt-3"},React.createElement("label",{className:"block text-xs font-medium text-gray-600 mb-1"},"Transfer decision note"),React.createElement("textarea",{value:t.transferRationale||"",onChange:e=>r({...t,transferRationale:e.target.value}),rows:"3",className:"w-full px-3 py-2 border border-gray-300 rounded-lg text-sm focus:ring-2 focus:ring-blue-500",placeholder:"Auto-generate or type the transfer decision note..."})),React.createElement("div",{className:"mt-2 flex flex-wrap gap-2"},React.createElement("button",{type:"button",onClick:()=>{let e=prompt("Reason for accepting transfer (optional)"),a=Ti("accept",e||"");r({...t,transferAccepted:!0,transferRationale:a}),navigator.clipboard.writeText(a),z("transfer-accept"),setTimeout(()=>z(""),2e3)},className:"px-3 py-2 bg-green-600 text-white rounded-lg text-xs font-semibold hover:bg-green-700"},le==="transfer-accept"?"Copied!":"Accept + copy"),React.createElement("button",{type:"button",onClick:()=>{let e=prompt("Reason for declining transfer");if(!e)return;let a=Ti("decline",e);r({...t,transferAccepted:!1,transferRationale:a}),navigator.clipboard.writeText(a),z("transfer-decline"),setTimeout(()=>z(""),2e3)},className:"px-3 py-2 bg-red-600 text-white rounded-lg text-xs font-semibold hover:bg-red-700"},le==="transfer-decline"?"Copied!":"Decline + copy"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"TNK risk/benefit discussion documentation:"),React.createElement("p",{className:"text-sm"},"After ensuring that there were no evident contraindications, TNK administration was recommended. Potential benefits, potential risks (including a potential risk of sx ICH of up to 4%), and alternatives to treatment were discussed with the OSH provider and patient/family prior to initiating treatment."))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"Post-IV TNK/tPA recommendations:"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Admit to ICU"),React.createElement("li",null,"\u2022 q1hour neurochecks and VS monitoring"),React.createElement("li",null,"\u2022 NO antithrombotics/anticoagulants for 24 hour after IV-tPA"),React.createElement("li",null,"\u2022 Maintain BP<180/105 for 24 hours after IV-tPA"),React.createElement("li",null,"\u2022 HCT 24 hours post-tPA administration"),React.createElement("li",null,"\u2022 MRI Brain with diffusion weighted imaging"),React.createElement("li",null,"\u2022 EKG/telemetry"),React.createElement("li",null,"\u2022 Transthoracic echocardiogram"),React.createElement("li",null,"\u2022 Fasting lipid panel, HgA1c"),React.createElement("li",null,"\u2022 PT/OT/SLP evaluations"),React.createElement("li",null,"\u2022 SCDs for DVT ppx"),React.createElement("li",null,"\u2022 Inpatient neurology consultation for further diagnostic evaluation and management"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"MT risk/benefit discussion:"),React.createElement("p",{className:"text-sm"},"Given the presence of a large vascular occlusion, disabling neurological symptoms, and no evident contraindications - the patient will be transferred to HMC for mechanical thrombectomy consideration. Potential benefits, potential risks, and alternatives to treatment were discussed with the OSH provider and patient/family; the neuro-IR team at HMC will obtain informed consent from the patient/family.")))),React.createElement("div",{className:"bg-gray-50 border-2 border-gray-300 rounded-lg p-4 shadow-md mt-4"},React.createElement("div",{className:"flex items-center justify-between mb-3"},React.createElement("h4",{className:"font-bold text-gray-800 flex items-center gap-2"},React.createElement("i",{"data-lucide":"file-text",className:"w-5 h-5"}),"Telestroke Note - Epic"),React.createElement("div",{className:"flex gap-2 flex-wrap"},React.createElement("button",{onClick:()=>{let e=Ei();navigator.clipboard.writeText(e),z("encounter-note"),setTimeout(()=>z(""),2e3)},className:"flex items-center gap-2 px-3 py-2 bg-green-600 text-white text-sm rounded-lg hover:bg-green-700 transition-colors"},React.createElement("i",{"data-lucide":le==="encounter-note"?"check":"copy",className:"w-4 h-4"}),le==="encounter-note"?"Copied!":"Copy Note"))),React.createElement("div",{className:"bg-white p-3 rounded border border-gray-200 max-h-96 overflow-y-auto"},React.createElement("pre",{className:"whitespace-pre-wrap text-xs text-gray-800 font-mono"},Ei())))),React.createElement("div",{className:"lg:col-span-1 space-y-4"},(()=>{let e=me();if(!e)return null;let a=e.total,i=a*60,s=4.5-a,o=s*60,n=6-a,c=24-a,d=Math.floor(ya/3600),m=Math.floor(ya%3600/60),l=ya%60,C=()=>a<3?"from-green-500 to-green-600":a<4?"from-yellow-500 to-yellow-600":a<4.5?"from-orange-500 to-orange-600":"from-red-600 to-red-700",k=()=>a<3?"text-green-100":a<4?"text-yellow-100":a<4.5?"text-orange-100":"text-red-100";return React.createElement("div",{className:`bg-white rounded-lg shadow-lg border-2 ${hs?"border-red-500 alert-flash":"border-blue-400"} lg:sticky lg:top-40 z-30 transition-all duration-300 ${Pe?"p-2":"p-4"}`},React.createElement("div",{className:`flex items-center justify-between ${Pe?"":"mb-3"}`},React.createElement("button",{onClick:()=>vi(!Pe),className:"font-bold text-lg text-blue-900 flex items-center gap-2 hover:text-blue-700 transition-colors",title:Pe?"Expand timer":"Collapse timer"},React.createElement("i",{"data-lucide":Pe?"chevron-right":"chevron-down",className:"w-4 h-4"}),React.createElement("i",{"data-lucide":"clock",className:"w-5 h-5"}),Pe?React.createElement("span",{className:"text-sm font-mono"},d,"h ",m.toString().padStart(2,"0"),"m"):React.createElement("span",null,"Treatment Windows")),React.createElement("div",{className:"flex items-center gap-1"},React.createElement("button",{onClick:ro,className:`p-2 rounded-full transition-colors ${Ke?"bg-gray-200 text-gray-500 hover:bg-gray-300":"bg-blue-100 text-blue-600 hover:bg-blue-200"}`,title:Ke?"Unmute alerts":"Mute alerts"},Ke?React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",className:"w-5 h-5",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"2",strokeLinecap:"round",strokeLinejoin:"round"},React.createElement("path",{d:"m11 5-6 6h-4v6h4l6 6v-18z"}),React.createElement("line",{x1:"23",y1:"9",x2:"17",y2:"15"}),React.createElement("line",{x1:"17",y1:"9",x2:"23",y2:"15"})):React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",className:"w-5 h-5",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"2",strokeLinecap:"round",strokeLinejoin:"round"},React.createElement("polygon",{points:"11 5 6 9 2 9 2 15 6 15 11 19 11 5"}),React.createElement("path",{d:"M15.54 8.46a5 5 0 0 1 0 7.07"}),React.createElement("path",{d:"M19.07 4.93a10 10 0 0 1 0 14.14"}))))),!Pe&&React.createElement(React.Fragment,null,React.createElement("div",{className:`bg-gradient-to-r ${C()} rounded-xl p-4 mb-4 text-white shadow-md ${a>=4&&a<4.5?"urgent-pulse":""}`},React.createElement("div",{className:"text-center"},(()=>{let I=(e==null?void 0:e.label)||"LKW",S=Di(),H=t.lkwUnknown?S?S.toLocaleTimeString([],{hour:"2-digit",minute:"2-digit"}):"--:--":g?new Date(g).toLocaleTimeString([],{hour:"2-digit",minute:"2-digit"}):"--:--";return React.createElement(React.Fragment,null,React.createElement("p",{className:`text-xs font-medium ${k()} opacity-90 uppercase tracking-wide`},"Time Elapsed from ",I),React.createElement("div",{className:"text-4xl font-mono font-bold mt-1 tracking-tight"},d,"h ",m.toString().padStart(2,"0"),"m ",l.toString().padStart(2,"0"),"s"),React.createElement("p",{className:`text-xs mt-1 ${k()} opacity-75`},I,": ",H))})()),s>0&&React.createElement("div",{className:`mt-3 pt-3 border-t border-white/30 text-center ${o<=30?"urgent-pulse":""}`},React.createElement("p",{className:"text-xs opacity-80 uppercase tracking-wide"},"TNK Window Closes In"),React.createElement("div",{className:`text-2xl font-bold ${o<=15?"text-yellow-200":"text-white"}`},Math.floor(o/60),"h ",Math.floor(o%60),"m"),o<=30&&React.createElement("p",{className:"text-xs text-yellow-200 font-semibold mt-1 animate-pulse"},o<=15?"CRITICAL - Less than 15 min remaining!":"Less than 30 min remaining")),s<=0&&React.createElement("div",{className:"mt-3 pt-3 border-t border-white/30 text-center"},React.createElement("p",{className:"text-lg font-bold text-white/90"},"TNK Window Closed"),React.createElement("p",{className:"text-xs text-white/70"},Math.abs(Math.floor(o/60)),"h ",Math.abs(Math.floor(o%60)),"m ago"))),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:`p-3 rounded-lg border-2 ${s>1?"bg-green-50 border-green-500":s>0?"bg-yellow-50 border-yellow-500":"bg-gray-50 border-gray-400"} ${s>0&&s<.5?"animate-pulse":""}`},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"font-semibold text-sm"},s>0?"TNK (Thrombolysis)":"TNK Closed")),s>0&&React.createElement("span",{className:`font-bold text-lg ${s<.5?"text-red-600":s<1?"text-yellow-600":"text-green-600"}`},Math.floor(s),"h ",Math.floor(s%1*60),"m left"),s<=0&&React.createElement("span",{className:"text-gray-600 text-xs font-semibold"},"-",Math.floor(Math.abs(s)),"h ",Math.floor(Math.abs(s)%1*60),"m")),React.createElement("div",{className:"w-full bg-gray-200 rounded-full h-2 overflow-hidden"},React.createElement("div",{className:`h-2 rounded-full transition-all ${s>1?"bg-green-500":s>0?"bg-yellow-500":"bg-gray-400"}`,style:{width:`${Math.max(0,Math.min(100,a/4.5*100))}%`}})),React.createElement("p",{className:"text-xs mt-1 text-gray-600"},"0-4.5h from LKW")),React.createElement("div",{className:`p-3 rounded-lg border-2 ${n>1?"bg-blue-50 border-blue-500":n>0?"bg-yellow-50 border-yellow-500":"bg-gray-50 border-gray-400"} ${n>0&&n<.5?"animate-pulse":""}`},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"font-semibold text-sm"},n>0?"EVT (Early Window)":"Early EVT Closed")),n>0&&React.createElement("span",{className:`font-bold text-lg ${n<.5?"text-red-600":n<1?"text-yellow-600":"text-blue-600"}`},Math.floor(n),"h ",Math.floor(n%1*60),"m left"),n<=0&&React.createElement("span",{className:"text-gray-600 text-xs font-semibold"},"-",Math.floor(Math.abs(n)),"h ",Math.floor(Math.abs(n)%1*60),"m")),React.createElement("div",{className:"w-full bg-gray-200 rounded-full h-2 overflow-hidden"},React.createElement("div",{className:`h-2 rounded-full transition-all ${n>1?"bg-blue-500":n>0?"bg-yellow-500":"bg-gray-400"}`,style:{width:`${Math.max(0,Math.min(100,a/6*100))}%`}})),React.createElement("p",{className:"text-xs mt-1 text-gray-600"},"0-6h from LKW")),a>=6&&React.createElement("div",{className:`p-3 rounded-lg border-2 ${c>0?"bg-purple-50 border-purple-500":"bg-gray-50 border-gray-400"}`},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("span",{className:"font-semibold text-sm"},c>0?"EVT (Extended Window)":"All Windows Closed")),c>0&&React.createElement("span",{className:"font-bold text-lg text-purple-600"},Math.floor(c),"h ",Math.floor(c%1*60),"m left"),c<=0&&React.createElement("span",{className:"text-gray-600 text-xs font-semibold"},"All closed")),React.createElement("div",{className:"w-full bg-gray-200 rounded-full h-2 overflow-hidden"},React.createElement("div",{className:`h-2 rounded-full transition-all ${c>0?"bg-purple-500":"bg-gray-400"}`,style:{width:`${Math.max(0,Math.min(100,a/24*100))}%`}})),React.createElement("p",{className:"text-xs mt-1 text-gray-600"},"6-24h (perfusion imaging required)"))),React.createElement("div",{className:"mt-3 pt-3 border-t border-gray-200 flex items-center justify-between text-xs text-gray-500"},React.createElement("span",null,"Alerts: ",Ke?"Muted":"Active",!Ke&&s>0&&s<.5&&" (30m, 15m, 0m)"),It&&React.createElement("span",{className:"text-orange-600 font-medium"},"Last: ",It==="warning-30"?"30m warning":It==="warning-15"?"15m warning":"Window closed"))))})(),we==="videoTelestroke"&&t.diagnosisCategory&&React.createElement("details",{className:"bg-white border-2 border-indigo-200 rounded-lg shadow-md overflow-hidden"},React.createElement("summary",{className:"bg-gradient-to-r from-indigo-500 to-purple-500 text-white p-3 cursor-pointer hover:from-indigo-600 hover:to-purple-600 transition-colors"},React.createElement("span",{className:"font-bold text-sm flex items-center gap-2"},"\u{1F52C} Clinical Trial Details",React.createElement("span",{className:"text-xs opacity-75"},"(click to expand full descriptions)"))),React.createElement("div",{className:"p-4 space-y-4 max-h-96 overflow-y-auto"},t.diagnosisCategory==="ischemic"&&React.createElement("div",{className:"space-y-3"},React.createElement("h4",{className:"font-bold text-indigo-800 border-b pb-2"},"Active Ischemic Stroke Trials"),React.createElement("div",{className:"bg-blue-50 p-3 rounded-lg border border-blue-200"},React.createElement("p",{className:"font-semibold text-blue-800"},"SISTER Trial (NCT05948566)"),React.createElement("p",{className:"text-sm text-gray-700"},"TS23 (monoclonal antibody to \u03B12-antiplasmin) for late thrombolysis in acute ischemic stroke patients presenting 4.5-24 hours from last known well. Anterior circulation, NIHSS \u22654, favorable perfusion imaging (mismatch ratio >1.2, core <70cc). No IV thrombolysis or EVT with clot engagement.")),React.createElement("div",{className:"bg-blue-50 p-3 rounded-lg border border-blue-200"},React.createElement("p",{className:"font-semibold text-blue-800"},"STEP-EVT Trial (NCT06289985)"),React.createElement("p",{className:"text-sm text-gray-700"},"NIH StrokeNet adaptive platform trial optimizing endovascular therapy for mild stroke (NIHSS 0-5 with LVO) and medium/distal vessel occlusions (M2, M3, A1-A3, P1-P3). Within 24 hours, pre-stroke mRS \u22642.")),React.createElement("div",{className:"bg-blue-50 p-3 rounded-lg border border-blue-200"},React.createElement("p",{className:"font-semibold text-blue-800"},"PICASSO Trial (NCT05611242)"),React.createElement("p",{className:"text-sm text-gray-700"},"Mechanical thrombectomy with vs without acute carotid stenting for tandem lesions. Age 18-79, tandem lesion (carotid stenosis 70-100% + intracranial LVO), within 16 hours, NIHSS \u22654, ASPECTS \u22657.")),React.createElement("div",{className:"bg-blue-50 p-3 rounded-lg border border-blue-200"},React.createElement("p",{className:"font-semibold text-blue-800"},"TESTED Trial (NCT05911568)"),React.createElement("p",{className:"text-sm text-gray-700"},"EVT vs medical therapy in LVO patients with pre-existing disability (mRS 3-4 for \u22653 months). Within 24 hours, NIHSS \u22656, ASPECTS \u22653. Includes ICA terminus, M1, dominant M2.")),React.createElement("div",{className:"bg-green-50 p-3 rounded-lg border border-green-200"},React.createElement("p",{className:"font-semibold text-green-800"},"VERIFY Study (NCT05338697) - Observational"),React.createElement("p",{className:"text-sm text-gray-700"},"Early TMS/MRI/clinical measures to predict upper extremity motor recovery. Acute ischemic stroke within 7 days with upper extremity weakness. Pre-stroke mRS \u22642. Inpatient enrollment opportunity.")),React.createElement("div",{className:"bg-green-50 p-3 rounded-lg border border-green-200"},React.createElement("p",{className:"font-semibold text-green-800"},"DISCOVERY Study (NCT04916210) - Observational"),React.createElement("p",{className:"text-sm text-gray-700"},"Cognitive trajectories and biomarkers after stroke (includes AIS/ICH/SAH). Baseline visit within 6 weeks, fluent in English/Spanish, needs study partner with regular contact.")),React.createElement("div",{className:"bg-purple-50 p-3 rounded-lg border border-purple-200"},React.createElement("p",{className:"font-semibold text-purple-800"},"ESUS Imaging Study (NCT03820375) - Observational"),React.createElement("p",{className:"text-sm text-gray-700"},"Cardiac and intracranial vessel wall MRI to reclassify ESUS. Within 30 days of index stroke, age \u226518, ESUS diagnosis. Helps identify occult cardioembolic or atherosclerotic sources.")),React.createElement("div",{className:"bg-purple-50 p-3 rounded-lg border border-purple-200"},React.createElement("p",{className:"font-semibold text-purple-800"},"MOCHA Imaging (PMC8821414) - Observational"),React.createElement("p",{className:"text-sm text-gray-700"},"Automated intracranial vessel-wall analysis for non-stenotic ICAD detection. Patients with atherosclerotic risk factors (age >50/60, HTN, DM, hyperlipidemia, obesity, smoking). High-resolution MRI vessel wall imaging required."))),t.diagnosisCategory==="ich"&&React.createElement("div",{className:"space-y-3"},React.createElement("h4",{className:"font-bold text-red-800 border-b pb-2"},"Active ICH Trials"),React.createElement("div",{className:"bg-red-50 p-3 rounded-lg border border-red-200"},React.createElement("p",{className:"font-semibold text-red-800"},"FASTEST Trial (NCT03496883)"),React.createElement("p",{className:"text-sm text-gray-700"},"Recombinant Factor VIIa (rFVIIa) for acute ICH within 2 HOURS of symptom onset to prevent hematoma expansion. Age 18-80, hematoma volume 2-60 mL, IVH score \u22647, GCS \u22658, not on anticoagulation. Very narrow time window.")),React.createElement("div",{className:"bg-red-50 p-3 rounded-lg border border-red-200"},React.createElement("p",{className:"font-semibold text-red-800"},"SATURN Trial (NCT03936361)"),React.createElement("p",{className:"text-sm text-gray-700"},"Statin continuation vs discontinuation after LOBAR ICH. Age \u226550, must already be on statin therapy at ICH onset. Randomization within 7 days. Excludes deep/basal ganglia ICH, recent MI.")),React.createElement("div",{className:"bg-red-50 p-3 rounded-lg border border-red-200"},React.createElement("p",{className:"font-semibold text-red-800"},"ASPIRE Trial (NCT03907046)"),React.createElement("p",{className:"text-sm text-gray-700"},"Apixaban vs aspirin for stroke prevention after ICH in patients with atrial fibrillation. Randomization 14-180 days post-ICH, CHA2DS2-VASc \u22652, mRS \u22644. Excludes mechanical valves, recent DVT/PE.")),React.createElement("div",{className:"bg-orange-50 p-3 rounded-lg border border-orange-200"},React.createElement("p",{className:"font-semibold text-orange-800"},"cAPPricorn-1 Trial (NCT06393712)"),React.createElement("p",{className:"text-sm text-gray-700"},"Intrathecal ALN-APP (mivelsiran) for cerebral amyloid angiopathy. Sporadic CAA (age \u226550, Boston Criteria v2.0) or Dutch-type hereditary CAA (age \u226530, E693Q APP variant). Prior symptomatic lobar ICH \u226590 days ago. Requires lumbar punctures.")),React.createElement("div",{className:"bg-green-50 p-3 rounded-lg border border-green-200"},React.createElement("p",{className:"font-semibold text-green-800"},"MIRROR Registry (NCT04494295) - Observational"),React.createElement("p",{className:"text-sm text-gray-700"},"Minimally invasive endoscopic ICH evacuation using Aurora Surgiscope System. Spontaneous supratentorial ICH \u226520mL, surgery within 24 hours, NIHSS >5, baseline mRS \u22642, GCS \u22655.")),React.createElement("div",{className:"bg-green-50 p-3 rounded-lg border border-green-200"},React.createElement("p",{className:"font-semibold text-green-800"},"DISCOVERY Study - ICH Cohort (NCT04916210) - Observational"),React.createElement("p",{className:"text-sm text-gray-700"},"Cognitive trajectories and biomarkers after ICH. Baseline visit within 6 weeks, fluent in English/Spanish, needs study partner with regular contact. Expected survival \u22651 year.")))),React.createElement("div",{className:"bg-indigo-50 p-2 text-center border-t border-indigo-200"},React.createElement("p",{className:"text-xs text-indigo-700"},"For full eligibility criteria, visit the Trials tab or ClinicalTrials.gov")))))),React.createElement("div",{id:"handoff-section",className:"bg-white border-2 border-slate-200 rounded-lg p-4 shadow-sm"},React.createElement("div",{className:"flex flex-wrap items-center justify-between gap-3 mb-3"},React.createElement("div",null,React.createElement("p",{className:"text-xs uppercase tracking-wide text-slate-500 font-semibold"},"Handoff Summary")),React.createElement("button",{type:"button",onClick:()=>{let e=Ri();navigator.clipboard.writeText(e),z("handoff-summary"),setTimeout(()=>z(""),2e3)},className:"px-3 py-2 bg-slate-900 text-white rounded-lg text-xs font-semibold hover:bg-slate-800"},le==="handoff-summary"?"Copied!":"Copy handoff")),(()=>{let e=Ii(),a=[{label:"Dx",value:e.diagnosis},{label:"Age/Sex",value:`${e.age} ${e.sex}`.trim()},{label:e.onsetLabel,value:`${e.onsetTime}${e.elapsed&&e.elapsed!=="Unknown"?` (${e.elapsed})`:""}`},{label:"NIHSS",value:`${e.nihss}${e.nihssDetails?` (${e.nihssDetails})`:""}`},{label:"Imaging",value:e.imagingSummary},{label:"Plan",value:`${e.tnkStatus}; ${e.evtStatus}`}];if(e.disposition&&a.push({label:"Disposition",value:e.disposition}),e.transferStatus||e.transportDetails){let i=[e.transferStatus,e.transportDetails?`Transport: ${e.transportDetails}`:""].filter(Boolean).join(" | ");a.push({label:"Transfer",value:i})}return e.imagingShare&&a.push({label:"Imaging share",value:e.imagingShare}),React.createElement(React.Fragment,null,React.createElement("div",{className:"grid grid-cols-1 sm:grid-cols-2 gap-3"},a.map(i=>React.createElement("div",{key:i.label,className:"rounded-lg border border-slate-200 bg-slate-50 px-3 py-2"},React.createElement("p",{className:"text-[11px] uppercase tracking-wide text-slate-500"},i.label),React.createElement("p",{className:"text-sm font-semibold text-slate-900"},i.value||"--")))),React.createElement("details",{className:"mt-3 bg-slate-50 border border-slate-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer px-3 py-2 text-xs font-semibold text-slate-700"},"Full handoff text"),React.createElement("div",{className:"px-3 pb-3"},React.createElement("pre",{className:"whitespace-pre-wrap text-xs text-slate-700"},Ri()))))})()),React.createElement("details",{id:"safety-section",className:"bg-white border border-slate-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-slate-800 hover:bg-slate-50 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Safety checks"),React.createElement("span",{className:"text-xs text-slate-500"},go,"/",Ua.length," complete")),React.createElement("div",{className:"p-4 space-y-4"},React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-2"},Ua.map(e=>React.createElement("div",{key:e.id,className:`flex items-center gap-2 p-2 rounded-lg border ${e.complete?"bg-green-50 border-green-200 text-green-800":"bg-amber-50 border-amber-200 text-amber-800"}`},React.createElement("span",{className:"text-xs font-bold"},e.complete?"\u2713":"!"),React.createElement("span",{className:"text-sm"},e.label)))))),(Ce||t.diagnosisCategory==="mimic")&&React.createElement("details",{className:"bg-white border border-slate-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-slate-800 hover:bg-slate-50 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Stroke mimic FAQ"),React.createElement("span",{className:"text-xs text-slate-500"},"Quick differentiators")),React.createElement("div",{className:"p-4 space-y-3 text-sm text-slate-700"},[{q:"When should I suspect a mimic?",a:"Rapidly resolving deficits, inconsistent exam, or normal imaging despite severe symptoms."},{q:"Seizure vs stroke?",a:"Consider Todd paralysis if witnessed seizure, postictal confusion, or EEG support."},{q:"Migraine vs stroke?",a:"Positive visual/aura symptoms and headache history favor migraine; deficits often march."},{q:"Metabolic causes?",a:"Check glucose, electrolytes, and intoxication if symptoms are diffuse or fluctuating."},{q:"Functional symptoms?",a:"Look for incongruent weakness patterns, Hoover sign, or variability with distraction."}].map(e=>React.createElement("div",{key:e.q,className:"border border-slate-200 rounded-lg p-3 bg-slate-50"},React.createElement("p",{className:"font-semibold text-slate-800"},e.q),React.createElement("p",{className:"mt-1"},e.a)))))),Q==="management"&&React.createElement("div",{className:"space-y-6"},React.createElement("div",{className:"bg-white border border-gray-200 rounded-xl p-2 flex flex-wrap gap-2"},[{id:"ich",label:"ICH",icon:"alert-triangle"},{id:"ischemic",label:"Ischemic Stroke",icon:"activity"},{id:"calculators",label:"Calculators",icon:"calculator"},{id:"references",label:"References",icon:"book-open"}].map(e=>{let a=he===e.id;return React.createElement("button",{key:e.id,onClick:()=>vt(e.id),className:`flex items-center gap-2 px-3 py-2 rounded-lg text-sm font-medium transition-colors ${a?"bg-blue-600 text-white":"bg-gray-50 text-gray-700 hover:bg-gray-100"}`},React.createElement("i",{"data-lucide":e.icon,className:"w-4 h-4"}),React.createElement("span",null,e.label))})),he==="ich"&&React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-4"},React.createElement("h2",{className:"text-xl font-semibold text-red-800 mb-4"},"ICH Management"),React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-4 mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-blue-800 mb-3"},"Minimally Invasive Evacuation (MIE)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4 mb-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-green-600 mb-2"},"ENRICH Trial Inclusion (NCT02880878)"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Spontaneous supratentorial lobar or basal ganglia ICH"),React.createElement("li",null,"\u2022 ICH onset \u226424 hours"),React.createElement("li",null,"\u2022 Age 18-80 years"),React.createElement("li",null,"\u2022 GCS 5-14 and NIHSS \u22656"),React.createElement("li",null,"\u2022 ICH volume 30-80 cc"),React.createElement("li",null,"\u2022 Pre-morbid mRS 0-1"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-red-600 mb-2"},"ENRICH Trial Exclusion"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Coagulopathy"),React.createElement("li",null,"\u2022 IVH >50% either lateral ventricle"),React.createElement("li",null,"\u2022 Thalamic/infratentorial ICH")))),React.createElement("div",{className:"bg-gray-100 p-3 rounded"},React.createElement("p",{className:"text-sm font-semibold mb-2"},"ICH Volume Calculation:"),React.createElement("p",{className:"text-sm"},React.createElement("strong",null,"ABC/2 Method:")),React.createElement("ul",{className:"text-sm ml-4"},React.createElement("li",null,"A = largest ICH diameter (cm)"),React.createElement("li",null,"B = largest diameter 90 degrees to A on same slice (cm)"),React.createElement("li",null,"C = (# CT slices with ICH) x (slice thickness)")),React.createElement("p",{className:"text-sm mt-2 font-semibold"},"Volume = A x B x C / 2"))),React.createElement("div",{className:"mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-red-700 mb-4"},"Anticoagulation Reversal"),React.createElement("div",{className:"bg-white p-4 rounded border mb-4"},React.createElement("h4",{className:"font-semibold text-blue-700 mb-3"},"Warfarin"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Vitamin K:")," 10 mg IV over 20 min"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"PCC (KCentra):")," 2000 U IV"))),React.createElement("div",{className:"bg-white p-4 rounded border mb-4"},React.createElement("h4",{className:"font-semibold text-purple-700 mb-3"},"Direct Oral Anticoagulants (DOACs)"),React.createElement("div",{className:"mb-3"},React.createElement("p",{className:"text-sm font-semibold text-gray-700"},"Direct Factor Xa Inhibitors:"),React.createElement("p",{className:"text-sm text-gray-600 mb-2"},"Apixaban, Rivaroxaban"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"PCC (KCentra):")," 50 IU/kg (max 5000 IU)"))),React.createElement("div",null,React.createElement("p",{className:"text-sm font-semibold text-gray-700"},"Direct Thrombin Inhibitor:"),React.createElement("p",{className:"text-sm text-gray-600 mb-2"},"Dabigatran"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Idarucizumab (Praxbind):")," 5g IV (2 x 2.5g)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"If unavailable:")," PCC (KCentra)")))),React.createElement("div",{className:"bg-white p-4 rounded border mb-4"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-3"},"Relative contraindications to PCC/FFP:"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 History of major thrombosis/thromboembolism \u22646 weeks"),React.createElement("li",null,"\u2022 Major surgery \u22646 weeks"),React.createElement("li",null,"\u2022 Known prothrombotic disorder"),React.createElement("li",null,"\u2022 IPH not considered survivable")))),React.createElement("div",{className:"mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-red-700 mb-4"},"Hematoma Expansion Prevention"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-red-600 mb-2"},"Blood Pressure Target"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Target SBP 130-150 mmHg")," within 2 hours"),React.createElement("li",null,"\u2022 Avoid SBP <130 (renal AKI risk)"),React.createElement("li",null,"\u2022 Nicardipine infusion preferred (reliable titration)"),React.createElement("li",null,"\u2022 Maintain target for at least 24 hours"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class I, LOE A \u2014 AHA/ASA ICH 2022"))),React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-red-600 mb-2"},"Expansion Risk Factors"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Spot sign on CTA"),React.createElement("li",null,"\u2022 Anticoagulant use"),React.createElement("li",null,"\u2022 Time from onset <3 hours"),React.createElement("li",null,"\u2022 Large initial volume (>30 mL)"),React.createElement("li",null,"\u2022 Irregular hematoma shape"),React.createElement("li",null,"\u2022 Blend sign on NCCT"))))),React.createElement("div",{className:"mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-red-700 mb-4"},"IVH & Hydrocephalus Management"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-orange-600 mb-2"},"EVD Indications"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 GCS \u22648 with IVH and hydrocephalus"),React.createElement("li",null,"\u2022 Obstructive hydrocephalus from IVH"),React.createElement("li",null,"\u2022 Cerebellar ICH with 4th ventricle compression"),React.createElement("li",null,"\u2022 Used for ICP monitoring and CSF drainage"))),React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-orange-600 mb-2"},"IVH-Specific Management"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Intraventricular alteplase may be considered (CLEAR III)"),React.createElement("li",null,"\u2022 Dose: alteplase 1 mg q8h via EVD"),React.createElement("li",null,"\u2022 Goal: accelerate clot resolution, reduce shunt dependency"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class IIb, LOE B-R \u2014 AHA/ASA ICH 2022"))))),React.createElement("div",{className:"mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-red-700 mb-4"},"ICH Disposition & Goals of Care"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-teal-600 mb-2"},"Surgical Indications"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Cerebellar ICH >15 mL:")," urgent surgical evacuation"),React.createElement("li",null,"\u2022 Lobar ICH 30-80 mL: consider MIE (ENRICH criteria)"),React.createElement("li",null,"\u2022 GCS deterioration by \u22652 points"),React.createElement("li",null,"\u2022 New pupil asymmetry or brainstem signs"),React.createElement("li",null,"\u2022 Obstructive hydrocephalus unresponsive to EVD"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class I, LOE B-NR \u2014 AHA/ASA ICH 2022"))),React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-teal-600 mb-2"},"Goals-of-Care Triggers"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"ICH Score \u22653:")," initiate GOC discussion"),React.createElement("li",null,"\u2022 Avoid early DNR orders limiting aggressive care"),React.createElement("li",null,"\u2022 Full care recommended for minimum 24-48h"),React.createElement("li",null,"\u2022 Self-fulfilling prophecy of withdrawal is well-documented"),React.createElement("li",null,"\u2022 Palliative care consult for symptom management"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class I, LOE C-LD \u2014 AHA/ASA ICH 2022 + AHA Palliative 2024"))))),React.createElement("div",{className:"mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-red-700 mb-4"},"Seizure Management in ICH"),React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Treat clinical seizures with antiseizure medication (ASM)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"7-day prophylactic ASM")," may be considered for lobar ICH"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"No routine long-term seizure prophylaxis")," (Class III)"),React.createElement("li",null,"\u2022 Continuous EEG monitoring for unexplained decrease in consciousness"),React.createElement("li",null,"\u2022 Preferred agents: levetiracetam 500-1000 mg IV/PO BID or lacosamide 200 mg IV/PO BID"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class IIb (7-day prophylaxis), Class III (routine long-term) \u2014 AHA/ASA ICH 2022")))),React.createElement("div",{className:"mb-6"},React.createElement("h3",{className:"text-lg font-semibold text-red-700 mb-4"},"ICH Supportive Care Bundle"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"Standard Orders"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 NPO until dysphagia screen passed"),React.createElement("li",null,"\u2022 IPC on admission for VTE prophylaxis"),React.createElement("li",null,"\u2022 Pharmacologic VTE ppx after 24-48h (stable hematoma)"),React.createElement("li",null,"\u2022 Glucose target 140-180 (no intensive insulin)"),React.createElement("li",null,"\u2022 Acetaminophen for temp >38\xB0C"),React.createElement("li",null,"\u2022 HOB 30 degrees"))),React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("h4",{className:"font-semibold text-gray-700 mb-2"},"Monitoring"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Neuro checks q1h x 24h, then q2h"),React.createElement("li",null,"\u2022 Continuous telemetry"),React.createElement("li",null,"\u2022 Repeat CT at 6h or with any neurological change"),React.createElement("li",null,"\u2022 Daily CBC, BMP, coags if on reversal"),React.createElement("li",null,"\u2022 Early PT/OT/SLP once medically stable")))))),he==="ischemic"&&React.createElement("div",{className:"space-y-6"},React.createElement("div",{className:"bg-blue-50 border border-blue-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-blue-800 mb-3"},"Blood Pressure Management"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4 mb-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-green-700 mb-2"},"BP Goals"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,React.createElement("strong",null,"Ischemic stroke:")," SBP <220, DBP <120"),React.createElement("li",null,React.createElement("strong",null,"Before lytics:")," SBP <185, DBP <110"),React.createElement("li",null,React.createElement("strong",null,"After lytics:")," SBP <180, DBP <105"),React.createElement("li",null,React.createElement("strong",null,"After thrombectomy:")," SBP <180, DBP <105"),React.createElement("li",null,React.createElement("strong",null,"ICH:")," SBP <160, DBP <105"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-blue-700 mb-2"},"Acute Treatment"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,React.createElement("strong",null,"Labetalol:")," 10 mg IV q15min"),React.createElement("li",null,"Increase to 20mg, then 40mg, then 60mg"),React.createElement("li",null,"Max total dose: 300mg in 2 hours"),React.createElement("li",null,React.createElement("strong",null,"Alternative:")," Nicardipine 5 mg/hr IV"),React.createElement("li",null,"Titrate by 2.5 mg/hr q15min"))))),React.createElement("div",{className:"bg-red-50 border border-red-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-red-800 mb-3"},"Post-Lytic ICH Protocol"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold mb-2"},"Immediate Actions"),React.createElement("ol",{className:"text-sm space-y-1 list-decimal list-inside"},React.createElement("li",null,"STAT non-contrast CT head"),React.createElement("li",null,"Emergency hemorrhage panel"),React.createElement("li",null,"Type & cross"),React.createElement("li",null,"Notify patient's family"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold mb-2"},"Reversal"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,React.createElement("strong",null,"Cryoprecipitate:")," 10 units IV"),React.createElement("li",null,React.createElement("strong",null,"Platelets:")," 6 units IV"),React.createElement("li",null,React.createElement("strong",null,"TXA:")," 1g IV over 10 min"))))),React.createElement("div",{className:"bg-yellow-50 border border-yellow-300 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-yellow-800 mb-3"},"Orolingual Angioedema Protocol"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-yellow-700 mb-2"},"Risk Factors"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ACE inhibitor use"),React.createElement("li",null,"\u2022 Insular cortex involvement"),React.createElement("li",null,"\u2022 Frontal operculum stroke"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-yellow-700 mb-2"},"Treatment"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,React.createElement("strong",null,"Stop thrombolytic infusion")," if running"),React.createElement("li",null,React.createElement("strong",null,"Methylprednisolone:")," 125 mg IV"),React.createElement("li",null,React.createElement("strong",null,"Diphenhydramine:")," 50 mg IV"),React.createElement("li",null,React.createElement("strong",null,"Ranitidine:")," 50 mg IV"),React.createElement("li",null,React.createElement("strong",null,"Epinephrine:")," 0.1% if severe"),React.createElement("li",null,React.createElement("strong",null,"Consider Berinert:")," 20 IU/kg (C1 esterase inhibitor)"),React.createElement("li",null,React.createElement("strong",null,"Supportive Care")))))),React.createElement("div",{className:"bg-green-50 border border-green-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-green-800 mb-3"},"Antiplatelet Loading Protocol"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-green-700 mb-2"},"Minor Stroke / TIA (NIHSS \u2264 3)"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,React.createElement("strong",null,"DAPT x 21 days:")),React.createElement("li",null,"\u2022 ASA 325 mg load \u2192 81 mg daily"),React.createElement("li",null,"\u2022 Clopidogrel 300 mg load \u2192 75 mg daily"),React.createElement("li",null,"\u2022 Then single antiplatelet after 21 days"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class I, LOE A (CHANCE/POINT) \u2014 AHA/ASA 2021"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-green-700 mb-2"},"Moderate-Severe Stroke (no lysis)"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,React.createElement("strong",null,"Single antiplatelet:")),React.createElement("li",null,"\u2022 ASA 325 mg within 24-48h of onset"),React.createElement("li",null,"\u2022 If post-TNK: delay ASA 24 hours"),React.createElement("li",null,"\u2022 If AF: transition to DOAC per CATALYST timing"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class I, LOE A \u2014 AHA/ASA 2021"))))),React.createElement("div",{className:"bg-purple-50 border border-purple-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-purple-800 mb-3"},"DOAC Initiation in AF-Stroke (CATALYST Meta-Analysis)"),React.createElement("div",{className:"bg-white p-3 rounded border mb-3"},React.createElement("p",{className:"text-sm text-gray-700 mb-2"},"Based on the CATALYST meta-analysis (pooled data from ELAN, OPTIMAS, TIMING, START), early DOAC initiation is safe and non-inferior to delayed initiation."),React.createElement("div",{className:"grid grid-cols-1 sm:grid-cols-3 gap-3 mt-3"},React.createElement("div",{className:"bg-green-50 p-2 rounded border border-green-200 text-center"},React.createElement("p",{className:"text-xs font-bold text-green-700 uppercase"},"Minor Stroke"),React.createElement("p",{className:"text-xs text-gray-500"},"NIHSS <8, small infarct"),React.createElement("p",{className:"text-lg font-bold text-green-800 mt-1"},"Within 48h")),React.createElement("div",{className:"bg-amber-50 p-2 rounded border border-amber-200 text-center"},React.createElement("p",{className:"text-xs font-bold text-amber-700 uppercase"},"Moderate Stroke"),React.createElement("p",{className:"text-xs text-gray-500"},"NIHSS 8-15"),React.createElement("p",{className:"text-lg font-bold text-amber-800 mt-1"},"Day 3-5")),React.createElement("div",{className:"bg-red-50 p-2 rounded border border-red-200 text-center"},React.createElement("p",{className:"text-xs font-bold text-red-700 uppercase"},"Severe Stroke"),React.createElement("p",{className:"text-xs text-gray-500"},"NIHSS >15 or large infarct"),React.createElement("p",{className:"text-lg font-bold text-red-800 mt-1"},"Day 6-14"))),React.createElement("p",{className:"text-xs text-gray-500 mt-2 italic"},"Fischer U et al. Lancet Neurol. 2025. CATALYST Collaboration. Reassess imaging before DOAC start if concern for hemorrhagic transformation.")),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-purple-700 mb-2"},"Preferred DOACs"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Apixaban")," 5 mg BID (2.5 mg if age \u226580, weight \u226460 kg, or Cr \u22651.5)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Rivaroxaban")," 20 mg daily (15 mg if CrCl 15-50)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Dabigatran")," 150 mg BID (110 mg if age \u226580)"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"DOAC preferred over warfarin (Class I, LOE A) \u2014 AHA/ASA 2021")))),React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-indigo-800 mb-3"},"Statin Initiation"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-indigo-700 mb-2"},"High-Intensity Statin (LDL <70)"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Atorvastatin 80 mg")," daily (preferred)"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"Rosuvastatin 20-40 mg")," daily"),React.createElement("li",null,"\u2022 Start during hospitalization"),React.createElement("li",null,"\u2022 Add ezetimibe 10 mg if LDL not at goal"),React.createElement("li",null,"\u2022 Consider PCSK9i if still above target"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class I, LOE A \u2014 AHA/ASA 2021"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-amber-700 mb-2"},"Special Considerations"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 sICAS (70-99%): high-intensity + LDL <70 (Class I)"),React.createElement("li",null,"\u2022 Lobar ICH: caution \u2014 SATURN trial pending"),React.createElement("li",null,"\u2022 Check LFTs at baseline, recheck 4-12 weeks"),React.createElement("li",null,"\u2022 Do not discontinue statin for mild transaminase elevation (<3x ULN)"))))),React.createElement("div",{className:"bg-violet-50 border border-violet-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-violet-800 mb-3"},"Post-EVT Management"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-violet-700 mb-2"},"Blood Pressure"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 SBP <180/105 (standard target)"),React.createElement("li",{className:"text-red-700 font-semibold"},"\u2022 Do NOT target SBP <140 (Class III: Harm)"),React.createElement("li",null,"\u2022 Based on ENCHANTED2/MT + OPTIMAL-BP"),React.createElement("li",null,"\u2022 Monitor q15 min x 2h, then q30 min x 6h"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-violet-700 mb-2"},"Post-Procedure Care"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Groin check q15 min x 4, q30 min x 4, then q1h"),React.createElement("li",null,"\u2022 Bed rest per protocol (typically 2-6h)"),React.createElement("li",null,"\u2022 Follow-up imaging: CT/CTA at 24h or if neuro change"),React.createElement("li",null,"\u2022 Antiplatelet: ASA 325 mg within 24h if no hemorrhagic conversion"),React.createElement("li",null,"\u2022 Neuro checks q1h x 24h minimum")))),React.createElement("div",{className:"mt-3 bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-violet-700 mb-2"},"Post-EVT BP Drip Protocol"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 text-sm"},React.createElement("div",null,React.createElement("p",{className:"font-semibold text-gray-700"},"Nicardipine (preferred):"),React.createElement("ul",{className:"space-y-0.5 text-xs"},React.createElement("li",null,"\u2022 Start 5 mg/hr IV"),React.createElement("li",null,"\u2022 Titrate by 2.5 mg/hr q5-15min"),React.createElement("li",null,"\u2022 Max 15 mg/hr"),React.createElement("li",null,"\u2022 Target SBP 140-180 mmHg"))),React.createElement("div",null,React.createElement("p",{className:"font-semibold text-gray-700"},"Clevidipine (alternative):"),React.createElement("ul",{className:"space-y-0.5 text-xs"},React.createElement("li",null,"\u2022 Start 1-2 mg/hr IV"),React.createElement("li",null,"\u2022 Titrate by doubling q90sec initially"),React.createElement("li",null,"\u2022 Max 32 mg/hr"),React.createElement("li",null,"\u2022 Ultra-short half-life (~1 min)")))),React.createElement("p",{className:"text-xs text-gray-500 mt-1 italic"},"ENCHANTED2/MT and OPTIMAL-BP: SBP <140 post-EVT worsened outcomes. Maintain 140-180 range for first 24-72h."))),React.createElement("div",{className:"bg-gray-50 border border-gray-300 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-gray-800 mb-3"},"Medium Vessel Occlusion (MeVO) EVT"),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("p",{className:"text-sm text-red-700 font-semibold mb-2"},"EVT for isolated MeVO (M2/M3) is NOT recommended based on current evidence"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"ESCAPE-MeVO:")," EVT did not improve outcomes vs medical therapy for M2/M3 occlusions"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"DISTAL:")," No benefit of EVT for distal occlusions"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"DISCOUNT:")," Negative for M2 thrombectomy"),React.createElement("li",null,"\u2022 All three trials showed similar functional outcomes with medical management alone"),React.createElement("li",null,"\u2022 Consider EVT only in trial setting (e.g., STEP-EVT adaptive platform)")),React.createElement("p",{className:"text-xs text-gray-500 mt-2 italic"},"Note: LVO (ICA-T, M1, basilar) EVT remains Class I. This applies only to isolated medium/distal vessel occlusions."))),React.createElement("div",{className:"bg-orange-50 border border-orange-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-orange-800 mb-3"},"Intracranial Atherosclerotic Disease (ICAD)"),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-orange-700 mb-2"},"Symptomatic ICAD (70-99% stenosis)"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 DAPT x 90 days (ASA + clopidogrel)"),React.createElement("li",null,"\u2022 High-intensity statin (LDL <70)"),React.createElement("li",null,"\u2022 SBP <140 mmHg"),React.createElement("li",null,"\u2022 ",React.createElement("strong",null,"NO intracranial stenting")," (SAMMPRIS, CASSISS: stenting inferior to medical therapy)"),React.createElement("li",{className:"text-gray-500 italic text-xs mt-1"},"Class III (Harm) for stenting \u2014 SAMMPRIS, CASSISS"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-orange-700 mb-2"},"Moderate ICAD (50-69%)"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 Single antiplatelet preferred"),React.createElement("li",null,"\u2022 Aggressive risk factor management"),React.createElement("li",null,"\u2022 Consider DAPT if recent symptomatic event"),React.createElement("li",null,"\u2022 Serial vascular imaging (MRA or CTA q6-12mo)")))))),he==="calculators"&&React.createElement("div",{className:"space-y-4"},(h||t.age)&&React.createElement("div",{className:"bg-gradient-to-r from-purple-50 to-indigo-50 border-2 border-purple-300 rounded-lg p-4 shadow-md"},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("h2",{className:"text-lg font-bold text-purple-900 flex items-center gap-2"},"\u{1F52C} Score \u2192 Trial Implications"),t.age&&React.createElement("span",{className:"text-sm text-purple-700"},"Current: ",t.age,t.sex||"?"," | NIHSS ",h||"?")),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 text-sm"},h!=null&&React.createElement("div",{className:"bg-white rounded p-3 border"},React.createElement("h3",{className:"font-semibold text-purple-800 mb-2"},"NIHSS = ",h),React.createElement("ul",{className:"space-y-1 text-xs text-gray-700"},h>=6&&React.createElement("li",{className:"text-green-700"},"\u{1F7E2} ",React.createElement("strong",null,"SISTER eligible"),": NIHSS \u22656 threshold met"),h<=5&&React.createElement("li",{className:"text-yellow-700"},"\u{1F7E1} ",React.createElement("strong",null,"STEP mild arm"),": Check for LVO (ICA/M1/basilar)"),h>8&&React.createElement("li",{className:"text-blue-700"},"\u{1F535} ",React.createElement("strong",null,"STEP MeVO arm"),": Check for M2/M3 occlusion"),h<6&&React.createElement("li",{className:"text-gray-600"},"\u26AA SISTER: NIHSS \u22656 required (current: ",h,")"))),(()=>{let e=Mt(T);return e===0?null:React.createElement("div",{className:"bg-white rounded p-3 border"},React.createElement("h3",{className:"font-semibold text-purple-800 mb-2"},"GCS = ",e),React.createElement("ul",{className:"space-y-1 text-xs text-gray-700"},e>=5&&e<=14&&React.createElement("li",{className:"text-blue-700"},"\u{1F535} ",React.createElement("strong",null,"ENRICH range"),": GCS 5-14 for MIE consideration"),e>14&&React.createElement("li",{className:"text-gray-600"},"\u26AA ENRICH: GCS 5-14 required (current: ",e,")"),e<5&&React.createElement("li",{className:"text-gray-600"},"\u26AA GCS too low for most trial eligibility")))})()),React.createElement("p",{className:"text-xs text-purple-600 mt-2 italic"},"\u{1F4A1} These are quick prompts only. Full eligibility requires complete patient assessment.")),React.createElement("details",{className:"bg-gray-50 border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-gray-800 hover:bg-gray-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Glasgow Coma Scale (GCS)"),React.createElement("span",{className:"text-sm font-normal text-gray-600"},"Score: ",Mt(T))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("div",{className:"text-right"},React.createElement("span",{className:"text-xl font-bold text-gray-600"},"Score: ",Mt(T)),React.createElement("div",{className:"text-xs text-gray-500"},"Range: 3-15")),React.createElement("button",{onClick:()=>re(`GCS: ${Mt(T)}`,"GCS Score"),className:"p-1.5 hover:bg-gray-100 rounded transition-colors","aria-label":"Copy GCS score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-gray-600"}))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-3 mb-2"},React.createElement("div",{className:"space-y-2"},React.createElement("h4",{className:"font-semibold"},"Eye Opening"),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_eye",value:"4",className:"text-gray-600",checked:T.eye==="4",onChange:e=>Y({...T,eye:e.target.value})}),React.createElement("span",{className:"text-sm"},"4 - Spontaneous")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_eye",value:"3",className:"text-gray-600",checked:T.eye==="3",onChange:e=>Y({...T,eye:e.target.value})}),React.createElement("span",{className:"text-sm"},"3 - To sound")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_eye",value:"2",className:"text-gray-600",checked:T.eye==="2",onChange:e=>Y({...T,eye:e.target.value})}),React.createElement("span",{className:"text-sm"},"2 - To pain")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_eye",value:"1",className:"text-gray-600",checked:T.eye==="1",onChange:e=>Y({...T,eye:e.target.value})}),React.createElement("span",{className:"text-sm"},"1 - None"))),React.createElement("div",{className:"space-y-2"},React.createElement("h4",{className:"font-semibold"},"Verbal Response"),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_verbal",value:"5",className:"text-gray-600",checked:T.verbal==="5",onChange:e=>Y({...T,verbal:e.target.value})}),React.createElement("span",{className:"text-sm"},"5 - Oriented")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_verbal",value:"4",className:"text-gray-600",checked:T.verbal==="4",onChange:e=>Y({...T,verbal:e.target.value})}),React.createElement("span",{className:"text-sm"},"4 - Confused")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_verbal",value:"3",className:"text-gray-600",checked:T.verbal==="3",onChange:e=>Y({...T,verbal:e.target.value})}),React.createElement("span",{className:"text-sm"},"3 - Inappropriate")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_verbal",value:"2",className:"text-gray-600",checked:T.verbal==="2",onChange:e=>Y({...T,verbal:e.target.value})}),React.createElement("span",{className:"text-sm"},"2 - Incomprehensible")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_verbal",value:"1",className:"text-gray-600",checked:T.verbal==="1",onChange:e=>Y({...T,verbal:e.target.value})}),React.createElement("span",{className:"text-sm"},"1 - None"))),React.createElement("div",{className:"space-y-2"},React.createElement("h4",{className:"font-semibold"},"Motor Response"),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_motor",value:"6",className:"text-gray-600",checked:T.motor==="6",onChange:e=>Y({...T,motor:e.target.value})}),React.createElement("span",{className:"text-sm"},"6 - Obeying")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_motor",value:"5",className:"text-gray-600",checked:T.motor==="5",onChange:e=>Y({...T,motor:e.target.value})}),React.createElement("span",{className:"text-sm"},"5 - Localizing")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_motor",value:"4",className:"text-gray-600",checked:T.motor==="4",onChange:e=>Y({...T,motor:e.target.value})}),React.createElement("span",{className:"text-sm"},"4 - Flexing")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_motor",value:"3",className:"text-gray-600",checked:T.motor==="3",onChange:e=>Y({...T,motor:e.target.value})}),React.createElement("span",{className:"text-sm"},"3 - Abnormal flexion")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_motor",value:"2",className:"text-gray-600",checked:T.motor==="2",onChange:e=>Y({...T,motor:e.target.value})}),React.createElement("span",{className:"text-sm"},"2 - Extending")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"radio",name:"gcs_motor",value:"1",className:"text-gray-600",checked:T.motor==="1",onChange:e=>Y({...T,motor:e.target.value})}),React.createElement("span",{className:"text-sm"},"1 - None")))))),React.createElement("details",{className:"bg-red-50 border border-red-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-red-800 hover:bg-red-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"ICH Score"),React.createElement("span",{className:"text-sm font-normal text-red-600"},"Score: ",Je(R))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("span",{className:"text-xl font-bold text-red-600"},"Score: ",Je(R)),React.createElement("button",{onClick:()=>re(`ICH Score: ${Je(R)}`,"ICH Score"),className:"p-1.5 hover:bg-red-100 rounded transition-colors","aria-label":"Copy ICH score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-red-600"}))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2"},React.createElement("div",{className:"space-y-2"},React.createElement("p",{className:"font-semibold text-sm mb-2"},"Glasgow Coma Scale:"),React.createElement("label",{className:"flex items-center space-x-2 cursor-pointer"},React.createElement("input",{type:"radio",name:"ich_gcs",className:"text-red-600",checked:R.gcs==="gcs34",onChange:()=>ve({...R,gcs:"gcs34"})}),React.createElement("span",{className:"text-sm"},"GCS 3-4 (+2 points)")),React.createElement("label",{className:"flex items-center space-x-2 cursor-pointer"},React.createElement("input",{type:"radio",name:"ich_gcs",className:"text-red-600",checked:R.gcs==="gcs512",onChange:()=>ve({...R,gcs:"gcs512"})}),React.createElement("span",{className:"text-sm"},"GCS 5-12 (+1 point)")),React.createElement("label",{className:"flex items-center space-x-2 cursor-pointer"},React.createElement("input",{type:"radio",name:"ich_gcs",className:"text-red-600",checked:R.gcs==="",onChange:()=>ve({...R,gcs:""})}),React.createElement("span",{className:"text-sm"},"GCS 13-15 (0 points)")),React.createElement("hr",{className:"my-3"}),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-red-600",checked:R.age80,onChange:e=>ve({...R,age80:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Age \u226580 (+1)"))),React.createElement("div",{className:"space-y-4"},React.createElement("div",{className:"bg-gradient-to-br from-white to-gray-50 p-4 rounded-xl border border-gray-200 shadow-sm relative overflow-hidden group"},React.createElement("div",{className:"absolute top-0 right-0 p-2 opacity-10 group-hover:opacity-20 transition-opacity pointer-events-none"},React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"64",height:"64",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"2",strokeLinecap:"round",strokeLinejoin:"round",className:"text-blue-500"},React.createElement("path",{d:"M9.5 2A2.5 2.5 0 0 1 12 4.5v15a2.5 2.5 0 0 1-4.96.44 2.5 2.5 0 0 1-2.96-3.08 3 3 0 0 1-.34-5.58 2.5 2.5 0 0 1 1.32-4.24 2.5 2.5 0 0 1 4.44-4A2.5 2.5 0 0 1 9.5 2Z"}),React.createElement("path",{d:"M14.5 2A2.5 2.5 0 0 0 12 4.5v15a2.5 2.5 0 0 0 4.96.44 2.5 2.5 0 0 0 2.96-3.08 3 3 0 0 0 .34-5.58 2.5 2.5 0 0 0-1.32-4.24 2.5 2.5 0 0 0-4.44-4A2.5 2.5 0 0 0 14.5 2Z"}))),React.createElement("div",{className:"mb-4 relative z-10"},React.createElement("h4",{className:"text-sm font-bold text-gray-700 flex items-center gap-2"},React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"16",height:"16",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"2",strokeLinecap:"round",strokeLinejoin:"round",className:"text-blue-500"},React.createElement("rect",{width:"16",height:"20",x:"4",y:"2",rx:"2"}),React.createElement("line",{x1:"8",x2:"16",y1:"6",y2:"6"}),React.createElement("path",{d:"M16 14v4"}),React.createElement("path",{d:"M16 10h.01"}),React.createElement("path",{d:"M12 10h.01"}),React.createElement("path",{d:"M8 10h.01"}),React.createElement("path",{d:"M12 14h.01"}),React.createElement("path",{d:"M8 14h.01"}),React.createElement("path",{d:"M12 18h.01"}),React.createElement("path",{d:"M8 18h.01"})),"ICH Volume Calculator (ABC/2)"),React.createElement("p",{className:"text-xs text-gray-500 mt-1"},"Calculate hematoma volume from CT measurements.")),React.createElement("div",{className:"grid grid-cols-2 gap-4 mb-4 relative z-10"},React.createElement("div",{className:"space-y-1"},React.createElement("label",{className:"text-xs font-semibold text-gray-600 uppercase tracking-wider"},"A: Length"),React.createElement("div",{className:"relative"},React.createElement("input",{type:"number",className:"w-full pl-3 pr-8 py-2 text-sm bg-white border border-gray-200 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500 outline-none transition-all shadow-sm",placeholder:"0.0",value:$.a,onChange:e=>Yt({...$,a:e.target.value})}),React.createElement("span",{className:"absolute right-3 top-2 text-xs text-gray-400 font-medium"},"cm"))),React.createElement("div",{className:"space-y-1"},React.createElement("label",{className:"text-xs font-semibold text-gray-600 uppercase tracking-wider"},"B: Width"),React.createElement("div",{className:"relative"},React.createElement("input",{type:"number",className:"w-full pl-3 pr-8 py-2 text-sm bg-white border border-gray-200 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500 outline-none transition-all shadow-sm",placeholder:"0.0",value:$.b,onChange:e=>Yt({...$,b:e.target.value})}),React.createElement("span",{className:"absolute right-3 top-2 text-xs text-gray-400 font-medium"},"cm")))),React.createElement("div",{className:"grid grid-cols-2 gap-4 mb-4 relative z-10"},React.createElement("div",{className:"space-y-1"},React.createElement("label",{className:"text-xs font-semibold text-gray-600 uppercase tracking-wider"},"Slice Thickness"),React.createElement("div",{className:"relative"},React.createElement("input",{type:"number",className:"w-full pl-3 pr-8 py-2 text-sm bg-white border border-gray-200 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500 outline-none transition-all shadow-sm",placeholder:"e.g. 5",value:$.thicknessMm,onChange:e=>Yt({...$,thicknessMm:e.target.value})}),React.createElement("span",{className:"absolute right-3 top-2 text-xs text-gray-400 font-medium"},"mm"))),React.createElement("div",{className:"space-y-1"},React.createElement("label",{className:"text-xs font-semibold text-gray-600 uppercase tracking-wider"},"# Slices"),React.createElement("div",{className:"relative"},React.createElement("input",{type:"number",className:"w-full pl-3 pr-8 py-2 text-sm bg-white border border-gray-200 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500 outline-none transition-all shadow-sm",placeholder:"0",value:$.numSlices,onChange:e=>Yt({...$,numSlices:e.target.value})}),React.createElement("span",{className:"absolute right-3 top-2 text-xs text-gray-400 font-medium"},"#")))),React.createElement("div",{className:`mt-4 pt-3 border-t border-dashed border-gray-200 flex justify-between items-center transition-all duration-300 ${$.a&&$.b&&$.thicknessMm&&$.numSlices?"opacity-100":"opacity-50"}`},React.createElement("span",{className:"text-xs font-medium text-gray-500"},"Calculated Volume"),React.createElement("div",{className:"flex items-baseline gap-1"},React.createElement("span",{className:"text-2xl font-bold text-blue-600"},$.a&&$.b&&$.thicknessMm&&$.numSlices?(parseFloat($.a)*parseFloat($.b)*(parseFloat($.thicknessMm)/10*parseFloat($.numSlices))/2).toFixed(1):"0.0"),React.createElement("span",{className:"text-sm font-medium text-blue-400"},"cc")))),React.createElement("div",{className:"space-y-3 pl-1"},React.createElement("label",{className:"flex items-center space-x-3 cursor-pointer group"},React.createElement("div",{className:`w-5 h-5 rounded border flex items-center justify-center transition-colors ${R.volume30?"bg-red-500 border-red-500":"bg-white border-gray-300 group-hover:border-red-400"}`},R.volume30&&React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"14",height:"14",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"3",strokeLinecap:"round",strokeLinejoin:"round",className:"text-white"},React.createElement("polyline",{points:"20 6 9 17 4 12"}))),React.createElement("input",{type:"checkbox",className:"sr-only",checked:R.volume30,onChange:e=>ve({...R,volume30:e.target.checked})}),React.createElement("span",{className:`text-sm ${R.volume30?"font-medium text-gray-900":"text-gray-600"}`},"ICH volume \u226530 cc (+1)")),React.createElement("label",{className:"flex items-center space-x-3 cursor-pointer group"},React.createElement("div",{className:`w-5 h-5 rounded border flex items-center justify-center transition-colors ${R.ivh?"bg-red-500 border-red-500":"bg-white border-gray-300 group-hover:border-red-400"}`},R.ivh&&React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"14",height:"14",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"3",strokeLinecap:"round",strokeLinejoin:"round",className:"text-white"},React.createElement("polyline",{points:"20 6 9 17 4 12"}))),React.createElement("input",{type:"checkbox",className:"sr-only",checked:R.ivh,onChange:e=>ve({...R,ivh:e.target.checked})}),React.createElement("span",{className:`text-sm ${R.ivh?"font-medium text-gray-900":"text-gray-600"}`},"Intraventricular hemorrhage (+1)")),React.createElement("label",{className:"flex items-center space-x-3 cursor-pointer group"},React.createElement("div",{className:`w-5 h-5 rounded border flex items-center justify-center transition-colors ${R.infratentorial?"bg-red-500 border-red-500":"bg-white border-gray-300 group-hover:border-red-400"}`},R.infratentorial&&React.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",width:"14",height:"14",viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:"3",strokeLinecap:"round",strokeLinejoin:"round",className:"text-white"},React.createElement("polyline",{points:"20 6 9 17 4 12"}))),React.createElement("input",{type:"checkbox",className:"sr-only",checked:R.infratentorial,onChange:e=>ve({...R,infratentorial:e.target.checked})}),React.createElement("span",{className:`text-sm ${R.infratentorial?"font-medium text-gray-900":"text-gray-600"}`},"Infratentorial origin (+1)"))))))),React.createElement("details",{className:"bg-gray-50 border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-gray-800 hover:bg-gray-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Modified Rankin Scale (mRS)"),React.createElement("span",{className:"text-sm font-normal text-gray-600"},"Score: ",M||"Not Selected")),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("div",{className:"text-right"},React.createElement("span",{className:"text-xl font-bold text-gray-600"},"Score: ",M||"Not Selected"),React.createElement("div",{className:"text-xs text-gray-500"},"Range: 0-6")),M&&React.createElement("button",{onClick:()=>re(`mRS: ${M}`,"mRS Score"),className:"p-1.5 hover:bg-gray-100 rounded transition-colors","aria-label":"Copy mRS score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-gray-600"}))),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"0",checked:M==="0",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"0 - No symptoms"),React.createElement("div",{className:"text-sm text-gray-600"},"Completely recovered; no residual symptoms"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"1",checked:M==="1",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"1 - No significant disability"),React.createElement("div",{className:"text-sm text-gray-600"},"Able to carry out all usual duties and activities despite some symptoms"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"2",checked:M==="2",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"2 - Slight disability"),React.createElement("div",{className:"text-sm text-gray-600"},"Unable to carry out all previous activities but able to look after own affairs without assistance"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"3",checked:M==="3",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"3 - Moderate disability"),React.createElement("div",{className:"text-sm text-gray-600"},"Requires some help, but able to walk without assistance"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"4",checked:M==="4",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"4 - Moderately severe disability"),React.createElement("div",{className:"text-sm text-gray-600"},"Unable to walk without assistance and unable to attend to own bodily needs without assistance"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"5",checked:M==="5",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"5 - Severe disability"),React.createElement("div",{className:"text-sm text-gray-600"},"Bedridden, incontinent, and requires constant nursing care and attention"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-gray-200 hover:bg-gray-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"mrs",value:"6",checked:M==="6",onChange:e=>fe(e.target.value),className:"mt-1 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"6 - Dead")))),M&&React.createElement("div",{className:"mt-4 p-3 bg-blue-50 rounded-lg border border-blue-200"},React.createElement("p",{className:"text-sm font-semibold text-blue-900 mb-1"},"Clinical Interpretation:"),React.createElement("p",{className:"text-sm text-blue-800"},M==="0"&&"Excellent outcome - Complete recovery with no residual deficits",M==="1"&&"Good outcome - Minor symptoms that do not interfere with lifestyle",M==="2"&&"Fair outcome - Some restriction in lifestyle but retains capacity for independent living",M==="3"&&"Moderate outcome - Significant lifestyle restriction; requires some assistance",M==="4"&&"Moderately severe outcome - Clearly dependent; requires assistance with basic activities",M==="5"&&"Severe outcome - Totally dependent; requires constant care",M==="6"&&"Death")))),React.createElement("details",{className:"bg-orange-50 border border-orange-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-orange-800 hover:bg-orange-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"ABCD\xB2 Score"),React.createElement("span",{className:"text-sm font-normal text-orange-600"},"Score: ",Ea(_))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("span",{className:"text-xl font-bold text-orange-600"},"Score: ",Ea(_)),React.createElement("button",{onClick:()=>re(`ABCD\xB2 Score: ${Ea(_)}`,"ABCD\xB2 Score"),className:"p-1.5 hover:bg-orange-100 rounded transition-colors","aria-label":"Copy ABCD\xB2 score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-orange-600"}))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-orange-600",checked:_.age60,onChange:e=>ye({..._,age60:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Age \u226560 (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-orange-600",checked:_.bp,onChange:e=>ye({..._,bp:e.target.checked})}),React.createElement("span",{className:"text-sm"},"BP: SBP\u2265140 or DBP\u226590 (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-orange-600",checked:_.unilateralWeakness,onChange:e=>ye({..._,unilateralWeakness:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Unilateral weakness (+2)"))),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-orange-600",checked:_.speechDisturbance,onChange:e=>ye({..._,speechDisturbance:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Speech disturbance w/o weakness (+1)")),React.createElement("p",{className:"font-semibold text-sm mt-3 mb-2"},"Symptom Duration:"),React.createElement("label",{className:"flex items-center space-x-2 cursor-pointer"},React.createElement("input",{type:"radio",name:"abcd2_duration",className:"text-orange-600",checked:_.duration==="duration60",onChange:()=>ye({..._,duration:"duration60"})}),React.createElement("span",{className:"text-sm"},"\u226560 minutes (+2 points)")),React.createElement("label",{className:"flex items-center space-x-2 cursor-pointer"},React.createElement("input",{type:"radio",name:"abcd2_duration",className:"text-orange-600",checked:_.duration==="duration10",onChange:()=>ye({..._,duration:"duration10"})}),React.createElement("span",{className:"text-sm"},"10-59 minutes (+1 point)")),React.createElement("label",{className:"flex items-center space-x-2 cursor-pointer"},React.createElement("input",{type:"radio",name:"abcd2_duration",className:"text-orange-600",checked:_.duration==="",onChange:()=>ye({..._,duration:""})}),React.createElement("span",{className:"text-sm"},"<10 minutes (0 points)")),React.createElement("hr",{className:"my-3"}),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-orange-600",checked:_.diabetes,onChange:e=>ye({..._,diabetes:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Diabetes mellitus (+1)")))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold mb-2"},"2-Day, 7-Day, and 90-Day Stroke Risk"),React.createElement("div",{className:"grid grid-cols-3 gap-4 text-sm"},React.createElement("div",null,React.createElement("p",null,React.createElement("strong",null,"0-3:")),React.createElement("p",null,"2-day: 1%"),React.createElement("p",null,"7-day: 1.2%"),React.createElement("p",null,"90-day: 3.1%")),React.createElement("div",null,React.createElement("p",null,React.createElement("strong",null,"4-5:")),React.createElement("p",null,"2-day: 4.1%"),React.createElement("p",null,"7-day: 5.9%"),React.createElement("p",null,"90-day: 9.8%")),React.createElement("div",null,React.createElement("p",null,React.createElement("strong",null,"6-7:")),React.createElement("p",null,"2-day: 8.1%"),React.createElement("p",null,"7-day: 11.7%"),React.createElement("p",null,"90-day: 17.8%")))))),React.createElement("details",{className:"bg-purple-50 border border-purple-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-purple-800 hover:bg-purple-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"CHA\u2082DS\u2082-VASc Score"),React.createElement("span",{className:"text-sm font-normal text-purple-600"},"Score: ",Da(W))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("span",{className:"text-xl font-bold text-purple-600"},"Score: ",Da(W)),React.createElement("button",{onClick:()=>re(`CHADS\u2082-VASc: ${Da(W)}`,"CHADS\u2082-VASc Score"),className:"p-1.5 hover:bg-purple-100 rounded transition-colors","aria-label":"Copy CHADS\u2082-VASc score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-purple-600"}))),React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-3 mb-2"},React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.age65,onChange:e=>xe({...W,age65:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Age 65-74 (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.age75,onChange:e=>xe({...W,age75:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Age \u226575 (+2)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.chf,onChange:e=>xe({...W,chf:e.target.checked})}),React.createElement("span",{className:"text-sm"},"CHF (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.hypertension,onChange:e=>xe({...W,hypertension:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Hypertension (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.diabetes,onChange:e=>xe({...W,diabetes:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Diabetes (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.strokeTia,onChange:e=>xe({...W,strokeTia:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Stroke/TIA (+2)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.vascular,onChange:e=>xe({...W,vascular:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Vascular disease (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-purple-600",checked:W.female,onChange:e=>xe({...W,female:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Female sex (+1)"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold mb-2"},"Annual Stroke and Thromboembolism Risk"),React.createElement("div",{className:"grid grid-cols-3 gap-4 text-sm"},React.createElement("div",null,React.createElement("p",null,React.createElement("strong",null,"Score 0:")," 0.8%"),React.createElement("p",null,React.createElement("strong",null,"Score 1:")," 2.0%"),React.createElement("p",null,React.createElement("strong",null,"Score 2:")," 3.7%")),React.createElement("div",null,React.createElement("p",null,React.createElement("strong",null,"Score 3:")," 5.9%"),React.createElement("p",null,React.createElement("strong",null,"Score 4:")," 9.3%"),React.createElement("p",null,React.createElement("strong",null,"Score 5:")," 15.3%")),React.createElement("div",null,React.createElement("p",null,React.createElement("strong",null,"Score 6:")," 19.7%"),React.createElement("p",null,React.createElement("strong",null,"Score 7:")," 21.5%"),React.createElement("p",null,React.createElement("strong",null,"Score 8:")," 22.4%"),React.createElement("p",null,React.createElement("strong",null,"Score 9:")," 23.6%")))))),React.createElement("details",{className:"bg-pink-50 border border-pink-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-pink-800 hover:bg-pink-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"HAS-BLED Score"),React.createElement("span",{className:"text-sm font-normal text-pink-600"},"Score: ",ot(D))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("span",{className:"text-xl font-bold text-pink-600"},"Score: ",ot(D)),React.createElement("button",{onClick:()=>re(`HAS-BLED: ${ot(D)}`,"HAS-BLED Score"),className:"p-1.5 hover:bg-pink-100 rounded transition-colors","aria-label":"Copy HAS-BLED score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-pink-600"}))),React.createElement("div",{className:"space-y-2 mb-4"},React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.hypertension,onChange:e=>de({...D,hypertension:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"H"),"ypertension (uncontrolled SBP >160) (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.renalDisease,onChange:e=>de({...D,renalDisease:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"A"),"bnormal renal function (dialysis, transplant, Cr >2.6) (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.liverDisease,onChange:e=>de({...D,liverDisease:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"A"),"bnormal liver function (cirrhosis, bilirubin >2x, AST/ALT >3x) (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.stroke,onChange:e=>de({...D,stroke:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"S"),"troke history (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.bleeding,onChange:e=>de({...D,bleeding:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"B"),"leeding history or predisposition (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.labileINR,onChange:e=>de({...D,labileINR:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"L"),"abile INR (TTR <60%) (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.elderly,onChange:e=>de({...D,elderly:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"E"),"lderly (age >65) (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.drugs,onChange:e=>de({...D,drugs:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"D"),"rugs (antiplatelet agents, NSAIDs) (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-pink-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-pink-600",checked:D.alcohol,onChange:e=>de({...D,alcohol:e.target.checked})}),React.createElement("span",{className:"text-sm"},React.createElement("strong",null,"D")," (cont.) Alcohol use (\u22658 drinks/week) (+1)"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-pink-700 mb-2"},"Annual Bleeding Risk"),React.createElement("div",{className:"text-sm space-y-1"},React.createElement("p",{className:ot(D)===0?"font-bold text-pink-600":""},React.createElement("strong",null,"Score 0:")," 1.13% per year"),React.createElement("p",{className:ot(D)===1?"font-bold text-pink-600":""},React.createElement("strong",null,"Score 1:")," 1.02% per year"),React.createElement("p",{className:ot(D)===2?"font-bold text-pink-600":""},React.createElement("strong",null,"Score 2:")," 1.88% per year"),React.createElement("p",{className:ot(D)>=3?"font-bold text-pink-600":""},React.createElement("strong",null,"Score \u22653:")," 3.74% per year (high risk)")),React.createElement("p",{className:"text-xs text-gray-600 mt-2 italic"},"High risk (\u22653) indicates need for more frequent monitoring and caution with anticoagulation, but should not automatically exclude from treatment.")))),React.createElement("details",{className:"bg-teal-50 border border-teal-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-teal-800 hover:bg-teal-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"ROPE Score and PASCAL Classification"),React.createElement("span",{className:"text-sm font-normal text-teal-600"},"Score: ",ee(P))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("span",{className:"text-xl font-bold text-teal-600"},"Score: ",ee(P)),React.createElement("button",{onClick:()=>re(`ROPE Score: ${ee(P)}`,"ROPE Score"),className:"p-1.5 hover:bg-teal-100 rounded transition-colors","aria-label":"Copy ROPE score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-teal-600"}))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2"},React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-teal-600",checked:P.noHypertension,onChange:e=>Ee({...P,noHypertension:e.target.checked})}),React.createElement("span",{className:"text-sm"},"No history of hypertension (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-teal-600",checked:P.noDiabetes,onChange:e=>Ee({...P,noDiabetes:e.target.checked})}),React.createElement("span",{className:"text-sm"},"No history of diabetes (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-teal-600",checked:P.noStrokeTia,onChange:e=>Ee({...P,noStrokeTia:e.target.checked})}),React.createElement("span",{className:"text-sm"},"No history of stroke or TIA (+1)"))),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-teal-600",checked:P.nonsmoker,onChange:e=>Ee({...P,nonsmoker:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Nonsmoker (+1)")),React.createElement("label",{className:"flex items-center space-x-2"},React.createElement("input",{type:"checkbox",className:"text-teal-600",checked:P.cortical,onChange:e=>Ee({...P,cortical:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Cortical infarct (+1)")),React.createElement("div",null,React.createElement("label",{className:"block text-sm font-medium text-gray-700 mb-1"},"Age (years)"),React.createElement("input",{type:"number",className:"w-full px-3 py-1 border border-gray-300 rounded-md text-sm",value:P.age,onChange:e=>Ee({...P,age:e.target.value}),placeholder:"Enter age",min:"18",max:"100"}),React.createElement("div",{className:"text-xs text-gray-500 mt-1"},"18-29: +5, 30-39: +4, 40-49: +3, 50-59: +2, 60-69: +1, \u226570: 0")))),React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold mb-2"},"PFO-attributable fraction"),React.createElement("div",{className:"text-sm"},React.createElement("p",{className:ee(P)<=3?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 0-3:")," 0-23%"),React.createElement("p",{className:ee(P)===4?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 4:")," 38%"),React.createElement("p",{className:ee(P)===5?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 5:")," 34%"),React.createElement("p",{className:ee(P)===6?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 6:")," 62%"),React.createElement("p",{className:ee(P)===7?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 7:")," 72%"),React.createElement("p",{className:ee(P)===8?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 8:")," 84%"),React.createElement("p",{className:ee(P)>=9?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 9-10:")," 88%"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold mb-2"},"2-Year Recurrent Stroke/TIA Risk"),React.createElement("div",{className:"text-sm"},React.createElement("p",{className:ee(P)<=3?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 0-3:")," 20%"),React.createElement("p",{className:ee(P)===4?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 4:")," 12%"),React.createElement("p",{className:ee(P)===5?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 5:")," 15%"),React.createElement("p",{className:ee(P)===6?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 6:")," 8%"),React.createElement("p",{className:ee(P)===7?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 7:")," 6%"),React.createElement("p",{className:ee(P)===8?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 8:")," 6%"),React.createElement("p",{className:ee(P)>=9?"font-bold text-teal-600":""},React.createElement("strong",null,"Score 9-10:")," 2%"))))),React.createElement("div",{className:"bg-indigo-50 border border-indigo-200 rounded-lg p-4"},React.createElement("h3",{className:"text-lg font-semibold text-indigo-800 mb-3"},"PASCAL Classification"),React.createElement("div",{className:"space-y-4"},React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-green-700 mb-2"},"Probable PFO-related stroke:"),React.createElement("p",{className:"text-sm"},"RoPE \u22657 + high-grade shunt / ASA")),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-amber-700 mb-2"},"Possible PFO-related stroke:"),React.createElement("ul",{className:"text-sm space-y-1"},React.createElement("li",null,"\u2022 RoPE <7 + high-grade shunt / ASA"),React.createElement("li",null,"\u2022 RoPE \u22657 but no high-grade shunt / ASA"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-red-700 mb-2"},"Unlikely PFO-related stroke:"),React.createElement("p",{className:"text-sm"},"RoPE <7, no high-grade shunt / ASA"))))),React.createElement("details",{className:"bg-cyan-50 border border-cyan-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-cyan-800 hover:bg-cyan-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"RCVS\xB2 Score"),React.createElement("span",{className:"text-sm font-normal text-cyan-600"},"Score: ",rt(q))),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"flex justify-end items-center gap-2 mb-3"},React.createElement("span",{className:"text-xl font-bold text-cyan-600"},"Score: ",rt(q)),React.createElement("button",{onClick:()=>re(`RCVS\xB2 Score: ${rt(q)}`,"RCVS\xB2 Score"),className:"p-1.5 hover:bg-cyan-100 rounded transition-colors","aria-label":"Copy RCVS\xB2 score to clipboard",title:"Copy to clipboard"},React.createElement("i",{"data-lucide":"copy",className:"w-4 h-4 text-cyan-600"}))),React.createElement("div",{className:"space-y-2 mb-4"},React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-cyan-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-cyan-600",checked:q.recurrentTCH,onChange:e=>Ye({...q,recurrentTCH:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Recurrent thunderclap headaches (+5)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-cyan-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-cyan-600",checked:q.carotidInvolvement,onChange:e=>Ye({...q,carotidInvolvement:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Intracranial carotid artery involvement (+3)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-cyan-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-cyan-600",checked:q.vasoconstrictiveTrigger,onChange:e=>Ye({...q,vasoconstrictiveTrigger:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Vasoconstrictive trigger exposure (+2)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-cyan-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-cyan-600",checked:q.female,onChange:e=>Ye({...q,female:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Female sex (+1)")),React.createElement("label",{className:"flex items-center space-x-2 p-2 hover:bg-cyan-50 rounded cursor-pointer"},React.createElement("input",{type:"checkbox",className:"text-cyan-600",checked:q.sah,onChange:e=>Ye({...q,sah:e.target.checked})}),React.createElement("span",{className:"text-sm"},"Subarachnoid hemorrhage on imaging (-2)"))),React.createElement("div",{className:"bg-white p-3 rounded border"},React.createElement("h4",{className:"font-semibold text-cyan-700 mb-2"},"RCVS Probability"),React.createElement("div",{className:"text-sm space-y-1"},React.createElement("p",{className:rt(q)<2?"font-bold text-cyan-600":""},React.createElement("strong",null,"Score <2:")," Low probability of RCVS"),React.createElement("p",{className:rt(q)>=2&&rt(q)<=4?"font-bold text-cyan-600":""},React.createElement("strong",null,"Score 2-4:")," Intermediate probability"),React.createElement("p",{className:rt(q)>=5?"font-bold text-cyan-600":""},React.createElement("strong",null,"Score \u22655:")," High probability of RCVS")),React.createElement("p",{className:"text-xs text-gray-600 mt-2 italic"},"RCVS\xB2 score helps distinguish RCVS from other causes of thunderclap headache. Consider vascular imaging and repeat imaging in 2-4 weeks if high suspicion.")))),React.createElement("details",{className:"bg-amber-50 border border-amber-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-amber-800 hover:bg-amber-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Hunt and Hess / WFNS Scale (SAH Grading)"),React.createElement("span",{className:"text-sm font-normal text-amber-600"},"H&H: ",De||"Not Selected"," | WFNS: ",Oe||"Not Selected")),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4"},React.createElement("div",{className:"space-y-3"},React.createElement("h4",{className:"text-base font-semibold text-amber-800 mb-2"},"Hunt and Hess Scale"),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"huntHess",value:"1",checked:De==="1",onChange:e=>ze(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 1"),React.createElement("div",{className:"text-sm text-gray-600"},"Asymptomatic or mild headache"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"huntHess",value:"2",checked:De==="2",onChange:e=>ze(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 2"),React.createElement("div",{className:"text-sm text-gray-600"},"Moderate-severe headache, nuchal rigidity, no deficit (except CN palsy)"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"huntHess",value:"3",checked:De==="3",onChange:e=>ze(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 3"),React.createElement("div",{className:"text-sm text-gray-600"},"Drowsiness, confusion, or mild focal deficit"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"huntHess",value:"4",checked:De==="4",onChange:e=>ze(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 4"),React.createElement("div",{className:"text-sm text-gray-600"},"Stupor, moderate-severe hemiparesis"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"huntHess",value:"5",checked:De==="5",onChange:e=>ze(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 5"),React.createElement("div",{className:"text-sm text-gray-600"},"Deep coma, decerebrate rigidity, moribund"))))),React.createElement("div",{className:"space-y-3"},React.createElement("h4",{className:"text-base font-semibold text-amber-800 mb-2"},"WFNS Scale"),React.createElement("div",{className:"space-y-2"},React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"wfns",value:"1",checked:Oe==="1",onChange:e=>qe(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 1"),React.createElement("div",{className:"text-sm text-gray-600"},"GCS 15, no motor deficit"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"wfns",value:"2",checked:Oe==="2",onChange:e=>qe(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 2"),React.createElement("div",{className:"text-sm text-gray-600"},"GCS 13-14, no motor deficit"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"wfns",value:"3",checked:Oe==="3",onChange:e=>qe(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 3"),React.createElement("div",{className:"text-sm text-gray-600"},"GCS 13-14, with motor deficit"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"wfns",value:"4",checked:Oe==="4",onChange:e=>qe(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 4"),React.createElement("div",{className:"text-sm text-gray-600"},"GCS 7-12, with or without motor deficit"))),React.createElement("label",{className:"flex items-start space-x-3 p-3 bg-white rounded-lg border border-amber-200 hover:bg-amber-50 cursor-pointer"},React.createElement("input",{type:"radio",name:"wfns",value:"5",checked:Oe==="5",onChange:e=>qe(e.target.value),className:"mt-1 text-amber-600"}),React.createElement("div",{className:"flex-1"},React.createElement("div",{className:"font-semibold text-gray-900"},"Grade 5"),React.createElement("div",{className:"text-sm text-gray-600"},"GCS 3-6, with or without motor deficit")))))))),React.createElement("details",{className:"bg-rose-50 border border-rose-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-rose-800 hover:bg-rose-100 rounded-lg"},"PREVENT 10-year ASCVD Risk Estimate"),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"bg-white p-4 rounded border"},React.createElement("a",{href:"https://professional.heart.org/en/guidelines-and-statements/prevent-calculator",target:"_blank",rel:"noopener noreferrer",className:"inline-flex items-center px-4 py-2 bg-rose-600 text-white rounded-md hover:bg-rose-700 transition-colors text-sm font-medium"},"Open PREVENT Calculator \u2192")))),React.createElement("details",{className:"bg-red-50 border border-red-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-red-800 hover:bg-red-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"ICH Volume Calculator (ABC/2 Method)")),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"grid grid-cols-3 gap-3 mb-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"A: Largest diameter (cm)"),React.createElement("input",{type:"number",step:"0.1",value:(t.ichVolumeCalc||{}).lengthCm||"",onChange:e=>r({...t,ichVolumeCalc:{...t.ichVolumeCalc||{},lengthCm:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"cm"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"B: Perpendicular diameter (cm)"),React.createElement("input",{type:"number",step:"0.1",value:(t.ichVolumeCalc||{}).widthCm||"",onChange:e=>r({...t,ichVolumeCalc:{...t.ichVolumeCalc||{},widthCm:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"cm"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"C: Slices x thickness (cm)"),React.createElement("input",{type:"number",step:"0.1",value:(t.ichVolumeCalc||{}).slicesCm||"",onChange:e=>r({...t,ichVolumeCalc:{...t.ichVolumeCalc||{},slicesCm:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"cm"}))),(()=>{let e=Ps(t.ichVolumeCalc||{});return e.volume?React.createElement("div",{className:`p-3 rounded-lg border ${e.isLarge?"bg-red-100 border-red-300":"bg-green-100 border-green-300"}`},React.createElement("p",{className:"text-lg font-bold"},"Volume: ",e.volume," mL"),React.createElement("p",{className:"text-sm text-gray-700"},e.volume>=60?"Very large hematoma \u2014 poor prognosis, consider GOC discussion":e.volume>=30?"Large hematoma (30-80 mL) \u2014 may qualify for ENRICH MIE":e.volume>=20?"Moderate hematoma \u2014 monitor for expansion":"Small hematoma"),React.createElement("button",{onClick:()=>re(`ICH Volume (ABC/2): ${e.volume} mL`,"ICH Volume"),className:"mt-1 px-2 py-1 bg-gray-200 rounded text-xs hover:bg-gray-300"},"Copy")):null})(),React.createElement("p",{className:"text-xs text-gray-500 mt-2"},"ABC/2 method: A = largest diameter, B = perpendicular diameter on same slice, C = number of slices with ICH x slice thickness."))),React.createElement("details",{className:"bg-purple-50 border border-purple-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-purple-800 hover:bg-purple-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Andexanet Alfa (Andexxa) Dosing")),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"grid grid-cols-2 gap-3 mb-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"DOAC Type"),React.createElement("select",{value:(t.andexanetCalc||{}).doacType||"",onChange:e=>r({...t,andexanetCalc:{...t.andexanetCalc||{},doacType:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:""},"Select DOAC"),React.createElement("option",{value:"apixaban"},"Apixaban (Eliquis)"),React.createElement("option",{value:"rivaroxaban"},"Rivaroxaban (Xarelto)"),React.createElement("option",{value:"other"},"Other (not indicated for andexanet)"))),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Hours since last DOAC dose"),React.createElement("input",{type:"number",step:"0.5",value:(t.andexanetCalc||{}).lastDoseHours||"",onChange:e=>r({...t,andexanetCalc:{...t.andexanetCalc||{},lastDoseHours:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"hours"}))),(()=>{let e=Ds((t.andexanetCalc||{}).doacType,(t.andexanetCalc||{}).lastDoseHours);return e.regimen==="N/A"?React.createElement("p",{className:"text-sm text-gray-500"},"Select apixaban or rivaroxaban. Andexanet not indicated for dabigatran (use idarucizumab) or edoxaban."):React.createElement("div",{className:`p-3 rounded-lg border ${e.regimen==="high-dose"?"bg-red-100 border-red-300":"bg-green-100 border-green-300"}`},React.createElement("p",{className:"text-sm font-bold uppercase"},e.regimen," regimen"),React.createElement("p",{className:"text-sm"},"Bolus: ",e.bolus),React.createElement("p",{className:"text-sm"},"Infusion: ",e.infusion),React.createElement("p",{className:"text-sm font-semibold"},"Total: ",e.total),React.createElement("button",{onClick:()=>re(`Andexanet ${e.regimen}: Bolus ${e.bolus}, Infusion ${e.infusion}, Total ${e.total}`,"Andexanet Dose"),className:"mt-1 px-2 py-1 bg-gray-200 rounded text-xs hover:bg-gray-300"},"Copy"))})(),React.createElement("p",{className:"text-xs text-gray-500 mt-2"},"ANNEXA-4 trial. Low-dose if last DOAC \u22658h ago (or apixaban \u22645mg). High-dose if last dose <8h ago (or rivaroxaban >10mg, apixaban >5mg). Monitor for thrombotic events post-reversal."))),React.createElement("details",{className:"bg-indigo-50 border border-indigo-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-indigo-800 hover:bg-indigo-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Creatinine Clearance (Cockcroft-Gault)")),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"grid grid-cols-2 md:grid-cols-4 gap-3 mb-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Age"),React.createElement("input",{type:"number",value:(t.crclCalc||{}).age||t.age||"",onChange:e=>r({...t,crclCalc:{...t.crclCalc||{},age:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"years"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Weight (kg)"),React.createElement("input",{type:"number",value:(t.crclCalc||{}).weight||t.weight||"",onChange:e=>r({...t,crclCalc:{...t.crclCalc||{},weight:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"kg"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Sex"),React.createElement("select",{value:(t.crclCalc||{}).sex||t.sex||"M",onChange:e=>r({...t,crclCalc:{...t.crclCalc||{},sex:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm"},React.createElement("option",{value:"M"},"Male"),React.createElement("option",{value:"F"},"Female"))),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Serum Cr (mg/dL)"),React.createElement("input",{type:"number",step:"0.1",value:(t.crclCalc||{}).cr||t.creatinine||"",onChange:e=>r({...t,crclCalc:{...t.crclCalc||{},cr:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"mg/dL"}))),(()=>{let e=xt((t.crclCalc||{}).age||t.age,(t.crclCalc||{}).weight||t.weight,(t.crclCalc||{}).sex||t.sex,(t.crclCalc||{}).cr||t.creatinine);if(!e)return React.createElement("p",{className:"text-xs text-gray-500 italic"},"Enter age, weight, sex, and creatinine to calculate.");let a=e.isLow?"bg-red-100 border-red-300":e.isBorderline?"bg-amber-100 border-amber-300":"bg-green-100 border-green-300";return React.createElement("div",{className:`p-3 rounded-lg border ${a}`},React.createElement("p",{className:"text-lg font-bold"},"CrCl: ",e.value," mL/min"),React.createElement("p",{className:"text-sm font-medium"},e.label),React.createElement("div",{className:"mt-2 text-xs space-y-1"},e.renalCategory==="severe-dialysis"&&React.createElement("p",{className:"text-red-700 font-semibold"},"Avoid DOACs. Consider warfarin or consult nephrology."),e.renalCategory==="severe"&&React.createElement("div",{className:"text-red-700"},React.createElement("p",null,React.createElement("strong",null,"Apixaban:")," 5mg BID (2.5mg BID if also age \u226580 or wt \u226460kg). Apixaban is the only DOAC with data in ESRD."),React.createElement("p",null,React.createElement("strong",null,"Rivaroxaban:")," 15mg daily (avoid if CrCl <15)."),React.createElement("p",null,React.createElement("strong",null,"Dabigatran:")," 75mg BID (avoid if CrCl <15). Idarucizumab available for reversal."),React.createElement("p",null,React.createElement("strong",null,"Edoxaban:")," 30mg daily (avoid if CrCl <15)."),React.createElement("p",null,React.createElement("strong",null,"Enoxaparin:")," 1 mg/kg SC ",React.createElement("strong",null,"daily")," (not BID). Check anti-Xa levels.")),e.renalCategory==="moderate"&&React.createElement("div",{className:"text-amber-700"},React.createElement("p",null,React.createElement("strong",null,"Apixaban:")," Standard 5mg BID (2.5mg BID if 2 of 3: age \u226580, wt \u226460kg, Cr \u22651.5)."),React.createElement("p",null,React.createElement("strong",null,"Rivaroxaban:")," 15mg daily for AF (20mg if CrCl >50)."),React.createElement("p",null,React.createElement("strong",null,"Dabigatran:")," 150mg BID preferred; 110mg BID if high bleed risk. Consider 75mg BID if CrCl 30-49 per FDA."),React.createElement("p",null,React.createElement("strong",null,"Edoxaban:")," 30mg daily."),React.createElement("p",null,React.createElement("strong",null,"Enoxaparin:")," Standard dosing; monitor anti-Xa if prolonged use.")),(e.renalCategory==="mild"||e.renalCategory==="normal")&&React.createElement("p",{className:"text-green-700"},"Standard DOAC and enoxaparin dosing. No renal adjustment needed. ",e.renalCategory==="normal"&&"Note: Edoxaban 60mg \u2014 avoid if CrCl >95 (reduced efficacy, ENGAGE AF).")),React.createElement("button",{onClick:()=>re(`CrCl (Cockcroft-Gault): ${e.value} mL/min \u2014 ${e.label}`,"CrCl"),className:"mt-2 px-2 py-1 bg-gray-200 rounded text-xs hover:bg-gray-300"},"Copy"))})(),React.createElement("p",{className:"text-xs text-gray-500 mt-2"},"Cockcroft-Gault: CrCl = [(140 - age) \xD7 weight \xD7 (0.85 if female)] / (72 \xD7 Cr). Uses actual body weight. For obesity, consider adjusted body weight or cystatin C-based eGFR."))),React.createElement("details",{className:"bg-teal-50 border border-teal-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-3 font-semibold text-teal-800 hover:bg-teal-100 rounded-lg flex items-center justify-between"},React.createElement("span",null,"Enoxaparin Weight-Based Dosing")),React.createElement("div",{className:"p-4"},React.createElement("div",{className:"grid grid-cols-2 gap-3 mb-3"},React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"Weight (kg)"),React.createElement("input",{type:"number",value:(t.enoxCalc||{}).weightKg||t.weight||"",onChange:e=>r({...t,enoxCalc:{...t.enoxCalc||{},weightKg:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"kg"})),React.createElement("div",null,React.createElement("label",{className:"text-xs text-gray-600"},"CrCl (mL/min)"),React.createElement("input",{type:"number",value:(t.enoxCalc||{}).crCl||(()=>{let e=xt(t.age,t.weight,t.sex,t.creatinine);return e?e.value:""})()||"",onChange:e=>r({...t,enoxCalc:{...t.enoxCalc||{},crCl:e.target.value}}),className:"w-full px-2 py-1 border border-gray-300 rounded text-sm",placeholder:"mL/min (auto from demographics)"}))),(()=>{let e=xt(t.age,t.weight,t.sex,t.creatinine),a=Es((t.enoxCalc||{}).weightKg||t.weight,(t.enoxCalc||{}).crCl||(e?e.value:""));return a?React.createElement("div",{className:`p-3 rounded-lg border ${a.isRenalAdjusted?"bg-amber-100 border-amber-300":"bg-green-100 border-green-300"}`},React.createElement("p",{className:"text-sm font-bold"},a.note),a.isRenalAdjusted&&React.createElement("p",{className:"text-xs text-amber-700"},"Renal dose adjustment applied (CrCl <30 mL/min)"),React.createElement("button",{onClick:()=>re(a.note,"Enoxaparin Dose"),className:"mt-1 px-2 py-1 bg-gray-200 rounded text-xs hover:bg-gray-300"},"Copy")):null})(),React.createElement("p",{className:"text-xs text-gray-500 mt-2"},"Treatment dose: 1 mg/kg SC BID. CrCl <30: 1 mg/kg SC daily. For DVT prophylaxis: 40 mg SC daily (30 mg if CrCl <30). Check anti-Xa levels for extremes of weight.")))),he==="references"&&React.createElement("div",{className:"space-y-6"},React.createElement("div",{className:"bg-white border border-gray-200 rounded-lg p-4"},React.createElement("div",{className:"relative"},React.createElement("input",{type:"text",placeholder:"Filter evidence documents...",value:bt,onChange:e=>Na(e.target.value),className:"w-full pl-10 pr-4 py-2 border border-gray-300 rounded-lg focus:outline-none focus:ring-2 focus:ring-blue-500","aria-label":"Filter evidence documents"}),React.createElement("i",{"data-lucide":"search",className:"w-5 h-5 absolute left-3 top-2.5 text-gray-400"}),bt&&React.createElement("button",{onClick:()=>Na(""),className:"absolute right-3 top-2.5 text-gray-400 hover:text-gray-600","aria-label":"Clear filter"},React.createElement("i",{"data-lucide":"x",className:"w-5 h-5"}))),bt&&React.createElement("p",{className:"text-sm text-gray-600 mt-2"},"Filtering by: ",React.createElement("span",{className:"font-semibold"},bt))),React.createElement("div",{className:"flex flex-col sm:flex-row gap-3"},React.createElement("div",{className:"flex items-center gap-2"},React.createElement("a",{href:"https://www.openevidence.com",target:"_blank",rel:"noopener noreferrer",className:"flex flex-1 items-center gap-2 px-4 py-3 bg-white border border-blue-300 rounded-lg hover:bg-blue-100 transition-colors text-blue-700 font-medium"},React.createElement("i",{"data-lucide":"external-link",className:"w-5 h-5"}),React.createElement("span",null,"OpenEvidence"))),React.createElement("div",{className:"flex items-center gap-2"},React.createElement("a",{href:"https://www.uptodate.com",target:"_blank",rel:"noopener noreferrer",className:"flex flex-1 items-center gap-2 px-4 py-3 bg-white border border-blue-300 rounded-lg hover:bg-blue-100 transition-colors text-blue-700 font-medium"},React.createElement("i",{"data-lucide":"external-link",className:"w-5 h-5"}),React.createElement("span",null,"UpToDate"))),React.createElement("div",{className:"flex items-center gap-2"},React.createElement("a",{href:"https://asta.allen.ai/chat",target:"_blank",rel:"noopener noreferrer",className:"flex flex-1 items-center gap-2 px-4 py-3 bg-white border border-blue-300 rounded-lg hover:bg-blue-100 transition-colors text-blue-700 font-medium"},React.createElement("i",{"data-lucide":"external-link",className:"w-5 h-5"}),React.createElement("span",null,"Asta (Ai2)")))),He("Aneurysms & Vascular Malformations",["Unruptured Cerebral Aneurysms"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Aneurysms & Vascular Malformations"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Unruptured Cerebral Aneurysms"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/aneurysms/Unruptured Cerebral Aneurysms.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/aneurysms/Unruptured Cerebral Aneurysms.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Unruptured Cerebral Aneurysms","documents/aneurysms/Unruptured Cerebral Aneurysms.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),He("Antiplatelet Therapy",["DAPT Minor Stroke-TIA Trials","DAPT After Ischemic Stroke-TIA"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Antiplatelet Therapy"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"DAPT Minor Stroke-TIA Trials"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/antiplatelet/DAPT Minor Stroke-TIA Trials.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/antiplatelet/DAPT Minor Stroke-TIA Trials.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("DAPT Minor Stroke-TIA Trials","documents/antiplatelet/DAPT Minor Stroke-TIA Trials.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"image",className:"w-6 h-6 text-green-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"DAPT After Ischemic Stroke-TIA"),React.createElement("p",{className:"text-xs text-gray-500"},"Infographic - Match Patient to Trial"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/antiplatelet/DAPT After Ischemic Stroke-TIA.jpeg",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/antiplatelet/DAPT After Ischemic Stroke-TIA.jpeg",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("DAPT After Ischemic Stroke-TIA","documents/antiplatelet/DAPT After Ischemic Stroke-TIA.jpeg"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),He("Cerebral Small Vessel Disease",["Lacunar Stroke"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Cerebral Small Vessel Disease"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Lacunar Stroke"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/csvd/Lacunar Stroke 7.13.22.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/csvd/Lacunar Stroke 7.13.22.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Lacunar Stroke","documents/csvd/Lacunar Stroke 7.13.22.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),He("EBM",["Interpretation of Clinical Trials","CEBM Oxford Resources"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Critical Appraisal"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Interpretation of Clinical Trials"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/ebm/Interpretation of Clinical Trials.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/ebm/Interpretation of Clinical Trials.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Interpretation of Clinical Trials","documents/ebm/Interpretation of Clinical Trials.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-6 h-6 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"CEBM Oxford Resources"),React.createElement("p",{className:"text-xs text-gray-500"},"Centre for Evidence-Based Medicine - University of Oxford"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"https://www.cebm.ox.ac.uk/resources",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-4 h-4"}),"Visit"))))),He("EVT",["Large Core Anterior Circulation LVO EVT Trials","Basilar Artery Occlusion EVT Trials","MeVO & Distal Vessel Occlusion EVT Trials"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Endovascular Therapy"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Large Core Anterior Circulation LVO EVT Trials"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/evt/Large Core Anterior Circulation LVO EVT Trials.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/evt/Large Core Anterior Circulation LVO EVT Trials.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Large Core Anterior Circulation LVO EVT Trials","documents/evt/Large Core Anterior Circulation LVO EVT Trials.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Basilar Artery Occlusion EVT Trials"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/evt/Basilar Artery Occlusion EVT Trials.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/evt/Basilar Artery Occlusion EVT Trials.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Basilar Artery Occlusion EVT Trials","documents/evt/Basilar Artery Occlusion EVT Trials.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"MeVO & Distal Vessel Occlusion EVT Trials"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/evt/MeVO & Distal Vessel Occlusion EVT Trials.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/evt/MeVO & Distal Vessel Occlusion EVT Trials.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("MeVO & Distal Vessel Occlusion EVT Trials","documents/evt/MeVO & Distal Vessel Occlusion EVT Trials.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),He("Risk Factors",["Timing of Anticoagulation after AF-Related Stroke","Atrial Fibrillation & Secondary Stroke Prevention","AFib Stroke EPI519","Diabetes and stroke","Lipids and Cerebrovascular Disease"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Risk Factors"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-4 p-4 pt-0"},React.createElement("div",{className:"border-l-4 border-purple-500 pl-4"},React.createElement("h4",{className:"text-base font-semibold text-purple-800 mb-3"},"Atrial Fibrillation"),React.createElement("div",{className:"space-y-3"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h5",{className:"text-sm font-medium text-gray-900"},"Timing of Anticoagulation after AF-Related Stroke"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/afib/AC timing after AF-related Stroke.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/afib/AC timing after AF-related Stroke.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("AC timing after AF-related Stroke","documents/afib/AC timing after AF-related Stroke.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h5",{className:"text-sm font-medium text-gray-900"},"Atrial Fibrillation & Secondary Stroke Prevention"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/afib/AF & secondary stroke prevention July 2024.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/afib/AF & secondary stroke prevention July 2024.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("AF & secondary stroke prevention July 2024","documents/afib/AF & secondary stroke prevention July 2024.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-6 h-6 text-purple-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h5",{className:"text-sm font-medium text-gray-900"},"2023 AHA AFib Guidelines"),React.createElement("p",{className:"text-xs text-gray-500"},"External Link - AHA Journals"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-purple-600 text-white rounded-lg text-xs font-medium hover:bg-purple-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-4 h-4"}),"Open Link"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-6 h-6 text-purple-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h5",{className:"text-sm font-medium text-gray-900"},"2024 ESC AFib Guidelines"),React.createElement("p",{className:"text-xs text-gray-500"},"External Link - European Heart Journal"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"https://academic.oup.com/eurheartj/article/45/36/3314/7738779",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-purple-600 text-white rounded-lg text-xs font-medium hover:bg-purple-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-4 h-4"}),"Open Link"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h5",{className:"text-sm font-medium text-gray-900"},"AFib Stroke EPI519"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/afib/AFib Stroke EPI519.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/afib/AFib Stroke EPI519.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("AFib Stroke EPI519","documents/afib/AFib Stroke EPI519.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Diabetes and stroke"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/epidemiology/Diabetes and stroke.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/epidemiology/Diabetes and stroke.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Diabetes and stroke","documents/epidemiology/Diabetes and stroke.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Lipids and Cerebrovascular Disease"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/epidemiology/Lipids and Cerebrovascular Disease.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/epidemiology/Lipids and Cerebrovascular Disease.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Lipids and Cerebrovascular Disease","documents/epidemiology/Lipids and Cerebrovascular Disease.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),He("Thrombolytic Therapy",["Thrombolytic Therapy 4.5-24h RCTs","WAKE-UP Trial"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Thrombolytic Therapy"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Thrombolytic Therapy 4.5-24h RCTs"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/thrombolytic/Thrombolytic Therapy 4.5-24h RCTs.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/thrombolytic/Thrombolytic Therapy 4.5-24h RCTs.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Thrombolytic Therapy 4.5-24h RCTs","documents/thrombolytic/Thrombolytic Therapy 4.5-24h RCTs.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-6 h-6 text-blue-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"WAKE-UP Trial"),React.createElement("p",{className:"text-xs text-gray-500"},"External Link - New England Journal of Medicine"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"https://www.nejm.org/doi/full/10.1056/NEJMoa1804355",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"external-link",className:"w-4 h-4"}),"Open Link"))))),He("Exam",["Differentiating Acute Confusional State (Delirium) from Aphasia","Coma Exam"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Exam"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Differentiating Acute Confusional State (Delirium) from Aphasia"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/exam/Differentiating Acute Confusional State (Delirium) from Aphasia.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/exam/Differentiating Acute Confusional State (Delirium) from Aphasia.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Differentiating Acute Confusional State (Delirium) from Aphasia","documents/exam/Differentiating Acute Confusional State (Delirium) from Aphasia.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Coma Exam"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/exam/coma exam.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/exam/coma exam.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("coma exam","documents/exam/coma exam.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))),He("Large Artery Disease",["Symptomatic Cervical Carotid Artery Stenosis","CREST-2 Trial"])&&React.createElement("details",{className:"bg-white border border-gray-200 rounded-lg"},React.createElement("summary",{className:"cursor-pointer p-4 font-semibold text-gray-800 hover:bg-gray-50 rounded-lg flex items-center justify-between text-lg"},React.createElement("span",null,"Large Artery Disease"),React.createElement("i",{"data-lucide":"chevron-down",className:"w-5 h-5"})),React.createElement("div",{className:"space-y-3 p-4 pt-0"},React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"Symptomatic Cervical Carotid Artery Stenosis"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/lad/Symptomatic Cervical Carotid Artery Stenosis.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/lad/Symptomatic Cervical Carotid Artery Stenosis.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("Symptomatic Cervical Carotid Artery Stenosis","documents/lad/Symptomatic Cervical Carotid Artery Stenosis.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))),React.createElement("div",{className:"flex items-center justify-between p-3 bg-gray-50 rounded-lg border border-gray-200 hover:bg-gray-100 transition-colors"},React.createElement("div",{className:"flex items-center gap-3 flex-1"},React.createElement("i",{"data-lucide":"file-text",className:"w-6 h-6 text-red-600"}),React.createElement("div",{className:"flex-1"},React.createElement("h4",{className:"text-sm font-medium text-gray-900"},"CREST-2 Trial (December 2025)"),React.createElement("p",{className:"text-xs text-gray-500"},"PDF Document"))),React.createElement("div",{className:"flex flex-wrap gap-2"},React.createElement("a",{href:"documents/lad/CREST-2 Trial - Dec 2025.pdf",target:"_blank",rel:"noopener noreferrer",className:"px-3 py-2 bg-blue-600 text-white rounded-lg text-xs font-medium hover:bg-blue-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"eye",className:"w-4 h-4"}),"View"),React.createElement("a",{href:"documents/lad/CREST-2 Trial - Dec 2025.pdf",download:!0,className:"px-3 py-2 bg-gray-600 text-white rounded-lg text-xs font-medium hover:bg-gray-700 transition-colors flex items-center gap-1"},React.createElement("i",{"data-lucide":"download",className:"w-4 h-4"}),"Download"),React.createElement("button",{onClick:()=>X("CREST-2 Trial (December 2025)","documents/lad/CREST-2 Trial - Dec 2025.pdf"),className:"px-3 py-2 bg-orange-600 text-white rounded-lg text-xs font-medium hover:bg-orange-700 transition-colors flex items-center gap-1",title:"Email this document"},React.createElement("i",{"data-lucide":"mail",className:"w-4 h-4"}),"Email"))))))),Q==="trials"&&React.createElement("div",{className:"space-y-6"},React.createElement("div",{className:"bg-gradient-to-r from-blue-600 via-indigo-600 to-purple-600 text-white p-6 rounded-lg shadow-lg"},React.createElement("div",{className:"flex flex-col lg:flex-row lg:items-center lg:justify-between gap-4"},React.createElement("div",null,React.createElement("h1",{className:"text-3xl font-bold flex items-center gap-3"},"\u{1F52C} Clinical Trials"),React.createElement("p",{className:"text-blue-100 mt-1"},"Reference for active clinical trials")))),t.diagnosisCategory&&(t.diagnosisCategory==="ischemic"||t.diagnosisCategory==="ich")&&React.createElement("div",{className:`mb-4 p-4 rounded-lg border-2 flex items-center gap-3 ${t.diagnosisCategory==="ischemic"?"bg-blue-50 border-blue-300 text-blue-800":"bg-red-50 border-red-300 text-red-800"}`},React.createElement("i",{"data-lucide":"target",className:"w-5 h-5"}),React.createElement("div",null,React.createElement("span",{className:"font-semibold"},"Patient Diagnosis: ",t.diagnosisCategory==="ischemic"?"Suspected Ischemic Stroke":"ICH"),React.createElement("span",{className:"ml-2 text-sm opacity-75"},"\u2014 Showing ",t.diagnosisCategory==="ischemic"?"ischemic stroke":"ICH"," trials by default")),Et!==t.diagnosisCategory&&React.createElement("button",{onClick:()=>Dt(t.diagnosisCategory),className:`ml-auto px-3 py-1 rounded text-sm font-medium ${t.diagnosisCategory==="ischemic"?"bg-blue-600 text-white hover:bg-blue-700":"bg-red-600 text-white hover:bg-red-700"}`},"Show Recommended Trials")),React.createElement("div",{className:"flex flex-wrap gap-2 mb-6"},Object.keys(Xt).map(e=>{let a=Xt[e],i=a.hasSubsections?Object.values(a.subsections).reduce((c,d)=>c+d.trials.length,0):a.trials.length,s=c=>{switch(c){case"ischemic":return"bg-blue-600 hover:bg-blue-700";case"ich":return"bg-red-600 hover:bg-red-700";case"rehab":return"bg-green-600 hover:bg-green-700";case"cadasil":return"bg-purple-600 hover:bg-purple-700";default:return"bg-gray-600 hover:bg-gray-700"}},o=c=>{switch(c){case"ischemic":return"Ischemic Stroke";case"ich":return"Intracerebral Hemorrhage";case"rehab":return"Rehabilitation";case"cadasil":return"CADASIL";default:return a.title}},n=t.diagnosisCategory===e;return React.createElement("button",{key:e,onClick:()=>Dt(e),className:`relative px-4 py-2 rounded-full font-medium transition-all ${Et===e?`${s(e)} text-white shadow-lg`:n?"bg-gray-200 text-gray-700 hover:bg-gray-300 ring-2 ring-offset-1 ring-yellow-400":"bg-gray-200 text-gray-700 hover:bg-gray-300"}`},n&&React.createElement("span",{className:"absolute -top-2 -right-1 text-xs bg-yellow-400 text-yellow-900 px-1.5 py-0.5 rounded-full font-bold"},"\u2605"),o(e)," (",i,")")})),React.createElement("div",{className:"space-y-4"},(()=>{let e=Xt[Et];return React.createElement("div",{className:"space-y-4"},React.createElement("h2",{className:"text-2xl font-bold text-gray-800 border-b-2 border-gray-300 pb-2"},e.title),e.hasSubsections?Object.entries(e.subsections).map(([a,i])=>React.createElement("div",{key:a,className:"space-y-4"},React.createElement("h3",{className:"text-xl font-semibold text-gray-700 ml-4"},i.title),i.trials.map((s,o)=>React.createElement(xi,{key:o,trial:s,category:Et})))):e.trials.map((a,i)=>React.createElement(xi,{key:i,trial:a,category:Et})))})())))),React.createElement("div",{className:"fixed right-4 fab-offset fab-layer"},jt&&React.createElement("div",{className:"absolute bottom-16 right-0 w-72 bg-white rounded-lg shadow-2xl border-2 border-red-300 overflow-hidden animate-fadeIn"},React.createElement("div",{className:"bg-gradient-to-r from-red-600 to-rose-500 text-white px-4 py-2 font-bold flex items-center justify-between"},React.createElement("span",{className:"flex items-center gap-2"},React.createElement("i",{"data-lucide":"phone-call",className:"w-4 h-4"}),"Quick Contacts"),React.createElement("button",{onClick:()=>zt(!1),className:"hover:bg-red-700 rounded p-1 transition-colors","aria-label":"Close contacts"},React.createElement("i",{"data-lucide":"x",className:"w-4 h-4"}))),React.createElement("div",{className:"divide-y divide-gray-100"},mo.map(e=>{let i=(e.phone||"").replace(/[^\d+]/g,""),s=i?`tel:${i.startsWith("+")?i:`+1${i}`}`:"#";return React.createElement("a",{key:e.id||e.label,href:s,className:"flex items-center gap-3 px-4 py-3 hover:bg-red-50 transition-colors",onClick:()=>zt(!1)},React.createElement("div",{className:"bg-red-100 rounded-full p-2"},React.createElement("i",{"data-lucide":"phone",className:"w-5 h-5 text-red-600"})),React.createElement("div",null,React.createElement("div",{className:"font-semibold text-gray-900 text-sm"},e.label||"Contact"),React.createElement("div",{className:"text-xs text-gray-500"},e.phone||"Add phone",e.note?` (${e.note})`:"")),React.createElement("i",{"data-lucide":"external-link",className:"w-4 h-4 text-gray-400 ml-auto"}))})),React.createElement("div",{className:"bg-gray-50 px-4 py-2 text-xs text-gray-500 text-center"},"Tap number to call directly")),React.createElement("button",{onClick:()=>zt(!jt),className:"w-14 h-14 rounded-full shadow-lg flex items-center justify-center transition-all duration-200 bg-gradient-to-br from-red-500 to-rose-600 hover:from-red-600 hover:to-rose-700 animate-pulse","aria-label":"Toggle emergency contacts","aria-expanded":jt,title:"Emergency Contacts"},React.createElement("i",{"data-lucide":"phone",className:"w-6 h-6 text-white"})),!jt&&React.createElement("div",{className:"absolute bottom-16 right-0 bg-gray-900 text-white text-xs py-1 px-2 rounded whitespace-nowrap opacity-0 hover:opacity-100 pointer-events-none transition-opacity hidden md:block"},"Quick Contacts")),React.createElement("div",{id:"mobile-bottom-nav",className:"md:hidden fixed bottom-0 left-0 right-0 bg-white border-t-2 border-gray-300 shadow-lg z-50 pb-safe"},React.createElement("div",{className:"flex flex-nowrap items-center gap-2 px-2 py-2 overflow-x-auto no-scrollbar"},co.map(e=>React.createElement("button",{key:e.id,onClick:()=>{Ne(e.id)},className:`flex flex-col items-center justify-center px-2 py-2 rounded-lg transition-all flex-shrink-0 ${Q===e.id?"text-blue-600 bg-blue-50":"text-gray-600"}`},React.createElement("i",{"data-lucide":e.icon,className:"w-6 h-6 mb-1"}),React.createElement("span",{className:"text-xs font-medium"},e.name))),Wa.length>0&&React.createElement("button",{onClick:()=>_t(!0),className:"flex flex-col items-center justify-center px-2 py-2 rounded-lg transition-all flex-shrink-0 text-gray-600"},React.createElement("i",{"data-lucide":"more-horizontal",className:"w-6 h-6 mb-1"}),React.createElement("span",{className:"text-xs font-medium"},"More")))),ls&&Wa.length>0&&React.createElement("div",{className:"md:hidden fixed inset-0 z-50 bg-black bg-opacity-40",onClick:()=>_t(!1)},React.createElement("div",{className:"absolute bottom-0 left-0 right-0 bg-white rounded-t-2xl p-4 space-y-2",onClick:e=>e.stopPropagation()},React.createElement("div",{className:"flex items-center justify-between mb-2"},React.createElement("h3",{className:"text-sm font-semibold text-gray-700 uppercase tracking-wide"},"More"),React.createElement("button",{onClick:()=>_t(!1),className:"text-gray-500"},React.createElement("i",{"data-lucide":"x",className:"w-5 h-5"}))),React.createElement("div",{className:"grid grid-cols-3 gap-3"},Wa.map(e=>React.createElement("button",{key:e.id,onClick:()=>{Ne(e.id),_t(!1)},className:`flex flex-col items-center justify-center px-2 py-2 rounded-lg transition-all ${Q===e.id?"bg-blue-50 text-blue-600":"text-gray-600"}`},React.createElement("i",{"data-lucide":e.icon,className:"w-6 h-6 mb-1"}),React.createElement("span",{className:"text-xs font-medium"},e.name)))))))},Fo=ReactDOM.createRoot(document.getElementById("root"));Fo.render(React.createElement(Vo,null));lucide.createIcons();})();
